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IC Internal conversion 
IR infrared spectroscopy 
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J coupling constant 
(spectroscopy) 
KSV Stern-Volmer-constant 
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 wavelength 
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LMCT ligand-to-metal 
charge-transfer 
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A. Introduction 
1. The Evolution of the Photoredox Catalysts in Organic Synthesis 
In 1886, Giacomo Ciamician and Paul Silber reported their observations of sunlight promoted 
transformations of quinone to hydroquinone and nitrobenzene to aniline, both in the presence 
of ethanol. The oxidation of alcohol to the corresponding aldehyde was identified as the 
reductant for the quinone and nitrobenzene.1 On the peak of the industrial revolution, driven 
by fossil fuels, the role of sunlight as an alternative energy source and reagent in chemical 
reactions was not strongly considered. However, in 1912 Giacomo Ciamician described his 
vision for the use of sunlight as the main energy source and reagent in organic synthesis thus 
making the mankind independent of ending fossil fuels such as coal.2 Indeed, in the 20th 
century, the increasing role of radical chemistry elevated the importance of the UV-light as a 
versatile tool for organic synthesis.3 However, the use of the high energy UV-light has several 
disadvantages. In general, the generation of high-energy UV-light requires specialized 
equipment, making the performance of the reactions more difficult, although recently this 
problem was solved by introduction of UV-LED. Moreover, the irradiation of organic molecules 
with high energy UV-light can, in the worst case, lead to an undesired bond cleavage and thus 
to the destruction of the organic compound before reacting in the desired way.4 To avoid these 
difficulties the use of low-energy visible light in combination with photocatalysts was discovered 
for many chemical transformations. Surprisingly, in addition to the mild reaction conditions, a 
variety of new synthetic pathways were enabled giving access to a broad range of new organic 
molecules.5 In the view of the increasing importance of sustainability and environmental 
friendliness for the modern society, the research field of visible-light photocatalysis moved 
strongly into the focus of chemists around the world. In recent years, a remarkable amount of 
visible-light promoted photoredox transformations, utilizing a broad selection of photocatalysts, 
have been presented. This synthetic progress is described in a large number of chemical 
reviews6 and development is still ongoing, resulting in a variety of publications every year. The 
success of visible-light mediated chemical transformations is strongly dependent on the 
employed photocatalyst and thus the generation of new catalytic systems is an important 
research field. Therefore, the requirements for the new photocatalysts are multifaceted.7 
Beside the photophysical properties and the efficiency in the desired transformation, other 
properties are gaining in importance. Considering resource depletion, sustainability and as a 
consequence thereof the price disparity, the employment of metal-free catalysts6f, complexes 
based on earth abundant metals6j or recyclable photocatalysts8 was extended in the recent 
years.  
In general, there are three groups of catalysts that are frequently used in photoredox catalysis 
induced by visible-light. An important group of visible light photocatalysts, commonly used 
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under blue light irradiation (455 nm), are complexes of ruthenium(II) and iridium(III) in 
combination with bipyridine, phenylpyridine and phenanthroline ligands. In 1978, Kellogg 
introduced [Ru(bpy)3]Cl2 as catalyst for the photoredox catalyzed reduction of sulfonium ions 
to the corresponding alkanes and thioethers in the presence of N-substituted 1,4-
dihydropyridines as the terminal reductant.6g, 9 Due to the promising photochemical properties 
and the good availability, these complexes were extensively explored in a broad range of 
organic transformations e.g. atom transfer radical addition (ATRA) reactions10, carbonyl 
reactions11, decarboxylations12 and more6a, 6c, 6g, 6k, 6l. 
 
Figure 1. Commonly used ruthenium- and iridium-based photocatalysts.  
In 1987, Sauvage et al.13 introduced [Cu(dap)2]+ (3a) as catalyst in the visible-light photoredox 
catalyzed dimerization reaction of 4-nitrobenzyl bromide, being the starting shot for the 
development of photoredox catalysts based on inexpensive earth-abundant metals such as 
copper, iron, chromium, molybdenum and more.6j  
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Figure 2. Commonly used photoredox catalysts based on earth-abundant metal centers. 
Especially the employment of copper-based catalysts delivered excellent results and often 
enabled new types of organic transformations. In particular the high efficiency in atom transfer 
radical addition (ATRA) reactions, initiated by activation of carbon-halogen or heteroatom-
halogen bonds established these catalysts as versatile tools in visible-light photoredox 
catalysis.14   
The last important group of photocatalysts are non-metal based organic dyes. With continuous 
exploration of radical reactions induced by visible-light irradiation the attempts towards 
prevention of metal-based catalysts and exchange of those by organic dyes gained in 
importance. The most established organic dyes in photochemistry are derivatives of 
fluorescein such as Eosin Y and Rose Bengal, rhodamines and acridinium-based organic 
catalysts also known as Fukuzumi-catalyst15. The latter is known to be an excellent oxidant, 
as was impressively demonstrated by Nicewicz group in the direct catalytic anti-Markovnikov 
hydroetherification of alkenols with alkene oxidation as mechanistic key step.6f, 16   
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Figure 3. Commonly used organic dyes for photoredox catalysis. 
 
2. Photophysics 
In general, the application of photocatalysts in organic transformations is based on the ability 
of metal complexes and organic dyes to interact after excitation with visible light in single-
electron-transfer (SET) processes or energy transfer reactions with organic molecules. The 
wavelengths of visible spectrum range from 380 to 740 nm. The high-energy UV-light is 
characterized by wavelength below 380 nm, while low-energy infrared light exhibits wavelength 
higher than 740 nm. The function of the photocatalyst as mediator, that can absorb visible light 
and utilize the energy for organic reactions is of great importance, because only a rather small 
selection of organic molecules is able to directly absorb the visible light. Therefore, the 
irradiation of the reaction mixture ideally results only in excitation of catalyst with no direct 
energy transfer to the substrate. Moreover, it is important that the reaction of the excited state 
of the catalyst and the substrate results in only small modifications of the catalyst structure, 
thus enabling the recovery of its original state by a second reaction on the electronic ground 
state.17 For this purpose it is crucial for the photocatalyst to be stable under irradiation with 
visible-light and only undergo reversible processes. The simplified analysis of the photophysics 
of the photocatalyst in the absence of the substrate is described by a Jablonsky diagram.17 
Therein, the transitions between different electronic states can occur either by absorption or 
emission of radiation or as radiationless transition. In Figure 4 the radiative transitions are 
described by straight lines, whereas the nonradiative transitions are shown as curly lines. The 
irradiation of the photocatalyst with visible-light leads to the absorption (hA) and the excitation 
of the photocatalyst from the ground state to the energetically higher excited state. For this 
process the energy of the photon must be high enough to reach the S1 stage and be in line 
with resonance condition. Since the relaxation from the higher excited states e.g. S2 occur very 
fast, the energy of S1 is the maximum that is available for the diffusion controlled 
photoreaction.17 Please notice that in the presented simplified diagram no vibrational levels are 
drawn and the internal conversion (IC) is shown as a summarized relaxation process. From 
the excited S1 level the photocatalyst can go through different routes. Beside the described 
internal conversion (IC), the direct emission of energetically poor light with longer wavelengths 
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from excited singlet state called fluorescence (hF) is possible. Moreover, the transition from 
one electronic state to another with a different spin multiplicity e.g. singlet state S1 to triplet 
state T1 is called inter system crossing (ISC). This type of transition is analogue to the internal 
conversion (IC) with additional spin factor which must be considered for the transition 
probability.17 From the excited triplet state T1 another inter system crossing (ISC) process is 
possible. Alternatively, the radiative transition from this triplet state to the ground state S0, 
called phosphorescence (hPh) can take place.        
 
Figure 4. Simplified Jablonsky diagram for a photoredox catalyst in the absence of substrate. 
For a successful photochemical transformation, the employed photocatalyst must be able to 
absorb light, which is energetically rich enough to reach the singlet state S1 and the lifetime of 
this excited state shall be long enough to enable the electron transfer or energy transfer 
between the catalyst and the substrate. Typical emission wavelengths of commonly used LEDs 
and other light sources are in the region of 400-700 nm. To ensure the generation of excited 
state catalyst by visible-light the UV-VIS-spectrum of the complex should be determined. In 
Table 1 the values for the excitation maximum and lifetime of the excited state are described 
for the commonly used photocatalysts. 
In general, the excitation maxima max for the ruthenium-, iridium-, copper-, and molybdenum-
based photocatalysts 1-5 are in the range of 375-454 nm (Table 1, entries 1-14). For the 
organic dyes 6-8 a slight shift of excitation maxima max towards longer wavelengths of 424-
550 nm can be observed (Table 1, entries 15-20). The lifetime analysis of the Ru- and Ir-based 
catalysts indicates that the variation of the electronic structure of the ligand leads to a 
significant change of lifetime values for the ruthenium-based catalysts 1a-1c (entries 1-3). 
[Ru(bpy)3]2+ (1a), fac-Ir(ppy)3 (2a) and [Ir(dF(CF3)ppy)2(dtbbpy)]+ (2c) show the longest excited 
state lifetimes in the range of more than 1 µs (entries 1, 5 and 7). The group of photocatalysts 
based on earth-abundant metals shows big differences in lifetime values (Table 1, entries 8-
14).  
Introduction 
6 
Table 1. Lifetime, excitation and emission values for selected photoredox catalysts.a 
Entry Photocatalyst 
Lifetime 
 [ns] 
Excitation 
max [nm] 
Emission 
max [nm] 
Ref. 
1 [Ru(bpy)3]2+ (1a) 1100 452 615 6a 
2 [Ru(bpz)3]2+ (1b) 740 443 591 6a 
3 [Ru(bpm)3]2+ (1c) 131b 454 639b 6a 
4 [Ru(phen)3]2+ (1d) 500 422 610c 6a 
5 fac-Ir(ppy)3 (2a) 1900 375 494d 6a 
6 [Ir(ppy)2(dtbbpy)]+ (2b) 557  581 6a 
7 [Ir(dF(CF3)ppy)2(dtbbpy)]+ (2c) 2300 380 470 6a 
8 [Cu(dap)2]+ (3a) 270/560e 437 670f 6a, 13-14 
9 [Cu(dmp)(DPEphos)]+ (3b) 14300 383 570 18 
11 [Cu(dpp)(binc)]+ (3c) 17000e 450f 560 14a 
12 [Cu(dpdmp)((PPh2)2 C2B9H10)] (3d) 1300 449f 602 19 
13 [Fe(bpy)3]2+ (4) 0.7   20 
14 [Mo(CNAr3NC)3] (5) 74g 420 617g 21 
15 Eosin Y (6b) 2.1 520  6f 
16 Rose Bengal (6c) 0.5 550  6f 
17 Rhodamine B (7a) 2.5 550  6f 
18 Rhodamine 6G (7b) 4.1 530  6f 
19 10-methyl-9-phenylacridinium (8b) 1.5 424  6f 
20 10-methyl-9-mesitylacridinium (8c) 6 425  6f 
aMeasurements were performed in acetonitrile at room temperature unless otherwise noted. 
bDetermined in propylene carbonate. cDetermined in aqueous solution. dDetermined in 
1:1 ethanol/methanol glass at 77 K. eDetermined in PMMA (poly(methyl methacrylate)). fDetermined in 
CH2Cl2. gDetermined in THF.  
 
In contrast to the commonly employed [Cu(dap)2]+ (3a) photocatalyst the copper-based 
complexes [Cu(dmp)(DPEphos)]+ (3b) and [Cu(dpp)(binc)]+ (3c) have very long excited state 
lifetimes of more than 14 µs. These values are more than six times higher compared to the 
long-lived excited state of [Ir(dF(CF3)ppy)2(dtbbpy)]+ (2c).  However, the broad application of 
[Cu(dap)2]+ (3a) in photoredox reactions indicates that the value of 270 ns is sufficient for the 
successful photoredox mediated transformations. The molybdenum-based photocatalyst 5 
introduced by Wenger et al. in 2016 demonstrated catalytic activity in rearrangement of acyl 
cyclopropane to 2,3-dihydrofuran21, although the lifetime of the excited state was only 74 ns. 
Surprisingly, the iron(II)-based complex [Fe(bpy)3]2+ (4) with 0.7 ns lifetime for the excited state 
showed excellent catalytic activity22. Even though this complex is a d6-analogue of the 
commonly employed [Ru(bpy)3]2+ (1a), the application of the iron-complex 4 in a variety of 
organic reactions is not possible so far. In general, the lifetime of the excited singlet state of 
the organic dyes is very short with values in the range of <1-45 ns6f. In contrast, the lifetimes 
for excited triplet states are in the range of microseconds to milliseconds. This difference in 
lifetimes is based on the fact that the T1→S0 transition is symmetry forbidden.6f  
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3. Interaction Between Photocatalyst and Substrate 
To understand the interaction process between the photocatalyst and the substrate, it is of 
great importance to analyze the molecular orbitals of the metal-based photocatalysts. For this 
purpose, the simplified molecular orbital diagrams for d6-complex fac-Ir(ppy)3 (2a) and for d10-
complexes [Cu(dap)2]Cl (3a) and [Cu(dpdmp)((PPh2)2 C2B9H10)] (3d) are shown in Figure 5 
and Figure 6. The octahedral complex fac-Ir(ppy)3 (2a) shows a low-spin configuration with six 
paired electrons in the t2g-orbitals.6g Under irradiation with visible-light the complex undergoes 
metal to ligand charge transfer (MLCT) in combination with inter system crossing to form the 
excited triplet state of the catalyst.  
 
Figure 5. Simplified molecular orbital depiction of octahedral low-spin d6-complex fac-Ir(ppy)3 (2a). 
In the presence of a substrate this species can run through two different processes. In the 
oxidative quenching the electron from the *-orbital can be transferred to the LUMO of the 
substrate resulting in the formation of a new SOMO. In contrast, the reductive quenching leads 
to an electron transfer from the substrate to the single occupied t2g-orbital of the complex, thus 
transforming the HOMO of the substrate into SOMO. The unique character of the d6-ruthenium- 
and iridium-based photocatalysts arise from the ability to act as both oxidant and reductant. In 
Figure 6 the simplified molecular orbital depiction of tetrahedral d10-complexes [Cu(dap)2]+ (3a) 
and [Cu(dpdmp)((PPh2)2 C2B9H10)] (3d) with completely occupied e- and t2-orbitals is shown. 
Similar to the d6-complexes (Figure 5), under irradiation with visible-light the complexes 
undergo metal to ligand charge transfer (MLCT) with subsequent inter system crossing (ISC) 
forming the excited triplet state species. The nature of the copper-based catalyst is responsible 
for the route the catalyst can run through in the presence of the substrate.  
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The well established [Cu(dap)2]+ (3a) is known to be a strong reductant applying the oxidative 
quenching. In this case the electron from the *-orbital can be transferred to the LUMO of the 
substrate to form the SOMO.  
 
Figure 6. Simplified molecular orbital depiction of tetrahedral d10-complexes [Cu(dap)2]+ (3a) and 
[Cu(dpdmp)((PPh2)2 C2B9H10)] (3d). 
Due to the low stability of the resulting Cu(0)-species, the reductive quenching cycle is not 
favored in the case of Cu-photocatalysts. However, in 2015 Chen and coworkers19 presented 
[Cu(dpdmp)((PPh2)2C2B9H10)] (3d) as copper catalyst for the reductive quenching. This 
complex has a zwitterionic character and a long-lived excited state, thus the reduction of the 
Cu(I)-center to Cu(0) is possible. The single electron transfer occurs from the HOMO of the 
substrate to the t2-orbital of the complex forming the Cu(0)-species. Compared to the 
ruthenium- and iridium-based catalysts that show the ability to go through both reductive and 
oxidative quenching cycle, the copper-based catalysts are limited to only one type of 
quenching.    
The concept of metal to ligand charge transfer (MLCT) described in Figure 5 and Figure 6 is 
commonly used in the literature for the explanation of catalytic photoredox properties. In 
contrast, the ligand to metal charge transfer (LMCT) process is less common in photocatalysis 
and enables the oxidation of the employed nucleophiles by metal coordination. Recently, 
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Reiser and Rehbein confirmed this concept in the efficient oxo-azidation of alkenes employing 
[Cu(dap)2]+ (3a) and Cu(II)-catalyst [Cu(dap)Cl2] (3e) (Scheme 1).23 The proposed mechanism 
includes the formation of Cu(II)-species 12 which can be transformed into the dimer 13 by a 
ligand exchange. The irradiation of the latter with green light results in visible light initiated 
homolysis (VLIH) and thus in the formation of azide radical which can be trapped by alkene 9 
followed by oxygen to give radical 16. The VLIH concept is based on the UV-light promoted 
homolysis of CuCl2 to CuCl and Cl-radical described by Kochi.24 The catalytic cycle is closed 
by recombination of the radical 16 with complex 14 providing Cu(II)-species 17 and after 
elimination the final product 11. The unique coordination properties of copper are discussed in 
section “Electron Transfer vs. Coordination” (vide infra).  
 
Scheme 1. Cu(II)-catalysis as example for ligand to metal charge transfer (LMCT). 
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4. Quenching and Quantum Yield 
Beside the analysis of excited state lifetimes, extintions, emissions and molecular orbitals of 
the employed catalysts, it is also important to analyze the spectroscopic characteristics of the 
reaction mixture. For example, some substrates or intermediates can undergo a quenching 
process of the excited state of the catalyst, thus blocking the desired reaction pathway. Hence, 
for determination of this property it is mandatory to measure a Stern-Volmer-plot, which 
describes the quenching of the excited species dependent on the concentration of the potential 
quencher. In 1919, Otto Stern and Max Volmer presented their work in this field and described 
the physical principles for their observations.25 The general fluorescence quenching process, 
also called Stern-Volmer-relationship, is described by equation 1 with F0 as fluorescence 
measured in the absence of a potential quencher, F as fluorescence determined in the 
presence of a quenching species with concentration [Q] and KSV as Stern-Volmer-constant.  
 𝐹0
𝐹
= 1 + 𝐾𝑆𝑉 ∙ [𝑄] (eq. 1) 
The transformation of equation 1 to equation 2 provides the direct linear proportionality 
between the measured fluorescence F and the concentration of the quencher [Q] simplifying 
graphical analysis for practical use (Figure 7 right side).  
 𝐹0
𝐹
− 1 = 𝐾𝑆𝑉 ∙ [𝑄] (eq. 2) 
 
 
Figure 7. Fluorescence spectrum with different quencher concentrations [Q] (left side) and exemplary 
Stern-Volmer-plot (right side). 
In general, there are two different ways of the quenching process. The direct collision of the 
fluorescent species in the excited state and the quencher is called dynamic quenching and 
leads to the radiationless energy transfer from excited singlet state compound A* to the 
quencher Q (eq. 3). In this process the lifetime  of the excited singlet state of compound A is 
dependent on the concentration of the quencher Q. The longer the lifetime  of the excited 
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state, the higher is the propability for the collision of the quencher Q with the excited state 
fluorophore A*. 
dynamic quenching: 
 
𝐹0
𝐹
=
𝜏0
𝜏
= 1 + 𝐾𝑑 ∙ [𝑄] (eq. 3) 
Alternatively, the quencher Q can recombine with the fluorophore A forming a new non-
fluorescent species AQ (eq. 4). This process is called static quenching and is based on the law 
of mass action for complex formation (eq. 5). The quenching of the fluorescence evolves from 
the blocking of the potential fluorophore A. Therefore, in this quenching process the lifetime  
of the fluorophore stays untouched resulting in equation 6.  
static quenching:  
𝐹0
𝐹
= 1 + 𝐾𝑠 ∙ [𝑄] (eq. 4) 
 
The simplified equation 1 is only valid when two assumptions are fulfilled. The quencher should 
have approximately identical access to all molecules of the investigated fluorophore, and it 
should undergo only one type of quenching (cf. eq. 3 and eq. 4). Otherwise the Stern-Volmer-
equation must be adjusted.26                                                                                                                   
Furthermore, the efficiency of photoabsorption can give important indications about the nature 
of the radical process in the investigated reaction. The quantum yield  describes the 
relationship between the amount of product molecules formed after time tx and the number of 
absorbed photons in this time (eq. 7). 
𝛷 =
𝑁𝑝𝑟𝑜𝑑
𝑁𝑝ℎ,𝑎𝑏𝑠
=
𝑚𝑜𝑙𝑒𝑠 𝑜𝑓 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑓𝑜𝑟𝑚𝑒𝑑 𝑎𝑓𝑡𝑒𝑟 𝑡𝑥 
𝑚𝑜𝑙𝑒𝑠 𝑜𝑓 𝑝ℎ𝑜𝑡𝑜𝑛𝑠 𝑎𝑏𝑠𝑜𝑟𝑏𝑒𝑑 𝑖𝑛 𝑡𝑥
 (eq. 7) 
In general, there are two established mechanistic pathways for the photoredox mediated 
transformations based on initial single electron transfer (Scheme 2).27 Herein, the oxidative 
quenching cycle of the photocatalyst Pc is used for the demonstration of the different 
mechanistic routes, however, similar considerations can also be made for the reductive 
quenching cycle. Both routes start with excitation of the photocatalyst Pc by visible-light 
irradiation forming the excited state species Pc* which can transfer a single electron to the 
substrate providing the substrate radical anion and oxidized photocatalyst Pc+. Subsequent 
transformation of the substrate radical anion to the product radical anion enables two 
conclusive reactions. In the closed catalytic cycle (depicted in red) Pc+ can act as oxidant, thus 
forming the desired product and regenerating the photocatalyst Pc. In contrast, in the chain 
with 𝐾𝑠 =
[𝐴𝑄]
[𝐴][𝑄]
 (eq. 5) and 
𝜏0
𝜏
= 1 (eq. 6) 
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propagation cycle (depicted in blue) the product radical anion reacts with another substrate 
molecule to form the final product and regenerate substrate radical anion. 
 
Scheme 2. General mechanistic pathways for the oxidative quenching cycle. 
In the case of closed catalytic cycle, the quantum yield can reach at most the value  = 1 
indicating that every photon absorbed by the photocatalyst leads to the formation of one 
product molecule. The occurence of events induced by photon uptake which do not lead to the 
formation of product molecules e.g. phosphorescence, internal conversion, or back electron 
transfer would only decrease the quantum yield to the values 0 <  < 1.27 In contrast, the chain 
propagation processes are characterized by the ability of one absorbed photon to generate 
more than one product molecule  > 1. Therefore, processes with  << 1 include catalytic 
cycle character, whereas transformations with  >> 1 indicate the presence of radical chain 
propagation. However, the interpretations based on quantum yield should be taken into 
account very carefully, because the analysis based on yield of the desired product and 
absorbed photons does not consider the participation of other photomediated transformations 
that do not lead to the desired product.27   
5. Photoredox Properties 
Based on the described photophysics the general catalytic cycles for different photoredox 
catalysts can be described as follows. In Scheme 3 the oxidative and reductive quenching 
cycles for fac-Ir(ppy)3 (2a) as representative for the ruthenium- and iridium-based d6-
complexes are described. The irradiation with blue LED leads to the generation of the 
photoexcited Ir(III)*-species  with enormously changed redox properties. The photoexcited fac-
IrIII(ppy)3* is a stronger oxidant (E1/2III*/II = +0.31 V vs. the saturated calomel electrode (SCE)) 
and reductant (E1/2IV/III* = -1.73 V vs. SCE) as compared to its respective electronic ground 
state with values of E1/2III/II = -2.19 V vs. SCE and E1/2IV/III = +0.77 V vs. SCE, respectively. 
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Therefore, this catalyst can interact with both types of substrates, oxidants and reductants. 
The strong reduction potentials are sufficient for a broad range of organic substrates.28 In 
general, the reduction potential of the reduced ruthenium- and iridium-based photocatalysts in 
the reductive quenching cycle is significantly higher compared to the reduction potential of the 
photoexcited catalyst. Therefore, this group of photoredox catalysts is often used in the 
presence of sacrificial electron donors e.g. amines. However, also the substrate derived 
reduction of the catalyst is well known in the literature.6a  
 
Scheme 3. Oxidative and reductive quenching cycles described for fac-Ir(ppy)3 (2a) photocatalyst with 
A as electron acceptor and D as electron donor. 
In contrast, the photoredox character of the copper-based photocatalysts differs from the one 
described for ruthenium- and iridium-based complexes. In general, the photoexcited Cu(I)*-
species can exclusively undergo one quenching cycle. Compared to its ground state (E1/2II/I = 
+0.62 V vs. SCE) the excited state of the [Cu(dap)2]+ (3a) is known to be a strong reductant 
(E1/2II/I* = -1.43 V vs. SCE) employing oxidative quenching cycle under irradiation with green 
LED (h = 530 nm). However, the reductive quenching cycle is not accessible for this catalyst 
due to the low stability of the proposed Cu(0)-species. In order to get access to the reductive 
quenching cycle, the modification of the employed ligands is necessary. In 2015 Chen and 
coworkers19 introduced the photostable zwitterionic copper-based photocatalyst 
[Cu(dpdmp)((PPh2)2 C2B9H10)] (3d) which can run through the reductive quenching cycle with 
Cu(0)-intermediate. This catalyst demonstrates strong oxidation potential (E1/20/I* = +1.01 V vs. 
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SCE) and strong reduction potential (E1/20/I = -1.39 V/ -1.60 V vs. SCE). Therefore, the main 
difference between the copper-based photocatalysts and the d6-configurated ruthenium- and 
iridium-catalysts is the ability of the latter to run through both the oxidative and reductive 
quenching cycles, whereas the former are limited to only one of them.  
 
Scheme 4. Oxidative and reductive quenching cycles described for copper-based photocatalysts 3a 
and 3d with A as electron acceptor and D as electron donor.  
In general, the photoredox properties of organic dyes are like those of the metal-based 
photocatalysts including oxidative and reductive quenching cycles. In literature, the redox 
potentials of both singlet and triplet states of the photoexcited organic dyes are known.6f 
However, in experimental studies it was shown that the overall efficiency for the formation of 
free ions was higher when electron transfer occurred from triplet state of the catalyst. 
Therefore, for reactions whose efficiencies suffer from back electron transfer, the triplet excited 
state of the employed photoredox catalyst is the most important one.6f In contrast to metal-
based photocatalysts, organic dyes often have acid-base character. The control of the pH-
value is very important due to the formation of inactive catalyst-species which are not able to 
perform the desired transformations. In Scheme 5 the four major structures of Eosin Y are 
shown. Beside the photocatalytically inactive H2-spiro-structure 18 and the ring-opened H2-
structure 6b, the active mono- and dianionic forms HNa-6b and Na2-6b are known. The 
photophysical properties of the long-wavelength absorbing xanthene core can be influenced 
by the negative charge of the conjugated substituents. Under acidic conditions the spirocyclic 
form is present which has no connected xanthenoid -system, thus enabling the absorption of 
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the visible light and the subsequent electron transfer.6i In literature, also disactivation of the 
reduced Na2-6b species by full 2e-/2H+ reduction is described.29 Therefore, in order to ensure 
the optimal pH-value and thus the formation of the photoactive catalyst structure it is often 
crucial to use additives such as amines. Similar observations are also described for other 
representatives of the organic dyes e.g. rhodamines.6f 
 
Scheme 5. pH-dependance6i and photoredox properties of Eosin Y (6b). 
The determination of the redox potentials in the ground state occurs by electrochemical 
measurement such as cyclovoltammetry. Therefore, the solution of the catalyst or investigated 
compound is analyzed in the presence of electrodes e.g. standard calomel electrode (SCE). 
The variation of the potential at the electrode leads to oxidation or reduction of the investigated 
compound and in this way gives the information about the redox potential. The estimation of 
the excited state redox potentials can then be obtained by calculation using excited state 
energy to correct the measured ground state redox potentials.30 In Table 2 the redox potentials 
of commonly employed photocatalysts are described. The group of ruthenium- and iridium-
based photocatalysts demonstrate excellent redox potentials for both the reductive and 
oxidative quenching cycles. For example, fac-Ir(ppy)3 (2a) is the strongest representative of 
this group with the reduction potentials of -1.73 V and -2.19 V. The commonly employed 
copper-based photocatalyst [Cu(dap)2]+ (3a) is a strong reductant  (E1/2II/I*= -1.43 V) for a wide 
range of organic molecules.28 However, in 2015 Reiser et al. introduced [Cu(dpp)(binc)]+ (3c) 
with longer excited state lifetime and stronger reduction potential of -1.88 V employing 
oxidative quenching cycle.14a Therefore, in reaction with no sacrificial substrates this catalyst 
is a stronger reductant compared to fac-Ir(ppy)3 (2a). In 2016, Wenger group demonstrated the 
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catalytic applicability of the molybdenum-based [Mo(CNAr3NC)3] (5) catalyst with very strong 
excited state reduction potential of -2.0 V to -2.2 V for the Mo(0)/Mo(I) pair.21 In the case of 
organic dyes the reduction potentials shown in Table 2 refer to the excited triplet states of the 
catalyst due to the photophysical properties described in literature6f.  
 
Table 2. Redox potentials for selected photoredox catalysts.a 
Entry 
 
Photocatalyst 
E1/2 
(Pc+/Pc*) 
[V] 
E1/2 
(Pc +/ Pc) 
[V] 
E1/2 
(Pc */ Pc -) 
[V] 
E1/2 
(Pc / Pc -) 
[V] 
Ref 
1  [Ru(bpy)3]2+ (1a) -0.81 +1.29 +0.77 -1.33 6a 
2  [Ru(bpz)3]2+ (1b) -0.26 +1.86 +1.45 -0.80 6a 
3  [Ru(bpm)3]2+ (1c) -0.21 +1.69 +0.99 -0.91 6a 
4  [Ru(phen)3]2+ (1d) -0.87 +1.26 +0.82 -1.36 6a 
5  fac-Ir(ppy)3 (2a) -1.73 +0.77 +0.31 -2.19 6a 
6  [Ir(ppy)2(dtbbpy)]+ (2b) -0.96 +1.21 +0.66 -1.51 6a 
7 
 [Ir(dF(CF3)ppy)2(dtbbpy)]+ 
(2c) 
-0.89 +1.69 +1.21 -1.37 6a 
8  [Cu(dap)2]+ (3a) -1.43 +0.62   13 
9  [Cu(dpp)(binc)]+ (3c) -1.88 +0.69   14a 
10 
 [Cu(dpdmp)((PPh2)2 
C2B9H10)] (3d) 
  +1.01 
-1.39,  
-1.60 
19 
11 
 
[Mo(CNAr3NC)3] (5) 
-2.0/ 
-2.2 
-0.02  
 21, 
31 
12  Eosin Y (6b) -1.15b -1.08b +0.83b +0.76b 6f 
13  Rose Bengal (6c) -0.96b -0.99b +0.81b +0.84b 6f 
14  Rhodamine B (7a) -0.89b -0.96b +0.84b +0.91b 6f 
15  Rhodamine 6G (7b) -0.86 -1.14 +0.95 +1.23 6f 
16 
 10-methyl-9-phenyl- 
acridinium (8b) 
 -0.54c  
 
6f 
17 
 10-methyl-9-mesityl- 
acridinium (8c) 
 -0.49 +1.45 
 
6f 
aAll potentials are given in volts versus the saturated calomel electrode (SCE). Pc: Photocatalyst. 
Measurements were performed in acetonitrile at room temperature unless otherwise noted. bIn MeOH. 
cIn DMF. 
6. Electron Transfer vs. Coordination 
As already mentioned in the description of reductive quenching cycle, amines can be used as 
sacrificial electron donors or hydrogen-atom sources. Beside this group of molecules, there is 
a range of further additives like ascorbic acid, Hantzsch ester, 2,6-lutidine and more which can 
help the photocatalyst to go through the desired transformation. Interestingly, the employment 
of the photocatalysts is also compatible with the use of chiral additives known from 
organocatalysis.6g This type of cocatalysis was impressively demonstrated e.g. by utilization of 
chiral amines for the in situ generation of enamines and subsequent radical addition derived 
from single electron transfer of the employed photocatalyst.32 Moreover, the use of chiral 
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Brønsted acid as cocatalyst in photocatalysis was demonstrated to give rise to high 
enantiomeric excess in the reaction of imines with N-arylamines.33 In this type of cocatalysis 
the function of the photocatalyst was limited to the single-electron-transfer with no direct 
coordination of the substrate. In contrast, Meggers group presented an efficient transformation 
of ,-unsaturated carbonyl compounds with allyl sulfones to the corresponding chiral products 
employing chiral metal-based lewis acid and Hantzsch ester as single-electron donor.34 In this 
reaction the role of the metal-complex was the coordination to the substrate and in this way 
the formation of the better electron acceptor. Moreover, iridium-based photocatalyst ()-Ir-S 
19 was introduced by Meggers et al. to act as both, chiral lewis acid and the photoredox 
catalyst as single-electron-donor (Scheme 6).35  
 
Scheme 6. Chiral iridium-based photocatalyst for enantioselective functionalization of carbonyl 
compounds.35 
In contrast, to the ruthenium- and iridium-based photocatalysts which are known to utilize 
closed catalytic cycle or radical chain propagations (see quantum yield section), copper can 
run through additional mechanistic pathways. The formation of Cu(III)-intermediates by 
oxidative additions or direct radical trapping processes demonstrate the unique character of 
copper-based photocatalysts and enables a variety of organic transformations. In several 
reports14a, 14b, 14d, 14e, 36, the employed copper catalysts are shown to go through inner-sphere 
mechanisms including trapping of the intermediary radical to form Cu(III)-species or direct 
ligand transfer process. In Scheme 7 these two mechanistic pathways are described 
exemplary for an atom transfer radical addition (ATRA) reaction.    
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Scheme 7. Alternative mechanistic pathways for copper-based photocatalysts. 
The variation of the ligands employed in established photocatalysts (vide supra) enables the 
synthesis of bimetallic complexes as was shown by Inagaki and coworkers.37 The described 
complex 33 contained photoactive ruthenium center and catalytically active palladium center 
and demonstrated excellent results in the dimerization of -methylstyrene (34) suppressing 
the polymerization of the substrate. Interestingly when mononuclear catalysts Ru(bpy)32+ 
and [(bpy)PdMe(MeCN)]+ were used separately or as mixture no reaction was observed. 
 
Scheme 8. Dimerization of -methylstyrene (34)37d and Suzuki-Miyaura coupling38 by bimetallic Ru/Pd-
complexes 33 and 39. 
In 2014, Mori et al. demonstrated visible-light enhanced Suzuki-Miyaura coupling reaction 
employing bimetallic complex 39.38 In this reaction the electron transfer from photoexcited 
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Ru(II)-catalyst to palladium center forms the catalytically active and electron rich Pd(0)-
species, thus facilitating the oxidative addition of the aryl halide 36.   
The variety of the photochemical transformations performed with different types of catalyst 
indicate the unique character of each photocatalyst. Therefore, in recent years the research 
interest focused on the combination of different types of catalysts.6h The two selected examples 
are presented in Scheme 9 and Scheme 10.  
 
Scheme 9. Iridium(III)-copper(I)-cocatalysis.39 
In 2018, the photomediated decarboxylative trifluoromethylation of aliphatic carboxylic acids 
was presented by MacMillan group (Scheme 9).39 In this reaction the employed iridium 
photocatalyst acts as the electron acceptor, whereas the use of copper cocatalyst is important 
for activation of carboxylic acid, thus facilitating the oxidative decarboxylation and coordination 
of the coupling partners CF3 and R. After insertion into Togni´s reagent 41 and ligand exchange 
the Cu(II)-species 44 is formed coordinating CF3 and carboxylic acid. Photochemical oxidation 
of Cu(II) to Cu(III)-species 45 with subsequent extrusion of CO2 results in formation of Cu(III)-
complex 46, which is finally reduced by iridium photocatalyst and undergoes reductive 
elimination to give the desired product 42 and to regenerate the Cu(II)-species 43. In the same 
year, MacMillan et al. employed Ir(III)-Ni(0) catalyst pair for the difluoromethylation of aryl 
bromides (Scheme 10).40 In the similar way as described for the Ir(III)-Cu(I)-cocatalysis, in this 
reaction the function of nickel metal was the coordination of the coupling partners. For this 
purpose, the Ni(0)-complex undergoes oxidative addition to the aryl bromide 48 forming a 
Ni(II)-species 53. The bromide ligand is exchanged by difluoromethyl-radical 52 forming Ni(III)-
intermediate 54 which can subsequently form the final product 50 and release Ni(I)-complex 
55.  
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Scheme 10. Iridium-nickel(0)-cocatalysis.40 
The latter is finally reduced by iridium-photocatalyst regenerating the Ni(0)-species. The 
regeneration of the photocatalyst occurs through oxidation of bromide to the bromine radical 
which is necessary for the formation of the difluoromethyl radical 52. 
7. Sustainability 
Compared to the metal-free organic dyes and photocatalysts based on earth-abundant metals, 
the main disadvantage of the iridium- and ruthenium-based photocatalysts is the relatively high 
price of the employed metals. This argument is often used when the same reactions can be 
also carried out by alternative catalysts. In order to increase the attractivity of the very efficient 
and variable Ir-/Ru-catalysts many efforts have been made to develop recyclable variations of 
the commonly used photocatalysts. The main strategies are based on the use of immobilized 
photocatalysts in ionic liquids41 or by introduction of polymer chains8 and alkyl chains42 at the 
ligands of the catalysts. Bergbreiter et al. developed a recyclable version of [Ru(bpy)3]2+ by 
installation of polyisobutylene (PIB) chains at the bpy-ligand. The separation and reuse of the 
synthesized catalyst was achieved by selective precipitation of the polymeric reaction product 
from the reaction solution.8a, 43 Moreover, a recyclable version of [Ir(ppy)2(dtbbpy)]+ 
photocatalyst was obtained by Kobayashi et al. through the use of the well-established 
suspension polymerization method leading to the iridium catalyst 2e with partially cross-linked 
acrylates. The separation and reuse of the catalyst was ensured by simple filtration from the 
reaction solution.8b In 2016, Reiser and coworkers presented a recyclable version of the 
strongly reducing fac-Ir(ppy)3 catalyst by installation of polyisobutylene (PIB) chain at one of 
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the ligands. The homogeneous catalyst allows automatic recovery and reuse in flow systems, 
employing thermomorphic or biphasic solvent systems.8c 
 
 
Figure 8. Recyclable representatives of the commonly used photocatalysts.8  
8. Aim of the work 
In the present work four types of transformations were investigated employing different 
photocatalysts. The differences in the catalytic properties of the catalysts were of great 
importance for the unique characters of the investigated reactions. In chapter B, fac-Ir(ppy)3 
was used in the visible-light mediated deoxygenation of activated amino alcohols to give 
polysubstituted N-heterocycles, which are important key structures in natural products and 
pharmaceuticals. In chapter C the performance of Cu(II)-based photocatalyst [Cu(dap)Cl2] in 
the iodoperfluoroalkylation reaction of alkenes was compared with the established 
[Cu(dap)2]Cl and plausible mechanistic pathways for copper based catalysts were 
investigated. In chapter D the copper-based catalysts were used for the transformation of 
sulfonylchlorides and unactivated alkenes into chlorosulfonylation products in the presence of 
inorganic base underlining the unique character of copper catalysis. Finally, in chapter E the 
visible-light induced reaction between commercially available allyl bromides and sulfonyl 
chlorides provided allylsulfones, being an important substrate class in organic synthesis.   
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B. Synthesis of Heterocycles via Photoredox 
Mediated Deoxygenation Reaction‡  
1. Introduction 
In 1975 Derek H. R. Barton and Stuart W. McCombie presented an efficient method for 
deoxygenation of alcohols by reductive carbon-oxygen bond cleavage.1 For this purpose, the 
strong C-O bond was activated by the formation of thiocarbonyl derivatives (Scheme 1). First, 
the hydroxy group of the substrate 1 is deprotonated by a strong base such as NaH and the 
resulting alkoxide 2 reacts with CS2 to form anion 3. The subsequent methylation of this anion 
yields the desired xanthate 4, which has a high reactivity to tributylstannyl radical 6 formed by 
reaction of tributyltin hydride (5) with AIBN. The formation of the very stable S-Sn bond acts 
as the driving force for this reaction.2 The resulting radical 7 undergoes a homolytical bond 
cleavage of the C-O bond providing alkyl radical 9 and tributyltin xanthate 8. In the final step, 
radical 9 abstracts a hydrogen atom from tributyltin hydride (5) to give the desired 
deoxygenation product 10 and regenerating a new tributylstannyl radical 6. 
 
Scheme 1. General mechanism of Barton-McCombie deoxygenation reaction.3 
Although the Barton-McCombie reaction is an efficient strategy for deoxygenating a wide range 
of alcohols, it contains some difficulties and limitations. For example, the preparation of S-
methyl dithiocarbonates requires prolonged use of alkali, so stable O-benzyl ethers must be 
used as protecting groups.4  
‡This chapter is partially based on Rackl, D.; Kais, V.; Lutsker, E.; Reiser; O. Eur. J. Org. Chem. 2017, 
2017 (15), 2130-2138. 
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In 1981 Robins et al.5 solved this problem by employment of O-phenoxythiocarbonyl 
derivatives, which make sensitive natural products such as ribonucleosides and 2’-
deoxynucleosides suitable substrates for the desired reaction.  
In addition, the employment of tributylstannane (5) has the disadvantage that stoichiometric 
amounts of toxic tin-containing byproducts are formed.6 For this reason, Stephenson et al.7 
presented in 2013 a deoxygenation protocol for alcohols by in situ conversion into alkyl iodides 
with subsequent hydrodeiodination reaction (Scheme 2). The alcohol 11 was converted by 
Garegg-Samuelsson reaction in a batch setup into the corresponding iodine 12 and then by 
photoredox catalyzed reaction in microflow setup to give the deoxygenated product 13 in high 
yields. This one-pot deoxygenation protocol is applicable to primary and secondary alcohols, 
can be carried out under mild reaction conditions and tolerates the presence of a wide range 
of functional groups.3, 7  
 
Scheme 2. Deoxygenation reaction by Stephenson et al.7 via transformation of alcohol into alkylhalide 
and subsequent dehalogenation. 
However, the protocol presented by Stephenson and coworkers7 also has the disadvantage, 
that an equimolar amount of halides is produced as a byproduct during the transformation. In 
order to solve this problem D. Rackl and V. Kais from the Reiser group developed efficient 
protocols for the halide free deoxygenation of primary and secondary alcohols (Scheme 3).8  
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Scheme 3. Deoxygenation strategies developed in Reiser group.8b, 8c 
Both synthetic pathways are based on the activation of the hydroxy group by esterification to 
the corresponding ethyl oxalates 16 or 3,5-bis(trifluoromethyl)benzoates 17. Afterwards, the 
intermediary radical 18 is formed by the homolytical C-O bond cleavage under photoredox 
conditions using an iridium photocatalyst. Fanally, radical 18 abstracts a hydrogen atom from 
a hydrogen source such as DMF or amine as sacrificial electron donor to form the 
deoxygenated product 19.  
In 1976 J. E. Baldwin9 published a series of rules allowing to predict the possibility of ring 
closure reactions. The ease of the ring formations depends on the stereochemical 
requirements of the transition states for the various ring constructions. First, the size of the 
formed ring is described by a numerical prefix. Secondly, the shortened terms tet (tetrahedral 
= sp3), trig (trigonal = sp2) or dig (diagonal = sp) describe the hybridization of the atom attacked 
by a nucleophile, radical or electrophile. Finally, the way in which the bonds are broken during 
the cyclization process is described by the terms endocyclic (endo = a bond is broken within 
the newly formed ring) or exocyclic (exo = a bond is broken outside the newly formed ring). 
The trend shows that sp2-hybridized carbons can undergo 3- to 7-exo-trig-reactions and 6- to 
7-endo-trig processes, while 3- to 5-endo-trig reactions are disfavored. In contrast, 5- to 7-exo-
dig-reactions and 3- to 7-endo-dig processes are favored for the sp-hybridized carbons, 
whereas 3- and 4-exo-dig-reactions are disfavored (Scheme 4).9 In the present work especially 
5-/6-exo-trig and 5-exo-dig ring closures are particularly important.  
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Scheme 4. Baldwin´s rule for 5-hexenyl- (21), 5-hexynyl- (24) and 6-heptenyl radicals (27). 
Further investigations on the use of the intermediary radical 18 led to the idea of intramolecular 
trapping via a radical 5-exo-trig cyclization reaction. Therefore, commercially available tartaric 
acid ester was monoallylated and O-activated providing substrates 29 and 30. Under 
photoredox conditions in the presence of the strong reductant fac-Ir(ppy)3, substituted 
tetrahydrofuran 31 was formed in good yields (Scheme 5).   
 
Scheme 5. Photomediated cyclization via deoxygenation reaction.10 
Based on the results from dissertations of D. Rackl8b and V. Kais8c, first efforts towards 
photomediated synthesis of substituted N-heterocycles were undertaken in my master thesis3. 
Thereby, the determination of the optimized reaction conditions and the successful synthesis 
of several pyrrolidines, mostly derived from ethyl oxalates, were performed. Tetrahydrofurans11 
and pyrrolidines12 are important key structures in numerous natural products and 
pharmaceuticals. Many synthetic strategies towards these important classes of heterocycles 
have been reported, among them visible light photocatalysis.13 In contrast to the reported 
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protocols, which include the ring closure by the formation of carbon-heteroatom bond, the 
synthesis of heterocycles by C-C bond formation has been achieved in the present work.10 The 
aim of this work was to investigate the substrate scope for the photomediated synthesis of 
polysubstituted pyrrolidines with a focus on the two activation groups ethyl oxalate 16 and 3,5-
bis(trifluoromethyl)benzoate 17. In addition, the extension of the developed protocol to the 
synthesis of further N-heterocycles was explored. 
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2. Synthesis of Substituted Pyrrolidines 
2.1. Preparation of Starting Materials 
The present study is linked to the results of my master thesis3. The focus of this project was 
on the synthesis of a broad substrate pool of ethyl oxalates as well as 3,5-
bis(trifluoromethyl)benzoates and their employment in the photoredox catalyzed cyclization 
reaction. In general, the target starting material should contain several properties: Besides the 
activated C-O bond next to a radical stabilizing group e.g. carbonyl, aryl or cyano8a, the 
molecule needs a double or triple bond, with an N-protected nitrogen as bridge between the 
two described parts in order to undergo a radical ring closure reaction (Scheme 6). The 
protection of the nitrogen is necessary due to the risks of oxidation of the lone pair and thus 
acting as a sacrificial electron donor for the catalyst. Such an oxidation process would lead to 
irreversible destruction of the starting material which would be incapable of performing the 
desired ring closure reaction. The employment of designed 1,2-amino alcohols 32 is required 
to obtain access to substituted pyrrolidines 33 via favored 5-exo-trig or 5-exo-dig reactions.  
 
Scheme 6. Proposed cyclization strategy. 
Due to the low stability of ethyl oxalyl esters and 3,5-bis(trifluoromethyl) benzoates under basic 
conditions necessary for N-alkylation and N-protection steps, O-activation is identified as the 
final synthetic step. The protection of nitrogen by an electron withdrawing group such as Boc- 
or Ac-group, leads to a strongly decreased nucleophilic character of the heteroatom making 
the subsequent alkylation of this atom more difficult. For this reason, the N-protection should 
be carried out after the allylation/propargylation step. In general, there are two feasible routes 
to the N-alkylated 1,2-amino alcohols 39 (Scheme 7). The synthetic pathway B is based on the 
ring opening reaction of epoxide 36 with alkylamine such as allylamine (40a) or propargylamine 
(40b), which leads in two steps to the anti-configurated product 39b, starting from commercially 
available alkenes.3, 14 This strategy is advantageous due to the small number of synthesis steps 
and allows the variation of the non-allylic part of the molecule (Scheme 6, blue part of 
compound 32). However, the limited number of commercially available substituted allylamines 
illustrates the disadvantage of this route. For this purpose, synthetic route A must be used 
starting from commercially available alkenes. After the formation of epoxide 36 followed by ring 
opening using sodium azide, the subsequent hydrogenation provides the 1,2-amino alcohol 
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37.3, 14a, 15 Next, the desired product 39a can be obtained under basic conditions in the 
presence of allyl bromide 38. This synthetic pathway enables the variation of the allylic part of 
the molecule (Scheme 6, green part of compound 32) due to the commercial and synthetic 
availability of substituted allyl bromides 38 (Scheme 7).  
 
Scheme 7. Synthetic routes towards alkylamino alcohols 39a and 39b starting from epoxide 36. 
First, literature known epoxide 36a was transformed into the 1,2-amino alcohol providing key 
compound 37a for the subsequent allylations reactions using synthetic route A (Scheme 8). 
The variation of the allylic part included the introduction of methyl groups at different positions 
of the alkene leading to alkylamino alcohols 39aa, 39ab and 39ac, as well as the introduction 
of sterically demanding cyclohexene moiety leading to compound 39ad. Moreover, the same 
allylation strategy was applied to the commercially available enantiopure 2-amino-1,3-diol 42 
resulting in product 43. All reaction showed moderate yields of 39-63% without significant 
sterical effect of additional groups at the alkene moiety. 
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Scheme 8. Allylation reaction of amino alcohols. 
Reagents and conditions: (a)14a mCPBA (1.5 equiv), CH2Cl2, reflux, 5 d, 88%; (b)15a NaN3 (1.4 equiv), 
NH4Cl (1.4 equiv), EtOH/H2O (3:11), reflux , 42 h, 51%; (c)15b Pd/C (10 wt%), H2 (1 atm), EtOH, rt, 24 h, 
99%; (d)3 alkyl bomide (38a-38e) (1.0-2.0 equiv), DBU (1.0-2.0 equiv), toluene, 60 °C , 96 h, 39%-63%.  
The ring opening reaction of various epoxides with allylamine 40a and propargylamine 40b 
provided a series of N-alkylated amino alcohols 39b (Table 1). In general, the equimolar 
amount of the corresponding alkylamine was used for epoxides containing ester moiety to 
avoid the formation of amides, while 2.0 equivalents of the alkylamine were used for other 
epoxides.  In the case of epoxide 36b, derived from commercially available ethyl (E)-but-2-
enoate, the reaction with allylamine (40a) provided the desired product 39ba only as minor 
diastereomer in 24% yield (Table 1, entry 1). The obtained major diastereomer 39ba´ was not 
a suitable substrate for the next synthetic steps as there was no radical stabilizing group next 
to the carbon containing the hydroxy group. The employment of epoxide 36a, which can be 
obtained from commercially available ethyl cinnamate (41), in combination with allylamine 
(40a) provided the desired product 39bb in 56% as a single diastereomer. The subsequent 
transesterification gave rise to isopropyl ester 39bc in 52% overall yield (entry 2). Switching 
allylamine (40a) to propargylamine (40b) resulted in comparable yields for the alkylation 
product 39bd (entry 3). According to the reported procedure14c compound 39be was 
synthesized in very good yield, but surprisingly the reaction of propargylamine (40b) with the 
same epoxide provided the desired alkylamino alcohol 39bf only in 27% yield (entries 4 and 
5). In contrast to entry 4 with high isolated yield, the reaction of the epoxide 36d derived from 
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trans-stilbene delivered the desired product 39bg in only 48% yield. To demonstrate the 
synthesis of 6-membered rings via 6-exo-dig cyclization reaction, but-3-yn-1-amine (40c) was 
used as alkylamine in combination with epoxide 36a, giving rise to the formation of product 
39bh in 46% yield (entry 7). The analysis of both the nucleophilicity of corresponding amines 
and sterical hindrance of the carbon backbone does not provide a clear explaination for the 
different yields. 
 
Table 1. Synthesis of alkylamino alcohols via epoxide ring opening reacion. 
 
Entry Epoxide Alkylamine Product 
1 
  
  
 36b (1.0 equiv) 40a (1.0 equiv) 39ba, 24% 39ba´, 32% 
2 
  
  
 36a (1.0 equiv) 40a (1.0 equiv) 39bb, 56% 39bc, 52%[a] 
3 
 
 
 
 36a (1.0 equiv) 40b (1.0 equiv)  39bd, 54%  
4 
  
 
 36c (1.0 equiv) 40a (2.0 equiv)  39be, 93%  
5 
  
 
 36c (1.0 equiv) 40b (2.0 equiv)  39bf, 27%  
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6 
  
 
 36d (1.0 equiv) 40a (2.0 equiv)  39bg, 48%  
7 
  
 
 36a (1.0 equiv) 40c (1.0 equiv)  39bh, 46%  
Reagents and conditions: epoxide (36a-36d) (1.0 equiv), alkyl amine (40) (1.0-2.0 equiv), EtOH, 80 °C, 
24 h, 24%-93%. [a]Product 39bc was obtained after acid catalyzed transesterification of compound 39bb 
in 93% yield.  
Next, the protection of the amine moiety was carried out employing the combination of Boc2O 
and triethylamine.3 To avoid double protection of the alkylamino alcohol, only a slight excess 
of di-tert-butyldicarbonat should be used (Scheme 9). For the compound 44a and the 
monoalkylated derivative 44b good yields of 65% and 74% were obtained. The introduction of 
an additional methyl group to the alkene moiety provided the Boc-protected product 44c in 
excellent yield. Surprisingly, switching the methyl group to the other carbon of the double bond 
resulted in strong decrease of the yield for the product 44d.  
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Scheme 9. Substrate scope of N-protected alkylamino alcohols. 
Reagents and conditions: alkylamino alcohol (39) (1.0 equiv), Boc2O (1.2 equiv), Et3N (1.2 equiv), 
CH2Cl2, rt, 20-90 h, 29%-97%. [a] The product was synthesized starting from substrate 43. [b]The product 
44m was obtained using Ac2O (2.1 equiv) and Et3N (2.2 equiv). 
This result can be explained by the steric interaction of the methyl group and the sterically 
demanding Boc-group. However, the low yield of the propargylated compound 44g cannot be 
explained by this argument. In further protection reactions, the desired products 44e, 44f, 44i 
and 44j were obtained in moderate to good yields, whereas the product 44h was formed in 
excellent yield of 97%. For the formation of product 44m acetic anhydride was used instead of 
Boc2O as a result of the obtained observations during the master thesis showing no product 
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formation with the sterically demanding Boc-group.3 Unfortunatelly, the protection reaction to 
the compounds 44k, 44l and 44n failed, resulting in very low conversion.  
As the final step of the synthesis, the strong C-O bond was activated by esterification to the 
appropriate ethyl oxalyl esters and 3,5-bis(trifluoromethyl) benzoates.  
 
Scheme 10. Substrate scope of ethyl oxalates 45. 
Reagents and conditions: alcohol 44 (1.0 equiv), ethyl 2-chloro-2-oxoacetate (15) (1.0-1.5 equiv), 
pyridine (1.0-1.5 equiv), CH2Cl2, 0 °C to rt, 20 h, 88%-100%. [a]The products were synthesized during 
the master thesis3. 
The esterification reactions employing ethyl 2-chloro-2-oxoacetate (15) in the presence of 
pyridine showed high yields for all substrates applying the method developed during my master 
thesis3 (Scheme 10). Similarly excellent results with very high yields in the range of 91-100% 
were obtained employing 3,5-bis(trifluoromethyl)benzoic anhydride (45) in the presence of 
N,N-diisopropylethylamine (Scheme 11). 
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Scheme 11. Substrate scope of 3,5-bis(trifluoromethyl)benzoates 47. 
Reagents and conditions: alcohol 44 (1.0 equiv), 3,5-bis(trifluoromethyl)benzoic anhydride (46) (1.2-
2.4 equiv), N,N-diisopropylethylamine (2.0-4.0 equiv), CH2Cl2, rt, 20 h, 91%-100%. [a]The product was 
synthesized during the master thesis3. 
 
2.2. Photomediated Deoxygenation Reactions 
The first attempt to synthesize pyrrolidine derivatives from ethyl oxalate activated N-allylated 
compounds was performed during my master thesis with substrate 45a.3 The reaction was 
carried out in a microflow reactor setup under irradiation with blue light and heating at 80 °C 
using the oxidative quenching cycle of fac-Ir(ppy)3 in DMF. Apart from the starting material 45a, 
photocatalyst and solvent no further additives were necessary. In contrast, the initial reaction 
with 3,5-bis(trifluoromethyl)benzoate 47m was carried out analogously to the procedure 
developed by D. Rackl8b. Employing a batch setup, the starting material 47m was converted 
in the presence of a sacrificial amine, water and MeCN as solvent at 80 °C using the reductive 
quenching cycle of photocatalyst. In specific, the main disadvantage of this pathway was the 
formation of the undesired deoxygenated acyclic side product 48m´ in 56% yield in addition to 
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the low yield of the desired cyclic product 48m. Interestingly, submitting the substrate 47m to 
the oxidative quenching cycle showed a yield of 50% of the desired pyrrolidine 48m and no 
formation of deoxygenated open-chain product 48m´. Optimizing the reaction conditions for 
the pyrrolidine synthesis revealed that the oxidative quenching cycle was the best choice for 
both activation groups. 3,5-Bis(trifluoromethyl)benzoate 47a and ethyl oxalate 45a showed 
comparable yields and diastereomeric ratios (Scheme 12). 
 
Scheme 12. Investigation of oxidative quenching cycle for substrates activated as 3,5-
bis(trifluoromethyl)benzoates. 
Reagents and conditions: a) reductive quenching cycle, substrate 47m (1.0 equiv), fac-Ir(ppy)3 
(1.0 mol%), Et3N (5.0 equiv), H2O (100.0 equiv), MeCN, 80 °C, 2 h. Reaction was carried out during the 
master thesis3. b) Oxidative quenching cycle, substrate 45a/47a or 47m (1.0 equiv), fac-Ir(ppy)3 
(1.0 mol%), DMF (0.1 M), 80 °C, 455 nm LED irradiation under N2 atmosphere in a microflow reactor 
setup 1.0 mL/h. 
With these results in hand, the photoredox catalyzed cyclization reactions with ethyl oxalates 
45 and 3,5-bis(trifluoromethyl)benzoates 47 were carried out using the oxidative quenching 
cycle of fac-Ir(ppy)3 in the microflow reactor, resulting in a series of substituted pyrrolidines 
(Table 2). The reduction potentials of other commonly used photocatalysts were not sufficient 
for the successful transformation.3 The yields and diastereomeric ratios are in general similar 
for both benzoates 47 or oxalates 45, and in the cases where diastereomers are formed, they 
can be easily separated. Using substrates 45a or 47a showed the formation of two separable 
diastereomers 48a and 48a’ in 61-62% yield (Table 2, entry 1).  
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Table 2. Photoredox catalyzed cyclization reaction towards substituted pyrrolidines. 
 
Entry Substrate Major product Minor product 
Total yield 
and dr [a] 
1 
   
47a: 61% 
(61:39) 
45a: 62% 
(63:37) 
 45a or 47a 48a (38-39%) 48a´ (23%)  
2 
   
47b: 52% 
(79:21) 
  45b: 47% 
(81:19) [b] 
 45b or 47b 48b (38-41%) 48b´ (9-11%)  
3 
   
47c: 53% 
(53:47) [b], [c] 
45c: 48% 
(52:48) [b], [c] 
 45c or 47c 48c (25-28%) 48c´ (23-25%)  
4 
 
 
/ 
47d: 45% 
(>99:01) 
45d: 38% 
(>99:01) [b] 
 45d or 47d 48d (38-45%)   
5 
   
47e: 66% 
(53:47) [d] 
45e: 66% 
(53:47) 
 45e or 47e 48e (35%) 48e´ (31%)  
6 
 
 
not isolated 
47f: 28% 
(68:32) [d] 
45f: 30% 
(73:27) [d] 
 45f or 47f 48f (18-21%)   
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/ 
47g: 45% 
(>99:01) 
45g: 47% 
(>99:01) 
 45g or 47g 48g (45-47%)   
8 
 
 
/ 
47h: 40% 
(>99:01) 
45h: 41% 
(>99:01) 
 45h or 47h 48h (38-39%)   
9 
  
not isolated 
47i: 70% 
(62:38) [e] 
45i: 64% 
(60:40) [e] 
 45i or 47i 48i (33-37%)   
10 
   
47j: 59% 
(57:43) 
45j: 59% 
(57:43) 
 45j or 47j 48j (34%) 48j´ (25%)  
11 
  
not isolated 
47m: 50% 
(74:26) [e] 
 
 47m 48m   
Reagents and conditions: 3,5-bis(trifluoromethyl) benzoate ester 47 or oxalate ester 45 (0.4 - 1.0 mmol), 
fac-Ir(ppy)3 (1.0 mol%), and DMF (0.1 M) at 80 °C under 455 nm LED irradiation under N2 atmosphere 
in a flow setup (flow rate 0.30-1.0 mL/h, 10-33 h); [a]isolated yield; [b]synthesized during master thesis3. 
[c]After hydrogenation, initial alkane/alkene ratio 23:77 for 47c, 15:85 for 45c. [d]Flowrate of 0.15 mL/h. 
[e]dr determined by 1H NMR integration, unseparable diastereomers.  
The introduction of an additional methyl group in γ-position of the allyl system had a significant 
effect on yield and diastereoselectivity (entries 2 and 3). The diastereomeric ratio of products 
48b and 48b´ rised up to 81:19, while the yield of benzoate 47b dropped from 61% to 52% 
and of oxalate 45b3 from 62% to 47% (entry 2). The introduction of an additional methyl group 
in γ-position did not lead to any further reduction of reaction yield with loss of stereo control at 
the iso-propyl bearing stereocenter (entry 3). The photoredox catalyzed transformation gave 
rise to larger amounts of the alkenes, which were subsequently hydrogenated with H2 and 
Pd/C to give rise to the desired products 48c and 48c´ in 48-53% yield. Methyl substitution in 
β-position in 45d3 and 47d gave pyrrolidine 48d with moderate yield, but excellent diastereo-
meric induction (entry 4). Only slightly higher yield and low diastereoselectivity were obtained 
when the aryl group in 1-position was replaced by a methyl group (entry 5). Employing 
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substrates 45f3 or 47f, synthesized from commercially available, enantiopure (1S,2S)-2-amino-
1-(4-nitrophenyl)propane-1,3-diol (42), gave rise to low yields of 28-30% and slightly higher 
diastereoselectivity (entry 6). An additional purification step via column chromatography was 
necessary to isolate the major diastereomer 48f. Moreover, 5-exo-dig cyclization reaction of 
substrates 45g and 47g gave rise to corresponding pyrrolidine 48g in 45-47% yield and 
excellent diastereoselectivity (entry 7). The comparison of this result with entry 1 shows clearly 
that exchange of the allylic moiety for a propargyl group leads to a reduction in yield but to an 
increase in diastereoselectivity. The introduction of hydrogen for a phenyl group, which 
reduces the steric bulk of the substrate, showed comparable yield and control of 
stereochemistry (entry 8) whereas a higher yield was obtained with allylic moiety (entry 9). 
However, in this case low diastereoselectivity was observed with hardly separable 
diastereomers. The comparison of sterically more demanding isopropyl ester (entry 10) and 
ethyl ester (entry 1) showed similar yields and diastereomeric ratios. Moreover, as already 
shown in Scheme 7, employing substrate 47m with an additional phenyl group instead of ester 
had only a moderate effect on diastereoselectivity and allowed to obtain 48m in 50% yield 
(entry 11).  
2.3. Mechanistic Studies 
The spectroscopic analysis of the successful cyclization process was performed with the 2D-
NMR experiment TOCSY (Figure 1). The colored spin systems (blue and green) are isolated 
in the starting material but combined after cyclization reaction (red: breaking bond in substrate, 
new formed bond in cyclization product). The evidence for the resulting cyclization is provided 
by correlation signals of each proton of the spin system to the other protons of the same spin 
system.3 Moreover 2D-NMR experiment NOESY was used to determine the absolute 
configuration of synthesized pyrrolidines (for details see Experimental Part).  
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Figure 1. TOCSY analysis as evidence for successful ring closure.3 
The proposed mechanism for both deoxygenation protocols starts with a single electron uptake 
from the photoexcited Ir3+* species thus activating the strong C-O bond for homolytical 
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cleavage leading to a carbon-centered radical 50 (Scheme 13). This radical can undergo either   
5-exo-trig or 5-exo-dig cyclization to give the desired pyrrolidine radical 52, or it can be trapped 
by hydrogen atom abstraction, leading to undesired simple deoxygenation (not depicted) as 
occured when reductive quenching cycle was used (Scheme 12).3 This undesired reduction 
process is facilitated when strong sacrificial electron donors such as Et3N or 
iPr2NEt are 
present. In the final step, the thus formed primary radical 52 undergoes a hydrogen trapping 
from DMF to form the final pyrrolidine 48. There are two plausible ways to regenerate the 
photocatalyst: on the one hand the electron uptake from the dehydrogenated DMF radical 54 
takes place with the formation of DMF cation 55, on the other hand in the case of ethyl oxalates 
the cleaved ester 57 can be oxidized to radical 58 and finally decompose to CO2, CO and 
EtOH.10, 16b-d  
 
Scheme 13. Proposed mechanism for a visible light mediated deoxygenated cyclization reaction.10   
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The hydrogen abstraction from the solvent was verified by V. Kais with a deuteration 
experiment using DMF-d7 as solvent providing the monodeuteration of the product at the 
terminal methyl group.8c 
For all obtained pyrrolidines, including various diastereomers (Table 2), the relative 
stereochemistry between C1 and C2 was trans. This result is very interesting due to the fact, 
that during the photoredox catalyzed C-O bond cleavage the intermediary radical is located on 
the C2 position thus destroying the stereocenter. In general, the formation of two new 
stereocenters can result in generation of four diastereomers. It is obvious, that the fixed 
stereocenter on the C1 carbon controls the stereochemistry on the adjacent C2 carbon and 
thus only allows the formation of two diastereomers. For a deeper understanding of this 
process, especially of the obtained major products and diastereomeric ratios, it is helpful to 
analyze the cyclization step. For this purpose, the results of cyclization reactions with different 
steric bulk groups at γ-position of allyl group were analyzed (Table 1, entries 1-3, oxalate 
results). The low diastereoselectivity does not allow to develop a universal explaination for the 
obtained results, but the present analysis serves as a basis for a plausible mechanistic 
approach. As shown in Figure 2, there are two plausible conformations of the carbon-centered 
radical that lead to the cyclization product. The concept is based on the discussion of 
analogous radical cyclizations to cyclopentanes.17 The more stable chair conformation 60 
leads to the formation of cis-product 48a, 48b or 48c´ if the 1,3-diaxial strain can be avoided 
where applicable. This is possible for substrates without a methyl group and with one methyl 
group at γ-position. Further increase of steric bulk at this position by introduction of an 
additional methyl group leads to a strong 1,3-diaxial strain, thus making the less stable boat 
conformation favorable giving rise to all-trans products 48a´, 48b´ or 48c.  
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Figure 2. Analysis of cyclization step forming two diastereomers.10 
 
2.4. Synthesis of Enantiopure Pyrrolidines  
The method presented here leads to epimers with respect to the stereocenter that forms when 
cyclization into a prochiral allyl group takes place. The enantioselective synthesis of starting 
materials enables access to enantiopure pyrrolidines. For this purpose, Sharpless 
Aminohydroxylation18 reaction of isopropyl cinnamate (63)19 derived from cinnamic acid (62) 
by an acid catalyzed esterification reaction was carried out forming the desired N-acetylated 
syn-1,2-amino alcohol 64 in 83% yield (Scheme 14). Under acidic reaction conditions 
compound 64 was deprotected and transesterificated to give syn-1,2-amino alcohol 65 in 62% 
yield.18 Submission of this compound to the standard allylation protocol (vide supra) delivered 
syn-1,2-allylamino alcohol 66 in 55% yield. Surprisingly, the Boc-protection step failed, thus 
disabling to continue the synthesis towards enantiopure pyrrolidines 48a and 48a´.  
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Scheme 14. Synthesis of enantiopure pyrrolidines via asymmetric Sharpless Aminohydroxylation 
reaction. 
Reagents and conditions: (a)19 isopropanol, HCl (cat.), reflux, 12 h, 75%; (b)18 (DHQD)2PHAL 
(5.0 mol%), K2[OsO2(OH)4] (4.0 mol%), CH3CONHBr (1.1 equiv), LiOH (1.0 equiv), tBuOH/H2O (1.5:1), 
0 °C, 4 h, 83%; (c)18 HCl (10%), H2O, reflux, 24 h; H2SO4 (cat.), EtOH, cyclohexane, reflux, 24 h, 62%; 
(d) Allyl bromide (38e) (1.1. equiv), Et3N (1.1 equiv), rt, 48 h, 55%; (e) Boc2O (1.2 equiv), Et3N (1.2 equiv), 
CH2Cl2, rt, 48 h, complex reaction mixture. 
A plausible explaination for this result can be the intramolecular attack of the free hydroxy 
group on the newly formed carbamate, which leads to a complex reaction mixture. In contrast 
to the presented racemic synthesis with anti-configuration, Sharpless Aminohydroxylation only 
forms syn-amino alcohols. To solve this problem a new strategy with asymmetric Shi-
Epoxidation was applied (Scheme 15).20 In the first step epoxide 36a was formed in 59% yield 
and 93% ee. After the ring-opening reaction with allylamine and Boc-protection step compound 
44a was obtained in a moderate yield. Finally, this compound was esterified to form ethyl 
oxalate 45a in 93% yield. The standard photocyclization protocol derived the two separable 
diastereomers 48a and 48a´ in 60% overall yield and diastereomeric ratio of 62:38. Chiral 
HPLC analysis of epoxide 36a and pyrrolidines 48a and 48a´ confirmed similar enantiomeric 
excesses of 93-94% (for details see Experimental Part). In this way enantiomerically and 
diastereomerically pure pyrrolidines with biologically relevant core structures, e.g. - and -
prolines, can be easily prepared. To demonstrate the formation of deprotected -prolines, 
racemic pyrrolidine 48a´ was treated with hydrochloric acid to give unprotected product 69 in 
excellent yield. 
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Scheme 15. Strategy towards enantiopure substituted β-proline derivatives including the photoredox 
catalyzed cyclization reaction as the key step.10 
Reagents and conditions: (a)20a Shi-catalyst (0.3 equiv), Na2(EDTA) (4x10-5M), Bu4NHSO4 (0.06 equiv), 
oxone (5.0 equiv), NaHCO3 (15.5 equiv), CH3CN/H2O, 0 °C to rt, 24 h, 59%; (b)14c allylamine (1.0 equiv), 
EtOH, reflux , 24 h, 58%; (c) Boc2O (1.2 equiv), Et3N (1.2 equiv), CH2Cl2, rt, 24 h, 54%; (d) ethyl oxalyl 
chloride (1.5 equiv), pyridine (1.5 equiv), CH2Cl2, 0 °C to rt, 20 h, 93%; (e) fac-Ir(ppy)3 (1.0 mol%), LED 
(455 nm), DMF, 80 °C, 1.0 mL/h, 60%; (f) HCl (6.0 M), rt, 24 h, 97%. 
 
3. Amino Acids as Starting Materials for the Photomediated 
Pyrrolidine Synthesis 
Amino acids are commercially available and accessible compounds that can be obtained as 
enantiopure starting materials in high quality and quantity. Based on the efficient 
transformation of corresponding ethyl oxalates and 3,5-bis(trifluoromethyl)benzoates to 
substituted pyrrolidines, the next idea was to synthesize starting materials derived from amino 
acids and thus enabling the enantioselective product formation (Scheme 16, top part). The 
study began with the ester of the achiral amino acid glycine 70a due to the smallest possible 
complications resulting from steric bulk and functional group tolerance during the synthesis 
(Scheme 16, bottom part). First, following common literature procedure21 the substrate 70a 
reacted with phenyl Grignard reagent to form amino alcohol 72 in 28% yield. The amino moiety 
was then alkylated with allyl bromide to form compound 73 in 58% yield followed by Boc-
protection to give alcohol 74 in 90% yield. The esterification step failed for both activating 
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groups resulting in a very low conversion of the starting material. Prolongation of the reaction 
time nor increase in temperature gave rise to the desired products. This result can be traced 
back to the steric bulk of the tertiary alcohol 74, which disables the esterification to the 
corresponding ester.  
 
 
Scheme 16. Synthesis of starting material for photoredox mediated deoxygenation starting from amino 
acids. 
Reagents and conditions: (a)21 PhMgBr (6.0 equiv), THF, reflux, 24 h, 28%; (b) allyl bromide (1.5 equiv), 
DBU (1.5 equiv), toluene, 60 °C, 48 h, 58%; (c) Boc2O (1.2 equiv), Et3N (1.2 equiv), CH2Cl2, rt, 72 h, 
90%; (d) ethyl oxalyl chloride (15) (3.6 equiv), pyridine (3.6 equiv), CH2Cl2, 4 °C to rt, 48 h; (e) 
((CF3)2Bz)2O (46) (1.2 equiv), DIPEA (2.0 equiv), CH2Cl2, rt, 72 h. 
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4. Photomediated Synthesis of Bicyclic Compounds 
As a consequence of the successful photoredox catalyzed synthesis of substituted 
pyrrolidines, a number of different bicyclic compounds such as tetrahydroquinolines22, 
tetrahydroisoquinolines22, chromanes and indolines were selected to be synthesized with the 
here developed cyclization protocol (Scheme 17). The tetrahydroquinoline23 key structure 79, 
tetrahydroisoquinoline24 skeleton 83, chromane25 and indoline cores 80 and 84 can be found 
in various drugs and natural products, e.g. viratmycin26, tubocurarine27, nomifensine28, 
diclofensine29, tocopherol30 or silodosin31.  
 
Scheme 17. Planned bicyclic compounds. 
Starting from commercially available ethyl anthranilate (85) the allylation product 86 was 
synthesized according to the procedure described in literature (Scheme 18).32 After reduction 
with LiAlH4 and Boc-protection step33, benzylic alcohol 88 was obtained in excellent yield. Both 
ethyl oxalate and 3,5-bis(trifluoromethyl)benzoate were used as activating groups to form 
compounds 89 and 90 as starting materials for the desired photoredox catalyzed cyclization 
reaction. The photoreaction was carried out in a microreactor setup under irradiation with blue 
light and heating at 80 °C using the oxidative quenching cycle of photocatalyst. Apart from the 
starting material 89 or 90, solvent DMF and fac-Ir(ppy)3 as photocatalyst no other additives 
were required. For both activating groups moderate yields of 37-38% were obtained for the 6-
exo-trig product 91. The relatively low yield can be caused by an unfavorable geometry of the 
generated radical during the cyclization process.  
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Scheme 18. Synthetic pathway towards monosubstituted 1,2,3,4-tetrahydroquinoline 91. 
Reagents and conditions: (a)32 allyl bromide (0.5 equiv), DMF, 0 °C to 40 °C, 20 h, 99%; (b) LiAlH4 
(4.0 equiv), THF, 0 °C to rt, 2 h, 99%; (c)33 Boc2O (1.5 equiv), EtOH, 50 °C, 16 h, 95%; (d) ethyl oxalyl 
chloride (15) (2.0 equiv), pyridine (2.0 equiv), CH2Cl2, 0 °C to rt, 20 h, 97%; (e) 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (1.2 equiv), N,N-diisopropylethylamine (2.0 equiv), CH2Cl2, rt, 
4 h, 98%;  (f) fac-Ir(ppy)3 (1.0 mol%), 455 nm, DMF, 80 °C, 0.15-0.30 mL/h, 37-38%.  
The proposed mechanism for this reaction is based on the previously described mechanism 
for the pyrrolidine formation (vide supra, Scheme 13). After single electron transfer from 
photoexcited Ir3+* species and subsequent dissociation of corresponding ester the benzylic 
radical 93 is formed which can undergo the more favorable 6-exo-trig cyclization reaction to 
form primary N-heterocyclic radical 94. Finally, after trapping with DMF as hydrogen source 
the desired 1,2,3,4-tetrahydroquinoline 91 can be formed. The regeneration of the catalyst is 
described in Scheme 13.  
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Scheme 19. Proposed mechanism for a visible light mediated deoxygenative cyclization reaction 
towards corresponding tetrahydroquinoline 91.  
The investigations of the steric effect on the cyclization process included the variation of the 
protecting group and the increase of the steric bulk of the benzylic alcohol. For this purpose, 
benzylic alcohol 87 was subjected to several N-protection reactions (Scheme 20). Acetylation 
of substrate 87 by acetyl chloride delivered compound 95 in 67% yield followed by a 
quantitative synthesis of the corresponding ethyl oxalate 97. In contrast the reaction of 
substrate 87 with acetic anhydride yielded in double acetylation product 96. 
 
Scheme 20. Variation of protecting groups in substrates for tetrahydroquinoline synthesis. 
Reagents and conditions: (a) AcCl (1.0 equiv), NaHCO3 (1.2 equiv), CH2Cl2, 0 °C to rt, 16 h, 67%; (a´) 
Ac2O (1.5 equiv), Et2O, 0 °C to rt, 18 h, 66%; (b) ethyl oxalyl chloride (2.0 equiv), pyridine (2.0 equiv), 
CH2Cl2 , 0 °C to rt, 20 h, 100%; (c) fac-Ir(ppy)3 (1.0 mol%), 455 nm, DMF, 80 °C, 0.30 mL/h, 27%; (d)  
CH3I (1.1 equiv), K2CO3 (1.5 equiv), DMF, rt, 20 h, 75%; (e) ethyl oxalyl chloride (2.0 equiv), pyridine 
(2.0 equiv), CH2Cl2 , 0 °C to rt, 20 h, 99%; (f) fac-Ir(ppy)3 (1.0 mol%), 455 nm, DMF, 80 °C, 0.30 mL/h, 
complex reaction mixture; (g) TsCl (1.0 equiv), Et3N (1.0 equiv), CH2Cl2, rt, 48 h, no reaction; (h) FmocCl 
(1.0 equiv), Et3N (1.0 equiv), CH2Cl2, rt, 48 h, complex reaction mixture. 
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Submission of this substrate 97, containing a less sterically demanding protecting group, to 
photoredox catalyzed deoxygenation reaction provided N-heterocycle 98 in 27% yield. The 
methylation of nitrogen provided the alkylated alcohol 99 in 75% yield and after esterification 
step the desired ethyl oxalate 100 in quantitative yield. The subsequent photoreaction led to 
the formation of complex reaction mixture. In this case, the absence of electron withdrawing 
group on the nitrogen acting as a sacrificial electron donor may be the reason for the 
unsuccessful reaction. Interestingly, the two small protecting groups acetyl and methyl could 
not improve the formation of the desired tetrahydroquinoline. Furthermore, the reaction of allyl 
amino alcohol 87 with TsCl showed no reaction and the use of the Fmoc protecting group 
resulted in the formation of a complex reaction mixture.   
The variation of the benzylic alcohol position was carried out by reaction of methyl benzoate 
86 and phenyl Grignard reagent to form alcohol 104 in 85% yield (Scheme 21). This 
transformation should facilitate the formation of the highly stable benzylic radical in the 
photoreaction. However, the subsequent Boc-protection step failed, even if the reaction 
conditions were varied, showing very low conversion of the starting material. For this reason, 
it was not possible to perform the desired reaction to product 106. 
 
Scheme 21. Variation of steric bulk at benzylic alcohol position. 
Reagents and conditions: (a) PhMgBr (3.2 equiv), THF, 0 °C to rt, 2 h, 85%; (b) Boc2O (1.2 equiv), Et3N 
(1.2-2.4 equiv), EtOH, 40-60 °C, 24-72 h, no reaction. 
 
Next, the starting material for the formation of chromane 111 was synthesized (Scheme 22). 
The synthetic route began with the allylation reaction of commercially available methyl 
salicylate (107) to form compound 108 in 90% yield.34 The subsequent reduction to the 
corresponding benzyl alcohol 109 and esterification with ethyl oxalyl chloride (15) gave the 
desired starting material 110 in high yield. However, the photomediated transformation to 
substituted chromane 111 failed resulting in the formation of a complex reaction mixture. Due 
to the unsuccessful transformation of the simplest O-substrate 110 no further variations of this 
substrate type were carried out. 
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Scheme 22. Synthesis of 3,4-dihydrochromene 111. 
Reagents and conditions: (a)34 allyl bromide (1.3 equiv), K2CO3 (2.0 equiv), DMF, rt, 24 h, 90%; (b) 
LiAlH4 (4.0 equiv), THF, 0 °C to rt, 2 h, 89%; (c) ethyl oxalyl chloride (2.0 equiv), pyridine (2.0 equiv), 
CH2Cl2, 0 °C to rt, 20 h, 95%; (d) fac-Ir(ppy)3 (1.0 mol%), 455 nm, DMF, 80 °C, 0.30 mL/h, complex 
reaction mixture. 
 
In 2015 the MacMillan group35 presented a protocol for photoredox mediated methylation of 
several N-heterocycles e.g. quinolines and pyridines with methanol as alkylating agent 
(Scheme 23, top part). In this procedure [Ir(ppy)2(dtbbpy)](PF6) was used as photocatalyst, 
ethyl 2-mercaptopropanoate (106) and TsOH as additives, and the reaction was carried out in 
DMSO at room temperature. Methanol as alkylation agent was added in hundredfold excess. 
The proposed reaction mechanism describes the formation of α-oxy methyl radical that adds 
to the protonated electrondeficient heteroarene in a Minisci-type pathway to afford the aminyl 
radical cation. After deprotonation of acidic α-C-H bond with subsequent water dissociation, 
the desired alkylated product is formed.35 The previously synthesized benzyl alcohol 88 was 
subjected to the reaction conditions employed by MacMillan due to the idea that formation of 
α-oxy radical should be easier facilitated compared to methanol in benzylic position. The 
formation of this radical can then lead to a cyclization reaction forming product 115 (Scheme 
23, Reaction a) and cyclization reaction by addition to the additive quinoline (116) (Scheme 
23, Reaction b). However, both photocatalytic transformations resulted in complex reaction 
mixtures with no sign of the proposed products 115 and 116. A conceivable reason can be, 
that in contrast to methanol benzyl alcohol 88 was not used in a large excess, which is 
necessary to form the high concentration of the α-oxo radical to perform the alkylation process.  
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Scheme 23. Application of protocol by MacMillan35 for deoxygenation of benzylic alcohol 88. 
Reagents and conditions: (a) benzyl alcohol 88 (1.0 equiv), Ir(ppy)2(dtbbpy)(PF6) (1.0 mol%), TsOH 
(2.0 equiv), ethyl 2-mercaptopropanoate (112) (5.0 mol%), DMSO, rt, 20 h, complex reaction mixture; 
(b) benzyl alcohol 88 (1.0 equiv), Ir(ppy)2(dtbbpy)(PF6) (1.0 mol%), TsOH (2.0 equiv), isoquinoline (113) 
(1.0 equiv), ethyl 2-mercaptopropanoate (112) (5.0 mol%), DMSO, rt, 20 h, complex reaction mixture. 
 
Based on the insignificant success in the synthesis of the bicyclic compounds a new strategy 
towards N-containing polycycles was developed. Starting from the previously introduced 
epoxide 36a (vide supra) the amino alcohol 117 was obtained in 70% yield using 4-
methoxybenzylamine as nucleophile for the epoxide ring-opening reaction as depicted in 
Scheme 24.  
 
Scheme 24. Synthesis of starting material for photoredox catalyzed formation of 1,2,3,4-
tetrahydroisoquinoline. 
Reagents and conditions: (a) p-methoxybenzylamine (1.0 equiv), EtOH, reflux, 24 h, 70%. (b) Boc2O 
(1.2 equiv), Et3N (1.2 equiv), CH2Cl2, rt, 72 h, no reaction; (c) Boc2O (1.2 equiv), Et3N (1.2 equiv), DMAP 
(10 mol%), CH2Cl2, rt, 72 h, complex reaction mixture; (d) Boc2O (1.2 equiv), EtOH, 60 °C, 48 h, 55%; 
(e) ethyl oxalyl chloride (1.5 equiv), pyridine (1.5 equiv), CH2Cl2 , 0 °C → rt, 20 h, 99%. 
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The protection of the amine moiety proved to be a demanding synthetic step: First the reaction 
was carried out using established conditions described in the synthesis of pyrrolidines 
(Scheme 9). These conditions led to a complete reisolation of the starting material. The 
addition of DMAP for a strong activation of the Boc-group resulted in the formation of a complex 
reaction mixture. Finally, the desired Boc-protected product 118 was obtained in 55% yield 
using Boc2O in ethanol at 60 °C. The subsequent reaction of compound 118 with ethyl oxalyl 
chloride (15) resulted in the formation of substrate 119 in 99% yield. Analogously, starting from 
the epoxide 36a the reaction with 4-methoxyaniline provided the amino alcohol 120 in 
quantitative yield (Scheme 25). Again, the protection step turned out to be a challenge.  
 
Scheme 25. Synthesis of starting material for photoredox catalyzed formation of indoline. 
Reagents and conditions: (a) p-methoxyaniline (1.0 equiv), EtOH, reflux, 24 h, 79%; (b) Boc2O 
(1.2 equiv), Et3N (1.2 equiv), CH2Cl2, rt, 72 h, no reaction; (c) Boc2O (1.2 equiv), Et3N (1.2 equiv), DMAP 
(2 mol%), CH2Cl2, rt, 72 h, 98%; (d) Boc2O (1.2 equiv), EtOH, 60 °C, 48 h, no reaction; (e) AcCl 
(2.0 equiv), Et3N (2.0 equiv), CH2Cl2, 0 °C to rt, 24 h, 33%; (f) ethyl oxalyl chloride (1.2 equiv), pyridine 
(1.2 equiv), CH2Cl2, 4 °C to rt, 20 h, 47%; (g) ethyl oxalyl chloride (2.4 equiv), pyridine (2.4 equiv), 
CH2Cl2, 4 °C to rt, 20 h, 96%. 
No conversion of the starting material was observed when carrying out the reaction under the 
established conditions described in the synthesis of pyrrolidines (Scheme 9). In contrast, the 
addition of DMAP resulted in the formation of the Boc-protected product 121 in 98% yield. 
Analysis of the product by 2D-NMR spectroscopy envisioned that the Boc-group was located 
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at oxygen and not at nitrogen. The reaction of the substrate 120 with Boc2O in ethanol at 60 °C 
showed no significant conversion. Changing the sterically demanding Boc-group to the smaller 
acetyl protecting group gave rise to O-Ac product 122 in 33% yield. Based on these results the 
protection step was skipped and a direct activation of the amino alcohol 120 was performed. 
Interestingly, when 1.2 equivalents of ethyl oxalalyl chloride (15) were used no full conversion 
and 47% of the product 123 with ethyl oxalyl groups at oxygen and nitrogen were obtained. 
Increasing the amount of ethyl oxalyl chloride (15) to 2.4 equivalents resulted in full conversion 
and 96% yield of the compound 123. The application of the photomediated deoxygenation 
protocol to the synthesized substrates 119 and 123 in both cases provided the formation of 
complex reaction mixtures (Scheme 26). Due to the challenging synthetic transformations and 
low chance of success for the variation of the substrates the synthesis towards substituted 
bicycles was stopped at this point.  
 
Scheme 26. Attempts towards tetrahydroisoquinoline 124 and indoline 125. 
 
5. Synthesis of Substituted Lactames 
The 5-membered lactames such as 2-pyrrolidones36 are important key structures in a variety 
of pharmaceutical drugs e.g. Cotinine37, Doxapram38 and Piracetam39. As demonstrated for the 
substituted pyrrolidines, the protoredox catalyzed cyclization reaction opens the door to new 
derivatives of substituted heterocycles which are not accessible by convential synthetic 
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strategies. The starting material 126 for the initial reaction was synthesized from literature 
known amino alcohol 37a14a, 15. Subsequent esterification with ethyl oxalyl chloride (15) 
resulted in the formation of substrate 127 in high yield. However, the photomediated 
deoxygenation reaction failed, leading to a complex reaction mixture (Scheme 27). 
 
Scheme 27. Synthetic pathway towards substituted lactames via photoredox mediated deoxygenation. 
Reagents and conditions: (a) acroylchloride (1.1 equiv), CH2Cl2, 0 °C to rt, 72 h, 50%; (b) ethyl oxalyl 
chloride (1.1 equiv), pyridine (1.1 equiv), CH2Cl2, 4 °C to rt, 20 h, 95%; (c) fac-Ir(ppy)3  
(1.0 mol%), DMF, 455 nm, 80 °C, 0.3 mL/h, complex reaction mixture. 
Another strategy for the synthesis of starting material for the cyclization reaction is shown in 
Scheme 28. The amidation reaction of ethyl lactate (129) with allylamine (40a) gave rise to 
allyl amido alcohol 130 in 80% yield.40 Afterwards, ester formation provided 3,5-
bis(trifluoromethyl)benzoate 131 and ethyl oxalate 131´ in excellent yields. 
 
Scheme 28. Synthetic pathway towards substituted lactames via photoredox mediated deoxygenation. 
Reagents and conditions: (a)40 allylamine (40a) (1.3 equiv), reflux, 72 h, 80%; (b) ((CF3)2Bz)2O (46) 
(1.2 equiv), DIPEA (2.0 equiv), CH2Cl2, rt, 72 h, 97 %; (c) ethyl oxalyl chloride (1.2 equiv), pyridine 
(1.2 equiv), CH2Cl2, 4 °C to rt, 20 h, 99%. 
Both starting materials were then subjected to the photoredox catalyzed process (Table 3). 
The standard reaction conditions for the photoinduced cyclization reaction did not lead to the 
successful reaction resulting in low conversion and only formation of complex reaction mixtures 
(Table 3, entries 1 and 4). The low conversion of the here employed substrate 131´ is surprising 
due to the similar redox potential (ERed = -1.81 V vs SCE in DMF) compared to the starting 
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material 45a (ERed = -1.76 V vs SCE in DMF) being successfully transformed into the 
corresponding pyrrolidines 48a and 48a´ (Table 2, entry 1). Lowering the flow rate of the 
microflow setup from 0.3 mL/h to 0.1 mL/h resulted in no significant change of the conversion 
and showed no product formation (Table 3, entries 2 and 5). In order to ensure the rotational 
freedom for all bonds of the substrates the reaction temperature was increased from 80 °C to 
120 °C (Table 3, entries 3 and 6). Again, no significant change of conversion was achieved, 
and the desired cyclization product was not detected. In all reactions, only starting materials 
and complex reaction mixtures were obtained.  
Table 3. Variation of reaction parameters for lactame synthesis. 
 
Entry R T [°C] 
Flow Rate 
[mL/h] 
Conversion 
[%] 
Yield 
[%] 
Result 
1 CO2Et 80 0.3 31 0 
substrate and complex 
reaction mixture  
2 CO2Et 80 0.1 42 0 
substrate and complex 
reaction mixture 
3 CO2Et 120 0.3 45 0 
substrate and complex 
reaction mixture 
4 Ph(CF3)2 80 0.3 26 0 
substrate and complex 
reaction mixture 
5 Ph(CF3)2 80 0.1 34 0 
substrate and complex 
reaction mixture 
6 Ph(CF3)2 120 0.3 40 0 
substrate and complex 
reaction mixture 
Reagents and conditions: 3,5-bis(trifluoromethyl) benzoate ester 131 or oxalate ester 131´ (0.2-
0.5 mmol), fac-Ir(ppy)3 (1.0 mol%), and DMF (0.1 M) at 80-120 °C under 455 nm LED irradiation under 
N2 atmosphere in a flow setup (flow rate 0.1-0.3 mL/h). 
In order to ensure the preferred conformation for the cycle formation the steric bulk at the 
nitrogen was increased. For this purpose, the desired amide 138 was synthesized by the 
reaction of N-protected allylamine 13741 and acid chloride 135 in 73% yield. The synthesis of 
both building blocks is depicted in Scheme 29: Starting from lactic acid (133) the acylation 
reaction led to the formation of product 13442 followed by the subsequent reaction with SOCl2 
to form acid chloride 135. In parallel N-protected allylamine 13741 was obtained by the reaction 
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of allyl bromide (38e) and tert-butylamine 136 providing the desired allyl amine 137 in 
quantitative yield. The amide 138 was deprotected giving rise to the alcohol 139 that was 
subsequently esterified to give ethyl oxalate 140 in an overall yield of 91% over two steps. 
 
 
Scheme 29. Synthesis of N-alkylated alcohol 139. 
Reagents and conditions a)42 AcCl (2.2 equiv), THF, rt, 24 h, 53%; (b) SOCl2 (1.2 equiv), DMF (5 mol%), 
CH2Cl2, rt, 24 h, 69%; (c)41 reflux, 48 h, 99%; (d) Et3N (2.0 equiv), DMAP (2 mol%), CH2Cl2, rt, 20 h, 
73%; (e) K2CO3 (4.0 equiv), MeOH/H2O (2:1), rt, 24 h, 95%. 
 
With ethyl oxalate 140 in hand, the subsequent photoredox process showed only the formation 
of complex reaction mixture and no full conversion (Scheme 30). Again, the reduction potential 
of fac-Ir(ppy)3 (E1/2IV/*III = -1.73 V vs SCE)43 should be sufficient for transfering an electron to 
the oxalate ester moiety of substrate 140 (ERed = -1.82 V vs SCE in DMF). Due to the 
unsuccessful transformation of all substrates in lactame synthesis no further investigations 
towards this product group were conducted. 
 
 
Scheme 30. Activation of N-alkylated alcohol 139 and subsequent photoredox catalyzed reaction of 
substrate 140. 
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6. Summary 
In conclusion an efficient protocol for the synthesis of substituted pyrrolidines is shown. Starting 
from commercially available starting materials various substrates for the photochemical 
transformation were synthesized in several simple steps. The polysubstituted pyrrolidines 48 
were obtained under photoredox conditions using microflow reactor at 80 °C in the presence 
of fac-Ir(ppy)3 as catalyst with the strong reduction potential. In contrast to the obtained yields 
being in moderate to good range, the diastereoselectivity could be increased to selective 
formation of only one diastereomer by reducing the number of stereocenters from three to two 
(products 48d, 48g and 48h).  
 
Scheme 31. Overview of the successful photoredox mediated deoxygenative cyclization 
transformations (only major products are shown). 
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For all products the stereoselective formation of trans-configuration between C1 and C2 
carbons was determined. Moreover, the successful photomediated synthesis of enantiopure 
substituted pyrrolidines was shown employing asymmetric Shi-Epoxidation as key step. The 
application of the developed protocol to the synthesis of bicyclic products failed, except the 
examples 91 and 98. Likewise, the synthesis of substituted 2-pyrrolidinons was not successful. 
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C. Copper Mediated Photochemical Iodoperfluoro-
alkylation‡  
1. Introduction 
The introduction of fluorine or fluorine containing alkyl chains strongly influence the chemical, 
physical or biological properties of the target molecules which are impressively demonstrated 
for example in medicinal chemistry or in the synthesis of pharmaceuticals.1 Thus, for the design 
of new drugs with improved biological half-life, bioabsorption and pharmaceutical effectiveness 
the selective introduction of fluorine or fluorine containing groups is an important synthetic 
challenge.2 Furthermore, in 2001 the advantage of fluorinated compounds was demonstrated 
in the synthetic approach of Curran and coworkers, who presented an efficient technique for 
the synthesis of mixtures of various organic compounds solving both separation and 
identification problems at the same time.3 This protocol increased the value of reactions 
introducing perfluorinated tags to the highly functionalized target molecules. As a result, many 
methods for efficient perfluorination processes were reported4 in recent years, including the 
photoredox catalyzed transformations5 with various photocatalytic systems.  
In 2012 Cho et al.6 presented the photomediated trifluoromethylation of alkenes employing 
[Ru(phen)3]Cl2 catalyst in the presence of a strong organic amine base acting as both sacrificial 
electron donor for regeneration of ruthenium-catalyst and base for the elimination reaction 
forming alkene 3 (Scheme 1). A broad substrate scope with high yields and 
diastereoselectivities was presented including, alcohols, amides, esters, ketones, and 
aldehydes. However, the reaction of styrene derivatives was not reported.  
 
Scheme 1. Photomediated trifluoromethylation of alkenes reported by Cho and coworkers.6 
In the same year Stephenson and coworkers7 published a protocol for the photoredox 
catalyzed addition of perfluoroalkyl iodide 6 to alkenes 4 and alkynes 5 (Scheme 2).  
‡This chapter is partially based on Rawner, T.; Lutsker, E.; Kaiser, C. A.; Reiser, O., ACS Catal. 2018, 
8 (5), 3950-3956. 
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The reductive quenching cycle of [Ru(bpy)3]Cl2 was used employing sodium ascorbate as 
sacrificial electron donor. The reaction delivered high yields for the desired ATRA products 7 
tolerating a broad range of functional groups. Nevertheless, all efforts to utilize styrenes as 
starting materials for this transformation resulted in complex reaction mixtures.7   
 
Scheme 2. Photoredox catalyzed iodoperfluoroalkylation of alkenes and alkynes reported by 
Stephenson and coworkers.7 
Furthermore, in 2016 Vincent et al.8 presented an efficient protocol for an UV-light-promoted 
ATRA reaction employing copper/benzophenone catalyst 8 (Scheme 3). While under reported 
reaction conditions the unactivated alkenes were successfully transformed into the 
corresponding ATRA products, the reaction with styrene again showed only trace amounts of 
the desired photoproduct 7e. Moreover, several activated and unactivated alkynes 5 were 
suitable substrates for the iodoperfluoroalkylation reaction. 
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Scheme 3. UV-light-promoted copper catalyzed ATRA reaction of perfluoroalkyl iodides 6 to alkenes 4 
and alkynes 5 by Vincent and coworkers.8  
In 2017 Yajima et al.9 investigated successfully the iodoperfluoroalkylation of unactivated 
alkenes and alkynes in the presence of organic dyes such as Eosin Y (11) (Scheme 4). 
However, the reaction of styrenes was not described by the authors, assuming that styrenes 
were no suitable substrates. Another protocol was described by Yu et al., who presented a 
metal-free halogen-bond-promoted ATRA reaction of terminal alkynes with perfluoroalkyl 
iodides under visible light irradiation in the presence of sacrificial amine.10   
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Scheme 4. Eosin Y (11) as catalyst for the visible light mediated reaction of perfluoroalkyl iodide 9 with 
alkenes / alkynes.9  
These literature reports show that styrenes are in principle an interesting substrate class with 
unique requirements for the employed catalyst. In 2016 T. Rawner described the successful 
generation of styrene derived ATRA products of perfluorooctyl iodides11 showing the unique 
character of copper catalyst under visible light irradiation. With these results in hand, the 
investigation of the newly synthesized Cu(II)-catalyst [Cu(dap)Cl2] (47)12 in 
iodoperfluoroalkylation reaction of alkenes, including styrenes was carried out. The aim of this 
chapter was the comparison with the results obtained with the Cu(I)-catalyst and proposition 
of plausible mechanistic pathways for both catalysts taking all experimental results into 
account. 
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2. Preliminary Studies with Styrene and Perfluorooctyl Iodide  
This study started with the investigation of the optimized reaction conditions for the new 
[Cu(dap)Cl2] (47) (Table 1). In 2012 Stephenson et al. reported that the reaction of styrene 
(12a) and perfluorooctyl iodide (6) in the presence of [Ru(bpy)3]Cl2 catalyst resulted in the 
formation of complex reaction mixture.7 The validation of this result was done according to the 
literature protocols using once the oxidative quenching cycle (entry 1) as well as the reductive 
quenching cycle with sodium ascorbate as sacrificial electron donor (entry 2) in MeCN/MeOH 
solvent mixture. As expected, both reactions provided the desired product 7e in very low yields. 
Employing [Ru(bpy)3]Cl2 and fac-Ir(ppy)3 as photocatalysts showed low yields with both the 
blue light (max= 455 nm) and the green light (max= 530 nm) (entries 3-5). The reaction with 
[Cu(dap)2]Cl (45) photocatalyst and 2.0 equivalents of perfluorooctyl iodide (6) in MeCN under 
irradiation with green light gave the iodoperfluoroalkylation product 7e in 88% yield (entry 6). 
This result was in accordance with the results presented by T. Rawner in his dissertation.11 
Employing similar reaction conditions for the [Cu(dap)Cl2] (47) provided the photoproduct 7e 
in 92% yield (entry 7). This result was surprising due to the fact, that the UV absorption of the 
new Cu(II)-catalyst was much lower compared to the Cu(I)-catalyst (for details see 
Experimental Part). With this result in hand further investigations were carried out to find the 
parameters which were disadvantageous for the reaction. When the catalyst loading was 
lowered to 0.1 mol% only 17% yield was observed (entry 8), whereas using equimolar amount 
of perfluorooctyl iodide (6) resulted in moderate yield of 47% (entry 9). Variation of solvents 
revealed CH2Cl2 and DMF as feasible alternatives for MeCN with 93% and 88% yields, whereas 
the yield with DMSO as solvent dropped to 36% (entries 10-12). Employing CuCl2 without 
ligand or vice versa, dap ligand without copper salt as well as the absence of light showed no 
reaction or only low yields (entries 13-15). Similarly, the reaction without catalyst showed no 
reaction (entry 16) and carrying out the reaction without prior degassing gave only 30% yield 
(entry 17). The latter indicates the quenching of the photoexcited catalyst by oxygen. The 
initiation of the reaction with AIBN under thermal conditions led to a complex reaction mixture 
and only trace amounts of the product 7e were detected (entry 18). Hu et al.13 reported iron-
catalyzed 1,2-addition of perfluoroalkyl iodides to alkenes and alkynes, however, also under 
these conditions only traces of the desired product 7e were obtained (entry 19). While 
switching the light source to blue light (max= 455 nm) gave the desired product only in 13% 
yield (entry 20), the employment of the energetically lower powered turquoise light (max= 
505 nm) delivered the ATRA product 7e in 69% yield (entry 21). In addition, it was shown that 
both Cu(I)- and Cu(II)-catalysts can be formed in situ with similar catalytic activity (entries 22 
and 23). 
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Table 1. Determination of the optimized reaction conditions for iodoperfluoroalkylation of sytrene (12a). 
  
  Entry Catalyst / Conditions Solvent Yield [%][a] 
 1[b] [Ru(bpy)3]Cl2 MeCN/MeOH (4:3) 2 
 2[b], [c] [Ru(bpy)3]Cl2 MeCN/MeOH (4:3) 3 
 3 [Ru(bpy)3]Cl2 MeCN 9 
 4[b] [Ru(bpy)3]Cl2 MeCN 10 
 5[b] fac-Ir(ppy)3 MeCN 16 
 6 [Cu(dap)2]Cl (45) MeCN 88 
 7 [Cu(dap)Cl2] (47) MeCN 92 
 8[d] [Cu(dap)Cl2] (47) MeCN 17 
 9[e] [Cu(dap)Cl2] (47) MeCN 47 
 10 [Cu(dap)Cl2] (47) CH2Cl2 93 
 11 [Cu(dap)Cl2] (47) DMF 83 
 12 [Cu(dap)Cl2] (47) DMSO 36 
 13 CuCl2 MeCN n.r. 
 14[f] [Cu(dap)Cl2] (47) MeCN n.r. 
 15 dap MeCN 11 
 16 no catalyst  MeCN n.r. 
 17 not degassed  MeCN 30 
 18[f], [g] AIBN MeCN 2 
 19[f], [h] FeBr2/Cs2CO3 MeCN 3 
 20[b] [Cu(dap)Cl2] (47) MeCN 13 
 21[i] [Cu(dap)Cl2] (47) MeCN 69 
 22 CuCl/dap (1:2) MeCN 86 
 23 CuCl2/dap (1:1) MeCN 89 
Reaction conditions: styrene (0.5 mmol, 1.0 equiv), C8F17I (1.0 mmol, 2.0 equiv), catalyst (1.0 mol%) in 
solvent (anh., degassed, 1.0 mL), N2, irradiation at 530 nm (green LED) for 16 h. [a]Determined by NMR 
with diphenoxymethane as an internal standard. [b]Irradiation at 455 nm (blue LED). [c]Sodium ascorbate 
(0.35 mmol, 0.35 equiv), reductive quenching cycle. [d]Catalyst loading 0.1 mol%. [e]C8F17I (1.0 mmol, 
1.0 equiv). [f]Dark reaction. [g]AIBN (10 mol%), 80 °C. [h]FeBr2(0.10 mmol, 10 mol%) and Cs2CO3 
(0.8 mmol, 0.8 equiv). [i]Irradiation at 505 nm (turquious LED). 
3. Substrate Scope 
With the optimized reaction conditions in hand the substrate scope was investigated. Scheme 
5 shows the comparison between Cu(I)- and Cu(II)-catalysts. The results were obtained using 
1.0 equivalents of styrene derivative 12 and 2.0 equivalents of C8F17I (6) in the presence of 
[Cu(dap)2]Cl (45) or [Cu(dap)Cl2] (47). The reaction of styrene (12a) provided the ATRA 
product 7e in 89% yield. The introduction of methyl group in para-position resulted in a 
moderate yield of 44% for product 13a. Since MeCN and CH2Cl2 showed comparable results 
during the investigation of optimized reaction conditions the reactions with low product yields 
were additionally carried out in CH2Cl2. Interestingly, when the reaction of 1-methyl-4-
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vinylbenzene with soft electron donating group was performed in CH2Cl2 the yield for the 
corresponding product 13a strongly increased to 85-88% for both copper catalysts. Further 
increase of electron donor properties by using 4-methoxystyrene resulted in no product 
formation for both tested catalysts and solvents. In these reactions only polymerization of the 
staring material was obtained.  
 
Scheme 5. Substrate scope of copper catalyzed iodoperfluoroalkylation of styrene derivatives 12. 
Reaction conditions: alkene (0.5 mmol, 1.0 equiv), C8F17I (1.0 mmol, 2.0 equiv), [Cu(dap)2]Cl (45) or 
[Cu(dap)Cl2] (47) (1.0 mol%) in MeCN (anh., degassed, 1.0  mL), N2, irradiation at 530 nm (green LED) 
for 16-20 h. [a]Result obtained by T. Rawner.11 [b]HI elimination product in 20% yield isolated.  
The reaction of 4-chlorostyrene gave rise to the ATRA product 13b in 87% yield demonstrating 
the tolerance towards soft electron withdrawing groups. Switching the chlorine-substituent to 
meta-position gave product 13c in comparable yield to para-substitution. In contrast to the 
para-methoxy substitution, when the methoxy group was switched to meta-position, a 
moderate yield was obtained for product 13d, both for the catalyst variation and for the solvent 
change. Moreover, the introduction of CF3-group at ortho-position provided the desired product 
13e in 88% yield being in accordance with the result obtained with 4-chlorostyrene. Further 
increase of electron withdrawing character showed no negative effect on yield, giving 
pentasubstituted ATRA product 13f in 81% and 83% yield. For all styrene derivatives 12 no 
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significant differences in yield or reactivity between [Cu(dap)2]Cl (45) or [Cu(dap)Cl2] (47) were 
observed. 
Next, the investigation of the substrate scope for unactivated alkenes 14 was carried out. For 
this purpose similar reaction conditions which were already employed for the styrene 
derivatives (Scheme 5), were used as depicted in Scheme 6. The tolerance towards amine 
moiety was demonstrated by the reaction of tert-butyl allylcarbamate with perfluorooctyl iodide 
(6) providing the desired ATRA product 7b in 88% yield. Furthermore, employing allyl 
phenylether delivered ATRA compound 15a in good yields. The presence of a free hydroxy 
group showed no negative effect on the photoredox catalyzed transformation giving rise to 
product 7j in 90% and 87% yield. Moreover, when 2-allylphenol was used the corresponding 
ATRA product 15b was obtained in excellent yields.  
 
Scheme 6. Substrate scope of copper catalyzed iodoperfluoroalkylation of alkenes 14. 
Reaction conditions: alkene (0.5 mmol, 1.0 equiv), C8F17I (1.0 mmol, 2.0 equiv), [Cu(dap)2]Cl (45) or 
[Cu(dap)Cl2] (47) (1.0 mol%) in MeCN (anh., degassed, 1.0  mL), N2, irradiation at 530 nm (green LED) 
for 16-20 h. [a]Result obtained by T. Rawner.11 
Surprisingly, no cyclization product was formed, although the ring closure process towards a 
five membered ring was conceivable. This result provides evidence about the absence of 
cationic intermediate during the ATRA process (vide infra). Additionally, the photoredox 
mediated atom transfer radical addition reaction of perfluorooctyl iodide (6) with 1-octene 
showed very good yields for both catalysts. In contrast to the results obtained for styrene (12a) 
(Table 1, entry 8) lowering the catalyst loading to 0.1 mol% showed no yield decreasing effect, 
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providing the desired product 15c in 83-86% yield. As expected, comparable results for 
unactivated alkenes 14 (Scheme 6) were obtained for both copper-catalysts 45 and 47. 
Next, a range of alkynes was subjected to the photomediated ATRA reaction employing the 
new type catalyst [Cu(dap)Cl2] (47) (Scheme 7). When phenylacetylene was used as a 
substrate the desired product 7k was obtained in 96% yield with an E/Z ratio of 92:8. In contrast 
to para-methoxy styrene (Scheme 5), employing 1-ethynyl-4-methoxybenzene provided the 
desired ATRA product 7l in excellent yields and diastereomeric ratios. When tert-butyl group 
was introduced in para-position of the aryl ring, again excellent yields and diastereoselectivities 
were observed for product 16a.  
 
Scheme 7. Substrate scope of copper catalyzed iodoperfluoroalkylation of alkynes 5. 
Reaction conditions: alkyne (0.5 mmol, 1.0 equiv), C8F17I (1.0 mmol, 2.0 equiv), [Cu(dap)2]Cl (45) or 
[Cu(dap)Cl2] (47) (1.0 mol%) in MeCN (anh., degassed, 1.0 mL), N2, irradiation at 530 nm (green LED) 
for 16-42 h. E/Z ratio was determined via NMR spectroscopy. [a]Result obtained by T. Rawner.11 
 
Surprisingly, a free hydroxy group like in propargyl alcohol lowered the yield of the 
corresponding ATRA product 16b from 84% to 48% when [Cu(dap)Cl2] (47) was used as 
photocatalyst, whereas in the presence of protected amine moiety comparably good yields and 
excellent E/Z ratios for product 16c were observed for both copper catalysts. No conversion 
was observed when the symmetrical 1,2-diphenylethyne was subjected to the reaction 
conditions in both MeCN and CH2Cl2. It was assumed that steric bulk of the additional phenyl 
group prevented the addition of perfluoroalkyl radical to the triple bond (vide infra). 
Consequently, the use of substrate with the smaller methyl group furnished the desired ATRA 
product 16e in 40% yield and an excellent diastereomeric ratio of >99:1. However, the 
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employment of CH2Cl2 as solvent showed no change in yield and E/Z ratio. With the exception 
of propargyl alcohol for all alkyne substrates 5, similar results were observed with [Cu(dap)2]Cl 
(45) or [Cu(dap)Cl2] (47).  
4. Cyclization Reaction via ATRA 
4.1. Initial Reaction 
Further investigation was focused on the substrates which in principle can undergo atom 
transfer radical addition reaction with subsequent ring closure forming heterocycles.14 The 
proposed transformation of 2-allylphenol (17) is shown in Scheme 8. Established mechanistic 
proposal for ATRA processes is the addition of the radical to the corresponding alkene with 
subsequent oxidation of the newly formed carbon centered radical to give cationic intermediate 
18 which can be attacked by a nucleophile to form the desired product.5a For substrate 17 the 
intramolecular nucleophilic attack of hydroxy group is conceivable (route A). Another possibility 
is the intramolecular nucleophilic substitution reaction of hydroxy group of the formed ATRA 
product 15b at the iodine containing carbon (route B). In these ways the formation of 
substituted 2,3-dihydrobenzofuran 19 can be achieved.  
 
Scheme 8. Expectable mechanistic pathway for the cyclization process. 
The presence of bases should be advantageous for both mechanistic pathways. Based on the 
previous result that no ring closure occurred at 15b, assuming that route B is preferred, a short 
screening of catalysts and especially additives (e.g. bases), was carried out (Table 2). The 
addition of weak bases such as NaHCO3 and K2HPO4 provided the ATRA product 15b almost 
quantitatively (Table 2, entries 1 and 2). Increasing the basicity of the added base led to lower 
yield for ATRA product and an inseparable product mixture with no generation of cyclic 
compound 19 (entry 3). The use of a strong organic base also showed no cyclization reaction 
with low yield of ATRA product 15b. CuCl2 is known to be able to act as radical trapping 
reagent15. It is conceivable that CuCl2 can trap the carbon-centered radical to form Cu(III)-
species that can undergo the intramolecular ring closure via reductive elimination to form Cu(I)-
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halide. However, this reaction resulted in a complex reaction mixture (entry 5). The strongly 
reductive fac-Ir(ppy)3 is known to undergo ATRA processes via oxidation of the carbon 
centered radical to form the corresponding cation.5a The reaction of 2-allylphenol (17) with 
C8F17I (6) delivered 54% yield for the ATRA product 15b and trace amounts of the desired 
cyclization product 19. To improve the nucleophilicity of the hydroxy group NaHCO3 was added 
to the reaction mixture with fac-Ir(ppy)3 photocatalyst. However, again only traces of 2,3-
dihydrobenzofuran 19 were obtained (entry 7). 
Table 2. Efforts towards cyclization product 19. 
 
Entry Catalyst [1.0 mol%] Additive [1.0 equiv] Yield [%][a] 15b:19 
1 [Cu(dap)2]Cl (45) NaHCO3 96:0 
2 [Cu(dap)2]Cl (45) K2HPO4 95:0 
3 [Cu(dap)2]Cl (45) Na2CO3 54:0 
4 [Cu(dap)2]Cl (45) DBU  21:0 
5 [Cu(dap)2]Cl (45) CuCl2 complex reaction mixture 
   6[b] fac-Ir(ppy)3 / 54:5 
   7[b] fac-Ir(ppy)3 NaHCO3 52:4 
Reaction conditions: 2-allylphenol (17) (0.5 mmol, 1.0 equiv), C8F17I (6) (1.0 mmol, 2.0 equiv), catalyst 
(1.0 mol%) and additive (1.0 equiv) in MeCN (anh., 1.0 mL), N2, irradiation at 530 nm (green LED) for 
16 h. [a]Isolated yield. [b]Irradiation at 455 nm (blue LED).  
 
4.2. Synthesis of Starting Materials for Cyclization Reaction 
Surprisingly, the addition of bases to the reaction mixture showed no positive effect on the 
formation of the cyclization product. To exclude the option that the investigated substrate 17 
had the wrong geometry for a successful ring closure, various substrates for the cyclization 
process were synthesized (Scheme 9). Starting from commercially available catechol (20) the 
monoallylated alcohol 21 was obtained in 49% yield using allyl bromide under basic 
conditions.16 Next, methyl 2-iodobenzoate (22) was treated with iPrMgBr in the presence of 
CuCN and LiCl to form soft cuprate being able to undergo nucleophilic substitution reaction to 
form allylbenzene 23 in 96% yield.17 Subsequently, the ester moiety was reduced by LiAlH4  to 
the corresponding benzylic alcohol to give the desired starting material 24 in 92% yield.18 
Finally, methyl salicylate (25) reacted with allyl bromide under basic reaction conditions 
providing product 26 in 90% yield19, which was reduced in the next step to form the benzylic 
alcohol 27 in 89% yield.  
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Scheme 9. Synthesis of starting materials for cyclization reactions.  
. 
4.3. Photoreactions 
The prepared starting materials were consequently employed in the photoredox catalyzed 
iodoperfluoroalkylation reaction using [Cu(dap)2]Cl (45) or [Cu(dap)Cl2] (47) as photocatalysts. 
In all cases no desired cyclization products 30a-30d were obtained whereas only the formation 
of ATRA products 15b, 29a, 29b and 29c was observed. The yields for both employed 
catalysts were similar. As a result of no successful cyclization reaction no further investigations 
were carried out towards the described cyclic product groups. 
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Table 3. Photoinduced addition of perfluorooctyl iodide (6) to arenes 28. 
 
Entry Substrate ATRA product Cyclization product 
1 
   
 
17  
 
15b  
98%   97% 
30a 
0%   0% 
2 
   
 
21 
 
29a 
73%   70% 
30b 
0%   0% 
3 
 
 
 
 
24  
 
29b 
69%   65% 
30c 
0%   0% 
4 
 
  
 
27  
 
29c 
56%   61% 
30d 
0%   0% 
Reaction conditions: alkene 28 (0.5 mmol, 1.0 equiv), C8F17I (6) (1.0 mmol, 2.0 equiv), 
catalyst (1.0 mol%) in MeCN (anh., degassed, 1.0 mL), N2, irradiation at 530 nm (green LED) for 16 h.   
 
5. Mechanistic Studies  
In order to get a deeper insight into the mechanism of the iodoperfluoroalkylation reaction a 
series of experiments was carried out. First, several mechanistic experiments were done using 
[Cu(dap)Cl2] (47) and the obtained results were compared with the results for [Cu(dap)2]Cl (45) 
described by T. Rawner11. In line with a radical pathway of the perfluorination reaction the 
addition of TEMPO (31) provided exclusively the radical trapping product 32 in 44% yield 
(Scheme 10). However, no other intermediates could be identified by this experiment. 
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Scheme 10. Radical trapping reaction with TEMPO (31). 
[a]Result obtained by T. Rawner.11 
Moreover, the radical character of the reaction was confirmed by 5-exo-trig cyclization reaction. 
Employing diallyl ester 33 as starting material led after perfluorooctyl radical addition to the 
formation of intermediary radical 35 which can undergo the favored 5-exo-trig cyclization to 
form cyclopentane 34 in 70% yield (Scheme 11). The reaction occured with high 
diastereoselectivity as confirmed by 2D-NMR towards the formation of syn-product which is in 
accordance with literature11, 20  
 
Scheme 11. Mechanistic study: Radical 5-exo-trig ring closure. 
[a]Result obtained by T. Rawner.11  
Furthermore, the radical clock experiment was carried out using substrate 36 under optimized 
reaction conditions (Scheme 12). In the first step perfluorooctyl radical adds to the double bond 
of the substrate 36 forming benzylic radical 38. The presence of the radical next to the 
cyclopropane ring resulted in ring opening process leading to the product 37, whereas the 
formation of cyclopropane product 39 was not observed.21 In addition, no indication for the 1,2-
hydride shift resulting in the formation of allyl radical 41 was detected being in agreement with 
the results obtained by T. Rawner11.  
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Scheme 12. Mechanistic study: radical clock experiment. 
[a]Result obtained by T. Rawner.11  
Since the results for [Cu(dap)Cl2] (47) and [Cu(dap)2]Cl (45) were similar for all mechanistic 
studies so far, further investigations were only carried out with [Cu(dap)2]Cl (45). Next, it was 
established that the formed ATRA products are stable under photoredox conditions. Therefore, 
the product 7e was firstly stirred under irradiation with blue light in the presence of 
[Ru(bpy)3]Cl2. Secondly, additional styrene was added to the reaction mixture of the ATRA 
product and irradiated with blue light in the presence of [Ru(bpy)3]Cl2. These experiments were 
important in order to exclude the possibility of subsequent product decomposition or a second 
ATRA reaction with styrene in the presence of [Ru(bpy)3]Cl2. Similar studies were carried out 
for [Cu(dap)2]Cl (45). All reactions demonstrated the high stability of the ATRA products under 
photoredox conditions.12a 
The ATRA reaction between allyl alcohol (43) or styrene 12a and perfluorooctyl iodide (6) 
illustrates the different mechanistic pathways that are involved depending on the catalyst 
employed. The reaction of allyl alcohol (43) delivers the desired product 7j in good yields 
employing visible light photoredox catalysis either by [Ru(bpy)3]Cl2 or by [Cu(dap)2]Cl (45). 
Moreover, the reaction is successful under thermal conditions using AIBN as radical initiator 
(Scheme 13). In contrast, neither AIBN nor [Ru(bpy)3]Cl2 are able to promote this 
transformation for styrene (12a), whereas [Cu(dap)2]Cl (45) provides the desired product in 
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very good yield. These results indicate different mechanistic pathways for the investigated 
catalysts. 
 
Scheme 13. Comparison between reactions with styrene (12a) and allyl alcohol (43).12a 
Reaction conditions: 12a/43 (1.0 mmol), 6 (2.0 equiv). [a][Cu(dap)2]Cl (45) (1.0 mol%) in MeCN (anh., 
degassed, 0.5 mL), N2, irradiation at 530 nm for 17 h. [b][Ru(bpy)3]Cl2 (1.0 mol%) in MeCN (anh., 
degassed, 0.5 mL), N2, irradiation at 455 nm for 17 h. [c]12a/43 (0.25 mmol), 6 (1.3 equiv), sodium 
ascorbate (0.35 equiv), [Ru(bpy)3]Cl2 (1.0 mol%) in MeCN/MeOH (anh., degassed,  4:3, 3.5 mL), N2, 
irradiation at 455 nm for 2 h. [d]12a (1.0 mmol), 6 (1.0 equiv), AIBN (10 mol%) in MeCN (anh., degassed, 
0.5 mL), N2, at 80 °C  for 16 h. [e]43 (2.0 mmol, 1.15 equiv), 6 (1.0 equiv), AIBN (10 mol%) at 80 °C  for 
14 h.   
With these results in hand a competitive reaction between styrene (12a) and allyl alcohol (43) 
was carried out using [Cu(dap)2]Cl (45) and [Ru(bpy)3]Cl2 (Scheme 14). When the reaction was 
performed in the presence of copper catalyst 69% of styrene derived product 7e and 13% of 
alcohol 7j were obtained indicating the higher reactivity of styrene (12a) compared to the 
unactivated alkene 43. Interestingly, when the catalyst was switched to [Ru(bpy)3]Cl2 both 
photoproducts 7e and 7j were obtained in very low yields. These observations indicate, that 
the higher reactivity of styrene (12a) provides the formation of benzylic radical but only leads 
to the desired ATRA product when copper catalyst is present. To exclude the possibility of 
simple quenching of the ruthenium catalyst with styrene (12a) fluorescence measurements 
were carried out in cooperation with C. Kaiser (for details see Experimental Part).  
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Scheme 14. Competitive reaction between styrene (12a) and allyl alcohol (43).12a 
Reaction conditions: 12a (1.0 mmol), 43 (1.0 mmol), C8F17I (6) (2.0 equiv): [a][Cu(dap)2]Cl (45) 
(1.0 mol%) MeCN (anh., degassed, 0.5 mL), N2, irradiation at 530 nm for 17 h. [b]Sodium ascorbate 
(0.35 equiv), [Ru(bpy)3]Cl2 (1.0 mol%) in MeCN/MeOH (anh., degassed, 4:3, 3.5 mL), N2, irradiation at 
455 nm for 2 h. 
The exclusive formation of [Cu(dap)Cl2] (47) upon treatment of CuCl2 (44) with 2.0 equivalents 
of dap ligand indicates, that the [Cu(dap)2]Cl (45) should lose one dap ligand when transferring 
a single electron to perfluorooctyl iodide (6), thus forming a Cu(II) species (Scheme 15).  
 
Scheme 15. Formation of [Cu(dap)2]Cl (45) and [Cu(dap)Cl2] (47) in the presence of 2.0 equivalents 
dap ligand.12a   
This assumption was confirmed by a 1H NMR experiment in CDCl3 using styrene (12a) 
(0.2 mmol), C8F17I (6) (0.4 mmol), [Cu(dap)2]Cl (45) (20 mol%) in MeCN (anh., degassed, 
1.0 mL), after irradiation for 16 h with 530 nm LED (green LED). The analyzed reaction mixture 
showed clearly the formation of free ligand after the ATRA-reaction (Figure 1). Control 
experiment without styrene (12a) and C8F17I (6), thus preventing the Cu(I) → Cu(II) transition, 
showed no free ligand formation (Figure 2). 
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Figure 1. Ligand dissociation experiment.12a 
 
 
Figure 2. Control experiment for ligand dissociation.12a 
 
6. Proposed Mechanism 
Taking all observations into account, the following mechanistic pathways can be proposed12a: 
The two commonly discussed and generally accepted mechanistic proposals for ATRA 
reactions are either a radical chain22 or a photoredox cycle5a, 5c, 7, 23. The ATRA process starts 
with initial generation of perfluoroalkyl radical 48 e.g. thermally in the presence of radical starter 
-OCH3 of dap-ligand in 
[Cu(dap)2]Cl (45) 
-OCH3 of free 
dap-ligand 
-OCH3 of dap-ligand in 
[Cu(dap)2]Cl (45) 
Diphenoxymethane as 
internal standard 
Styrene 
ATRA-product 
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AIBN or via single electron transfer from the photoexcited catalyst. Perfluoroalkyl iodides are 
accessible substrates for both types of initiation. AIBN mediated ATRA reactions of 
perfluroalkyl iodides with a wide range of alkyl substituted alkenes have been described in the 
literature.24 In the case of photoredox process the reduction potentials of both, [Ru(bpy)3]Cl2 
(reductive quenching cycle: Ru2+/Ru+ = –1.33 V vs SCE)5a and [Cu(dap)2]Cl (45) (oxidative 
quenching cycle: Cu2+/Cu+* = –1.43 V vs SCE)5a are strong enough for the reduction of C8F17I 
(6) (–1.32 V vs SCE)7 to generate a perfluoroalkyl radical 48. This radical can then add to the 
alkene 12 to form carbon centered radical 49. Subsequently the radical 49 can undergo a 
radical chain propagation by abstraction of iodine from C8F17I (6) forming the desired product 
13 and regenerating perfluoroalkyl radical 48 (Scheme 16, Path A). Alternatively, radical 49 
can be oxidized by the photoredox catalyst forming carbocation 50 and regenerating the 
catalyst. This mechanistic pathway is closed by subsequent recombination of iodide and 
carbocation 50 giving rise to the desired ATRA compound 13 (Scheme 16, Path B). Both 
mechanistic pathways are not totally in agreement with the experimental results obtained for 
the iodoperfluoroalkylation of styrenes. On the one hand the radical chain mechanism 
(Scheme 16, Path A) appears not to be plausible because the corresponding thermally initiated 
reaction with AIBN showed only traces of the ATRA product (Table 1, entry 18). On the other 
hand the quantum yield25 for this reaction catalyzed by [Cu(dap)2]Cl (45) or [Cu(dap)Cl2] (47) 
was determined to be 0.48 and 0.52, respectively, which is not characteristic for a radical chain 
propagation. However, the interpretations based on quantum yield should be considered very 
carefully as the analysis based on yield of the desired product and absorbed photons does not 
take into account the participation of other photomediated transformations that do not lead to 
the desired ATRA product (for detailed calculation of quantum yield see Experimental Part).26  
 
Scheme 16. Mechanistic pathways for the ATRA reaction of perfluoroalkyl iodide 6 and alkene 12.12a 
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Moreover, the photoredox cycle with included oxidation of radical to the corresponding 
carbocation is not plausible due to the failure of [Ru(bpy)3]Cl2 in the transformation of styrene 
(12a) and C8F17I (6) (Table 1, entries 1-4). The oxidation of benzyl radicals 
(PhCH2+/PhCH2• = +0.73 V vs SCE)27 and (PhCH+CH3/ PhCH•CH3 = +0.37 V vs SCE)27 to the 
corresponding cations should be in principle possible by [Ru(bpy)3]Cl2 (reductive quenching 
cycle: Ru2+/ Ru+ = +0.77 V vs SCE)5a. As consequence, it can be assumed that the 
recombination of benzylic cation and iodide is not working well in this reaction, thus stopping 
the reaction at this stage of the transformation. This observation is in accordance with the 
competitive reaction of styrene (12a) and allyl alcohol (43) (Scheme 13 and Scheme 14).  
As an alternative, two additional plausible mechanistic pathways can be described that are in 
agreement with the experimental observations. Again, the catalytic cycles start with single 
electron transfer from the photoexcited copper catalyst 51 to perfluroalkyl iodide 6 resulting in 
the formation of radical 48, iodide and oxidized Cu(II) species 52 which undergoes a ligand 
dissociation process as was described earlier (vide supra). The analogy between the Cu(II)-
species 52 and the stable and catalytically active [Cu(dap)Cl2] (47) is obvious (Scheme 15). 
Subsequent radical addition to alkene 12 forms the benzyl radical 49 which can undergo two 
different pathways, rebound mechanism (Scheme 16, Path C) and ligand transfer cycle 
(Scheme 16, Path D). The radical 49 can be trapped directly by the Cu(II)-center of complex 
52 thus forming four coordinated Cu(III) species 53 which can undergo a reductive elimination 
to form the desired ATRA product 13 and [Cu(dap)2]Cl (45) (Scheme 16, Path C). Monomeric 
Cu(III)-complexes are known to have the favored coordination number four, whereas the five 
coordinated complexes are rare.28 Alternatively, the intermediary radical 49 adds to the iodine 
ligand of Cu(II)-species 52, with simultaneous homolytic Cu-I bond cleavage and the formation 
of ATRA compound 13 and regenerated copper(I)-complex 45 (Scheme 16, Path D). The 
considerations for the proposed mechanistic pathways base on the concepts of an inner 
sphere mechanism for copper-catalyzed transformations, which were described in the 
literature29. 
Finally, to understand the successful transformation of alkenes with C8F17I (6) using 
[Cu(dap)Cl2] (47) following mechanistic proposal was developed (Scheme 17). When irradiated 
with visible light the photoexcited Cu(II)-complex 56 is formed which can undergo homolytic 
Cu(II)-Cl bond cleavage to form Cu(I) intermediate 57 and chlorine.12c  
 
Scheme 17. Transformation of Cu(II)-catalyst 47 into catalytically active Cu(I)-species 57.12c 
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The coordination of the newly formed copper species occurs by another dap ligand and 
chloride counteranion, thus resulting in the formation of catalytically active [Cu(dap)2]Cl (45) 
which can act as described in Scheme 16. Another possibility is the coordination of Cu(I)-
center by solvent30 or halides. Moreover, the transformation of Cu(II)-catalyst  into the 
[Cu(dap)2]Cl (45) is a plausible explanation for the similarity of the obtained yields and 
diastereoselecivities for the most of the investigated substrates.    
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7. Summary 
In summary, an efficient atom transfer radical addition (ATRA) reaction of perfluorooctyl iodide 
(6) with a broad range of alkenes and alkynes is described employing [Cu(dap)Cl2] (47) as 
photocatalyst. The comparison with the results obtained with [Cu(dap)2]Cl (45) showed similar 
yields and diastereoselectivities for the most of the substrates. Mechanistic studies for both 
catalytic systems provided an extensive proposal for the mechanistic behavior of the current 
ATRA reaction. The unique character of copper catalysts was shown by presenting two 
alternative mechanistic pathways: ligand transfer cycle with homolytic Cu-halide bond 
cleavage and a rebound mechanism including a Cu(III)-intermediate. These mechanisms are 
especially important for the explanation of the reaction with styrene derivatives that are not 
accessible substrates for thermally initiated AIBN reaction and photoredox catalyzed 
transformation with [Ru(bpy)3]Cl2.12a Moreover, the explanation for the successful Cu(II)-
catalyzed process was proposed including homolytic Cu-Cl bond cleavage and the formation 
of the catalytically active Cu(I)-species.12c   
 
Scheme 18. The unique mechanistic pathways of copper catalysts.12a 
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D. Copper Mediated Chlorosulfonylation of Alkenes‡  
1. Introduction 
Sulfones are important motifs in a variety of natural products and pharmaceuticals.1 The 
importance of the direct introduction of this functional group is reflected by a broad range of 
publications.1b-d, 2 The incorporation to the highly functionalized substrates can be challenging, 
making soft and non-destructive methods necessary. In recent years, photoredox catalysis 
with visible light became an important technique in the organic synthesis, demonstrating 
outstanding advantages in comparison with UV-light mediated reactions.3 For example, 
irradiation of functionalized organic molecules with high energy UV-light in the 
worst case can destroy them before reacting in the desired way. Recent progress in the 
successful synthesis of important class of sulfones by visible-light mediated photoredox 
catalysis was described in several literature reports.1b In 2012 Stephenson and coworkers4 
demonstrated efficient ATRA reaction of tosyl chloride (2a) with styrene (1a) and norbornene 
(1b) (Scheme 1). The reactions showed high yields employing oxidative quenching cycle with 
no need for additives like sacrificial amines. However, only these two examples were 
presented.   
 
Scheme 1. Atom transfer radical addition reaction of tosyl chloride (2a) with styrene (1a) and norbornene 
(1b) by Stephenson and coworkers.4 
In 2015, the unique character of copper-based photocatalysts was demonstrated by Reiser 
group in trifluoromethylchlorosulfonylation reaction of alkenes (Scheme 2).5  In contrast to the 
[Ru(bpy)3]Cl2 catalyst which provided trifluoromethylchlorination products 5a and 5e 
[Cu(dap)2]Cl (25) was able to prevent the SO2 excursion for a variety of substrates giving rise 
to trifluoromethylchlorosulfonylation products 4a-4e.  
‡This chapter is partially based on Hossain, A.; Engl, S.; Lutsker, E.; Reiser, O., ACS Catal. 2019, 9 (2), 
1103-1109. 
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However, also with copper catalyst for some substrates only the trifluoromethylchlorination 
products 5i-5k were obtained. The generation of sulfonylchloride products enabled interesting 
follow-up chemistry as was reported recently for the synthesis of substituted sultones.6 
 
Scheme 2. Trifluoromethylchlorosulfonylation versus trifluoromethylchlorination of alkenes 1 by Reiser 
and coworkers5. 
Moreover, the exclusive formation of SO2-products in the presence of copper-based 
photocatalyst was exploited to form sulfonyl chlorides 4 which were subsequently transformed 
into corresponding -hydroxysulfones 9 via iridium-mediated photoreaction (Scheme 3).7  
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Scheme 3. Photoredox catalyzed synthesis of -hydroxysulfones from sulfonyl chlorides by Reiser and 
coworkers7. 
This procedure was an outstanding demonstration for the consecutive formation of two C-S-
bonds via photoredox catalysis, forming highly substituted sulfones.  
Recently, the reaction conditions developed by Stephenson et al.4 (Scheme 1) were used by 
Niu and Ni to explore the substrate scope of the ruthenium catalyzed chlorosulfonylation of 
alkenes.8 However, only few successful transformations of unactivated alkenes were described 
and interestingly the results obtained for product 3a were even not consistent with the results 
presented by Stephenson and coworkers. Moreover, for several examples only the elimination 
products were formed. Due to the ability of copper to provide successful chlorosulfonylation 
reaction of alkenes under thermal conditions as was demonstrated by the pioneering studies 
with CuCl and CuCl29, the employment of copper catalyst as an alternative to ruthenium 
complex was promising. The aim of this chapter was the investigation of visible light mediated 
photoredox catalyzed chlorosulfonylation of alkenes using [Cu(dap)2]Cl (25) and [Cu(dap)Cl2] 
(27) photocatalysts demonstrating the unique character and advantages of copper-mediated 
photocatalysis.  
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2. Preliminary Studies with Tosyl Chloride and Styrene or Allyl 
Phenyl Ether  
The initial reaction for this project was a control experiment carried out during the study of the 
iodoperfluoroalkylation reaction of styrenes (chapter C). Due to the proposed mechanism of 
this reaction, including the impossibility of recombination between iodide and benzylic cation 
(for details see mechanistic discussion of chapter C), a plausible explanation was the HSAB 
concept, which describes the favorable reactions between Lewis acids and Lewis bases.10 It 
was proposed that softer copper catalyst undergoes exclusively the rebound mechanism or 
ligand exchange pathway with the softer iodide and thus enables the creation of the carbon-
iodine bond. Switching the anion from the softer iodide to the harder chloride should lead to a 
lower yield, which confirms the described assumption for copper catalysis. However, the 
reaction between styrene (1a) and tosyl chloride (2a) resulted in the formation of 
chlorosulfonylation product 3a in excellent yield (Scheme 4). The comparison of the obtained 
results with the reported literature4 showed a higher catalytic activity compared to the 
established [Ru(bpy)3]Cl2. The responsibility for the investigation of chlorosulfonylation 
reaction of styrene derivatives employing copper photocatalysis was then transferred to 
S. Engl as the project for his master thesis11. 
  
Scheme 4. Initial copper catalyzed chlorosulfonylation of styrene (1a). 
Further investigation of the chlorosulfonylation reaction focused on unactivated alkenes, 
especially substrates which could possibly undergo a cyclization process forming heterocyclic 
products12 (Scheme 5). For this purpose, allyl phenyl ether (1c) was synthesized according to 
the protocol described in the literature13. The idea for the cyclization reaction was based on 
the copper mediated photoinduced generation of sulfonyl radical, which can add to the alkene 
1c and forms the carbon-centered radical 10. Due to the favorable intramolecular process, 
which should be faster compared to the intermolecular ATRA product formation, the radical 10 
can cyclize into the aryl system to form compound 11 which is subsequently oxidized by Cu(II)-
complex to regenerate the catalyst and to form cation 12. Finally, the deprotonation of 
compound 12 leads to the rearomatization and the formation of the substituted 2,3-
dihydrobenzofuran 13. To ensure the success of the aromatization step base was added as 
an additive to the reaction mixture. 
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Scheme 5. Proposed photomediated cyclization reaction. 
The investigation of the photomediated process started with the reaction of 2.0 equivalents 
allyl phenyl ether (1c) and 1.0 equivalent tosyl chloride (2a) in the presence of 1.0 equivalent 
NaHCO3 and [Cu(dap)2]Cl (25) in MeCN under irradiation with green LED (Table 1, entry 1). 
This reaction gave no desired cyclization product 13 but only the ATRA product 3c in 15% 
yield. When different alkali metal carbonates were employed as additives no cyclization 
product could be obtained, but the yield of the ATRA product 3c was interesting. While lithium 
carbonate (entry 2) and potassium carbonate (entry 4) showed only 23% and 11% yield 
respectively, the reaction with caesium carbonate showed no product formation at all (entry 5). 
Surprisingly, the reaction with sodium carbonate delivered the ATRA product in 78% yield 
(entry 3). These results are unexpected as the basicities of these alkali metal carbonates do 
not differ much. Further increase of basicity by employing NaOH as base resulted in no product 
formation (entry 6), whereas low yield of the addition product 3c was obtained by using organic 
amine base (entry 7). In order to understand the reason for the strongly increased product yield 
when using sodium carbonate, two experiments were carried out. On the one hand when 
sodium chloride as sodium source was used no conversion was observed, thus indicating the 
need of a basic additive (entry 8). On the other hand, when sodium chloride was used in 
combination with potassium carbonate only 13% yield was obtained (entry 9). This result 
shows, that the function of sodium carbonate in the successful transformation does not only 
refer to its behaviour as sodium and as a base source. Interestingly, reducing the amount of 
the base to 0.2 equivalents resulted in lower yield (entry 10) and when no base was added to 
the reaction mixture no conversion of the starting material was observed (entry 11). This result 
is curious due to the fact, that several other ATRA reactions catalyzed by [Cu(dap)2]Cl (25) 
were carried out successfully without addition of base. Furthermore, it was not possible to 
reduce the reaction time from 48 h to 24 h resulting in only 46 % yield (entry 12). When the 
amount of alkene 1c was decreased to only 1.0 equivalent or 2.0 equivalents of TsCl (2a) were 
used, the yield dropped to 43% and 49%, respectively (entries 13 and 14). Next, the light 
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source for the irradiation was switched from a green LED (max = 530 nm) to a blue LED 
(max = 455 nm), generating slightly lower yield of the desired product 3c (entry 15). Variation 
of the solvents demonstrated that the reaction did not work in DMF and DMSO (entries 16 and 
17), whereas only low amounts of the ATRA product 3c were formed in CH2Cl2 (entry 18).  
Furthermore, different catalytic systems were employed in the current reaction.  
Table 1. Determination of optimal reaction conditions. 
 
Entry Conditions Product 3c[a] Product 13[a] 
1 NaHCO3 (1.0 equiv) 15 0 
2 Li2CO3 (1.0 equiv) 23 0 
3 Na2CO3 (1.0 equiv) 78 0 
4 K2CO3 (1.0 equiv) 11 0 
5 Cs2CO3 (1.0 equiv) 0 0 
6 NaOH (1.0 equiv) 0 0 
7 NEt3 (1.0 equiv) 6 0 
8 NaCl (1.0 equiv) 0 0 
9 K2CO3 (1.0 equiv) + NaCl (1.0 equiv) 13 0 
10 Na2CO3 (0.2 equiv) 61 0 
11 no base 0 0 
12 24 h 46 0 
13 TsCl (2.0 equiv) 43 0 
14 alkene (1.0 equiv) 49 0 
   15[b]   455 nm LED 64 0 
16 DMF 0 0 
17 DMSO 0 0 
18 CH2Cl2 24 0 
19 [Cu(dap)Cl2] (27) (1.0 mol%) 76 0 
20 CuCl (10 mol%) 2 0 
   21[b] [Ru(bpy)3]Cl2 (1.0 mol%) 31 0 
   22[b] [Ru(bpy)3]Cl2 (1.0 mol%) + Na2CO3 (1.0 equiv) 32 0 
   23[b] fac-Ir(ppy)3 (1.0 mol%) 28 0 
   24[b] fac-Ir(ppy)3 (1.0 mol%) + Na2CO3 (1.0 equiv) 26 0 
 25 no catalyst 0 0 
 26 no light 0 0 
Reaction conditions: alkene 1c (1.0 mmol, 2.0 equiv), TsCl (2a) (0.5 mmol, 1.0 equiv), Na2CO3 
(1.0 equiv), [Cu(dap)2]Cl (25) (1.0 mol%) in MeCN (anh., degassed, 2.0  mL), irradiation at 530 nm 
(green LED) for 48 h. [a]Determined by NMR with diphenoxymethane as an internal standard. 
[b]Irradiation at 455 nm (blue LED). 
When the copper(II)-catalyst [Cu(dap)Cl2] (27) was used, the desired ATRA product 3c was 
obtained in 76% yield (entry 19), whereas the reaction with CuCl in the absence of dap ligand 
gave only trace amounts of the product (entry 20). The reactions with [Ru(bpy)3]Cl2 in the 
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presence and in the absence of equimolar amount of sodium carbonate delivered product 3c 
in only low yields (entries 21 and 22). Similar results were obtained when fac-Ir(ppy)3 was used 
(entries 23 and 24). Moreover, the control experiments without the catalyst as well as with no 
light showed no conversion of the starting material indicating the photoredox character of the 
investigated reaction. Although the formation of the desired cyclization product was not 
observed for any entry, particularly the comparison of copper catalysts with [Ru(bpy)3]Cl2 and 
fac-Ir(ppy)3 demonstrated interesting results. Furthermore, the unique role of sodium 
carbonate in this transformation was curious.  
3. Substrate Scope 
With the optimized reaction conditions in hand the substrate scope for the atom transfer radical 
addition reaction of sulfonyl chlorides with unactivated alkenes was explored employing both 
[Cu(dap)2]Cl (25) and [Cu(dap)Cl2] (27) photocatalysts (Scheme 6). The product 3c which was 
also used for the screening reactions was isolated in 73% and 70% yield. Employing allyl 
benzene (1d) as substrate in the presence of copper(I)-catalyst 25 provided the desired 
product 3d in 86% yield, whereas with copper(II)-catalyst 29 a slightly lower yield was obtained. 
When the N-Boc protected allylamine 1e was submitted to the reaction conditions high yields 
of 75-80% for the desired product 3e were observed. The successful transformation of allyl 
alocohol (1f) to the corresponding ATRA product 3f demonstrated high functional group 
tolerance towards free hydroxy groups. Moreover, 1-octen (1g) as representative of substrates 
with a long alkyl chain showed very good yields for both catalytic systems. The primary bromide 
1h was a feasible substrate for the photoredox catalyzed reaction forming the desired ATRA 
product 3h in very good yield. To achieve the full consumption of the starting material, it was 
necessary to increase the amount of alkene from 2.0 equivalents to 4.0 equivalents. In contrast 
to the obtained result for allyl alcohol (1f), when 2-allylphenol (1i) was applied to the present 
reaction no photoproduct formation was observed. This observation can be explained by the 
stronger acidity of phenol compared to the allyl alcohol (1f), thus leading to the fast acid-base 
reaction between phenol 1i and sodium carbonate. The consumption of sodium carbonate 
results in low activity of the catalyst and in this way the slower photoreaction is blocked. To 
solve this problem and to verify the explanation, 2-allylphenol (1i) was methylated according 
to the procedure described in the literature14. The obtained substrate 1j was transformed in the 
presence of [Cu(dap)2]Cl (25) and [Cu(dap)Cl2] (27) to the desired ATRA product 3j in 83% 
and 69% yield, respectively.  
Copper Mediated Chlorosulfonylation of Alkenes 
97 
 
Scheme 6. Substrate scope for the visible light mediated chlorosulfonylation of unactivated alkenes. 
Reaction conditions: alkene 1 (1.0 mmol, 2.0 equiv), TsCl (2a) (0.5 mmol, 1.0 equiv), Na2CO3 (1.0 equiv), 
[Cu(dap)2]Cl (25) or [Cu(dap)Cl2] (27) (1.0 mol%) in MeCN (anh., degassed, 2.0  mL), irradiation at 
530 nm (green LED) for 48 h. aAlkene (2.0 mmol, 4.0 equiv). bReaction time 72 h.  
The variation of the O-protecting group showed, that when the substrate with the sterically 
demanding Boc-group15 was used, the yields for both catalysts dropped dramatically. In both 
cases even after 72 h no full conversion of the starting material was achieved, thus leading to 
the reisolation of the remained substrate 1k. The yields based on the recovered starting 
material are given in parenthesis. Moreover, no full conversion was obtained when the 
products 3l and 3m were synthesized. For both substrates [Cu(dap)Cl2] (27) showed higher 
isolated yields, but the analysis of the yield based on recovered starting material revealed quite 
similar results fo both catalytic systems. When norbornene (1b) was employed as the starting 
material the corresponding ATRA product 3b was obtained in very good yields. Similar results 
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were observed by Stephenson et al. using [Ru(bpy)3]Cl2, indicating that the high ring strain in 
norbornene16 facilitates the atom transfer radical addition reaction. Besides, two additional 
unsuccessful transformations were performed. The developed protocol does not tolerate 
internal alkenes e.g. 3-hexene (1n) and vinyl esters like prop-1-en-2-yl acetate (1o). 
Interestingly, when the reaction was carried out using allyl bromide (1p) instead of 4-bromobut-
1-ene (1h) full conversion of the starting material but no ATRA product formation were 
observed (Scheme 7, reaction b). The obtained product was identified as the allylsulfone 14 
which was obtained in 87% yield. Carrying out the reaction without adding sodium carbonate 
showed no conversion of the starting material (Scheme 7, reaction c). Since both allyl bromide 
(1p) and tosyl chloride (2a) are electrophiles, a simple nucleophilic attack can be excluded as 
the reason for the formation of product 14. Further investigations of this allylation reaction are 
shown in chapter E. 
 
Scheme 7. Allyl bromide (1p) as substrate for the ATRA reaction.  
 
Similarly to the comparison of the results between [Cu(dap)2]Cl (25) and [Cu(dap)Cl2] (27) in 
chapter C no clear differences in yield were observed for the chlorosulfonylation reaction of 
unactivated alkenes. Due to this fact, the variation of sulfonyl chlorides 2 was carried out 
focusing on [Cu(dap)2]Cl (25) photocatalyst (Scheme 8). The reactions were carried out once 
with allyl phenyl ether (1c) and with allyl alcohol (1f) in order to test the functional group 
tolerance towards different sulfonyl chlorides. When the reaction was carried out with O-
protected alkene 1c and electron rich 4-methoxybenzenesulfonyl chloride (2b) the desired 
ATRA product 15b was obtained in 76% yield, whereas the reaction of unprotected allyl alcohol 
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(1f) with this sulfonyl chloride showed only 50% yield of the ATRA product 15b´ and additional 
29% of the elimination product 16b´. Surprisingly, decreasing the electronic densitiy in the aryl 
ring by using 4-methylbenzenesulfonyl chloride (2a) resulted only in the formation of ATRA 
products 15a and 15a´ in good yields for both employed alkenes with no generation of 
elimination compounds. This result is unexpectable because the acidity of the proton next to 
the sulfonyl moiety should be increased by a lower electronic density of the aryl ring. Next, 
phenylsulfonyl chloride (2c) was used as ATRA reagent bearing no functional group which can 
influence the electronic density in the aryl ring. The reaction of allyl phenyl ether (1c) with this 
sulfonyl chloride gave the desired ATRA compound 15c in 59% yield with no formation of 
elimination product 16c. In contrast the reaction of alcohol 1f provided the product 15c´ in only 
30% yield with additional 48% of the alkene 16c´.  
 
Scheme 8. Variation of sulfonyl chlorides 2 for the ATRA reaction with unactivated alkenes 1c and 1f. 
Reaction conditions: alkene 1c or 1f (1.0 mmol, 2.0 equiv), sulfonyl chloride 2 (0.5 mmol, 1.0 equiv), 
Na2CO3 (1.0 equiv), [Cu(dap)2]Cl (25) (1.0 mol%) in MeCN (anh., degassed, 2.0  mL), irradiation at 
530 nm (green LED) for 48 h.  
 
Moreover, when electron withdrawing CF3 group was employed in combination with allyl phenyl 
ether (1c), 17% of the elimination product 16d and 43% of ATRA product 15d were obtained. 
Interestingly, when allyl alcohol (1f) was employed in the reaction with 4-
trifluoromethylbenzenesulfonyl chloride (2d) the formation of the elimination product 16d´ 
occurred selectively with 75% yield. Further increase of the electron withdrawal by introducing 
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nitro group in para-position resulted in the formation of both the ATRA product 15e and 
elimination product 16e in 39% yield and 20% yield, respectively. Again, the reaction of allyl 
alcohol (1f) showed only the generation of the alkene 16e´ in 70% yield. The formation of the 
elimination products can be favored by the initial deprotonation of the free hydroxy group of 
allyl alcohol which can easily abstract the acidic proton next to the sulfonyl group. This effect 
is enhanced when electron withdrawing groups are present which can stabilize the resulting 
anion. The easy elimination of hydrochloric acid in chlorosulfonylated products was 
demonstrated by S. Engl11 thus underlining the acidic character of this compound class. The 
amount of the elimination product rises from electron rich to electron poor substrates. However, 
the result obtained with tosyl chloride (2a) is not in accordance wih this proposal, thus 
indicating additional mechanistic reasons responsible for the elimination process. 
4. Mechanistic Studies  
In order to get a deeper insight into the mechanism of the photoinduced chlorosulfonylation 
reaction several mechanistic studies were performed in cooperation with S. Engl and A. 
Hossain. To bring the reaction in line with a radical pathway of the chlorosulfonylation reaction, 
the radical trapping experiment with TEMPO (17) was carried out. However, no radical could 
be trapped during this reaction (Scheme 9). Conceivably, the basic reaction conditions lead to 
the decomposition of the formed TEMPO trapping products 18 and 19. In contrast, S. Engl 
observed the formation of benzylic radical, when the reaction of styrene (1a) with tosyl chloride 
(2a) in the presence of TEMPO (17) was investigated.11  
 
Scheme 9. Radical trapping experiment using TEMPO (17). 
Furthermore, when diallyl ester 20 was applied to the optimized reaction conditions the cyclic 
product 21 was obtained in 83% yield and excellent syn/anti ratio of 96:4 (Scheme 10). The 
cyclization occurs by addition of the formed tosyl radical to the double bond of substrate 20 
forming free intermediary radical 22. This radical can undergo a 5-exo-trig cyclization to form 
substituted cyclopentane 21. Another evidence for the free radical pathway was delivered by 
S. Engl, when he carried out the radical clock experiment. Moreover, he demonstrated the 
ligand dissociation during the ATRA process and determined the quantum yield of the reaction 
to be 9%.11 These results were in accordance with the experimental data which were obtained 
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for the iodoperfluoroalkylation reaction (see chapter C), thus indicating analogue inner sphere 
mechanisms.17 
 
Scheme 10. Light promoted radical cyclization reaction.  
Finally, the role of sodium carbonate, which has also been shown to be beneficial in other 
reported copper mediated photoredox catalyzed transformations towards alkylsulfones5, 18, 
was investigated by A. Hossain.19 For this purpose he used allyl benzene (1d) under standard 
reaction conditions without adding sodium carbonate (Scheme 11, reaction a, conditions i). 
After 24 h styrene (1a) was added and the reaction mixture was stirred for additional 24 h 
(Scheme 11, reaction a, conditions ii). The NMR analysis of reaction mixture detected the 
ATRA products 3a and 3d in 47% yield and 7% yield, respectively. The yield obtained for 
product 3a is much lower compared to the reaction of styrene (1a) with tosyl chloride (2a) 
(Scheme 4), thus suggesting poisoning of the catalyst in the presence of unactivated alkenes 
without sodium carbonate. When the reaction was repeated, but Na2CO3 was added in 
combination with styrene (1a) (Scheme 11, reaction b, conditions ii) both ATRA products were 
obtained in higher yields. These results indicate the protective or regenerative character of the 
sodium carbonate for the copper catalyst. The higher yields for product 3a can be explained 
by a higher reactivity of styrene compared to unactivated alkene (cf. chapter C). 
  
Scheme 11. Mechanistic studies carried out by A. Hossain.19 
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5. Proposed Mechanism 
With all the experimental results in hand the mechanism of chlorosulfonylation reaction of 
alkenes can be described as follows. The presence of radical chain mechanism can be 
excluded through the failure of performing the reaction under thermal conditions in the 
presence of AIBN11, 19 and a quantum yield of 9%11, 19 which is not characteristic for a radical 
chain propagation. However, the interpretations based on quantum yield should be taken very 
carefully into account because the analysis based on yield of the desired product and absorbed 
photons does not consider the participation of other photomediated transformations that do not 
lead to the desired ATRA product.20 Since Stephenson et al.4 demonstrated that [Ru(bpy)3]Cl2 
(oxidative quenching cycle: Ru3+/Ru2+* = -0.81 V vs SCE)21 is capable to generate sulfonyl 
radical (Scheme 1), both the highly reductive fac-Ir(ppy)3 (oxidative quenching cycle: 
Ir4+/Ir3+* = -1.73 V vs SCE)21 and [Cu(dap)2]Cl (25) (oxidative quenching cycle: Cu2+/Cu+* =  
-1.43 V vs SCE)21  should also be able to generate this radical. However, the simple back 
electron transfer mechanism, including oxidation of the radical to cation is also not plausible, 
due to the low yields obtained with highly oxidative [Ru(bpy)3]Cl2 (oxidative quenching cycle: 
Ru3+/ Ru2+ = +1.29 V vs SCE)21 and fac-Ir(ppy)3 (oxidative quenching cycle: Ir4+/ Ir3+ = +0.77 V 
vs SCE)21 compared to [Cu(dap)2]Cl (25) (Cu2+/ Cu+ = +0.62 V vs SCE)21. In the similar way as 
described in chapter C for iodoperfluoroalkylation reaction, two plausible mechanisms can be 
proposed as follows (Scheme 12).17 After single electron transfer from the photoexcited copper 
catalyst 26 to sulfonyl chloride 2 sulfur-centered radical 23 is formed which adds to alkene 1 
to give carbon-centered radical 24. As the consequence of the catalyst oxidation one dap 
ligand is replaced by two chlorines forming the copper(II)-species 27. Radical 24 can now 
undergo two different pathways, rebound mechanism (Scheme 12, Path A) and ligand transfer 
cycle (Scheme 12, Path B). In the rebound pathway radical 24 adds directly to Cu(II)-center of 
27 forming Cu(III)-species 28 with coordination number four (Scheme 12, Path A). Monomeric 
Cu(III)-complexes are known to have the favored coordination number four, whereas the five 
coordinated complexes are rare.22 For this purpose, one chloride leaves the coordination 
sphere of copper and acts as counteranion. Subsequent reductive elimination provides the 
desired ATRA product 3 / 15 and regenerates [Cu(dap)2]Cl (25) photocatalyst. 
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Scheme 12. Proposed mechanism for the chlorosulfonylation reaction of alkenes. 
Alternatively, the intermediary radical 24 adds to the chlorine ligand of Cu(II) complex 27, thus 
forming the desired product 3 / 15 through a homolytical copper-chlorine bond cleavage and 
regenerating [Cu(dap)2]Cl (25) (Scheme 12, Path B). Similarly to the discussion in chapter C, 
the mechanistic pathway for [Cu(dap)Cl2] (27) is described to start with photoexcitation and 
generation of Cu(II)-complex 29 This complex can undergo homolytic Cu(II)-Cl bond cleavage 
to form Cu(I)-species 30 and chlorine.19 In the new formed complex 30 another dap ligand, 
solvent23 or halide coordinate to the copper center and chloride acts as counteranion, thus 
forming the catalytically active Cu(I)-species 30. The transformation of Cu(II)-catalyst 27 into 
Cu(I)-species 30 is a plausible way to explain the similarity of the obtained yields for both 
catalytic systems. 
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6. Summary 
In summary, an efficient protocol for chlorosulfonylation of unactivated alkenes was described. 
Compared to the commonly used photocatalysts [Ru(bpy)3]Cl2 and fac-Ir(ppy)3 the employed 
copper catalysts [Cu(dap)2]Cl (25) and [Cu(dap)Cl2] (27) demonstrated higher yields with 
excellent functional group tolerance. However, for the successful transformation the addition 
of equimolar amount of sodium carbonate was crucial. In collaboration with S. Engl and A. 
Hossain plausible inner sphere mechanisms were proposed and verified by various 
mechanistic experiments thus underlining the unique attributes of copper catalysts in 
photoredox catalysis. The use of the inorganic base was determined to have protective or 
regenerative function for the copper catalyst.19 
 
Scheme 13. Copper mediated photoredox catalyzed chlorosulfonylation of unactivated alkenes.  
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E. Copper Mediated Light Promoted Synthesis of 
Allylsulfones  
1. Introduction 
A variety of natural products and phamaceuticals contain sulfone key structures1 including 
cyclic allyl sulfones which are known to act as antibacterial agents.2 In organic synthesis allyl 
sulfones play a relevant role as synthetic building blocks due to the unique properties of this 
substrate class. For example the allyl sulfones have electrophilic character and can react as 
equivalents to a 1,3- or 1,1-dipoles as demonstrated by Trost and coworkers.3 Under basic 
conditions the carbon next to the sulfonyl group can be deprotonated to produce a nucleophile 
that can undergo coupling reactions or Julia olefinations.1a, 4 In general, allyl sulfone 
nucleophiles can add to carbonyls or other electrophiles, thus acting as building blocks for 
example in the synthesis of polycyclic products5 as shown in Scheme 1 or heterocycles6.  
 
Scheme 1. Allylsulfones as building blocks in the synthesis of polycyclic compounds by Chang and 
coworkers.5 
In 2017 Meggers et al.7 presented enantioselective addition of allylsulfones to ,-unsaturated 
double bonds employing chiral Rhodium-Lewis acid and Hantzsch ester under irradiation with 
21 W compact fluorescent lamp (CFL) (Scheme 2). In this reaction the allylsulfone 6 was used 
as a nucleophile providing the desired products 7 and 8 in good yield and high enantiomeric 
excess. Further examples for enantioselective synthesis employing allyl sulfones are 
described in the literature8.   
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Scheme 2. Synthesis of chiral compounds using allylsulfones as nucleophiles reported by Meggers and 
coworkers.7 
Moreover, allylsulfones can be used in radical allylation reactions as demonstrated by 
Fensterbank and coworkers9. In this reaction sulfone moiety acts as a leaving group after the 
addition of aryl radical to the double bond of the allyl group, thus enabling the formation of 
monoallylated arenes 11 (Scheme 3). 
 
 
Scheme 3. Photoredox catalyzed addition of aryl radicals to allyl sulfones by Fensterbank and 
coworkers9. 
The most commonly used strategy for the synthesis of allyl sulfones is the oxidation of 
corresponding sulfides with peracids or with tetra-n-butylammonium oxone.10 Furthermore, the 
compound class of allylsulfones can be obtained by palladium catalyzed reactions of allyl 
alcohols11 (12) and allyl amines12 (15) with oxcess of sodium sulfinates (Scheme 4). In these 
reactions the boron-based lewis acids coordinate to the hydroxy or amine moieties and enable 
the formation of Pd-coordinated allyl cation which is finally attacked by sulfinate 13/16 as a 
nucleophile to form the allyl sulfones 14 and 17.  
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Scheme 4. Pd-catalyzed synthesis of allylsulfones starting from allyl alcohols11 and allyl amines12. 
Furthermore, the generation of allyl sulfones from allyl bromide can be usually achieved 
through two synthetic strategies (Scheme 5): First, initial transformation of allyl bromide (18a) 
to the corresponding metal organyl, using zinc13, magnesium14 or bismuth10, can be used for 
the subsequent nucleophilic attack on sulfonyl chlorides 19 to form the final product (Scheme 
5, upper part). Secondly, sodium sulfinate 21 can be employed as nucleophile in the direct 
reaction with allyl bromide (18a) under reflux15 or in the presence of phase transfer catalyst16 
(Scheme 5, bottom part). 
 
Scheme 5. Synthetic pathways towards allylsulfones starting from allyl bromide. 
Aim of this project was the investigation of the unexpected photoreaction of allyl bromide (18a) 
with tosyl chloride (19a) (cf. chapter D) forming allylsulfone product 20a and subsequent 
development of photoredox catalyzed procedure for the synthesis of allylsulfones employing 
[Cu(dap)2]Cl and other commonly used photocatalysts.  
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2. Preliminary Studies with Tosyl Chloride and Allyl Bromide  
The initial reaction for this project was carried out in chapter D when allyl bromide (18a) was 
used as the alkene for the chlorosulfonylation reaction with tosyl chloride (19a) (Chapter D, 
Scheme 7). Surprisingly, instead of the desired ATRA product 22 the formation of the allyl 
sulfone 20a was obtained in 87% isolated yield. 
 
Scheme 6. Allyl bromide (18a) as substrate for the ATRA reaction. 
With this first result in hand, the optimized reaction conditions using allyl bromide (18a) and 
tosyl chloride (19a) as benchmark substrates were determined (Table 1). The monitoring of 
the reaction time showed that after 24 h the allylation product 20a was formed in 71% yield 
(entry 2), whereas the increase of the reaction time to 72 h resulted in a similar yield as after 
48 h (entries 1 and 3). The variation of solvent showed low yield for CH2Cl2 (entry 4) and no 
conversion for DMF and DMSO (entries 5 and 6). The reaction in the absence of sodium 
carbonate resulted in 9% yield indicating a key function of the base during the transformation 
(entry 7). When the amount of sodium carbonate was lowered to 0.5 equivalents or even 
0.1 equivalents excellent yields were obtained (entries 8 and 9). Further decrease of base 
loading to 0.01 equivalents resulted in only 24% yield (entry 10). In contrast to the results 
obtained in chapter D, where only sodium carbonate was a suitable inorganic base, the here 
presented allylation reaction showed good results with potassium carbonate and very high 
yields employing NaHCO3 (entries 11 and 12). When the excess of allyl bromide (18a) was 
decreased, lower yields for the desired product 20a were observed (entries 13-15). While the 
reduction of the catalyst loading to 0.5 mol% gave only slightly lower yield (entry 16), a further 
decrease of catalyst amount resulted in only 38% yield (entry 17). As expected, the reaction 
with [Cu(dap)Cl2] photocatalyst showed similar yield as with copper(I)-catalyst (entry 18). This 
result is in accordance with the outcomes obtained in the previous chapters C and D. In the 
presence of [Ru(bpy)3]Cl2 only 52% yield were observed, whereas the employment of fac-
Ir(ppy)3 resulted in 85% yield (entries 19 and 20). The results for fac-Ir(ppy)3 were further 
improved when the reaction was carried out in the absence of the base, suggesting no positive 
effect of inorganic base for the iridium-catalyzed reaction (entry 21).  
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Table 1. Determination of optimal reaction conditions for the photoredox catalyzed synthesis of 
allylsulfones. 
 
Entry Conditions Yield [%][a] 
1 / 90 
2 24 h 71 
3 72 h 92 
4 CH2Cl2 28 
5 DMF 0 
6 DMSO 0 
7 no base 9 
8 Na2CO3 (0.5 equiv) 96 
9 Na2CO3 (0.1 equiv) 95 
10 Na2CO3 (0.01 equiv) 24 
11 K2CO3 (1.0 equiv) 62 
12 NaHCO3 (1.0 equiv) 90 
13 Allyl bromide (2.0 equiv) 36 
14 Allyl bromide (4.0 equiv) 62 
15 Allyl bromide (5.0 equiv) 80 
16 [Cu(dap)2]Cl (0.5 mol%) 85 
17 [Cu(dap)2]Cl (0.1 mol%) 38 
18 [Cu(dap)Cl2] (1.0 mol%) 90 
19 [Ru(bpy)3]Cl2 (1.0 mol%) 52 
20 fac-Ir(ppy)3 (1.0 mol%) 85 
21 fac-Ir(ppy)3 (1 mol%), no base 95 
  22[b] no catalyst, 530 nm LED 24 
  23[b] no catalyst, 455 nm LED 42 
  24[b] no catalyst, 455 nm LED, no base 10 
25 no light 2 
26 AIBN 29 
27 dap (2.0 mol%) 455nm 38 
28 dap (2.0 mol%) 530nm 16 
29 CuCl (10.0 mol%) 455nm 10 
30 CuCl (10.0 mol%) 530nm 4 
31 CuCl2 (10.0 mol%) 455nm 12 
32 CuCl2 (10.0 mol%) 530nm 5 
33 O2-atmosphere 55 
34 air-atmosphere, not degassed 90 
Reaction conditions: allyl bromide (18a) (3.0 mmol, 6.0 equiv), TsCl (19a) (0.5 mmol, 1.0 equiv), Na2CO3 
(1.0 equiv), [Cu(dap)2]Cl (1.0 mol%) in MeCN (dry, degassed, 2.0  mL), irradiation at 530 nm (green 
LED) for 48 h. a Determined by NMR with 1,1,2,2-tetrachloroethane as an internal standard. b 72 h 
reaction time.  
The reactions with no photocatalyst using green light (530 nm LED) and blue light (455 nm 
LED) provided the allylation product 20a in 24% yield and 42% yield, respectively (entries 22 
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and 23). Although the reaction time for these experiments was increased to 72 h it is an 
important result for the understanding of the mechanism (vide infra). However, carrying out the 
reaction in the absence of photocatalyst and sodium carbonate gave only 10% yield, thus again 
demonstrating the important role of base additive (entry 24). The key role of light was 
underlined by the dark reaction resulting in only 2% yield (entry 25) and thermal initiation of 
the reaction in the presence of AIBN, which provided the desired product in only 29% yield 
(entry 26). The usage of free dap ligand under irradiation with blue light (455 nm LED) or green 
light (530 nm LED) resulted in very low yields (entries 27 and 28). Likewise, the reactions with 
copper chloride salts in the absence of dap ligand produced only low amounts of the desired 
allylsulfone 20a (entries 29-32). Finally, it was demonstrated, that the reaction is not very 
sensitive to oxygen. While the reaction with O2-saturated solution, under oxygen atmosphere 
gave 55% yield, the reaction with no degassed solution under air atmosphere provided the 
desired product in very good yield (entries 33 and 34). 
3. Substrate Scope 
With the optimized reaction conditions in hand the substrate scope for the photoredox 
catalyzed synthesis of allyl sulfones 20 was explored (Scheme 7 and Table 3). First, the 
variation of sulfonyl chlorides 19 was carried out using allyl bromide (18a) as allylation reagent 
(Scheme 7). The reaction of 4-methoxybenzenesulfonyl chloride (19b) with methoxy-moiety 
as strong electron donating group provided the desired allylation product 20b in 83% yield. 
Likewise, employing electron rich tosyl chloride (19a) gave product 20a in very good yield of 
93%. When the electron donating group in para-position was removed, the yield for the 
corresponding allylsulfone 20c dropped to 63%. Decreasing the electronic density in the aryl 
ring by introducing trifluoromethyl group resulted in 70% yield for the desired product 20d and 
the employment of the strongly withdrawing nitro group led to the formation of the product 20e 
in 69% yield. Likewise, the use of pentafluorobenzenesulfonyl chloride (19i) provided sulfone 
20i in 70% yield. When sterically hindered 2,4,6-triisopropylbenzenesulfonyl chloride (19f) was 
investigated in this reaction, no conversion of the starting material was observed. A similar 
result was obtained when using the sterically less hindered 2,4,6-trimethylbenzenesulfonyl 
chloride (19g). In order to prove the steric argument for the unsuccessful transformation, 2-
methylbenzenesulfonyl chloride (19h) was employed as starting material, having similar 
electronic properties compared to the tosyl chloride (19a) which showed excellent yield for the 
allylsulfone 20a. Interestingly, when the methyl group was switched to the ortho-position of the 
aryl ring the yield of product 20h dropped to 42% with no full consumption of the starting 
material. However, based on recovered starting material 79% yield was achieved being in 
accordance with the result for the tosyl chloride (19a). This result indicates a strong steric effect 
of the methyl group in ortho-position.  
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Scheme 7. Substrate scope for the photomediated synthesis of allylsulfones 20. 
Reaction conditions: Alkene (3.0 mmol, 6.0 equiv), TsCl (0.5 mmol, 1.0 equiv), Na2CO3 (0.1 equiv), 
[Cu(dap)2]Cl (1.0 mol%) in MeCN (dry, degassed, 2.0  mL), irradiation at 530 nm (green LED) for 48 h. 
In addition, the reactions with thiophenesulfonyl chlorides 19j and 19k showed very good yields 
for the desired allylsulfones 20j and 20k in 91% yield and 83% yield, respectively. Finally, the 
successful transformation of ethylsulfonyl chloride (19l) to the corresponding allylsulfone 20l 
was demonstrated in 70% yield. Particularly, this result is important for the understanding of 
the mechanism of the present reaction (vide infra). 
Next, selected reactions with fac-Ir(ppy)3 (cf. Table 1, entry 21) as photocatalyst or in the 
absence of the catalyst (cf. Table 1, entry 23) were carried out in addition to the results of 
copper catalysis. The comparison of these results is summarized in Table 2. In the case of the 
electron rich allylsulfones 20a and 20b copper and iridium catalysts showed similar yields, 
while in the absence of the catalyst only moderate yields were obtained (entries 1-6). These 
results in combination with the control experiments (cf. Table 1, entry 24 and 25) indicate that 
aromatic sulfonyl chlorides can interact with visible light and thus are able to initiate the 
allylation reaction even in the absence of the catalyst. However, the photocatalysts have a 
significant effect on the reaction time and yield. Even with the prolonged reaction time of 72 h 
no full conversion was obtained in the absence of photocatalyst. The formation of para-nitro 
substituted allylsulfone 20e in 65% yield in the absence of photocatalyst compared to 70% 
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yield for copper catalysis confirmed the assumption that aromatic sulfonyl chlorides can initiate 
the reaction via visible-light absorption (entries 7-9). However, for the heterocyclic allylsulfone 
20j again only moderate yield was observed when no photocatalyst was added to the reaction 
mixture (entries 10-12). Furthermore, when ethylsulfonyl chloride was employed in the 
allylation reaction no product was formed in the absence of the catalyst, whereas in the 
presence of [Cu(dap)2]Cl or fac-Ir(ppy)3 good yields of the desired product 20l were observed 
(entries 13-15). In summary the ability of product formation in the absence of photocatalyst 
was limited to aromatic sulfonyl chlorides. Moreover, the iridium catalyst and copper catalyst 
showed comparable results for all substrates.   
Table 2. Comparison of yields obtained in the absence of photocatalyst and in the presence of 
[Cu(dap)2]Cl and fac-Ir(ppy)3. 
 
Entry Product Catalyst Yield [%] 
1[a] 
 
No catalyst 42 
2[b] 
[Cu(dap)2]Cl 93 
3[c] 
fac-Ir(ppy)3 95 
4[a] 
 
No catalyst 44 
5[b] 
[Cu(dap)2]Cl 83 
6[c] 
fac-Ir(ppy)3 87 
7[a] 
 
No catalyst 65 
8[b] 
[Cu(dap)2]Cl 70 
9[c] 
fac-Ir(ppy)3 87 
10[a] 
 
No catalyst 41 
11[b] 
[Cu(dap)2]Cl 91 
12[c] 
fac-Ir(ppy)3 90 
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13[a] 
 
No catalyst 0 
14[b] 
[Cu(dap)2]Cl 70 
15[c] 
fac-Ir(ppy)3 68 
Reaction conditions: [a]allyl bromide (18a) (3.0 mmol, 6.0 equiv), sulfonyl chloride (19) (0.5 mmol, 
1.0 equiv), Na2CO3 (0.1 equiv) in MeCN (dry, degassed, 2.0  mL), irradiation at 455 nm (blue LED) for 
72 h. [b] Allyl bromide (18a) (3.0 mmol, 6.0 equiv), sulfonyl chloride (19) (0.5 mmol, 1.0 equiv), Na2CO3 
(0.1 equiv), [Cu(dap)2]Cl (1.0 mol%) in MeCN (dry, degassed, 2.0  mL), irradiation at 530 nm (green 
LED) for 48 h. [c] Allyl bromide (18a) (3.0 mmol, 6.0 equiv), sulfonyl chloride (19) (0.5 mmol, 1.0 equiv), 
fac-Ir(ppy)3 (1.0 mol%) in MeCN (dry, degassed, 2.0  mL), irradiation at 455 nm (blue LED) for 48 h.  
 
In the next step, the variation of alkyl halides 18 with tosyl chloride (19a) as model substrate 
was performed (Table 3). Using allyl chloride (18b) instead of allyl bromide (18a) full 
conversion of the starting material was observed, but only 17% of the desired allylsulfone 20a 
were obtained (entry 2) besides the ATRA product 24 in 56% yield. Increasing the steric 
demand of the double bond by introducing methyl group in 2-position of allyl bromide resulted 
in the formation of the expected allylsulfone 23c in excellent yield (entry 3). However, when 
the methyl group was switched to the 3-position using crotyl bromide (18d) two types of product 
were formed (entry 4). On the one hand the inseparable E/Z mixture of product 23d was 
generated in 31% yield and diastereomeric ratio of 74:26. On the other hand, the product 23d´ 
was obtained in 50% yield. The latter was in accordance with results obtained by Reiser and 
coworkers17 in 2015.  
 
Table 3. Variation of alkyl halides 18 in photoredox catalyzed synthesis of allylsulfones 23. 
 
 
Entry Alkene Product Yield  
1  
 
 
 
18a 
 
20a  
 93% 
 
2  
  
 
18b 
 
20a 
17% 
24 
56% 
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3 
 
 
 
 
18c 
 
23c 
92% 
 
4  
  
 
18d 
 
23d 
31% E/Z =74/26 
23d´ 
50% 
5 
 
  
 18e 23e 23e´ 
  overall 40-46% 
6 
 
 
 
 
18f 
 
23f 
0% 
 
Reaction conditions: Alkyl halide (18) (3.0 mmol, 6.0 equiv), TsCl (19a) (0.5 mmol, 1.0 equiv), Na2CO3 
(0.1 equiv), [Cu(dap)2]Cl (1.0 mol%) in MeCN (dry, degassed, 2.0  mL), irradiation at 530 nm (green 
LED) for 48 h. 
Unexpectedly, when introducing the additional methyl group into the double bond, no desired 
product was obtained but the formation of an inseparable mixture of halogenated allylsulfones 
23e and 23e´ in 40-46% yield and indeterminable ratio was observed (entry 5). Moreover, the 
employment of the sterically demanding 1-bromocyclohexene (18f) resulted in no product 
formation and low conversion of the starting material (entry 6). The variation of the alkyl halides 
demonstrated the strong limitation of the presented protocol. 
4. Proposed Mechanism 
Scheme 8 describes the proposed mechanisms for the formation of products 20a, 23c and 
23d/23d´. All three mechanisms are based on a free radical proposal. In the presence of 
copper photocatalyst the tosyl radical 25 is formed through a single electron transfer from 
[Cu(dap)2]Cl. This radical can abstract the bromine from the allyl bromide 26 generating allyl 
radical 27 and TsBr (28). The latter is known to undergo a homolytical S-Br bond cleavage in 
the presence of radicals providing bromine radical and regenerating tosyl radical 25.18 The 
tosyl radical 25 can then undergo a radical recombination reaction with allyl radical 27 to form 
the desired product 29. Finally, the bromine radical can recombine with chloride forming ClBr 
and simultaneously reduce the Cu(II)-species to [Cu(dap)2]Cl. In the case of allyl bromide (18a) 
the formed allyl radical is symmetrical, thus both mesomeric structures 27a are identical. This 
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is the reason for the selective formation of only one allylsulfone product (Scheme 8, pathway 
a). When 3-bromo-2-methylpropene (18c) is used in the reaction, the formation of the allyl 
radical 27c occurs. Also, for this radical both mesomeric structures are identical, thus leading 
to the same allyl sulfone 23c in excellent yield (Scheme 8, pathway b). In contrast, the 
employment of crotyl bromide (18d) results in the formation of allyl radical with three different 
mesomeric structures (Scheme 8, pathway c). The recombination of tosyl radical 25 with allyl 
radicals E-27d and Z-27d results in the formation of E/Z mixture of the desired allyl sulfone 
23d, whereas the reaction with allyl radical 27d´ generates the major product 23d´. The ratio 
of the three products can be explained by the different stability of the intermediary allyl 
radical19. The major product 23d´ is formed via more stable secondary radical 27d´, whereas 
the E/Z products 23d result from less stable primary radicals E-27d and Z-27d.  However, the 
stability of the radical can also be unfavorable for a successful reaction if the radical is not 
reactive enough.19c   
 
Scheme 8. Mechanistic analysis for different alkyl bromides.  
As depicted in Scheme 9 a proposed mechanism for the reaction between tosyl chloride (19a) 
and 3,3-dimethylallyl bromide (18e) explains the unexpected outcome for the generation of the 
inseparable product mixture 23e and 23e´. After formation of the mesomeric structures 29 and 
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29´ like in the above proposed mechanism for other allyl bromides the generation of two 
products 30 and 30´ was expected. However, instead of the expected allyl sulfones the 
halogenated allyl sulfones 23e and 23e´ were obtained as inseparable product mixture. The 
mesomeric structure 29´ of the allyl radical undergoes a bromine abstraction from TsBr18 (28) 
forming allyl bromide 31. Subsequent elimination of HBr in the presence of a base provides 
the formation of 1,3-diene 32 that can be consequently attacked by a tosyl radical 25 forming 
carbon centered radical 33/33´. Due to its mesomeric structure 33´ a chlorine can be 
abstracted from TsCl (19a) or a bromine from 3,3-dimethylallyl bromide (18e), thus forming the 
halogenated allyl sulfones E-34 and E-34´. Although the secondary radical 33 should be more 
stable than the primary radical 33´, the latter leads to the formation of products with higher 
substituted double bond and thus forms the thermodynamically more stable product. This 
observation is consistent with the higher reactivity of radical 33´ compared to the more stable 
radical 33, but is not in agreement with the results observed for the reaction of crotyl bromide 
(cf. Scheme 8).  
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Scheme 9. Proposed mechanism for the reaction of 3,3-dimethylallyl bromide (18e) with tosyl chloride 
(19a). 
Further mechanistic investigations were focused on trapping the intermediary allyl radical 27a 
with excess of styrene (35) to form ATRA type product 37 (Table 4). When the reaction was 
carried out with 1.0 equivalent allyl bromide (18a), 1.0 equivalent TsCl (19a) and 
5.0 equivalents styrene (35) in the presence of [Cu(dap)2]Cl and sodium carbonate in MeCN 
under irradiation with green LED, only the ATRA product 37 was obtained in 95% yield 
(entry 1). In order to prevent the undesired formation of ATRA product 37, the amount of allyl 
bromide (18a) was drastically increased to 6.0 equivalents. However, again only ATRA product 
37 was obtained in quantitative yield (entry 2). When no tosyl chloride (19a) was used no 
conversion of the starting material was observed (entry 3). The obtained results underline the 
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role of tosyl radical as initiator for the allylation reaction. However, the allylation process seems 
to be much slower compared to the atom transfer radical addition reaction, thus losing the 
competition between these reactions.   
Table 4. Efforts towards trapping of allyl radical. 
 
Entry 18a [equiv] 19a [equiv] 35 [equiv] 36 [%] 20a [%] 37 [%] 
1 1.0 1.0 5.0 95 0 0 
2 6.0 1.0 6.0 99 0 0 
3 1.0 0.0 1.0 0 0 0 
Furthermore, the allylation reaction was investigated with other radical sources in visible light 
mediated processes established in the literature20 (Scheme 10). The reaction of diethyl 
bromomalonate (38) under established reaction conditions led to the formation of product 39 
in 75% yield, derived from the nucleophilic attack of deprotonated malonate on sp3-center of 
allyl bromide (18a). Additionally, only 11% of the desired photoproduct 40 were obtained. 
Nevertheless, when the reaction was carried out with fac-Ir(ppy)3 in the absence of sodium 
carbonate the allylated photoproduct 40 was formed in 84% yield. This reaction shows an 
additional limitation of the copper-mediated process, disabling the employment of substrates 
with acidic protons. Moreover, the reaction of benzyl bromides 41a and 41b showed only low 
conversion and traces of the desired products 42a and 42b. These results are somehow 
surprising, because the reaction of 4-nitrobenzyl bromide (41b) with alkenes catalyzed by 
copper catalyst is well known and thus the generation of benzyl radical by [Cu(dap)2]Cl should 
be possible.17, 21 Finally, the allylation reaction was carried out employing diazonium salts 44.20d 
The purpose of this reaction was to develop a protocol for the selective monoallylation of 
arenes without disadvantage like polyalkylation, which are known in Friedel-Crafts-alkylation 
reactions. The reaction with copper catalyst and additional inorganic base provided the 
monoallylated arene 45 in 28% yield. Employing iridium photocatalyst in the absence of base 
additive delivered the product 45 in slightly higher yield of 44%. Although both reactions gave 
the desired product, the obtained yields were too low for further investigation of this 
transformation. 
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Scheme 10. Variation of radical source for the photoinitiated allylation reaction. 
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5. Summary 
In conclusion an efficient protocol for the photoredox catalyzed synthesis of allylsulfones 46 
was developed employing copper- and iridium-photocatalysts (Scheme 11). The variation of 
sulfonyl chlorides 19 showed high functional group tolerance, whereas the variation of alkyl 
halides 18 was strongly limited to allylbromide (18a) and substrates with symmetrical 
mesomeric structures of the intermediary allyl radical. The proposed mechanism is assumed 
on the recombination of free radicals, thus explaining the results obtained in the absence of 
photocatalyst (vide supra). The comparison of the results obtained by copper catalysis and 
iridium catalysis showed slight advantages in the use of iridium catalyst as no base addition is 
required. Nevertheless, the present reaction again underlined the protective character of 
sodium carbonate for the [Cu(dap)2]Cl catalyst. The extension of the protocol to other radical 
sources known in visible light photoredox catalysis showed additional limitation of copper 
catalyst (e.g. reaction of diethyl bromomalonate) or only low yields of the desired allylation 
products obtained in the presence of both photocatalysts (reactions with benzyl bromides and 
diazonium salts).  
 
Scheme 11. Photoredox catalyzed synthesis of allylsulfones 46. 
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F. Summary 
1. Summary in English 
The present PhD thesis demonstrates the unique character of the employed photoredox 
catalysts in organic transformations. In chapter A the introduction into the field of photocatalysis 
is given by an overview about the commonly employed photocatalysts and the most important 
properties of photoredox catalysts such as photophysics, redox behavior and coordination 
ability.  
Chapter B “Synthesis of Heterocycles via Photoredox Mediated Deoxygenation Reaction” is 
directly linked to the results obtained during my master thesis and is focused on the synthesis 
of substituted N-heterocycles via photoredox catalyzed C-O bond activation. Due to the 
strongly negative reduction potentials of the employed ethyl oxalates and 3,5-
bis(trifluoromethyl)benzoates, a catalyst with strong reduction potential such as fac-Ir(ppy)3 is 
crucial for the successful transformation. While the synthesis of the polysubstituted pyrrolidines 
was successful, the limitations of the developed protocol were revealed by the failure in the 
synthesis of bicyclic compounds and lactames. 
In chapter C “Copper Mediated Photochemical Iodoperfluoroalkylation” the new photocatalyst 
[Cu(dap)Cl2] is employed in the copper mediated iodoperfluoroalkylation of alkenes and 
alkynes, which was already reported by T. Rawner employing [Cu(dap)2]Cl. After determination 
of the optimized reaction conditions and the investigation of the substrate scope, several 
mechanistic studies were performed. Both catalysts show outstanding results in the 
transformation of styrene derivatives which are no suitable substrates for other catalytic 
systems reported in the literature. Moreover, the enhanced mechanistic investigation provided 
information about the unique character of copper-based photocatalysts and the plausible 
mechanism for this transformation including rebound pathway and ligand exchange process. 
Chapter D “Copper Mediated Chlorosulfonylation of Alkenes” demonstrates the protective role 
of sodium carbonate for the copper catalyst in efficient chlorosulfonylation reaction of 
unactivated alkenes. In contrast to the commonly used ruthenium- and iridium-based 
photocatalysts, showing only low yields of the desired product, the employment of copper 
catalysts enables the formation of chlorosulfonylated compounds in high yields. In cooperation 
with S. Engl and A. Hossain the mechanistic studies were performed providing information 
about plausible mechanism. Analogous to the results described in chapter C the inner sphere 
mechanisms of copper catalysts are proposed. 
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Finally, in chapter E “Copper Mediated Light Promoted Synthesis of Allylsulfones” the 
investigation of the unexpected reaction between allyl bromide and sulfonyl chloride obtained 
in chapter D is performed. After determination of optimal reaction conditions, the investigation 
of the substrate scope was carried out resulting in excellent yields for the variation of sulfonyl 
chlorides and strong limitations when modifying the alkyl halide part. The plausible mechanism 
for this photoinduced reaction includes radical recombination. Application of the developed 
protocol to other radical sources commonly used in photoredox catalysis resulted in low yields, 
thus demonstrating the limitations of the employed protocol.  
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2. Summary in German (Zusammenfassung) 
Die vorliegende Doktorarbeit besteht aus vier Projekten und befasst sich mit der Untersuchung 
der photoredox-katalysierten Reaktionen für deren Erfolg universelle Eigenschaften der 
eingesetzten Photokatalysatoren entscheidend sind. Zu Beginn werden in Kapitel A 
verschiedene gängige Katalysatortypen vorgestellt, die in photochemischen Reaktionen 
verwendet werden und die wichtigsten Eigenschaften von Photokatalysatoren beschrieben. 
Dabei wird unter anderem auf photophysikalische Eigenschaften, Redoxverhalten und 
Koordinationsfähigkeit eingegangen.    
Kapitel B “Synthesis of Heterocycles via Photoredox Mediated Deoxygenation Reaction” 
knüpft direkt an die Resultate meiner Masterarbeit und beschäftigt sich mit der Synthese von 
N-Heterozyklen mittels photoredox-katalysierten Aktivierung der C-O Bindung. Aufgrund der 
stark negativen Redoxpotentiale der eingesetzten Ethyloxalate und 3,5-
Bis(trifluoromethyl)benzoate ist der Einsatz eines stark reduzierenden Photokatalysators wie 
fac-Ir(ppy)3 für eine erfolgreiche Reaktion unabdingbar. Neben der erfolgreichen Synthese 
polysubstituierter Pyrrolidine wurde zudem die Limitierung des entwickelten Protokolls 
während der Synthese von Bizyklen und Lactam-Derivaten ermittelt.  
Im Kapitel C “Copper Mediated Photochemical Iodoperfluoroalkylation” wurde der neu 
entwickelte Photokatalysator [Cu(dap)Cl2] in der Iodoperfluoroalkylierungsreaktion von 
Alkenen und Alkinen untersucht. Die erhaltenen Ergebnisse wurden dabei mit den Resultaten 
von T. Rawner verglichen die beim Einsatz des etablierten [Cu(dap)2]Cl Katalysators erhalten 
wurden. Im Anschluss an die Bestimmung der optimalen Reaktionsbedingungen und der 
Substratbreite, wurden mehrere mechanistische Untersuchungen durchgeführt, um die 
universellen Eigenschaften von Kupferkatalysatoren zu belegen. Im Gegensatz zu den 
gängigen Katalysatoren, die in der photochemischen Iodoperfluoroalkylierung eingesetzt 
werden, zeigen kupferbasierte Komplexe herausragende Ergebnisse bei der Umsetzung von 
Styrolderivaten. Diese universelle Eigenschaft wurde durch mechanistische Studien belegt 
und Rebound Mechanismus mittels postulierter Cu(III)-Spezies, sowie Ligandenaustausch 
Mechanismus als plausible Erklärungen für die erhaltenen Resultate präsentiert. 
Kapitel D “Copper Mediated Chlorosulfonylation of Alkenes” beschreibt die schützende 
Wirkung von Natriumcarbonat für Kupferkatalysatoren bei der effizienten 
Chlorosulfonylierungsreaktion von unaktivierten Alkenen. Im Gegensatz zu gängigen 
ruthenium- und iridiumbasierten Photokatalysatoren, die lediglich niedrige Ausbeuten des 
erwünschten Produkts liefern, zeigt Kupfer herausragende katalytische Aktivität in der 
beschriebenen Reaktion. In Kooperation mit S. Engl und A. Hossain wurden zudem 
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mechanistische Untersuchungen durchgeführt und analog zum Kapitel C Mechanismen 
postuliert, die auf der koordinierenden Funktion des Kupfers basieren. 
Abschließend wurde im Kapitel E “Copper Mediated Light Promoted Synthesis of Allylsulfones” 
die photochemische Synthese von Allylsulfonen aus Allylbromid und Sulfonylchloriden 
untersucht. Nach erfolgter Bestimmung optimaler Reaktionsbedingungen wurde die 
Substratbreite der beschriebenen Reaktion untersucht. Dabei wurde bei der Variation von 
Sulfonylchloriden Toleranz gegenüber einer Reihe von funktionellen Gruppen ermittelt. Bei der 
Modifizierung der Allylbromide wurden jedoch starke Limitierungen der verwendeten 
Reaktionsbedingungen deutlich und der vorliegende Mechanismus als Rekombination freier 
Radikale beschrieben. Zudem wurde beim Einsatz weiterer in der Photoredoxchemie gängiger 
Radikalquellen zusätzliche Schwächen der entwickelten Methode deutlich. 
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G. Experimental Part 
1. General Information 
Commercially available chemicals were purchased in high quality and were used without 
further purification. All reactions were carried out in flame dried glassware under atmospheric 
conditions unless otherwise stated. Reactions with moisture or oxygen sensitive reagents were 
carried out in flame dried glassware under an atmosphere of predried nitrogen. Anhydrous 
solvents were prepared by established laboratory procedures1. DCM, EtOAc and hexanes  
(40-60 °C) for chromatography were distilled prior to use. All photochemical reactions were 
carried out in flame dried glassware applying three consecutive freeze-pump-thaw cycles. The 
reported yields are referred to the isolated compounds unless otherwise stated.  
Chromatography 
Thin layer chromatography was performed with TLC precoated aluminum sheets (Merck) Silica 
gel 60 F254, 0.2 mm layer thickness. Visualization was done with UV light 
 (λ= 254 nm) and staining with vanillin (6 g vanillin, 100 mL ethanol (95%), 1 mL conc. sulfuric 
acid), ninhydrin (300 mg ninhydrin, 3 mL conc. acetic acid, 100 mL ethanol) or potassium 
permanganate (1.0 g KMnO4, 2 g Na2CO3, 100 mL water) followed by heating. Column 
chromatography was performed with silica gel (Merck, 0.063-0.200 mm particle size) and flash 
silica gel 60 (Merck, 0.040-0.063 mm particle size). 
NMR-Spectroscopy 
1H NMR spectra were recorded on FT-NMR-spectrometer of the type Bruker Avance 300 
(300 MHz for 1H, 75 MHz for 13C, 282 MHz for 19F) or BRUKER Avance III 400 “Nanobay” 
(400 MHz for 1H, 100 MHz for 13C, 386 MHz for 19F). Chemical shifts for 1H NMR were reported 
as δ, parts per million (ppm), relative to the signal of CHCl3 at 7.26 ppm, H2O at 4.79 ppm, 
relative to the center line signal of the CH3CN quintet at 1.94 ppm and relative to the center 
line signal of the DMSO quintet at 2.50 ppm. Spectra were evaluated in 1st order and coupling 
constants J were reported in Hertz (Hz). The following notations indicate the multiplicity of the 
signals: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, p = quintet, sex = 
sextet, hept = septet, and m = multiplet, and combinations thereof. Chemical shifts for 13C NMR 
were reported as δ, parts per million (ppm), relative to the center line signal of the CDCl3 triplet 
at 77.2 ppm, CD3CN singlet at 118.3 and DMSO-d6 septet at 39.5 ppm. NMR yields were 
determined using diphenoxymethane or 1,1,2,2-tetrachloroethane as internal standards. 
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IR-Spectroscopy 
FTIR spectroscopy was carried out on a Cary 630 FTIR Spectrometer. Solid and liquid 
compounds were measured neatly, and the wave numbers are reported as cm-1. 
Mass Spectrometry 
Mass spectra were recorded by the Central Analytical Laboratory (University of Regensburg) 
using Jeol AccuTOF GCX and Agilent Q-TOF 6540 UHD. High-resolution mass spectra were 
measured using atmospheric pressure chemical ionization (APCI), electron ionization (EI), 
electrospray ionization (ESI) with a quadrupole time-of-flight (Q-TOF) detector. 
Polarimetry 
Determination of optical rotation was carried out on a MCP 500 Modular Circular Polarimeter 
by Anton Paar using 589 nm (Na-D-line) as measurement wavelength.  
Light Source 
Blue light irradiation in batch processes was performed using light emitting diodes OSLO 80 
rb (700 mA, 3 W, max = 455 nm), OSLO SSL 80 (700 mA, 3 W, max = 455 nm), CREE XP rb 
LED (700 mA, 3 W, max = 455 nm). Green light irradiation in batch processes was performed 
using a light emitting diode OSLON SSL 80 (700 mA, 3 W, max = 530 nm). In microreactor 
processes eight light emitting diodes OSRAM OSLON Black Series LD H9GP (700 mA, 3W, 
max = 455±10 nm) were employed.   
HPLC  
Enantiomeric excess was determined by chiral HPLC (Phenomenex Lux Cellulose-2, 4.6 x 
250 mm, particle size 5 µm). 
Melting Point Apparatus 
The measurement of melting point was carried out on a MPA100 - Automated melting point 
system by OptiMelt using a ramp rate of 1K/min.  
Cyclic Voltammetry 
Cyclic voltammetry measurements were carried out on an Autolab PGSTAT 302N set-up at   
20 °C in the stated solvent containing tetrabutyl ammonium tetrafluoroborate as the supporting 
electrolyte under an argon atmosphere with use of a conventional undivided electrochemical 
cell, a glassy carbon working electrode, platinum wire as the counter electrode and silver wire 
as the reference electrode. The solvent was degassed by vigorous argon bubbling prior to the 
Experimental Part 
131 
measurements. Redox potentials were referenced against ferrocene as internal standard. For 
better comparsion all values are reported in reference to the SCE electrode. The values were 
converted according to reference2.  
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2. Chapter B: Synthesis of Heterocycles via Visible Light Mediated 
Deoxygenation Reaction 
2.1. Synthesis of Literature Known Compounds and Reagents 
The following compounds were synthesized according to the reported literature procedures. 
The spectral data were in agreement with the data reported: fac-Ir(ppy)33, rac. ethyl 3-
phenyloxirane-2-carboxylate (36a)4, ethyl 3-methyloxirane-2-carboxylate (36b)4, 2,3-
diphenyloxirane (36d)5, rac. ethyl (2S,3S)-3-amino-2-hydroxy-3-phenylpropanoate (37a)4, 6, 2-
(allylamino)-1-phenylethan-1-ol (39be)7, isopropyl cinnamate (63)8, N-bromoacetamide9, 
isopropyl (2S,3R)-3-acetamido-2-hydroxy-3-phenylpropanoate (64)10, Shi-catalyst11, 2-amino-
1,1-diphenylethan-1-ol (72)12, methyl 2-aminobenzoate (85)13, methyl 2-(allylamino)benzoate 
(108)14, 2-acetoxypropanoic acid (134)15, N-(tert-butyl)prop-2-en-1-amine (137)16.     
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2.2. Compound Characterization 
2.2.1. Preparartion of Starting Materials for the Synthesis of 
Pyrrolidines 
General Procedure (GP-1) for the Synthesis of Alkylated Amino Alcohols via Allylation 
A 500 mL round bottom flask equipped with a magnetic stir bar and reflux condenser was 
charged with rac. ethyl (2R,3R)-3-amino-2-hydroxy-3-phenylpropanoate (37a) (2.6 mmol, 
1.0 equiv), DBU (5.2 mmol, 2.0 equiv) and toluene (200 mL). Alkyl bromide (5.2 mmol, 
2.0 equiv) was added dropwise at room temperature and the reaction mixture was stirred for 
96 h at 60 °C. After addition of water (100 mL) the mixture was extracted with EtOAc (2x 
100 mL). The combined organic layers were washed with water (3x 100 mL), dried over 
anhydrous Na2SO4, the solvent was evaporated in vacuo and the residue purified by silica gel 
column chromatography to give monoalkylated amino alcohol.  
rac. Ethyl (2S,3S)-3-(((E)-but-2-en-1-yl)amino)-2-hydroxy-3-phenylpropanoate (39aa) 
Following general procedure GP-1, using rac. ethyl (2S,3S)-3-amino-2-
hydroxy-3-phenylpropanoate (37a) (1.1 g, 5.1 mmol, 1.0 equiv), DBU 
(1.5 mL, 1.5 g, 10.1 mmol, 2.0 equiv), crotyl bromide (38a) (1.2 mL, 
1.37 g, 10.1 mmol, 2.0 equiv) and toluene (200 mL) gave 586 mg 
(2.2 mmol, 44%) of rac. ethyl (2S,3S)-3-(((E)-but-2-en-1-yl)amino)-2-hydroxy-3-
phenylpropanoate (39aa) as a colorless oil after purification by silica gel column 
chromatography (hexanes / EtOAc,  2:1 to 1:1). Rf (hexanes / EtOAc, 1:1) = 0.20, Staining: 
KMnO4 (UV active). 1H NMR (300 MHz, CDCl3): δ 7.40 – 7.01 (m, 5H), 5.62 – 5.35 (m, 2H), 
4.50 (d, J = 4.0 Hz, 1H), 4.07 – 3.92 (m, 3H), 3.25 (bs, 2H), 3.12 – 2.91 (m, 2H), 1.72 – 1.34 
(m, 3H), 1.08 (t, J = 7.2 Hz, 3H).13C NMR (75 MHz, CDCl3): δ 172.5, 137.8, 137.7, 128.7, 
128.1, 128.0, 127.9, 127.8, 127.7, 127.7, 127.6, 126.6, 73.2, 73.1, 63.5, 63.4, 61.1, 61.1, 48.7, 
42.9, 17.7, 13.9, 12.8. IR (neat): 3329, 3064, 3027, 2982, 2919, 1733, 1454, 1368, 1260, 1200, 
1103, 1025, 969, 936, 861, 753 cm-1. HRMS (ESI) m/z calculated for 
C15H22NO3 ([M+H]+) 264.1594, found 264.1597.  
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rac. Ethyl (2S,3S)-2-hydroxy-3-((3-methylbut-2-en-1-yl)amino)-3-phenylpropanoate 
(39ab) 
Following general procedure GP-1, using rac. ethyl (2S,3S)-3-amino-2-
hydroxy-3-phenylpropanoate (37a) (1.4 g, 6.9 mmol, 1.0 equiv), DBU 
(2.1 mL, 2.1 g, 13.8 mmol, 2.0 equiv), 1-bromo-3-methyl-but-2-ene 
(38b) (1.7 mL, 2.1 g, 13.8 mmol, 2.0 equiv) and toluene (200 mL) gave 
1.2 g (4.3 mmol, 63%) of rac. ethyl (2S,3S)-2-hydroxy-3-((3-methylbut-
2-en-1-yl)amino)-3-phenylpropanoate (39ab) as a yellowish oil after purification by silica gel 
column chromatography (hexanes / EtOAc, 2:1 to 1:2). Rf (hexanes / EtOAc, 1:1) = 0.15, 
Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3): δ 7.41 – 7.09 (m, 5H), 5.21 (t, J = 
7.0 Hz, 1H), 4.50 (d, J = 4.0 Hz, 1H), 4.15 – 3.86 (m, 3H), 3.33 (bs, 2H), 3.08 (dd, J = 13.0, 
6.7 Hz, 1H), 3.01 (dd, J = 13.0, 7.2 Hz, 1H), 1.65 (s, 3H), 1.43 (s, 3H), 1.07 (t, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 172.5, 137.9, 134.7, 128.1, 127.8, 127.6, 122.2, 73.2, 63.7, 
61.1, 44.3, 25.6, 17.7, 13.9. IR (neat): 3317, 3064, 3030, 2978, 2915, 2859, 1733, 1454, 1372, 
1267, 1238, 1197, 1115, 1025, 932, 865, 753 cm-1. HRMS (ESI) m/z calculated for 
C16H24NO3 ([M+H]+) 278.1751, found 278.1751.  
rac. Ethyl (2S,3S)-2-hydroxy-3-((2-methylallyl)amino)-3-phenylpropanoate (39ac) 
Following general procedure GP-1, using rac. ethyl (2S,3S)-3-amino-2-
hydroxy-3-phenylpropanoate (37a) (2.1 g, 10.2 mmol, 1.0 equiv), DBU 
(2.3 mL, 2.3 g, 15.3 mmol, 1.5 equiv), 3-bromo-2-methylprop-1-ene 
(38c) (1.6 mL, 2.1 g, 15.7 mmol, 1.5 equiv) and toluene (300 mL) gave 
1.5 g (5.6 mmol, 55%) of rac. ethyl (2S,3S)-2-hydroxy-3-((2-
methylallyl)amino)-3-phenylpropanoate (39ac) as a yellowish oil after purification by silica gel 
column chromatography (hexanes / EtOAc, 2:1 to 1:2). Rf (hexanes / EtOAc, 1:1) = 0.19, 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3): δ 7.40 – 7.14 (m, 5H), 4.81 (d, J = 
6.8 Hz, 2H), 4.49 (d, J = 4.1 Hz, 1H), 4.15 – 3.87 (m, 3H), 3.23 – 2.79 (m, 4H), 1.70 (s, 3H), 
1.09 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 172.5, 143.3, 137.9, 128.1, 127.7, 111.2, 
73.4, 63.4, 61.1, 52.6, 20.7, 13.9. IR (neat): 3314, 3083, 3038, 2974, 2847, 2796, 1748, 1655, 
1457, 1433, 1372, 1249, 1207, 1129, 1029, 977, 898, 824, 757, 701 cm-1. HRMS (ESI) m/z 
calculated for C15H22NO3 ([M+H]+) 264.1594, found 264.1597.  
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rac. Ethyl (2S,3S)-3-(cyclohex-2-en-1-ylamino)-2-hydroxy-3-phenylpropanoate (39ad) 
A 500 mL round bottom flask equipped with a magnetic stir bar and reflux 
condenser was charged with ethyl 3-amino-2-hydroxy-3-
phenylpropanoate (37a) (1.7 g, 7.9 mmol, 1.0 equiv), DBU (1.2 mL, 1.2 g, 
7.9 mmol, 1.0 equiv) and toluene (300 mL). 3-bromocyclohex-1-ene (38d) 
(1.3 g, 8.2 mmol, 1.0 equiv) was added dropwise at room temperature and 
the reaction mixture was stirred for 72 h at 60 °C. After addition of water (100 mL) the mixture 
was extracted with EtOAc (2x 100 mL). The combined organic layers were washed with water 
(3x 100 mL), dried over anhydrous Na2SO4, the solvent was evaporated in vacuo and the 
residue purified by silica gel column chromatography (hexanes / EtOAc,  2:1 to 1:1) to give 
900 mg (3.1 mmol, 39%) of rac. ethyl (2S,3S)-3-(cyclohex-2-en-1-ylamino)-2-hydroxy-3-
phenylpropanoate (39ad) as a colorless oil. Rf (hexanes / EtOAc, 1:1) = 0.33, Staining: KMnO4 
(UV active). 1H NMR (400 MHz, CDCl3):  δ 7.37 – 7.20 (m, 5H), 5.85 – 5.46 (m, 2H), 4.45 (dd, 
J = 4.2, 3.0 Hz, 1H), 4.20 (dd, J = 13.1, 4.2 Hz, 1H), 4.10 – 3.92 (m, 2H), 3.23 – 2.55 (m, 3H), 
2.06 – 1.84 (m, 2H), 1.73 (dddd, J = 19.8, 16.8, 7.5, 3.4 Hz, 2H), 1.59 – 1.36 (m, 2H), 1.10 (td, 
J = 7.2, 1.9 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 172.6, 138.6, 138.2, 129.7, 129.6, 129.2, 
128.9, 128.4, 128.4, 128.0, 127.9, 73.8, 73.4, 62.0, 61.9, 61.4, 61.4, 50.3, 49.8, 30.5, 29.1, 
25.3, 20.3, 19.7, 14.1. IR (neat): 3299, 3027, 2933, 2866, 2837, 1703, 1495, 1454, 1398, 1364, 
1297, 1264, 1234, 1129, 1088, 1021, 980, 902, 839, 763 cm-1. HRMS (ESI) m/z calculated 
for C17H24NO3 ([M+H]+) 290.1751, found 290.1756. 
(1S,2S)-2-(allylamino)-1-(4-nitrophenyl)propane-1,3-diol (43) 
Following general procedure GP-1, using (1S,2S)-2-amino-1-
(4-nitrophenyl)propane-1,3-diol (42) (4.6 g, 21.6 mmol, 
1.0  equiv), DBU (3.2 mL, 3.3 g, 21.6 mmol, 1.0 equiv), allyl-
bromide (38e) (1.9 mL, 2.7 g, 22.2 mmol, 1.0 equiv) and 
toluene (200 mL) gave 3.1 g (12.4 mmol, 57%) of (1S,2S)-2-
(allylamino)-1-(4-nitrophenyl)propane-1,3-diol (43) as a 
yellow oil after 4 h reaction time and purification by silica gel column chromatography 
(CH2Cl2 / MeOH, 9:1). Rf (CH2Cl2 / MeOH, 9:1) = 0.18, Staining: Ninhydrin (UV active). 
Specific Rotation: [α]𝐷
25 = + 49.1 °. 1H NMR (400 MHz, CDCl3): δ 8.12 (dd, J = 8.6, 1.4 Hz, 2H), 
7.53 (d, J = 8.5 Hz, 2H), 5.74 (ddt, J = 16.3, 11.0, 5.7 Hz, 1H), 5.11 – 5.00 (m, 2H), 4.71 (d, J = 
6.7 Hz, 1H), 3.73 – 3.60 (m, 1H), 3.47 – 3.24 (m, 4H), 3.19 (ddd, J = 14.0, 5.8, 1.0 Hz, 1H), 
3.05 (ddd, J = 14.1, 6.0, 0.9 Hz, 1H), 2.73 – 2.62 (m, 1H). 13C NMR (101 MHz, CDCl3): δ 150.1, 
147.3, 135.9, 127.4, 123.5, 116.7, 72.1, 63.8, 59.8, 50.1. IR (neat): 3310, 3079, 2881, 1644, 
1603, 1513, 1410, 1401, 1341, 1200, 1107, 1043, 995, 921, 853, 823, 753, 701 cm-1. HRMS 
(ESI) m/z calculated for C12H17N2O4 ([M+H]+) 253.1183, found 253.1186. 
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General Procedure (GP-2) for Epoxide Ring Opening with Alkyl Amines 
A 500 mL round bottom flask equipped with a magnetic stir bar and reflux condenser was 
charged with appropriate epoxide 36 (46.3 mmol, 1.0 equiv), alkylamine 40 (46.3 mmol, 
1.0 equiv) and EtOH (250 mL). The resulting mixture was refluxed for 24 h at 80 °C. Afterwards 
the solvent was evaporated in vacuo, and the residue was purified by silica gel column 
chromatography (hexanes / EtOAc) to give monoalkylated amino alcohol 39b. 
rac. Ethyl allyl-D-allothreoninate (39ba´, major) and rac. ethyl (2S,3S)-3-(allylamino)-2-
hydroxybutanoate (39ba, minor) 
Following general procedure GP-2, using ethyl 3-
methyloxirane-2-carboxylate (36b) (3.1 g, 23.8 mmol, 
1.0 equiv), allylamine (40a) (1.8 mL, 1.4 g, 23.8 mmol, 
1.0 equiv) and EtOH (125 mL) gave 1.4 g (7.6 mmol, 
32%) of rac. ethyl allyl-D-allothreoninate (39ba´) and 
1.1 g (5.7 mmol, 24%) of rac. ethyl (2S,3S)-3-(allylamino)-2-hydroxybutanoate (39ba) as 
colorless oils after purification by silica gel column chromatography (hexanes / EtOAc, 2:1 to 
1:3). Rf (39ba´, hexanes / EtOAc, 1:1) = 0.30, Rf (39ba, hexanes / EtOAc, 1:1) = 0.08, 
Staining: Ninhydrin (UV active). 1H NMR (39ba´, 300 MHz, CDCl3) δ 5.88 (ddt, J = 17.2, 10.2, 
6.0 Hz, 1H), 5.18 (dq, J = 17.2, 1.6 Hz, 1H), 5.08 (dq, J = 10.2, 1.3 Hz, 1H), 4.29 (d, J = 3.4 
Hz, 1H), 4.23 (qd, J = 7.2, 0.7 Hz, 2H), 3.28 (dt, J = 6.0, 1.5 Hz, 2H), 3.05 (qd, J = 6.6, 3.4 Hz, 
1H), 2.49 (bs, 2H), 1.28 (t, J = 7.1 Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H). 1H NMR (39ba, 400 MHz, 
CDCl3) δ 5.85 – 5.70 (m, 1H), 5.11 (dq, J = 17.2, 1.7 Hz, 1H), 5.03 (dq, J = 10.1, 1.4 Hz, 1H), 
4.21 – 4.08 (m, 2H), 3.97 – 3.89 (m, 1H), 3.32 – 3.20 (m, 2H), 3.07 (ddt, J = 13.8, 6.1, 1.4 Hz, 
1H), 2.61 (bs, 2H), 1.22 (td, J = 7.2, 3.9 Hz, 3H), 1.03 (dd, J = 6.6, 1.4 Hz, 3H). 13C NMR 
(39ba´, 75 MHz, CDCl3) δ 173.8, 136.6, 116.3, 71.2, 61.6, 54.6, 49.6, 15.0, 14.3. 13C NMR 
(39ba, 101 MHz, CDCl3) δ 173.2, 136.1, 116.7, 67.3, 65.3, 60.9, 51.3, 18.9, 14.3. IR (39ba´, 
neat): 3497, 3332, 3079, 2982, 2937, 1730, 1644, 1450, 1372, 1301, 1260, 1185, 1156, 1096, 
1021, 921, 857, 775 cm-1. IR (39ba, neat): 3317, 3079, 2978, 2937, 1730, 1644, 1450, 1372, 
1252, 1204, 1129, 1029, 917, 865, 753 cm-1. HRMS (39ba´, ESI) m/z calculated 
for C9H18NO3 ([M+H]+) 188.1281, found 188.1284. HRMS (39ba, ESI) m/z calculated 
for C9H18NO3 ([M+H]+) 188.1281, found 188.1286. 
rac. Isopropyl (2S,3S)-3-(allylamino)-2-hydroxy-3-phenylpropanoate (39bc) 
 A 500 mL round bottom flask equipped with a magnetic stir bar and 
reflux condenser was charged with ethyl 3-phenyloxirane-2-carboxylate 
(36a) (8.9 g, 46.3 mmol, 1.0 equiv), allylamine (40a) (3.5 mL, 2.6 g, 
Experimental Part 
137 
46.3 mmol, 1.0 equiv) and EtOH (250 mL). The resulting mixture was refluxed for 24 h at 
80 °C. Afterwards the solvent was evaporated in vacuo, and the residue was purified by silica 
gel column chromatography (hexanes / EtOAc, 2:1 to 1:1) to give 6.5 g (26.1 mmol, 56%) of 
rac. ethyl (2S,3S)-3-(allylamino)-2-hydroxy-3-phenylpropanoate (39bb) as a colorless oil. 
Spectral data were in agreement with those reported in literature.7 A 250 mL round bottom 
flask equipped with a magnetic stir bar was charged with rac. ethyl (2S,3S)-3-(allylamino)-2-
hydroxy-3-phenylpropanoate (39bb) (1.4 g, 5.7 mmol, 1.0 equiv) and isopropanol (200 mL). 
H2SO4 (conc., 2.0 mL) was added dropwise while stirring and the resulting mixture was refluxed 
for 72 h, neutralized with solid NaHCO3 and filtered off. The solvent was evaporated under 
reduced pressure and the obtained residue was purified by silica gel column chromatography 
(hexanes / EtOAc, 10:1 to 3:1) to yield 1.4 g (5.3 mmol, 93%) of rac. Isopropyl (2S,3S)-3-
(allylamino)-2-hydroxy-3-phenylpropanoate (39bc) as colorless oil. Rf (hexanes / EtOAc, 1:1) 
= 0.31, Staining: Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 7.35 – 7.22 (m, 5H), 5.89 
(ddt, J = 17.1, 10.2, 6.0 Hz, 1H), 5.20 – 5.04 (m, 2H), 4.89 (sex, J = 6.3 Hz, 1H), 4.50 (d, J = 
4.0 Hz, 1H), 4.05 (d, J = 3.9 Hz, 1H), 3.22 (ddt, J = 13.9, 5.8, 1.5 Hz, 1H), 3.08 (ddt, J = 14.0, 
6.3, 1.5 Hz, 1H), 2.78 (bs, 2H), 1.13 (d, J = 6.3 Hz, 3H), 1.10 (d, J = 6.3 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 172.2, 137.7, 136.3, 128.4, 128.1, 128.0, 116.5, 77.6, 77.2, 76.7, 73.4, 69.6, 
63.7, 49.7, 21.8, 21.7. IR (neat): 3474, 3332, 3064, 3030, 2982, 2933, 1722, 1644, 1495, 1454, 
1375, 1271, 1241, 1208, 1103, 995, 913, 824, 749 cm-1. HRMS (ESI) m/z calculated 
for C15H22NO3 ([M+H]+) 264.1594, found 264.1598. 
rac. Ethyl (2S,3S)-2-hydroxy-3-phenyl-3-(prop-2-yn-1-ylamino)propanoate (39bd) 
Following general procedure GP-2, using ethyl 3-phenyloxirane-2-
carboxylate (36a) (4.0 g, 20.9 mmol, 1.0 equiv), propargylamine (40b) 
(1.3 mL, 1.2 g, 20.9 mmol, 1.0 equiv) and EtOH (150 mL) gave 2.8 g 
(11.3 mmol, 54%) of rac. ethyl (2S,3S)-2-hydroxy-3-phenyl-3-(prop-2-yn-
1-ylamino) propanoate (39bd) as a colorless oil after purification by silica 
gel column chromatography (hexanes / EtOAc, 2:1 to 1:1). 1.4 g (7.4 mmol, 35%) of starting 
material could be isolated. Based on the uncomplete conversion the yield of the desired 
product is 84%. Rf (hexanes / EtOAc, 1:1) = 0.43, Staining: Ninhydrin (UV active). 1H NMR 
(400 MHz, CDCl3) δ 7.34 – 7.22 (m, 5H), 4.53 (d, J = 4.0 Hz, 1H), 4.24 (d, J = 4.0 Hz, 1H), 
4.08 (qd, J = 7.1, 1.9 Hz, 2H), 3.41 (dd, J = 16.8, 2.5 Hz, 1H), 3.20 (dd, J = 16.8, 2.5 Hz, 1H), 
2.75 (bs, 2H), 2.21 (t, J = 2.5 Hz, 1H), 1.15 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 
172.5, 137.0, 128.4, 128.2, 81.5, 73.4, 71.9, 63.3, 61.7, 35.8, 14.1. IR (neat): 3474, 3288, 
3064, 3030, 2982, 2933, 2840, 1730, 1454, 1368, 1264, 1200, 1115, 1025, 939, 861, 753 cm-
1. HRMS (ESI) m/z calculated for C14H18NO3 ([M+H]+) 248.1281, found 248.1283. 
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1-phenyl-2-(prop-2-yn-1-ylamino)ethan-1-ol (39bf)  
Following general procedure GP-2, using 2-phenyloxirane (36c) (2.4 g, 
20.0 mmol, 1.0 equiv), propargylamine (40b) (2.6 mL, 2.2 g, 40.0 mmol, 
2.0 equiv) and EtOH (200 mL) gave 932 mg (5.3 mmol, 27%) of 1-phenyl-2-
(prop-2-yn-1-ylamino) ethan-1-ol (39bf) as a brownish oil after 72 h and 
purification by silica gel column chromatography (hexanes / EtOAc, 5:1 to 1:2). 
Rf (hexanes / EtOAc, 1:1) = 0.13, Staining: Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) 
δ 7.46 – 7.18 (m, 5H), 4.75 (dd, J = 8.9, 3.6 Hz, 1H), 3.44 (dd, J = 2.5, 1.1 Hz, 2H), 2.98 (ddd, 
J = 12.2, 3.6, 1.5 Hz, 1H), 2.91 – 2.64 (m, 3H), 2.22 (t, J = 2.4 Hz, 1H). 13C NMR (75 MHz, 
CDCl3) δ 142.5, 128.5, 127.7, 126.0, 81.7, 72.0, 71.9, 56.0, 37.9. IR (neat): 3310, 3203, 3064, 
2911, 2851, 2743, 1491, 1435, 1342, 1215, 1111, 1062, 1025, 943, 898, 857, 760 cm-1. HRMS 
(ESI) m/z calculated for C11H14NO ([M+H]+) 176.1070, found 176.1067. 
rac. (1R,2S)-2-(allylamino)-1,2-diphenylethan-1-ol (39bg) 
Following general procedure GP-2, using 2,3-diphenyloxirane (36d) (4.7 g, 
23.7 mmol, 1.0 equiv), allylamine (40a) (3.6 mL, 2.7 g, 47.4 mmol, 2.0 equiv) 
and EtOH (350 mL) gave 2.9 g (11.3 mmol, 48%) of rac. (1R,2S)-2-
(allylamino)-1,2-diphenylethan-1-ol (39bg) as a white solid after purification 
by silica gel column chromatography (hexanes / EtOAc, 1:2). Rf (hexanes / EtOAc, 1:2) = 0.25, 
Staining: Ninhydrin (UV active).  1H NMR (400 MHz, CDCl3): δ 7.32 – 7.20 (m, 6H), 7.19 – 7.08 
(m, 4H), 5.80 (ddt, J = 15.7, 10.0, 5.9 Hz, 1H), 5.12 – 4.99 (m, 2H), 4.84 (d, J = 5.7 Hz, 1H), 
3.95 (d, J = 5.7 Hz, 1H), 3.17 (dd, J = 14.3, 5.5 Hz, 1H), 3.04 (dd, J = 14.2, 6.3 Hz, 1H), 1.72 
(br, 2H). 13C NMR (101 MHz, CDCl3): δ 140.7, 139.2, 136.5, 128.4, 128.3, 128.1, 127.8, 
127.7, 126.9, 116.2, 76.7, 68.0, 49.7. IR (neat): 3213, 3153, 3080, 3032, 2900, 2886, 2857, 
2845, 2056, 1987, 1490, 1450, 1423, 1360, 1197, 1100, 1050, 996, 958, 926, 880, 841, 767, 
698, 663, 598, 509 cm-1. HRMS (ESI) m/z calculated for C17H20NO ([M+H]+) 254.1539, found 
254.1547. mp: 117 °C. 
rac. ethyl (2S,3S)-3-(but-3-yn-1-ylamino)-2-hydroxy-3-phenylpropanoate (38bh) 
Following general procedure GP-2, using ethyl 3-phenyloxirane-2-
carboxylate (36a) (1.4 g,  7.3 mmol,  1.0 equiv), but-3-yn-1-amine (40c) 
(501 mg, 7.3 mmol, 1.0 equiv) and EtOH (50 mL) gave 880 mg (3.4 mmol, 
46%)  of  rac. ethyl (2S,3S)-3-(but-3-yn-1-ylamino)-2-hydroxy-3-
phenylpropanoate (39bh) as a colorless oil purification by silica gel column chromatography 
(hexanes / EtOAc, 2:1 to 1:1). Rf (hexanes / EtOAc, 1:1) = 0.44, Staining: Ninhydrin (UV active). 
1H NMR (400 MHz, CDCl3) δ 7.40 – 7.19 (m, 5H), 4.50 (d, J = 4.0 Hz, 1H), 4.15 – 3.98 (m, 3H), 
2.77 – 2.59 (m, 2H), 2.43 – 2.32 (m, 2H), 2.00 (t, J = 2.7 Hz, 1H), 1.14 (t, J = 7.2 Hz, 3H). 
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13C NMR (101 MHz, CDCl3) δ 172.6, 137.8, 128.5, 128.0, 127.8, 82.4, 73.5, 69.8, 64.4, 61.5, 
45.6, 19.9, 14.1. IR (neat): 3288, 3068, 3038, 2989, 2911, 2870, 2771, 1748, 1491, 1435, 
1372, 1297, 1256, 1204, 1129, 1092, 1029, 980, 947, 906, 839, 764, 701 cm-1. HRMS (ESI) 
m/z calculated for C15H20NO3 ([M+H]+) 262.1438, found 262.1439. 
General Procedure (GP-3) for N-Protection of Monoalkylated Amino Alcohols 
A 50 mL round bottom flask equipped with a magnetic stir bar was charged with monoalkylated 
amino alcohol 39 (4.0 mmol, 1.0 equiv), triethylamine (4.7 mmol, 1.2 equiv) and 
CH2Cl2 (20 mL). After addition of di-tert-butyl-dicarbonate (4.6 mmol, 1.2 equiv) the solution 
was stirred for 20 h at room temperature. The solvent was evaporated under reduced pressure 
and the obtained residue was purified by silica gel column chromatography to give 
monoalkylated and N-protected amino alcohol 44. 
rac. Ethyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate 
(44a) 
Following general procedure GP-3, using rac. ethyl (2S,3S)-3-(allylamino)-
2-hydroxy-3-phenylpropanoate (39bb) (5.40 g, 21.7 mmol, 1.0 equiv), 
triethylamine (3.5 mL, 2.6 g, 25.3 mmol, 1.2 equiv), di-tert-butyl 
dicarbonate (5.4 g, 24.9 mmol, 1.2 equiv) and CH2Cl2 (70 mL) gave 4.9 g 
(14.1 mmol, 65%) of rac. ethyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxy-3-
phenylpropanoate (44a) as a colorless oil after purification by silica gel column 
chromatography (hexanes / EtOAc, 5:1 to 4:1). Rf (hexanes / EtOAc, 5:1) = 0.23, Staining: 
Ninhydrin (UV active). 1H NMR (400 MHz, CDCl3): δ 7.41 – 7.22 (m, 5H), 5.58 (br, 1H), 5.41 
(br, 1H), 4.92 (d, J = 11.3 Hz, 2H), 4.82 (t, J = 4.9 Hz, 1H), 4.19 (q, J = 6.5 Hz, 2H), 3.93 – 3.67 
(m, 2H), 3.52 (br, 1H), 1.43 (s, 9H), 1.20 (t, J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 
173.3, 155.8, 136.9, 135.2, 129.0, 128.4, 127.9, 116.1, 80.6, 72.0, 62.2, 61.8, 48.7, 28.5, 14.1. 
IR (neat): 3445, 3067, 2978, 2932, 1734, 1686, 1454, 1393, 1366, 1300, 1270, 1251, 1166, 
1144, 1128, 1096, 1021, 913, 887, 755, 701, 652, 624, 537, 498 cm-1. HRMS (ESI) m/z 
calculated for C19H28NO5 ([M+H]+) 350.1962, found 350.1960. 
rac. Ethyl (2S,3S)-3-(((E)-but-2-en-1-yl)(tert-butoxycarbonyl)amino)-2-hydroxy-3-
phenylpropanoate (44b) 
Following general procedure GP-3, using rac. ethyl (2S,3S)-3-(((E)-but-
2-en-1-yl)amino)-2-hydroxy-3-phenylpropanoate (39aa) (280 mg, 
1.1 mmol, 1.0 equiv), triethylamine (172 µL, 126 mg, 1.2 mmol, 
1.2 equiv), di-tert-butyl dicarbonate (267 mg, 1.2 mmol, 1.2 equiv) and 
CH2Cl2 (5 mL) gave 285 mg (784 µmol, 74%) of rac. ethyl (2S,3S)-3-(((E)-but-2-en-1-yl)(tert-
butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate (44b) as a colorless oil after stirring for 
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48 h and purification by silica gel column chromatography (hexanes / EtOAc, 5:1). Rf (hexanes 
/ EtOAc, 5:1) = 0.33, Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3): δ 7.44 – 7.23 
(m, 5H), 5.57 – 5.01 (m, 3H), 4.84 (t, J = 5.5 Hz, 1H), 4.20 (qd, J = 7.2, 2.6 Hz, 2H), 3.96 – 
3.36 (m, 3H), 1.56 (d, J = 5.9 Hz, 3H), 1.43 (s, 9H), 1.22 (t, J = 7.0 Hz, 3H). 13C NMR (75 MHz, 
CDCl3, E/Z-isomers present): δ 173.4, 155.8, 137.0, 135.1, 128.9, 128.4, 128.4, 128.0, 127.8, 
127.6, 80.5, 80.4, 72.0, 62.2, 62.0, 48.4, 43.1, 28.5, 17.8, 14.1, 13.0. IR (neat): 3437, 2978, 
2937, 1737, 1670, 1454, 1401, 1364, 1282, 1249, 1163, 1129, 1096, 1021, 965, 887, 861, 753, 
701 cm-1. HRMS (ESI) m/z calculated for C20H30NO5 ([M+H]+) 364.2118, found 364.2118. 
rac. Ethyl (2S,3S)-3-((tert-butoxycarbonyl)(3-methylbut-2-en-1-yl)amino)-2-hydroxy-3-
phenylpropanoate (44c) 
Following general procedure GP-3, using rac. ethyl (2S,3S)-2-hydroxy-
3-((3-methylbut-2-en-1-yl)amino)-3-phenylpropanoate (39ab) (285 mg, 
1.0 mmol, 1.0 equiv), triethylamine (167 µL, 122 mg, 1.2 mmol, 
1.2 equiv), di-tert-butyl dicarbonate (258 mg, 1.2 mmol, 1.2 equiv) and 
CH2Cl2 (10 mL) gave 380 mg (1.0 mmol, 98%) of rac. ethyl (2S,3S)-3-
((tert-butoxycarbonyl)(3-methylbut-2-en-1-yl)amino)-2-hydroxy-3-phenylpropanoate (44c) as 
a colorless oil after stirring for 90 h and purification by silica gel column 
chromatography (hexanes / EtOAc, 5:1). Rf (hexanes / EtOAc, 5:1) = 0.33, Staining: KMnO4 
(UV active). 1H NMR (400 MHz, CDCl3): δ 7.45 – 7.16 (m, 5H), 5.26 (bs, 1H), 5.01 (s, 1H), 4.83 
(t, J = 5.6 Hz, 1H), 4.31 – 4.10 (m, 2H), 3.92 – 3.48 (m, 3H), 1.61 (s, 3H), 1.49 (s, 3H), 1.42 (s, 
9H), 1.23 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3):  δ 173.3, 156.0, 137.1, 133.8, 128.7, 
128.3, 127.7, 121.9, 80.4, 72.2, 62.3, 62.1, 44.6, 28.5, 25.7, 17.8, 14.1. IR (neat): 3437, 2978, 
2933, 1737, 1689, 1454, 1402, 1364, 1313, 1252, 1159, 1126, 1096, 1021, 947, 891, 775, 701 
cm-1. HRMS (ESI) m/z calculated for C21H32NO5 ([M+H]+) 378.2275, found 378.2281. 
rac. Ethyl (2S,3S)-3-((tert-butoxycarbonyl)(2-methylallyl)amino)-2-hydroxy-3-
phenylpropanoate) (44d) 
Following general procedure GP-3, using rac. ethyl (2S,3S)-2-hydroxy-3-
((2-methylallyl)amino)-3-phenylpropanoate (39ac) (305 mg, 1.2 mmol, 
1.0 equiv), triethylamine (188 µL, 137 mg, 1.4 mmol, 1.2 equiv), di-tert-
butyl dicarbonate (291 mg, 1.3 mmol, 1.2 equiv) and CH2Cl2 (10 mL) 
gave 120 mg (330 µmol, 29%) of rac. ethyl (2S,3S)-3-((tert-
butoxycarbonyl)(2-methylallyl)amino)-2-hydroxy-3-phenylpropanoate) (44d) as a colorless oil 
after stirring for 72 h and purification by silica gel column chromatography (hexanes / EtOAc, 
5:1). Rf (hexanes / EtOAc, 5:1) = 0.25, Staining: KMnO4 (UV active). 1H NMR (400 MHz, 
CDCl3): δ 7.47 – 7.11 (m, 5H), 5.28 (bs, 1H), 4.84 (d, J = 4.6 Hz, 1H), 4.70 (s, 1H), 4.65 (s, 
1H), 4.17 (q, J = 7.1 Hz, 2H), 3.97 – 3.64 (m, 3H), 1.55 (s, 3H), 1.40 (s, 9H), 1.19 (t, J = 8.2 
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Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 172.9, 156.0, 142.2, 128.8, 128.2, 127.7, 110.6, 80.5, 
72.4, 62.6, 62.0, 52.0, 28.3, 20.1, 14.1. IR (neat): 3444, 2978, 2933, 1737, 1685, 1454, 1394, 
1368, 1249, 1163, 1111, 1021, 943, 891, 861, 813, 753, 701 cm-1. HRMS (ESI) m/z calculated 
for C20H29NNaO5 ([M+Na]+) 386.1938, found 386.1944. 
rac. Ethyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxybutanoate (44e) 
Following general procedure GP-3, using rac. ethyl (2S,3S)-3-
(allylamino)-2-hydroxybutanoate (39ba) (773 mg, 4.1 mmol, 1.0 equiv), 
triethylamine (670 µL, 489 mg, 4.8 mmol, 1.2 equiv), di-tertbutyl 
dicarbonate (1.0 g, 4.8 mmol, 1.2 equiv) and CH2Cl2 (40 mL) gave 920 mg 
(3.2 mmol, 78%) of rac. ethyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxybutanoate 
(44e) as a colorless oil after stirring for 48 h and purification  by  silica  gel  column  
chromatography  (hexanes  / EtOAc,  5:1 to 4:1). Rf (hexanes / EtOAc, 3:1) = 0.38, Staining: 
KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 5.80 (ddt, J = 17.2, 10.5, 5.5 Hz, 1H), 5.16 – 
5.00 (m, 2H), 4.44 – 4.00 (m, 4H), 3.95 – 3.48 (m, 3H), 1.43 (s, 9H), 1.28 (t, J = 7.1 Hz, 3H), 
1.20 – 1.11 (m, 3H). 13C NMR (75 MHz, CDCl3) δ 173.4, 156.0, 135.8, 115.6, 80.2, 74.1, 62.1, 
54.4, 47.9, 28.5, 14.3, 12. IR (neat): 3448, 3083, 2982, 2937, 1733, 1689, 1450, 1402, 1368, 
1327, 1249, 1148, 1096, 1018, 913, 865, 775 cm-1. HRMS (APCI) m/z calculated 
for C14H26NO5 ([M+H]+) 288.1805, found 288.1812. 
tert-butyl allyl((1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)carbamate (44f) 
Following general procedure GP-3, using (1S,2S)-2-
(allylamino)-1-(4-nitrophenyl)propane-1,3-diol (43) (3.1 g, 
12.4 mmol, 1.0 equiv), triethylamine (2.0 mL, 1.5 g, 14.5 mmol, 
1.2 equiv), di-tert-butyl dicarbonate (3.1 g, 14.2 mmol, 1.2 equiv) 
and CH2Cl2 (75 mL) gave 3.1 g (8.8 mmol, 71%) of tert-butyl 
allyl((1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)carbamate (44f) as a white solid after 
purification by silica gel column chromatography (CH2Cl2 / MeOH, 9:1). 
Rf (CH2Cl2 / MeOH, 9:1) = 0.49, Staining: Ninhydrin (UV active). Specific Rotation: [α]𝐷
25 = 
+ 91.9 °. 1H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 8.8 Hz, 2H), 7.51 (d, J = 8.7 Hz, 2H), 5.44 
– 5.14 (m, 2H), 5.07 – 4.89 (m, 2H), 4.22 – 4.08 (m, 1H), 3.84 (dd, J = 11.4, 6.6 Hz, 1H), 3.68 
– 3.48 (m, 2H), 3.37 – 3.22 (m, 1H), 1.41 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 157.6, 150.1, 
147.4, 133.6, 127.1, 123.5, 117.9, 81.8, 72.8, 67.0, 60.8, 54.3, 28.4. IR (neat): 3504, 3384, 
2982, 2937, 2911, 1659, 1637, 1521, 1461, 1416, 1353, 1320, 1274, 1148, 1081, 1047, 992, 
913, 857, 828, 753, 701 cm-1. HRMS (ESI) m/z calculated for C17H24N2NaO6 ([M+Na]+) 
375.1527, found 375.1529. mp: 97 °C. 
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rac. Ethyl (2S,3S)-3-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-2-hydroxy-3-
phenylpropanoate (44g) 
Following general procedure GP-3, using rac. ethyl (2S,3S)-2-hydroxy-3-
phenyl-3-(prop-2-yn-1-ylamino)propanoate (39bd) (2.0 g,  8.2 mmol,  
1.0 equiv),  triethylamine (1.3 mL, 972 mg, 9.6 mmol, 1.2 equiv), di-tert-
butyl  dicarbonate (2.1 g, 9.4 mmol,  1.2 equiv) and CH2Cl2 (80 mL) gave 
950 mg  (2.7 mmol,  33%)  of  rac. ethyl (2S,3S)-3-((tert-
butoxycarbonyl)(prop-2-yn-1-yl)amino)-2-hydroxy-3-phenylpropanoate 
(44g) as a yellow oil after stirring for  72  h  and purification  by  silica  gel  column  
chromatography  (hexanes  / EtOAc,  5:1 to 4:1). Rf (hexanes / EtOAc, 3:1) = 0.36, Staining: 
KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.37 (m, 2H), 7.36 – 7.23 (m, 3H), 
5.47 (bs, 1H), 4.91 (s, 1H), 4.20 (q, J = 7.2 Hz, 2H), 4.11 – 3.92 (m, 2H), 3.29 (bs, 1H), 2.06 
(s, 1H), 1.46 (s, 9H), 1.20 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 173.0, 155.1, 136.3, 
128.9, 128.5, 128.0, 110.1, 81.3, 80.8, 72.2, 70.5, 62.3, 61.2, 35.4, 28.4, 14.1. IR (neat): 3444, 
3295, 3064, 2982, 2937, 1733, 1689, 1446, 1394, 1368, 1252, 1159, 1125, 941, 887, 753, 701 
cm-1. HRMS (ESI) m/z calculated for C19H25NNaO5 ([M+Na]+) 370.1625, found 370.1628. 
tert-butyl-(2-hydroxy-2-phenylethyl)(prop-2-yn-1-yl)carbamate (44h) 
Following general procedure GP-3, using 1-phenyl-2-(prop-2-yn-1-
ylamino)ethan-1-ol (39bf) (339 mg,  1.9 mmol,  1.0 equiv),  triethylamine 
(322 µL, 235 mg, 2.3 mmol, 1.2 equiv), di-tert-butyl  dicarbonate (507 mg, 
2.3 mmol,  1.2 equiv) and CH2Cl2 (60 mL) gave 517 mg  (1.9 mmol,  97%)  
of tert-butyl-(2-hydroxy-2-phenylethyl)(prop-2-yn-1-yl)carbamate (44h) as a 
yellowish solid after stirring for  72  h  and purification  by  silica  gel  column  chromatography  
(hexanes  / EtOAc,  15:1 to 2:1). Rf (hexanes / EtOAc, 1:1) = 0.86, Staining: Ninhydrin (UV 
active). 1H NMR (300 MHz, CDCl3) δ 7.46 – 7.25 (m, 5H), 4.99 (t, J = 5.8 Hz, 1H), 4.28 – 3.76 
(m, 2H), 3.56 (d, J = 6.4 Hz, 2H), 2.25 (t, J = 2.5 Hz, 1H), 1.49 (s, 9H). 13C NMR (101 MHz, 
CDCl3) δ 142.2, 128.6, 127.8, 125.9, 81.5, 79.6, 74.0, 71.9, 55.5, 38.6, 28.5. IR (neat): 3440, 
3247, 3064, 3012, 2982, 2937, 2113, 1685, 1457, 1394, 1368, 1312, 1252, 1189, 1155, 1129, 
1029, 954, 887, 849, 783, 757, 705 cm-1. HRMS (ESI) m/z calculated 
for C16H21NNaO3 ([M+Na]+) 298.1414, found 298.1410. 
tert-butyl allyl(2-hydroxy-2-phenylethyl)carbamate (44i) 
Following general procedure GP-3, using  2-(allylamino)-1-phenylethan-1-ol 
(39be) (1.7 g,  9.8 mmol,  1.0 equiv),  triethylamine (1.6 mL, 1.2 g, 11.7 mmol, 
1.2 equiv), di-tert-butyl  dicarbonate (2.6 g, 11.7 mmol,  1.2 equiv) and CH2Cl2 
(80 mL) gave 1.6 g  (5.8 mmol,  59%)  of tert-butyl allyl(2-hydroxy-2-phenylethyl)carbamate 
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(44i) as a yellow oil after stirring for  48  h  and purification  by  silica  gel  column  
chromatography  (hexanes  / EtOAc,  9:1 to 3:1). Rf (hexanes / EtOAc, 3:1) = 0.53, Staining: 
Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 7.40 – 7.25 (m, 5H), 5.78 – 5.61 (m, 1H), 
5.20 – 5.00 (m, 2H), 4.92 (dt, J = 7.6, 3.6 Hz, 1H), 4.41 (bs, 1H), 3.98 – 3.22 (m, 4H), 1.47 (s, 
9H). 13C NMR (75 MHz, CDCl3) δ 158.1, 142.5, 133.8, 128.5, 127.6, 125.9, 116.6, 80.8, 74.4, 
55.8, 51.9, 28.5. IR (neat): 3429, 3064, 2978, 2933, 1670, 1457, 1409, 1364, 1249, 1163, 
1100, 1059, 995, 917, 872, 753, 701cm-1. HRMS (ESI) m/z calculated for 
C16H23NNaO3 ([M+Na]+) 300.1570, found 300.1577. 
rac. isopropyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxy-3-phenyl-
propanoate (44j) 
 Following general procedure GP-3, using rac. isopropyl (2S,3S)-3-
(allylamino)-2-hydroxy-3-phenylpropanoate (39bc) (1.4 g,  5.2 mmol,  
1.0 equiv),  triethylamine (865 µL, 632 mg, 6.2 mmol, 1.2 equiv), di-tert-
butyl  dicarbonate (1.4 g, 6.2 mmol,  1.2 equiv) and CH2Cl2 (60 mL) gave 
1.2 g  (3.3 mmol,  63%)  of  rac. isopropyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-
hydroxy-3-phenyl-propanoate (44j) as a colorless oil after stirring for  48  h  and purification  by  
silica  gel  column  chromatography  (hexanes  / EtOAc,  7:1 to 3:1). Rf (hexanes / EtOAc, 3:1) 
= 0.53, Staining: Ninhydrin, KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.36 (m, 
2H), 7.27 (dq, J = 6.6, 5.5, 4.5 Hz, 3H), 5.56 (s, 2H), 5.01 (p, J = 6.2 Hz, 1H), 4.90 (d, J = 
12.2 Hz, 2H), 4.79 (t, J = 4.8 Hz, 1H), 3.88 (t, J = 7.6 Hz, 2H), 3.60 – 3.20 (m, 1H), 1.44 (s, 
9H), 1.24 (d, J = 6.3 Hz, 3H), 1.06 (bs, 3H). 13C NMR (101 MHz, CDCl3) δ 172.8, 155.9, 137.1, 
135.3, 129.2, 128.4, 127.9, 115.9, 80.5, 72.3, 70.2, 61.2, 48.7, 28.5, 21.8, 21.5. IR (neat): 
3444, 3068, 2982, 2937, 1730, 1685, 1454, 1394, 1368, 1252, 1167, 1103, 992, 910, 820, 753, 
701 cm-1. HRMS (ESI) m/z calculated for C20H29NNaO5 ([M+Na]+) 386.1938, found 386.1950. 
N-Ac Protection 
rac. N-allyl-N-((1S,2R)-2-hydroxy-1,2-diphenylethyl)acetamide (44m) 
A 100 mL round bottom flask equipped with a magnetic stir bar was charged 
with rac. (1S,2R)-2-(allylamino)-1,2-diphenylethan-1-ol (39bg) (2.1 g, 
8.4 mmol, 1.0 equiv), triethylamine (2.6 mL, 1.9 g, 18.5 mmol, 2.2 equiv) 
and CH2Cl2 (60 mL). Acetic anhydride (1.6 mL, 1.8 g, 17.3 mmol, 2.1 equiv) 
was added dropwise at 0 °C and the reaction mixture was stirred for 30 h at room temperature. 
The resulting solution was washed with water (30 mL), 1M HCl (40 mL) and brine (30 mL). The 
organic layer was dried over anhydrous Na2SO4 and the solvent was evaporated under 
reduced pressure. The obtained residue was purified by silica gel column chromatography 
(hexanes / EtOAc, 2:1) to give 1.7 g (5.9 mmol, 70%) of rac. N-allyl-N-((1S,2R)-2-hydroxy-1,2-
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diphenylethyl)acetamide (44m) as a white solid. Rf (hexanes / EtOAc, 1:1) = 0.44, Staining: 
Ninhydrin (UV active).  1H NMR (400 MHz, CDCl3): δ 7.35 – 7.23 (m, 10H), 5.54 – 5.41 (m, 
2H), 5.18 – 5.05 (m, 2H), 4.93 (d, J = 5.0 Hz, 1H), 4.38 (bs, 1H), 3.84 (dd, J = 17.5, 5.0 Hz, 
1H), 3.67 (dd, J = 17.5, 5.2 Hz, 1H), 2.02 (s, 3H). 13C NMR (101 MHz, CDCl3): δ 172.4, 141.8, 
136.6, 133.3, 129.7, 128.3, 128.2, 128.0, 127.8, 126.9, 117.3, 74.2, 69.6, 52.2, 22.9.  IR (neat): 
3247, 3019, 2870, 1603, 1500, 1424, 1320, 1275, 1178, 1066, 1033, 915, 771, 701 cm-1. 
HRMS (ESI) m/z calculated for C19H22NO2 ([M+H]+) 296.1645, found 296.1650. mp: 98 °C. 
General Procedure (GP-4) for the Preparation of Ethyl Oxalyl Esters via Acylation with 
Ethyl 2-chloro-2-oxoacetate 
A 50 mL round bottom flask equipped with a magnetic stir bar was charged with N-alkylated 
and protected amino alcohol 44 (10.8 mmol, 1.0 equiv) and pyridine (10.8 mmol, 
1.0 equiv) in CH2Cl2 (50 mL). The solution was cooled to 0 °C and ethyl 2-chloro-2-oxoacetate 
(15) (10.8 mmol, 1.0 equiv) was added over 1 h. Afterwards, the mixture was stirred in an ice 
bath for 4 h, allowed to come to room temperature and stirred overnight. The reaction mixture 
was washed with water (3x 20 mL), dried over anhydrous MgSO4 and the solvent was 
evaporated under reduced pressure to give ethyl oxalyl ester 45. 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 
ethyl oxalate (45a) 
Following general procedure GP-4, using rac. ethyl (2S,3S)-3-(allyl(tert-
butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate (44a) (3.8 g, 
10.8 mmol, 1.0 equiv), pyridine (869 µL, 851 mg, 10.8 mmol, 
1.0 equiv), ethyl 2-chloro-2-oxoacetate (15) (1.2 mL, 1.5 g, 10.8 mmol, 
1.0 equiv) and CH2Cl2 (50 mL) gave 4.5 g (10.1 mmol, 93%) of rac. 
(1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-phenyl-
propan-2-yl ethyl oxalate (45a) as a colorless oil. Rf (hexanes / EtOAc, 3:1) = 0.59, Staining: 
KMnO4 (UV active). 1H NMR (400 MHz, CDCl3):  δ 7.51 – 7.39 (m, 2H), 7.35 – 7.27 (m, 3H), 
6.16 – 5.70 (m, 2H), 5.42 (s, 1H), 4.99 – 4.65 (m, 2H), 4.42 – 4.28 (m, 2H), 4.19 – 4.02 (m, 
2H), 3.70 (bs, 2H), 1.46 (s, 9H), 1.35 (t, J = 7.1 Hz, 3H), 1.10 (s, 3H). 13C NMR (101 MHz, 
CDCl3): δ 166.7, 156.8, 156.8, 135.3, 134.9, 129.5, 128.6, 128.4, 115.7, 81.0, 75.2, 63.5, 62.2, 
58.9, 48.0, 28.4, 14.0, 13.9. IR (neat): 3034, 2981, 2936, 2910, 2878, 1775, 1747, 1690, 1499, 
1476, 1453, 1393, 1368, 1351, 1309, 1271, 1250, 1153, 1094, 1018, 954, 921 884, 860, 771, 
755, 701, 606 cm-1. HRMS (ESI) m/z calculated for C23H32NO8 ([M+H]+) 450.2122, 
found 450.2122. 
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rac. (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-1-ethoxy-1-oxobutan-2-yl ethyl oxalate 
(45e) 
Following general procedure GP-4, using rac. ethyl (2S,3S)-3-(allyl(tert-
butoxycarbonyl)amino)-2-hydroxybutanoate (44e) (200 mg, 696 µmol, 
1.0 equiv), pyridine (165 µL, 162 mg, 1.3 mmol, 1.8 equiv), ethyl 2-chloro-
2-oxoacetate (15) (139 µL, 171 mg, 1.3 mmol, 1.8 equiv) and CH2Cl2 
(10 mL) gave 268 mg (692 µmol, 99%) of rac. (2S,3S)-3-(allyl(tert-
butoxycarbonyl)amino)-1-ethoxy-1-oxobutan-2-yl ethyl oxalate (45e) as a 
colorless oil. Rf (hexanes / EtOAc, 3:1) = 0.55, Staining: KMnO4 (UV active). 1H NMR 
(300 MHz, CDCl3) δ 5.87 – 5.69 (m, 1H), 5.26 (s, 1H), 5.15 – 4.99 (m, 2H), 4.74 (rotamer, bs, 
1H), 4.37 (qd, J = 7.1, 1.3 Hz, 2H), 4.22 (q, J = 7.1 Hz, 2H), 3.96 – 3.71 (m, 2H), 1.52 – 1.40 
(m, 9H), 1.38 (t, J = 7.1 Hz, 3H), 1.32 – 1.23 (m, 6H). 13C NMR (101 MHz, CDCl3, rotamers 
present) δ 167.1, 157.0, 155.3, 154.6, 135.8, 135.0, 116.4, 115.5, 80.9, 80.5, 76.9, 63.5, 62.1, 
52.8, 51.4, 48.0, 46.9, 28.5, 14.0, 13.5. IR (neat): 2982, 2941, 1744, 1692, 1450, 1392, 1368, 
1316, 1252, 1148, 1018, 917, 861, 775 cm-1. HRMS (ESI) m/z calculated 
for C18H29NNaO8 ([M+Na]+) 410.1785, found 410.1790. 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl ethyl oxalate (45g) 
Following general procedure GP-4, using rac. ethyl (2S,3S)-3-((tert-
butoxycarbonyl)(prop-2-yn-1-yl)amino)-2-hydroxy-3-phenylpropanoate 
(44g) (401 mg, 1.2 mmol, 1.0 equiv), pyridine (183 µL, 179 mg, 1.4 mmol, 
1.2 equiv), ethyl 2-chloro-2-oxoacetate (15) (154 µL, 189 mg, 1.4 mmol, 
1.2 equiv) and CH2Cl2 (20 mL) gave 504 mg (1.1 mmol, 98%) of rac. 
(1S,2S)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl ethyl oxalate (45g) as a colorless oil. Rf (hexanes / 
EtOAc, 3:1) = 0.58, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.54 – 7.46 (m, 
2H), 7.39 – 7.27 (m, 3H), 6.01 (bs, 1H), 5.84 (d, J = 4.7 Hz, 1H), 4.37 (qd, J = 7.1, 1.9 Hz, 2H), 
4.12 (q, J = 7.1 Hz, 2H), 4.00 – 3.60 (m, 2H), 1.97 (s, 1H), 1.50 (s, 9H), 1.36 (t, J = 7.1 Hz, 
3H), 1.09 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3, rotamers present) δ 166.5, 156.8, 
156.5, 154.6, 134.8, 129.2, 128.8, 128.5, 81.8, 81.1, 75.5, 70.3, 63.5, 62.3, 58.2, 34.7, 28.4, 
14.0, 14.0. IR (neat):  3288, 2982, 2937, 1748, 1696, 1443, 1394, 1368, 1308, 1252, 1156, 
1018, 958, 883, 820, 772, 701 cm-1. HRMS (ESI) m/z calculated for C23H29NNaO8 ([M+Na]+) 
470.1785, found 470.1785. 
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2-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl ethyl oxalate (45h) 
 Following general procedure GP-4, using tert-butyl-(2-hydroxy-2-
phenylethyl)(prop-2-yn-1-yl)carbamate (44h) (205 mg, 745 µmol, 
1.0 equiv), pyridine (72 µL, 71 mg, 893 µmol, 1.2 equiv), ethyl 2-chloro-
2-oxoacetate (15) (100 µL, 122 mg, 893 µmol, 1.2 equiv) and CH2Cl2 
(10 mL) gave 279 mg (743 µmol, 100%) of 2-((tert-
butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl ethyl oxalate 
(45h) as a colorless oil. Rf (hexanes / EtOAc, 3:1) = 0.63, Staining: 
Vanillin (UV active). 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.31 (m, 5H), 6.18 – 6.05 (m, 1H), 
4.34 (q, J = 7.1 Hz, 2H), 4.21 – 3.94 (m, 2H), 3.86 – 3.61 (m, 2H), 2.28 – 2.13 (m, 1H), 1.46 
(s, 9H), 1.37 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3, rotamers present) δ 157.6, 157.0, 
154.9, 154.7, 136.6, 129.0, 126.6, 81.2, 81.1, 79.7, 79.4, 77.6, 72.2, 71.7, 63.4, 63.3, 51.6, 
51.3, 38.2, 37.3, 28.4, 14.1. IR (neat): 3288, 2982, 2937, 1760, 1744, 1696, 1463, 1405, 1368, 
1305, 1245, 1156, 1129, 1003, 932, 865 760, 701 cm-1. HRMS (ESI) m/z calculated 
for C20H25NNaO6 ([M+Na]+) 398.1574, found 398.1580. 
2-(allyl(tert-butoxycarbonyl)amino)-1-phenylethyl ethyl oxalate (45i) 
Following general procedure GP-4, using tert-butyl allyl(2-hydroxy-2-
phenylethyl)carbamate (44i) (411 mg, 1.5 mmol, 1.0 equiv), pyridine 
(179 µL, 176 mg, 2.2 mmol, 1.5 equiv), ethyl 2-chloro-2-oxoacetate (15) 
(248 µL, 303 mg, 2.2 mmol, 1.5 equiv) and CH2Cl2 (15 mL) gave 526 mg 
(1.4 mmol, 94%) of 2-(allyl(tert-butoxycarbonyl)amino)-1-phenylethyl ethyl 
oxalate (45i) as a colorless oil. Rf (hexanes / EtOAc, 3:1) = 0.63, Staining: 
KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.47 – 7.30 (m, 5H), 6.23 – 6.01 (m, 1H), 
5.73 (ddd, J = 16.2, 10.7, 5.3 Hz, 1H), 5.21 – 5.00 (m, 2H), 4.35 (q, J = 7.2 Hz, 2H), 3.98 – 
3.75 (m, 2H), 3.74 – 3.40 (m, 2H), 1.50 – 1.42 (m, 9H), 1.37 (t, J = 7.1 Hz, 3H). 13C NMR (75 
MHz, CDCl3, rotamers present) δ 157.8, 157.6, 157.2, 157.1, 155.6, 155.1, 136.8, 133.8, 
128.9, 128.8, 126.6, 117.0, 116.3, 80.6, 80.3, 63.4, 63.3, 51.9, 51.5, 51.3, 50.5, 28.5, 14.1. IR 
(neat): 2982, 2937, 1769, 1751, 1692, 1457, 1405, 1305, 1249, 1144, 999, 924, 865, 757, 701 
cm-1. HRMS (ESI) m/z calculated for C20H27NNaO6 ([M+Na]+) 400.1731, found 400.1739. 
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rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-isopropoxy-3-oxo-1-phenylpropan-2-
yl ethyl oxalate (45j) 
Following general procedure GP-4, using rac. isopropyl (2S,3S)-3-
(allyl(tert-butoxycarbonyl)amino)-2-hydroxy-3-phenyl-propanoate (44j) 
(408 mg, 1.1 mmol, 1.0 equiv), pyridine (175 µL, 133 mg, 1.7 mmol, 
1.5 equiv), ethyl 2-chloro-2-oxoacetate (15) (187 µL, 230 mg, 1.7 mmol, 
1.5 equiv) and CH2Cl2 (11 mL) gave 494 mg (1.1 mmol, 95%) of rac. 
(1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-isopropoxy-3-oxo-1-
phenylpropan-2-yl ethyl oxalate (45j) as a orange oil. Rf (hexanes / EtOAc, 3:1) = 0.55, 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.46 (bs, 2H), 7.38 – 7.26 (m, 3H), 
6.10 – 5.69 (m, 2H), 5.55 – 5.22 (m, 1H), 5.04 – 4.62 (m, 3H), 4.37 (dt, J = 7.9, 6.5 Hz, 2H), 
3.86 – 3.54 (m, 2H), 1.46 (s, 9H), 1.37 (t, J = 7.1 Hz, 3H), 1.19 (d, J = 6.3 Hz, 3H), 0.90 (bs, 
3H). 13C NMR (75 MHz, CDCl3) δ 166.2, 156.9, 156.8, 135.3, 134.9, 129.6, 128.6, 128.4, 115.3, 
80.9, 75.4, 70.2, 63.5, 58.5, 47.7, 28.5, 21.6, 21.3, 14.0. IR (neat): 2982, 2937, 1774, 1744, 
1689, 1454, 1394, 1308, 1252, 1144, 1103, 1000, 913, 880, 820, 753, 701 cm-1. HRMS (ESI) 
m/z calculated for C24H33NNaO8 ([M+Na]+) 486.2098, found 486.2104. 
General Procedure (GP-5) for the Preparation of 3,5-Bis(trifluoromethyl)benzoate Esters 
via Benzoylation with 3,5-Bis(trifluoromethyl)benzoic Anhydride 
A flame dried 50 mL Schlenk flask equipped with a magnetic stir bar was charged with N-
alkylated and protected amino alcohol 44 (1.1 mmol, 1.0 equiv) and dry CH2Cl2 (20 mL). N,N-
diisoproylethylamine (2.2 mmol, 2.0 equiv) was added followed by the addition of 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (1.3 mmol, 1.2 equiv). After stirring for 16 h at room 
temperature, CH2Cl2 (40 mL) was added and the organic layer was washed with Na2CO3 (aq. 
10%, 20 mL) and water (20 mL). The organic phase was dried over anhydrous Na2SO4 and 
the solvent evaporated under reduced pressure. The residue was purified by flash 
chromatography to give the 3,5-bis(trifluoromethyl)benzoate ester 47. 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 
3,5-bis(trifluoromethyl)benzoate (47a) 
Following general procedure GP-5, using rac. ethyl (2S,3S)-3-
(allyl(tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate (44a) 
(1.1 g, 3.0 mmol, 1.0 equiv), N,N-diisoproylethylamine (1.0 mL, 775 mg, 
6.0 mmol, 2.0 equiv), 3,5-bis(trifluoromethyl)benzoic anhydride (46) 
(1.8 g, 3.6 mmol, 1.2 equiv) and dry CH2Cl2 (60 mL)  gave 1.8 g 
(3.0 mmol, 100%) of rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-
3-ethoxy-3-oxo-1-phenylpropan-2-yl 3,5-bis(trifluoro- methyl)benzoate 
(47a) as colorless oil after purification by flash chromatography (hexanes / EtOAc, 3:1). Rf 
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(hexanes / EtOAc, 3:1) = 0.75, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3): δ 8.31 
(s, 2H), 8.04 (s, 1H), 7.48 – 7.41 (m, 2H), 7.38 – 7.30 (m, 3H), 6.01 (d, J = 8.0 Hz, 1H), 5.79 
(bs, 1H), 5.51 (bs, 1H), 4.99 – 4.78 (m, 2H), 4.22 (q, J = 7.1 Hz, 2H), 3.87 – 3.66 (m, 2H), 1.48 
(s, 9H), 1.24 (t, J = 7.0 Hz, 3H). 19F NMR (376 MHz, CDCl3): δ -63.62 (s, 6F). 13C NMR 
(101 MHz, CDCl3): δ 168.1, 163.2, 136.1, 134.7, 132.5 (q, J = 34.1 Hz), 131.5, 130.0 (d, J = 
3.3 Hz), 128.8, 128.5, 127.1 – 126.8 (m), 127.3 – 118.4 (m), 116.4, 81.1, 73.6, 62.3, 59.6, 48.6, 
28.5, 14.1. IR (neat): 3071, 2982, 1741, 1692, 1625, 1454, 1394, 1367, 1279, 1249, 1174, 
1133, 1033, 954, 913, 883, 846, 816, 757, 701 cm-1. HRMS (ESI) m/z calculated for 
C28H29F6NNaO6 ([M+Na]+) 613.1824, found 613.1827. 
rac. (1S,2S)-1-(((E)-but-2-en-1-yl)(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47b)  
 
Following general procedure GP-5, using rac. ethyl (2S,3S)-3-(((E)-
but-2-en-1-yl)(tert-butoxycarbonyl) amino)-2-hydroxy-3-
phenylpropanoate (44b) (204 mg, 561 μmol, 1.0 equiv), N,N-
diisoproylethylamine (191 μL, 145 mg, 1.1 mmol, 2.0 equiv), 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (336 mg, 674 μmol, 
1.2 equiv) and dry CH2Cl2 (60 mL) gave 336. mg (557 μmol, 99%) of 
rac. (1S,2S)-1-(((E)-but-2-en-1-yl)(tert-butoxycarbonyl)amino)-3-
ethoxy-3-oxo-1-phenylpropan-2-yl 3,5-bis(trifluoro-methyl)benzoate (47b)  as colorless oil 
after purification by flash chromatography (hexanes / EtOAc, 3:1). Rf (hexanes / EtOAc, 3:1) = 
0.88. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3): δ 8.31 (s, 2H), 8.03 (s, 1H), 
7.54 – 7.21 (m, 5H), 6.03 (d, J = 8.1 Hz, 1H), 5.95 – 4.87 (m, 3H), 4.22 (q, J = 12.0, 6.0 Hz, 
2H), 3.96 – 3.44 (m, 2H), 1.45 (s, 12H), 1.22 (t, J = 6.0 Hz, 3H). 19F NMR (376 MHz, CDCl3): 
δ -63.69 (s, 6F). 13C NMR (75 MHz, CDCl3, E/Z-isomers present) δ 168.2, 163.2, 163.2, 155.2, 
136.3, 132.4 (q, J = 34.2 Hz), 131.5, 130.1 – 129.9 (m), 128.8, 128.7, 128.4, 128.3, 127.2, 
127.0 – 126.7 (m), 122.8 (q, J = 272.9 Hz), 80.8, 73.7, 73.5, 62.2, 59.7, 48.1, 28.4, 17.6, 14.1, 
12.7. IR (neat): 2982, 2937, 1741, 1692, 1454, 1394, 1368, 1279, 1174, 1133, 1036, 962, 910, 
846, 816, 768, 701 cm-1. HRMS (ESI) m/z calculated for C29H31F6NNaO6 ([M+Na]+) 626.1948, 
found 626.1956. 
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rac. (1S,2S)-1-((tert-butoxycarbonyl)(3-methylbut-2-en-1-yl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47c)  
Following general procedure GP-5, using rac. ethyl (2S,3S)- 
3-((tert-butoxycarbonyl) (3-methylbut-2-en-1-yl)amino)-2-hydroxy-3-
phenylpropanoate (44c) (203 mg, 538 μmol, 1.0 equiv), N,N-
diisoproylethylamine (183 μL, 139 mg, 1.1 mmol, 2.0 equiv), 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (322 mg, 645 μmol, 
1.2 equiv) and dry CH2Cl2 (60 mL) gave 321 mg (520 μmol, 97%) of 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(3-methylbut-2-en-1-yl)amino)-3-
ethoxy-3-oxo-1-phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate 
(47c)  as colorless oil after purification by flash chromatography (hexanes / EtOAc, 3:1). Rf 
(hexanes / EtOAc, 6:1) = 0.63. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 8.32 
(s, 2H), 8.03 (s, 1H), 7.49 – 7.25 (m, 5H), 6.04 (d, J = 7.8 Hz, 1H), 5.68 (bs, 1H), 4.90 (s, 1H), 
4.22 (q, J = 7.1 Hz, 2H), 3.93 – 3.55 (m, 2H), 1.47 (s, 12H), 1.38 (s, 3H), 1.23 (t, J = 7.1 Hz, 
3H). 19F NMR (282 MHz, CDCl3) δ -63.67 (s, 6F). 13C NMR (75 MHz, CDCl3) δ 168.2, 163.2, 
155.2, 136.3, 132.4 (q, J = 34.2 Hz), 131.5, 130.0 (d, J = 3.1 Hz), 128.7, 128.3, 127.0 – 126.7 
(m), 128.4 – 117.1 (m), 122.0, 121.9, 80.8, 73.8, 62.2, 59.7, 44.3, 28.5, 25.5, 17.6, 14.1. IR 
(neat): 3068, 2982, 2937, 1741, 1692, 1625, 1454, 1394, 1368, 1279, 1249, 1178, 1137, 1029, 
954, 913, 846, 760, 701 cm-1. HRMS (ESI) m/z calculated for C30H33F6NNaO6 ([M+Na]+) 
640.2104, found 640.2109. 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(2-methylallyl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47d) 
Following general procedure GP-5, using rac. ethyl (2S,3S)-3-((tert-
butoxycarbonyl)(2-methylallyl)amino)-2-hydroxy-3-phenylpropanoate) 
(44d) (70 mg, 193 μmol, 1.0 equiv), N,N-diisopropylethylamine (66 μL, 
50 mg, 385 μmol, 2.0 equiv), 3,5-bis(trifluoromethyl)benzoic anhydride 
(46) (115 mg, 231 μmol, 1.2 equiv) and dry CH2Cl2 (60 mL) gave 
113 mg (187 µmol, 97%) of rac. (1S,2S)-1-((tert-butoxycarbonyl)(2-
methylallyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 3,5-
bis(trifluoromethyl)benzoate (47d) as colorless oil after purification by 
flash chromatography (hexanes / EtOAc, 3:1). Rf (hexanes / EtOAc, 6:1) = 0.63. Staining: 
KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 8.29 (s, 2H), 8.04 (s, 1H), 7.52 – 7.26 (m, 
5H), 6.06 (d, J = 7.3 Hz, 1H), 5.73 (bs, 1H), 4.61 (d, J = 9.2 Hz, 2H), 4.22 (q, J = 7.1 Hz, 2H), 
3.98 – 3.50 (m, 2H), 1.47 (s, 9H), 1.41 (s, 3H), 1.22 (t, J = 7.2 Hz, 3H). 19F NMR (376 MHz, 
CDCl3): δ -63.63 (s, 6F). 13C NMR (75 MHz, CDCl3): δ 168.1, 163.1, 155.5, 141.6, 136.1, 
132.4 (q, J = 34.2 Hz), 131.6, 130.1 – 129.8 (m), 129.0, 128.7, 128.4, 127.0 – 126.7 (m), 122.8 
(q, J = 272.9 Hz), 111.1, 81.0, 73.9, 62.3, 60.0, 51.8, 28.4, 20.0, 14.1. IR (neat): 3071, 2982, 
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2937, 1744, 1696, 1625, 1454, 1394, 1372, 1279, 1249, 1174, 1137, 1029, 958, 913, 846, 816, 
768, 701 cm-1. HRMS (ESI) m/z calculated for C29H31F6NNaO6 ([M+Na]+) 626.1948, found 
626.1951. 
rac. (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-1-ethoxy-1-oxobutan-2-yl 3,5-
bis(trifluoromethyl)benzoate (47e) 
Following general procedure GP-5, using rac. ethyl (2S,3S)-3-
(allyl(tert-butoxycarbonyl)amino)-2-hydroxybutanoate (44e) (298 mg, 
1.0 mmol, 1.0 equiv), N,N-diisoproylethylamine (529 µL, 402 mg, 
3.1 mmol, 3.0 equiv), 3,5-bis(trifluoromethyl)benzoic anhydride (46) 
(930 mg, 1.9 mmol, 1.8 equiv) and dry CH2Cl2 (20 mL) gave 535 mg 
(1.0 mmol, 98%) of rac. (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-1-
ethoxy-1-oxobutan-2-yl 3,5-bis(trifluoromethyl)benzoate (47e) as 
yellow oil after purification by flash chromatography (hexanes / EtOAc, 5:1). Rf (hexanes / 
EtOAc, 3:1) = 0.74, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 8.49 (s, 2H), 
8.10 (s, 1H), 5.77 (td, J = 10.7, 5.2 Hz, 1H), 5.45 (d, J = 6.1 Hz, 1H), 5.16 – 4.99 (m, 2H), 4.76 
(rotamer, bs, 1H), 4.25 (q, J = 7.1 Hz, 2H), 4.05 – 3.66 (m, 2H), 1.57 – 1.43 (m, 9H), 1.40 (d, 
J = 7.1 Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H). 19F NMR (282 MHz, CDCl3) δ -63.64 (s, 6F). 13C NMR 
(75 MHz, CDCl3, rotamers present) δ 168.3, 168.0, 163.3, 155.3, 154.7, 140.7, 135.5, 134.9, 
132.5 (q, J = 34.1 Hz), 131.7, 129.97 (d, J = 3.9 Hz), 127.08 – 126.76 (m), 122.9 (q, J = 272.9 
Hz), 126.9, 116.6, 115.7, 81.0, 80.5, 76.1, 62.0, 53.2, 51.9, 48.6, 47.3, 28.4, 15.4, 14.2. IR 
(neat): 2982, 2941, 1741, 1696, 1625, 1454, 1368, 1323, 1279, 1245, 1174, 1133, 1018, 913, 
860, 768, 701 cm-1. HRMS (ESI) m/z calculated for C23H27F6NNaO6 ([M+Na]+) 550.1635, 
found 550.1649. 
(1S,2S)-2-(allyl(tert-butoxycarbonyl)amino)-1-(4-nitrophenyl)propane-1,3-diyl bis(3,5-
bis(trifluoro-methyl)benzoate) (47f) 
Following general procedure GP-5, using  
tert-butyl allyl((1S,2S)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)carbamate (44f) (238 mg, 
675 µmol, 1.0 equiv), N,N-diisoproylethylamine 
(459 µL, 349 mg, 2.7 mmol, 4.0 equiv), 3,5-
bis(trifluoromethyl)-benzoic anhydride (46) (808 mg, 
1.6 mmol, 2.4 equiv) and dry CH2Cl2 (20 mL) gave 
554 mg (665 µmol, 99%) of (1S,2S)-2-(allyl(tert-butoxycarbonyl)amino)-1-(4-
nitrophenyl)propane-1,3-diyl bis(3,5-bis(trifluoro-methyl)benzoate) (47f) as yellow oil after 
purification by flash chromatography (hexanes / EtOAc, 5:1). Rf (hexanes / EtOAc, 6:1) = 0.67, 
Staining: KMnO4 (UV active). Specific Rotation: [α]𝐷
25 = + 22.7 °. 1H NMR (400 MHz, CDCl3) δ 
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8.55 – 8.41 (m, 2H), 8.35 – 8.20 (m, 4H), 8.08 (d, J = 17.8 Hz, 2H), 7.70 (dd, J = 21.6, 8.4 Hz, 
2H), 6.76 – 6.07 (m, 1H), 5.97 – 5.67 (m, 1H), 5.43 – 3.72 (m, 7H), 1.35 (s, 9H). 19F NMR 
(282 MHz, CDCl3) δ -63.52 (s, 6F), -63.60 (s, 6F). 13C NMR (101 MHz, CDCl3) δ 163.3, 162.7, 
148.5, 143.5, 134.4, 132.9, 132.7, 132.6, 132.4, 131.6, 130.0, 129.7, 128.6, 126.9, 124.5, 
127.4 – 118.6 (m), 81.4, 74.7, 62.9, 58.2, 50.4, 28.1. IR (neat): 3090, 2982, 1737, 1700, 1610, 
1528, 1457, 1349, 1279, 1238, 1179, 1133, 992, 962, 913, 846, 768, 682 cm-1. HRMS (ESI) 
m/z calculated for C35H28F12N2NaO8 ([M+Na]+) 855.1546, found 855.1545. 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47g) 
Following general procedure GP-5, using rac. ethyl  
(2S,3S)-3-((tert butoxycarbonyl)(prop-2-yn-1-yl)amino)-2-hydroxy-3 
phenylpropanoate (44g) (324 mg, 933 µmol, 1.0 equiv),  N,N-
diisoproylethylamine (317 µL, 241 mg, 1.9 mmol, 2.0 equiv), 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (558 mg, 1.1 mmol, 
1.2 equiv) and dry CH2Cl2 (20 mL) gave 527 mg (897 µmol, 96%) of 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-
3-oxo-1-phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47g) as 
yellow oil after purification by flash chromatography (hexanes / EtOAc, 5:1). Rf (hexanes / 
EtOAc, 3:1) = 0.75, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 8.38 (s, 2H), 
8.06 (s, 1H), 7.54 – 7.45 (m, 2H), 7.43 – 7.30 (m, 3H), 6.09 (d, J = 6.6 Hz, 1H), 5.89 (bs, 1H), 
4.22 (q, J = 7.1 Hz, 2H), 4.07 – 3.64 (m, 2H), 1.90 (s, 1H), 1.51 (s, 9H), 1.21 (t, J = 7.1 Hz, 
3H). 19F NMR (376 MHz, CDCl3) δ -63.63 (s, 6F). 13C NMR (101 MHz, CDCl3) δ 167.8, 163.2, 
154.6, 135.4, 132.4 (q, J = 34.2 Hz), 131.8, 130.2 – 129.9 (m), 129.0, 128.6, 127.0 – 126.8 
(m), 127.0 – 118.6 (m), 81.9, 80.3, 74.0, 70.9, 62.4, 59.3, 35.2, 28.4, 14.1. IR (neat):  3314, 
2982, 1741, 1700, 1443, 1394, 1372, 1279, 1249, 1174, 1133, 1033, 910, 883, 846, 760, 682 
cm-1. HRMS (ESI) m/z calculated for C28H27F6NNaO6 ([M+Na]+) 610.1635, found 610.1638. 
2-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl 3,5-bis(trifluoromethyl)-
benzoate (47h) 
Following general procedure GP-5, using tert-butyl-(2-hydroxy-2-
phenylethyl)(prop-2-yn-1-yl)carbamate (44h) (149 mg, 541 µmol, 
1.0 equiv),  N,N-diisoproylethylamine (184 µL, 140 mg, 1.1 mmol, 
2.0 equiv), 3,5-bis(trifluoromethyl)benzoic anhydride (46) (324 mg, 
649 µmol, 1.2 equiv) and dry CH2Cl2 (20 mL) gave 274 mg (532 µmol, 
98%) of 2-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl 
3,5-bis(trifluoromethyl)benzoate (47h) as colorless oil after purification 
by flash chromatography (hexanes / EtOAc, 12:1 to 3:1). Rf (hexanes / 
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EtOAc, 3:1) = 0.89, Staining: Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 8.56 (s, 2H), 
8.08 (s, 1H), 7.59 – 7.32 (m, 5H), 6.43 – 6.21 (m, 1H), 4.34 – 3.88 (m, 3H), 3.84 – 3.57 (m, 
1H), 2.24 (d, J = 9.1 Hz, 1H), 1.43 (d, J = 13.1 Hz, 9H). 19F NMR (282 MHz, CDCl3) δ -63.44 
(s, 6F). 13C NMR (75 MHz, CDCl3) δ 163.3, 163.2, 154.9, 154.8, 137.4, 137.3, 133.1, 132.5, 
132.1, 130.3 – 129.7 (m), 129.0, 126.6, 123.0 (q, J = 273.0 Hz), 81.2, 81.0, 79.3, 79.2, 76.2, 
76.0, 72.8, 72.2, 51.2, 37.6, 37.2, 28.3. IR (neat): 3314, 3071, 2982, 2937, 1733, 1700, 1625, 
1454, 1409, 1368, 1279, 1241, 1174, 1133, 1010, 913, 846, 764, 701 cm-1. HRMS (ESI) m/z 
calculated for C25H23F6NNaO4 ([M+Na]+) 538.1423, found 538.1420. 
2-(allyl(tert-butoxycarbonyl)amino)-1-phenylethyl 3,5-bis(trifluoromethyl)benzoate (47i) 
Following general procedure GP-5, using tert-butyl allyl(2-hydroxy-2-
phenylethyl)carbamate (44i) (300 mg, 1.1 mmol, 1.0 equiv), N,N-
diisoproylethylamine (378 µL, 280 mg, 2.2 mmol, 2.0 equiv), 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (647 mg, 1.3 mmol, 
1.2 equiv) and dry CH2Cl2 (22 mL)  gave 532 mg (1.0 mmol, 95%) of 
2-(allyl(tert-butoxycarbonyl)amino)-1-phenylethyl 3,5-
bis(trifluoromethyl)benzoate (47i) as yellow oil after 24 h stirring and 
purification by flash chromatography (hexanes / EtOAc, 5:1). Rf (hexanes / EtOAc, 3:1) = 0.75, 
Staining: KMnO4 (UV active).  1H NMR (400 MHz, CDCl3) δ 8.66 – 8.37 (m, 2H), 8.18 – 7.90 
(m, 1H), 7.58 – 7.31 (m, 5H), 6.41 – 6.15 (m, 1H), 5.72 (ddd, J = 14.6, 10.9, 5.5 Hz, 1H), 5.25 
– 4.98 (m, 2H), 4.11 – 3.40 (m, 4H), 1.54 – 1.27 (m, 9H). 19F NMR (376 MHz, CDCl3) δ -63.45 
(s, 6F). 13C NMR (101 MHz, CDCl3) δ 163.4, 163.1, 155.7, 155.2, 137.6, 133.9, 132.6, 132.2, 
130.1, 129.9, 128.9, 128.9, 126.7, 126.6, 127.3 – 118.7 (m), 117.1, 116.5, 80.6, 80.3, 76.2, 
51.6, 51.6, 50.8, 50.5, 28.5, 28.3. IR (neat): 3090, 2982, 2933, 1733, 1696, 1457, 1409, 1368, 
1279, 1241, 1174, 1133, 1003, 913, 846, 764, 701 cm-1. HRMS (ESI) m/z calculated for 
C25H25F6NNaO4 ([M+Na]+) 540.1580, found 540.1587. 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-isopropoxy-3-oxo-1-phenylpropan-2-
yl 3,5-bis(trifluoromethyl)benzoate (47j) 
Following general procedure GP-5, using rac. isopropyl (2S,3S)-3-
(allyl(tert-butoxycarbonyl) amino)-2-hydroxy-3-phenyl-propanoate 
(44j) (420 mg, 1.2 mmol, 1.0 equiv), N,N-diisoproylethylamine 
(415 µL, 299 mg, 2.3 mmol, 2.0 equiv), 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (691 mg, 1.4 mmol, 
1.2 equiv) and dry CH2Cl2 (22 mL)  gave 677 mg (1.1 mmol, 97%) of 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-isopropoxy-3-oxo-
1-phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47j) as yellow oil after 24 h stirring and 
purification by flash chromatography (hexanes / EtOAc, 5:1). Rf (hexanes / EtOAc, 3:1) = 0.83, 
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Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 8.41 – 8.26 (m, 2H), 8.05 (dt, J = 
2.0, 1.0 Hz, 1H), 7.51 – 7.39 (m, 2H), 7.40 – 7.26 (m, 3H), 5.99 (d, J = 7.6 Hz, 1H), 5.90 – 5.30 
(m, 2H), 5.05 (p, J = 6.2 Hz, 1H), 4.93 – 4.68 (m, 2H), 3.94 – 3.54 (m, 2H), 1.48 (s, 9H), 1.29 
(d, J = 6.3 Hz, 3H), 1.11 (s, 3H). 19F NMR (376 MHz, CDCl3) δ -63.61 (s, 6F). 13C NMR (101 
MHz, CDCl3) δ 167.6, 163.3, 155.3, 136.2, 134.7, 132.5 (q, J = 34.2 Hz), 131.6, 130.1 – 130.0 
(m), 128.8, 128.5, 127.1 – 126.8 (m), 127.1 – 118.7 (m), 116.4, 81.1, 73.9, 70.2, 59.5, 48.7, 
28.5, 21.8, 21.6. IR (neat): 3071, 2982, 2937, 1741, 1696, 1454, 1394, 1279, 1249, 1179, 
1133, 1036, 962, 913, 846, 760, 701 cm-1. HRMS (ESI) m/z calculated for C29H31F6NNaO6 
([M+Na]+) 626.1948, found 626.1954. 
rac. (1R,2S)-2-(N-allylacetamido)-1,2-diphenylethyl 3,5-bis(trifluoro-methyl)benzoate 
(47m) 
Following general procedure GP-5, using rac. N-allyl-N-((1R,2S)-2-
hydroxy-1,2-diphenylethyl)acetamide (44m) (317 mg, 1.1 mmol, 
1.0 equiv), N,N-diisoproylethylamine (367 µL, 277 mg, 2.2 mmol, 
2.0 equiv), 3,5-bis(trifluoromethyl)benzoic anhydride (46) (642 mg, 
1.3 mmol, 1.2 equiv) and dry CH2Cl2 (20 mL) gave 521 mg 
(973 µmol, 91%) of rac. (1R,2S)-2-(N-allylacetamido)-1,2-
diphenylethyl 3,5-bis(trifluoromethyl)benzoate (47m) as a colorless 
oil after purification by flash chromatography (hexanes / EtOAc, 3:1). Rf (hexanes/ EtOAc, 3:1) 
= 0.30, Staining: Ninhydrin (UV active).  1H NMR (400 MHz, CDCl3): δ 8.18 (s, 2H), 7.96 (s, 
1H), 7.66 – 7.52 (m, 4H), 7.45 – 7.27 (m, 6H), 6.92 (d, J = 10.6 Hz, 1H), 6.13 (d, J = 10.6 Hz, 
1H), 5.10 (ddd, J = 16.6, 10.5, 5.5 Hz, 1H), 4.92 (dd, J = 10.3, 1.0 Hz, 1H), 4.84 (dd, J = 17.1, 
1.0 Hz, 1H), 3.84 – 3.76 (m, 1H), 3.66 (dd, J = 17.4, 6.2 Hz, 1H), 1.81 (s, 3H). 19F NMR (376 
MHz, CDCl3) δ -63.04 (s, 6F). 13C NMR (101 MHz, CDCl3): δ 171.5, 163.0, 137.4, 136.8, 133.6, 
132.3, 132.2 (q, J = 34.0 Hz), 129.7 (d, J = 3.3 Hz), 129.3, 128.9, 128.9, 128.6, 128.4, 128.1, 
126.6 – 126.4 (m), 127.1 – 118.6 (m), 117.5, 76.0, 61.4, 49.8, 22.3.  IR (neat): 3092, 3068, 
3036, 3010, 2988, 2975, 2938, 2905, 1732, 1651, 1498, 1456, 1406, 1366, 1334, 1278, 1245, 
1176, 1131, 1077, 1032, 989, 968, 947, 912, 871, 845, 831, 756, 697, 681, 623, 610, 542 cm-
1. HRMS (ESI) m/z calculated for C28H24F6NO3 ([M+H]+) 536.1655, found 536.1662. 
2.2.2. Deoxygenative Cyclization Towards Substituted Pyrrolidines 
General Procedure (GP-6) for Reaction of Ethyl Oxalyl Esters and 3,5-
Bis(trifluoromethyl)benzoate Esters to Pyrrolidine Derivatives 
A flame dried Schlenk tube equipped with a magnetic stir bar was charged with ethyl oxalate 
ester 45 or 3,5-bis(trifluoromethyl)benzoate ester 47, fac-Ir(ppy)3 (1.0 mol%) and DMF (0.1 M). 
The reaction mixture was degassed by three freeze-pump-thaw-cycles and pumped through a 
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previously N2 purged micro reactor equipped with eight LED’s at a flow rate of 0.15-1.00 mL/h 
via a syringe pump while heated at 80 °C. Afterwards, the reaction mixture was diluted with 
diethyl ether (150 mL) and washed with brine (3x 100 mL). The combined organic layers were 
dried over anhydrous Na2SO4, the solvent was evaporated under reduced pressure and the 
residue purified by flash column chromatography. 
rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-methyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48a) and rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48a´) 
From oxalate ester: Following general procedure GP-
6, using rac. (1R,2R)-1-(allyl(tert-
butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl ethyl oxalate (45a) (456 mg, 
1.0 mmol, 1.0 equiv), fac-Ir(ppy)3 (6.6 mg, 10.0 µmol, 
1.0 mol%) and DMF (10 mL, 0.1 M) at a flow rate of 
1.00 mL/h gave 131 mg (393 µmol, 39%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-methyl-2-
phenylpyrrolidine-1,3-dicarboxylate (48a) and 79 mg (237 µmol, 23%) of rac. 1-(tert-butyl) 3-
ethyl (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-1,3-dicarboxylate (48a´) as colorless oils after 
flash column purification (diethyl ether / n-pentane, 1:20 to 1:3), (dr = 63:37).  
From 3,5-bis(trifluoromethyl) benzoate ester: Following general procedure GP-6, using rac. 
(1R,2R)-1-(allyl(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 3,5-
bis(trifluoro- methyl)benzoate (47a) (593 mg, 1.0 mmol, 1.0 equiv), fac-Ir(ppy)3 (6.6 mg, 
10.0 µmol, 1.0 mol%) and DMF (10 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 126 mg 
(378 µmol, 38%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48a) and 76 mg (228 µmol, 23%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-
methyl-2-phenylpyrrolidine-1,3-dicarboxylate (48a´) as colorless oils after flash column 
purification (diethyl ether / n-pentane, 1:20 to 1:3), (dr = 61:39).  
Rf (48a, diethyl ether / n-pentane, 1:3) = 0.20, Staining: Ninhydrin (UV active). Rf (48a´, diethyl 
ether / n-pentane, 1:3) = 0.25, Staining: Ninhydrin (UV active). 1H NMR (48a, 400 MHz, 
CDCl3): δ 7.33 – 7.14 (m, 5H), 5.06 (m, 1H), 4.25 – 3.98 (m, 2H), 3.84 – 3.66 (m, 1H), 3.58 – 
3.33 (m, 1H), 3.06 – 2.82 (m, 1H), 2.71 – 2.54 (m, 1H), 1.45 (bs, 3H), 1.26 (t, J = 7.2 Hz, 3H), 
1.12 (m, 6H), 1.01 (d, J = 7.0 Hz, 3H). 1H NMR (48a´, 400 MHz, CDCl3): δ 7.35 – 7.11 (m, 5H), 
5.16 – 4.85 (m, 1H), 4.24 – 3.98 (m, 3H), 3.18 (t, J = 10.7 Hz, 1H), 2.63 – 2.40 (m, 2H), 1.46 – 
1.01 (m, 15H). 13C NMR (48a, 101 MHz, CDCl3): δ 172.2, 171.6, 154.6, 143.8, 128.4, 127.1, 
127.1, 126.0, 125.6, 79.6, 62.3, 61.0, 60.8, 57.9, 53.5, 33.9, 28.6, 28.2, 14.6, 14.4. 13C NMR 
(48a´, 101 MHz, CDCl3): δ 172.3, 154.1, 143.9, 128.4, 127.1, 125.9, 79.7, 65.2, 61.9, 61.0, 
54.6, 37.4, 28.1, 16.0, 14.4. IR (48a, neat): 2974, 2930, 1730, 1685, 1480, 1398, 1282, 1256, 
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1230, 1185, 1141, 1036, 1006, 887, 760, 701 cm-1. IR (48a´, neat): 2978, 2933, 1733, 1692, 
1480, 1394, 1279, 1163, 1126, 1025, 951, 895, 861, 760, 701 cm-1. HRMS (48a, ESI) m/z 
calculated for C19H28NO4 ([M+H]+) 334.2013, found 334.2020. HRMS (48a´, ESI) m/z 
calculated for C19H27NNaO4 ([M+Na]+) 356.1832, found 356.1838. 
rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-ethyl-2-phenylpyrrolidine-1,3-dicarboxylate (48b) 
and rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-ethyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48b´)  
From 3,5-bis(trifluoromethyl) benzoate ester: 
Following general procedure GP-6, using  
rac. (1R,2R)-1-(((E)-but-2-en-1-yl) (tert-
butoxycarbonyl) amino)-3-ethoxy-3-oxo-1 phenyl-
propan-2-yl 3,5-bis(trifluoro-methyl)benzoate 
(47b) (446 mg, 739 µmol, 1.0 equiv), fac-Ir(ppy)3 
(4.9 mg, 7.4 µmol, 1.0 mol%) and DMF (7.5 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 106 mg 
(305 µmol, 41%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-ethyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48b) and 27 mg (78 µmol, 11%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-ethyl-
2-phenylpyrrolidine-1,3-dicarboxylate (48b´) as colorless oils after flash column purification 
(diethyl ether / n-pentane, 1:20 to 1:1), (dr = 79:21). 
Rf (48b, diethyl ether / n-pentane, 1:3) = 0.33, Staining: Ninhydrin (UV active).  Rf (48b´, 
diethyl ether / n-pentane, 1:3) = 0.40, Staining: Ninhydrin (UV active).  1H NMR (48b, 400 MHz, 
CDCl3): δ 7.34 – 7.16 (m, 5H), 5.29 – 4.93 (m, 1H), 4.18 (m, 2H), 3.84 – 3.61 (m, 1H), 3.58 – 
3.29 (m, 1H), 3.09 – 2.81 (m, 1H), 2.38 (q, J = 7.2 Hz, 1H), 1.53 – 1.08 (m, 14H), 0.98 – 0.84 
(m, 3H). 1H NMR (48b´, 400 MHz, CDCl3): δ 7.36 – 7.12 (m, 5H), 5.08 – 4.81 (m, 1H), 4.22 – 
4.02 (m, 3H), 3.20 (t, J = 10.7 Hz, 1H), 2.63 (t, J = 10.0 Hz, 1H), 2.47 – 2.31 (m, 1H), 1.74 – 
1.53 (m, 2H), 1.51 – 1.30 (m, 3H), 1.21 (t, J = 7.1 Hz, 3H), 1.10 (s, 6H), 0.92 (t, J = 7.5 Hz, 
3H). 13C NMR (48b, 101 MHz, CDCl3): δ 172.2, 154.6, 143.6, 142.5, 128.6, 128.4, 127.1, 
125.8, 125.6, 79.6, 63.7, 63.3, 60.7, 56.7, 55.2, 51.4, 50.8, 41.2, 40.8, 28.6, 28.2, 22.2, 14.4, 
14.3, 12.7, 12.2. 13C NMR (48b´, 101 MHz, CDCl3):  δ 172.7, 154.2, 143.9, 128.5, 127.1, 125.8, 
79.8, 65.5, 61.0, 60.4, 52.9, 44.0, 28.2, 25.0, 14.4, 12.2. IR (48b, neat):  2989, 2930, 2863, 
1733, 1681, 1480, 1405, 1279, 1163, 1074, 1014, 928, 898, 865, 768, 705 cm-1. IR (48b´, 
neat): 3034, 2989, 2930, 2866, 1733, 1685, 1480, 1405, 1279, 1163, 1107, 1070, 1010, 961, 
928, 895, 764, 705 cm-1. HRMS (48b, ESI) m/z calculated for 
C20H29NNaO4 ([M+Na]+) 370.1989, found 370.1992. HRMS (48b´, ESI) m/z calculated for 
C20H29NNaO4 ([M+Na]+) 370.1989, found 370.1991. 
 
 
Experimental Part 
156 
rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-isopropyl-2-phenylpyrrolidine-1,3-dicarboxy-late 
(48c) / rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-2-phenyl-4-(prop-1-en-2-yl)pyrrolidine-1,3-
dicarboxylate (48cS1) and rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-isopropyl-2-
phenylpyrrolidine-1,3-dicarboxylate (48c´) / rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-2-
phenyl-4-(prop-1-en-2-yl)pyrrolidine-1,3-dicarboxylate (48c´S1) 
From 3,5-bis(trifluoromethyl) benzoate 
ester: Following general procedure GP-6, 
using rac. (1R,2R)-1-((tert-butoxycarbonyl)(3-
methylbut-2-en-1-yl) amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)-
benzoate (47c) (351 mg, 568 µmol, 1.0 equiv), 
fac-Ir(ppy)3 (3.7 mg, 5.7 µmol, 1.0 mol%) and DMF (5.7 mL, 0.1 M) at a flow rate of 0.30 mL/h 
gave 57 mg (158 µmol, 28%) of a mixture of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-isopropyl-
2-phenylpyrrolidine-1,3-dicarboxy-late (48c) / rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-2-phenyl-4-
(prop-1-en-2-yl)pyrrolidine-1,3-dicarboxylate (48cS1) and 51 mg (140 µmol, 25%) of a mixture 
of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-isopropyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48c´) / rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-2-phenyl-4-(prop-1-en-2-yl)pyrrolidine-1,3-
dicarboxylate (48c´S1) as colorless oils after flash column purification (diethyl ether / n-
pentane, 1:20 to 1:1). (Alkene/Alkane ratio 77:23 for 47c (dr = 53:47). 
Rf (48c/48cS1, diethyl ether / n-pentane, 1:3) = 0.35, Staining: Ninhydrin (UV 
active). Rf (48c´/48c´S1, diethyl ether / n-pentane, 1:3) = 0.40, Staining: Ninhydrin (UV active). 
1H NMR (48cS1, 400 MHz, CDCl3): δ 7.40 – 7.07 (m, 5H), 5.10 – 4.74 (m, 3H), 4.11 (ddq, J = 
11.0, 7.1, 3.7 Hz, 3H), 3.43 (t, J = 11.0 Hz, 1H), 3.14 (td, J = 11.4, 7.6 Hz, 1H), 2.96 (t, J = 10.5 
Hz, 1H), 1.75 (s, 3H), 1.48 – 1.35 (m, 2H), 1.23 – 1.01 (m, 10H). 1H NMR (48c´S1, 400 MHz, 
CDCl3): δ 7.37 – 7.19 (m, 5H), 5.19 (d, J = 56.1 Hz, 1H), 4.81 (d, J = 33.6 Hz, 2H), 4.28 – 4.02 
(m, 2H), 3.82 (dd, J = 12.0, 7.1 Hz, 2H), 3.18 – 2.95 (m, 2H), 1.72 (s, 3H), 1.47 (s, 2H), 1.32 – 
1.13 (m, 10H). 13C NMR (48cS1, 101 MHz, CDCl3): δ 172.1, 154.1, 143.5, 141.4, 128.5, 127.3, 
125.8, 113.3, 79.9, 65.4, 61.0, 58.1, 51.6, 49.2, 28.1, 20.0, 14.3. 13C NMR (48c´S1, 101 MHz, 
CDCl3): δ 171.6, 154.5, 143.5, 142.0, 128.5, 127.2, 125.7, 112.6, 79.8, 63.5, 60.8, 56.5, 49.3, 
45.2, 28.6, 28.2, 22.2, 21.2, 14.3. IR (neat): 3034, 2967, 1733, 1696, 1476, 1390, 1370, 1274, 
1261, 1163, 1126, 1018, 951, 898, 768, 701 cm-1. HRMS (ESI) m/z calculated for major product 
C21H29NNaO4 ([M+Na]+) 382.1989, found 382.1994.  
 
 
 
Experimental Part 
157 
rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4 isopropyl-2-phenylpyrrolidine-1,3-dicarboxy-late 
(48c) and rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-isopropyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48c´) 
A 5 mL Schlenk tube was charged with a mixture 
of rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-
isopropyl-2-phenylpyrrolidine-1,3-dicarboxy-late 
(48c) / rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-2-
phenyl-4-(prop-1-en-2-yl) pyrrolidine-1,3-
dicarboxylate (48cS1) (57 mg, 158 µmol, 
1.0 equiv), Pd/C (10 wt%, 34 mg, 0.25 equiv) and dry EtOH (1.0 mL). The atmosphere was 
exchanged to hydrogen (3 times), a balloon of hydrogen gas was fitted to the Schlenk flask 
and the mixture was stirred for 24 h at room temperature. The reaction mixture was evaporated 
under reduced pressure to give 56 mg (155 µmol, 98%) of rac. 1-(tert-butyl) 3-ethyl 
(2R,3R,4R)-4-isopropyl-2-phenylpyrrolidine-1,3-dicarboxy-late (48c) as a colorless oil. In an 
analogue way rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-4-isopropyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48c´) (49 mg, 137 µmol, 97%) was obtained. (dr = 53:47). 
Rf (48c, diethyl ether / n-pentane, 1:3) = 0.35, Staining: Ninhydrin (UV active).  Rf (48c´, diethyl 
ether / n-pentane, 1:3) = 0.40, Staining: Ninhydrin (UV active). 1H NMR (48c, 400 MHz, 
CDCl3):  δ 7.35 – 7.04 (m, 5H), 4.98 – 4.77 (m, 1H), 4.13 (ddq, J = 10.8, 7.2, 3.7 Hz, 2H), 4.07 
– 3.91 (m, 1H), 3.29 (t, J = 10.9 Hz, 1H), 2.71 (t, J = 9.9 Hz, 1H), 2.40 (tt, J = 10.9, 7.6 Hz, 1H), 
1.68 (dd, J = 13.7, 6.6 Hz, 1H), 1.50 – 1.35 (m, 2H), 1.20 (t, J = 7.1 Hz, 3H), 1.09 (s, 7H), 0.93 
(d, J = 6.7 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H). 1H NMR (48c´, 400 MHz, CDCl3): δ 7.36 – 7.14 
(m, 5H), 5.11 (d, J = 65.5 Hz, 1H), 4.30 – 4.07 (m, 2H), 3.76 (dt, J = 45.3, 9.5 Hz, 1H), 3.44 
(td, J = 10.7, 4.0 Hz, 1H), 2.91 (dd, J = 14.8, 6.6 Hz, 1H), 2.17 – 2.00 (m, 1H), 1.64 – 1.51 (m, 
1H), 1.47 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H), 1.22 (s, 6H), 0.91 (d, J = 6.6 Hz, 3H), 0.89 (d, J = 
7.2 Hz, 3H). 13C NMR (48c, 101 MHz, CDCl3): δ 173.4, 154.2, 143.8, 128.5, 127.2, 125.7, 79.7, 
66.5, 61.0, 58.8, 50.8, 48.4, 30.3, 28.1, 21.0, 19.9, 14.3. 13C NMR (48c´, 101 MHz, CDCl3): δ 
172.9, 172.8, 154.7, 154.5, 143.2, 142.3, 128.6, 128.4, 128.4, 127.2, 127.1, 125.6, 125.5, 79.7, 
79.6, 64.7, 60.7, 60.7, 55.0, 50.1, 47.0, 46.1, 28.9, 28.9, 28.7, 28.3, 21.8, 21.6, 21.6, 14.4. IR 
(48c, neat): 3034, 2967, 1733, 1696, 1476, 1390, 1275, 1163, 1126, 1018, 951, 898, 865, 768, 
701 cm-1. IR (48c´, neat):  2967, 2937, 1730, 1696, 1476, 1390, 1256, 1215, 1163, 1115, 1040, 
943, 902, 772, 701 cm-1. HRMS (48c, ESI) m/z calculated for 
C21H31NNaO4 ([M+Na]+) 384.2145, found 384.2159. HRMS (48c´, ESI) m/z calculated for 
C21H31NNaO4 ([M+Na]+) 384.2145, found 384.2154. 
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rac. 1-(tert-butyl) 3-ethyl (2R,3R)-4,4-dimethyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48d) 
From 3,5-bis(trifluoromethyl) benzoate ester: Following general 
procedure GP-6, using rac. (1R,2R)-1-((tert-butoxycarbonyl)(2-
methylallyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 3,5-bis(trifluoro-
methyl) benzoate (47d) (230 mg, 381 µmol, 1.0 equiv), fac-Ir(ppy)3 
(2.5 mg, 3.8 µmol, 1.0 mol%) and DMF (3.8 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 59 mg 
(170 µmol, 45%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R)-4,4-dimethyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48d) as a colorless oil after flash column purification (diethyl ether / n-pentane, 
1:7 to 1:1). Rf (diethyl ether / n-pentane, 1:3) = 0.29, Staining: Ninhydrin (UV active). 1H NMR 
(400 MHz, CDCl3, rotamers present): δ 7.40 – 7.09 (m, 5H), 5.11 (d, J = 9.5 Hz, 1H), 4.30 – 
3.98 (m, 2H), 3.69 (d, J = 10.8 Hz, 1H), 3.38 (d, J = 10.7 Hz, 1H), 2.74 (d, J = 9.5 Hz, 1H), 1.41 
(s, 2H), 1.26 – 1.19 (m, 6H), 1.09 (s, 7H), 1.03 (s, 3H). 13C NMR (101 MHz, CDCl3): δ 170.5, 
154.4, 144.1, 128.3, 127.0, 126.1, 79.6, 64.0, 62.8, 61.0, 60.7, 40.6, 28.5, 28.1, 25.3, 22.4, 
14.4. IR (neat): 3034, 2974, 2933, 2874, 1730, 1692, 1457, 1394, 1364, 1297, 1264, 1226, 
1185, 1156, 1007, 1028, 898, 861, 757, 701 cm-1. HRMS (ESI) m/z calculated for 
C20H29NNaO4 ([M+Na]+) 370.1989, found 370.1995. 
rac. 1-(tert-butyl) 3-ethyl (2S,3R,4S)-2,4-dimethylpyrrolidine-1,3-dicarboxylate (48e) and 
rac. 1-(tert-butyl) 3-ethyl (2S,3R,4R)-2,4-dimethylpyrrolidine-1,3-dicarboxylate (48e´) 
From oxalate ester: Following general procedure GP-
6, using rac. (2R,3R)-3-(allyl(tert-butoxycarbonyl) 
amino)-1-ethoxy-1-oxobutan-2-yl ethyl oxalate (45e) 
(330 mg, 852 µmol, 1.0 equiv), fac-Ir(ppy)3 (5.6 mg, 
8.5 µmol, 1.0 mol%) and DMF (8.5 mL, 0.1 M) at a flow 
rate of 0.30 mL/h gave 80 mg (295 µmol, 35%) of rac. 
1-(tert-butyl) 3-ethyl (2S,3R,4S)-2,4-dimethylpyrrolidine-1,3-dicarboxylate (48e) and 71 mg 
(262 µmol, 31%) of rac. 1-(tert-butyl) 3-ethyl (2S,3R,4R)-2,4-dimethylpyrrolidine-1,3-
dicarboxylate (48e´) as colorless oils after flash column purification (diethyl ether / n-pentane, 
1:20 to 1:3), (dr = 53:47).  
From 3,5-bis(trifluoromethyl) benzoate ester: Following general procedure GP-6, using rac. 
(2R,3R)-3-(allyl(tert-butoxycarbonyl)amino)-1-ethoxy-1-oxobutan-2-yl 3,5-bis(trifluoromethyl)-
benzoate (47e) (268 mg, 508 µmol, 1.0 equiv), fac-Ir(ppy)3 (3.4 mg, 5.1 µmol, 1.0 mol%) and 
DMF (5.1 mL, 0.1 M) at a flow rate of 0.15 mL/h gave 48 mg (177 µmol, 35%) of rac. 1-(tert-
butyl) 3-ethyl (2S,3R,4S)-2,4-dimethylpyrrolidine-1,3-dicarboxylate (48e) and 43 mg 
(158 µmol, 31%) of rac. 1-(tert-butyl) 3-ethyl (2S,3R,4R)-2,4-dimethylpyrrolidine-1,3-
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dicarboxylate (48e´) as colorless oils after flash column purification (diethyl ether / n-pentane, 
1:20 to 1:3), (dr = 53:47).  
Rf (48e, diethyl ether / n-pentane, 1:3) = 0.29, Staining: Ninhydrin (UV active). Rf (48e´, diethyl 
ether / n-pentane, 1:3) = 0.40, Staining: Ninhydrin (UV active). 1H NMR (48e, 400 MHz, CDCl3) 
δ 4.11 (qq, J = 10.1, 6.4, 4.7 Hz, 3H), 3.44 (dd, J = 10.6, 6.7 Hz, 1H), 3.21 (s, 1H), 2.55 (td, J 
= 16.1, 13.7, 9.3 Hz, 2H), 1.43 (s, 9H), 1.29 – 1.19 (m, 6H), 0.94 (d, J = 6.7 Hz, 3H). 1H NMR 
(48e´, 400 MHz, CDCl3) δ 4.15 (q, J = 7.1 Hz, 2H), 3.89 (s, 1H), 3.80 (s, 1H), 2.82 (t, J = 10.7 
Hz, 1H), 2.31 (tt, J = 10.6, 6.6 Hz, 1H), 2.20 (dd, J = 10.8, 8.4 Hz, 1H), 1.42 (s, 9H), 1.30 (d, J 
= 6.0 Hz, 3H), 1.24 (t, J = 7.1 Hz, 3H), 1.03 (d, J = 6.4 Hz, 3H). 13C NMR (48e, 101 MHz, 
CDCl3) δ 172.4, 154.6, 79.2, 60.5, 55.0, 52.6, 33.8, 28.6, 20.7, 14.4, 14.1. 13C NMR (48e´, 
101 MHz, CDCl3) δ 172.8, 154.2, 79.4, 60.9, 59.8, 57.0, 53.2, 36.5, 28.6, 21.03, 16.2, 14.4. IR 
(48e, neat): 2974, 2937, 2878, 1733, 1692, 1457, 1390, 1282, 1252, 1174, 1107, 1062, 1029, 
954, 869, 775 cm-1. IR (48e´, neat): 2974, 2933, 2878, 1733, 1692, 1457, 1394, 1290, 1256, 
1163, 1096, 1033, 910, 869, 772 cm-1. HRMS (48e, ESI) m/z calculated 
for C14H25NNaO4 ([M+Na]+) 294.1676, found 294.1678. HRMS (48e´, ESI) m/z calculated 
for C14H25NNaO4 ([M+Na]+) 294.1676, found 294.1683.  
tert-butyl (2R,3S,4R)-2-(((3,5-bis(trifluoromethyl)benzoyl)oxy)methyl)-4-methyl-3-(4-
nitrophenyl)pyrrolidine-1-carboxylate (48f)  
From 3,5-bis(trifluoromethyl) benzoate ester: 
Following general procedure GP-6,  
using (1S,2S)-2-(allyl(tert-butoxycarbonyl)amino)-1-(4-
nitrophenyl)propane-1,3-diyl bis(3,5-bis(trifluoro-
methyl)benzoate) (47f) (458 mg, 550 µmol, 1.0 equiv), 
fac-Ir(ppy)3 (3.6 mg, 5.5 µmol, 1.0 mol%) and DMF 
(5.5 mL, 0.1 M) with a flow rate of 0.15 mL/h gave 88 mg 
(153 µmol, 28%) of diastereomeric mixture of tert-butyl -
2-(((3,5-bis(trifluoromethyl) benzoyl) oxy)-methyl)-4-
methyl-3-(4-nitrophenyl)pyrrolidine-1-carboxylate (d.r. 
= 68:32) as a colorless oil after flash column purification (diethyl ether / n-pentane, 1:2). An 
additional column chromatography gave 56 mg (97 µmol, 18%) of tert-butyl (2R,3S,4R)-2-
(((3,5-bis(trifluoromethyl)benzoyl)oxy)methyl)-4-methyl-3-(4-nitrophenyl)pyrrolidine-1-
carboxylate (48f) as a single diastereomer. Rf (48f, diethyl ether / n-pentane, 1:1) = 0.61, 
Staining: Ninhydrin (UV active). Specific Rotation: [α]𝐷
25 = + 2.5 °. 1H NMR (48f, 400 MHz, 
CDCl3) δ 8.23 – 8.08 (m, 4H), 8.01 (s, 1H), 7.40 (d, J = 8.7 Hz, 2H), 4.71 (dd, J = 10.9, 3.6 Hz, 
1H), 4.65 – 4.43 (m, 1H), 4.42 – 4.19 (m, 1H), 4.19 – 3.97 (m, 1H), 3.07 – 2.72 (m, 2H), 2.34 
– 2.19 (m, 1H), 1.50 (s, 9H), 0.92 (d, J = 6.4 Hz, 3H). 19F NMR (282 MHz, CDCl3) δ -63.62 (s, 
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6F). 13C NMR (48f, 101 MHz, CDCl3) δ 163.5, 154.5, 153.9, 147.7, 147.3, 132.3 (q, J = 
34.2 Hz), 129.6, 128.9, 126.6, 124.2, 121.5, 81.1, 80.6, 66.7, 66.1, 63.1, 58.5, 57.6, 54.6, 54.0, 
42.0, 41.6, 28.6, 14.9. IR (48f, neat): 2971, 2930, 2874, 1733, 1692, 1603, 1525, 1457, 1394, 
1349, 1279, 1249, 1170, 1133, 984, 913, 846, 753 cm-1. HRMS (48f, ESI) m/z calculated for 
C26H26F6N2NaO6 ([M+Na]+) 599.1587, found 599.1587. 
rac. 1-(tert-butyl) 3-ethyl (2R,3R)-4-methylene-2-phenylpyrrolidine-1,3-dicarboxylate 
(48g) 
From oxalate ester: Following general procedure GP-6, using  
rac. (1R,2R)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-3-oxo-
1-phenylpropan-2-yl ethyl oxalate (45g) (405 mg, 905 µmol, 1.0 equiv), fac-
Ir(ppy)3 (6.0 mg, 9.1 µmol, 1.0 mol%) and DMF (9.1 mL, 0.1 M) at a flow rate 
of 0.40 mL/h gave 140 mg (422 µmol, 47%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R)-4-methylene-
2-phenylpyrrolidine-1,3-dicarboxylate (48g) as a colorless oil after flash column purification 
(diethyl ether / n-pentane, 1:7 to 1:1).  
From 3,5-bis(trifluoromethyl) benzoate ester: Following general procedure GP-6, using rac. 
(1R,2R)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 
3,5-bis(trifluoromethyl)benzoate (47g) (386 mg, 657 µmol, 1.0 equiv), fac-Ir(ppy)3 (4.3 mg, 
6.6 µmol, 1.0 mol%) and DMF (6.6 mL, 0.1 M) at a flow rate of 0.40 mL/h gave 97 mg 
(294 µmol, 45%) of rac. 1-(tert-butyl) 3-ethyl (2R,3R)-4-methylene-2-phenylpyrrolidine-1,3-
dicarboxylate (48g) as a colorless oil after flash column purification (diethyl ether / n-pentane, 
1:7 to 1:1).  
Rf (diethyl ether / n-pentane, 1:3) = 0.34, Staining: Ninhydrin (UV active). 1H NMR (400 MHz, 
CDCl3) δ 7.40 – 7.04 (m, 5H), 5.39 – 5.13 (m, 3H), 4.36 (dq, J = 15.0, 2.2 Hz, 1H), 4.28 – 4.12 
(m, 3H), 3.46 (s, 1H), 1.56 – 1.13 (m, 12H). 13C NMR (101 MHz, CDCl3) δ 171.2, 154.1, 143.1, 
142.0, 128.5, 127.3, 125.7, 111.2, 79.9, 65.9, 63.9, 61.4, 58.4, 51.2, 28.3, 14.2. IR 
(neat):  3064, 2978, 2933, 2870, 1733, 1696, 1454, 1390, 1320, 1252, 1159, 1111, 1033, 898, 
753, 701 cm-1. HRMS (APCI) m/z calculated for C19H26NO4 ([M+H]+) 332.1856, 
found 332.1861. 
tert-butyl-3-methylene-4-phenylpyrrolidine-1-carboxylate (48h) 
From oxalate ester: Following general procedure GP-6, using  
2-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl ethyl oxalate (45h) 
(203 mg, 541 µmol, 1.0 equiv), fac-Ir(ppy)3 (3.6 mg, 0.54 µmol, 1.0 mol%) and 
DMF (5.4 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 56 mg (216 µmol, 40%) of 
tert-butyl-3-methylene-4-phenylpyrrolidine-1-carboxylate (48h) as a colorless oil after flash 
column purification (diethyl ether / n-pentane, 1:9 to 1:2).  
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From 3,5-bis(trifluoromethyl) benzoate ester: Following general procedure GP-6, using 2-
((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl 3,5-bis(trifluoromethyl)benzoate 
(47h) (258 mg, 501 µmol, 1.0 equiv), fac-Ir(ppy)3 (3.3 mg, 0.50 µmol, 1.0 mol%) and DMF 
(5.0 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 53 mg (204 µmol, 41%) of tert-butyl-3-
methylene-4-phenylpyrrolidine-1-carboxylate (48h) as a colorless oil after flash column 
purification (diethyl ether / n-pentane, 1:9 to 1:2).  
Rf (diethyl ether / n-pentane, 1:3) = 0.50, Staining: Ninhydrin (UV active). 1H NMR (400 MHz, 
CDCl3) δ 7.43 – 7.15 (m, 5H), 5.06 (d, J = 12.4 Hz, 1H), 4.67 (s, 1H), 4.24 – 4.04 (m, 2H), 4.03 
– 3.79 (m, 2H), 3.55 – 3.35 (m, 1H), 1.48 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 154.5, 150.2, 
149.3, 140.4, 128.7, 128.4, 127.1, 108.5, 108.2, 79.7, 53.9, 53.0, 51.1, 50.8, 49.8, 49.1, 28.6. 
IR (neat): 3064, 3030, 2974, 2930, 2870, 1696, 1539, 1476, 1394, 1252, 1163, 1107, 980, 892, 
876, 753 cm-1. HRMS (ESI) m/z calculated for C16H21NNaO2 ([M+Na]+) 282.1465, 
found 282.1470. 
tert-butyl 3-methyl-4-phenylpyrrolidine-1-carboxylate (48i) 
From oxalate ester: Following general procedure GP-6, using  
2-(allyl(tert-butoxycarbonyl)amino)-1-phenylethyl ethyl oxalate (45i) (350 mg, 
927 µmol, 1.0 equiv), fac-Ir(ppy)3 (6.1 mg, 0.93 µmol, 1 mol%) and DMF 
(9.3 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 156 mg (597 µmol, 64%) of a 
diastereomeric mixture of tert-butyl 3-methyl-4-phenylpyrrolidine-1-carboxylate (48i)  
(dr = 60:40) as a colorless oil after flash column purification (diethyl ether / n-pentane, 1:10). 
Additional flash column purification (diethyl ether / n-pentane, 1:20 to 1:10) gave 80 mg 
(306 µmol, 33%) of tert-butyl 3-methyl-4-phenylpyrrolidine-1-carboxylate (48i) as single 
diastereomer.  
From 3,5-bis(trifluoromethyl) benzoate ester: Following general procedure GP-6, using 2-
(allyl(tert-butoxycarbonyl)amino)-1-phenylethyl 3,5-bis(trifluoromethyl)benzoate (47i) (391 mg, 
756 µmol, 1.0 equiv), fac-Ir(ppy)3 (5.0 mg, 0.76 µmol, 1 mol%) and DMF (7.6 mL, 0.1 M) at a 
flow rate of 0.30 mL/h gave 138 mg (529 µmol, 70%) of a diastereomeric mixture of tert-butyl 
3-methyl-4-phenylpyrrolidine-1-carboxylate (48i) (dr=62:38) as a colorless oil after flash 
column purification (diethyl ether / n-pentane, 1:19 to 1:10). Additional flash column purification 
(diethyl ether / n-pentane, 1:20 to 1:10) gave 74 mg (283 µmol, 37%) of tert-butyl 3-methyl-4-
phenylpyrrolidine-1-carboxylate (48i) as single diastereomer. Rf (diethyl ether / n-
pentane, 1:3) = 0.38, Staining: Ninhydrin (UV active). 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.19 
(m, 5H), 3.78 (ddd, J = 21.7, 10.8, 7.8 Hz, 2H), 3.35 (t, J = 10.8 Hz, 1H), 2.99 (t, J = 10.4 Hz, 
1H), 2.80 (td, J = 10.6, 7.9 Hz, 1H), 2.38 – 2.22 (m, 1H), 1.47 (s, 9H), 0.95 (d, J = 6.5 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 154.5, 140.1, 128.8, 127.8, 127.1, 79.3, 66.0, 53.6, 53.4, 52.3, 
40.6, 28.7, 15.7. IR (neat):  2974, 2933, 2874, 1692, 1480, 1402, 1252, 1174, 1148, 1085, 965, 
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924, 876, 753, 701 cm-1. HRMS (ESI) m/z calculated for C16H23NNaO2 ([M+Na]+) 284.1621, 
found 284.1624. 
rac. 1-(tert-butyl) 3-isopropyl (2R,3R,4S)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48j) and rac. 1-(tert-butyl) 3-isopropyl (2R,3R,4R)-4-methyl-2-
phenylpyrrolidine-1,3-dicarboxylate (48j´) 
From oxalate ester: Following general procedure GP-
6, using rac. (1S,2S)-1-(allyl(tert butoxycarbonyl) 
amino)-3-isopropoxy-3-oxo-1-phenylpropan-2-yl ethyl 
oxalate (45j) (400 mg, 863 µmol, 1.0 equiv), fac-Ir(ppy)3 
(5.7 mg, 0.86 µmol, 1.0 mol%) and DMF (8.6 mL, 
0.1 M) at a flow rate of 0.30 mL/h gave 101 mg 
(291 µmol, 34%) of rac. 1-(tert-butyl) 3-isopropyl (2R,3R,4S)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48j) and 76 mg (219 µmol, 25%) of rac. 1-(tert-butyl) 3-isopropyl (2R,3R,4R)-4-
methyl-2-phenylpyrrolidine-1,3-dicarboxylate (48j´) as colorless oils after flash column 
purification (diethyl ether / n-pentane, 1:10), (dr = 57:43).  
From 3,5-bis(trifluoromethyl) benzoate ester: Following general procedure GP-6, using rac. 
(1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-isopropoxy-3-oxo-1-phenylpropan-2-yl 3,5-
bis(trifluoromethyl)benzoate (47j) (602 mg, 997 µmol, 1.0 equiv), fac-Ir(ppy)3 (6.6 mg, 
1.0 µmol, 1.0 mol%) and DMF (10 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 117 mg 
(337 µmol, 34%) of rac. 1-(tert-butyl) 3-isopropyl (2R,3R,4S)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48j) and 88 mg (253 µmol, 25%) of rac. 1-(tert-butyl) 3-isopropyl (2R,3R,4R)-4-
methyl-2-phenylpyrrolidine-1,3-dicarboxylate (48j´) as colorless oils after flash column 
purification (diethyl ether / n-pentane, 1:19 to 1:10), (dr = 57:43).  
Rf (48j, diethyl ether / n-pentane, 1:3) = 0.28, Staining: Ninhydrin (UV active). Rf (48j´, diethyl 
ether / n-pentane, 1:3) = 0.35, Staining: Ninhydrin (UV active). 1H NMR (48j, 400 MHz, CDCl3): 
δ 7.37 – 7.14 (m, 5H), 5.31 – 4.92 (m, 2H), 3.85 – 3.64 (m, 1H), 3.57 – 3.34 (m, 1H), 3.03 – 
2.78 (m, 1H), 2.68 – 2.44 (m, 1H), 1.50 – 1.41 (m, 2H), 1.28 – 1.21 (m, 7H), 1.19 – 1.12 (m, 
6H), 1.02 (d, J = 7.0 Hz, 3H). 1H NMR (48j´, 400 MHz, CDCl3): δ 7.32 – 7.13 (m, 5H), 5.13 – 
4.84 (m, 2H), 4.15 – 3.93 (m, 1H), 3.17 (t, J = 10.6 Hz, 1H), 2.63 – 2.35 (m, 2H), 1.48 – 0.99 
(m, 18H).  13C NMR (48j, 101 MHz, CDCl3): δ 171.1, 154.6, 143.9, 128.4, 127.0, 126.0, 79.6, 
68.4, 62.3, 58.0, 53.6, 34.0, 28.2, 22.0, 14.5.13C NMR (48j´, 101 MHz, CDCl3): δ 171.8, 154.1, 
144.0, 128.4, 127.1, 125.8, 79.7, 68.5, 65.2, 62.1, 54.5, 37.4, 28.1, 22.0, 16.0.  IR (48j, 
neat): 2974, 2937, 2878, 1730, 1696, 1454, 1390, 1256, 1223, 1170, 1141, 1103, 984, 906, 
861, 824, 757, 701 cm-1. IR (48j´, neat): 2978, 2933, 2878, 1730, 1692, 1454, 1402, 1364, 
1279, 1215, 1168, 1103, 992, 990, 951, 861, 820, 760, 701 cm-1. HRMS (48j, ESI) m/z 
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calculated for C20H30NO4 ([M+H]+) 348.2169, found 348.2178. HRMS (48j´, ESI) m/z 
calculated for C20H29NNaO4 ([M+Na]+) 370.1989, found 370.1999.  
rac. 1-((2R,3S,4S)-4-methyl-2,3-diphenylpyrrolidin-1-yl)ethan-1-one (48m) 
Following general procedure GP-6, using rac. (1S,2R)-2-(N-
allylacetamido)-1,2-diphenylethyl 3,5-bis(trifluoromethyl)benzoate (47m)  
(315 mg, 588 µmol, 1.0 equiv), fac-Ir(ppy)3 (3.9 mg, 5.9 µmol, 1.0 mol%), 
and DMF (8.5 mL, 0.1 M) at a flow rate of 0.30 mL/h gave 82 mg (294 µmol, 
50%) of rac. 1-((2R,3S,4S)-4-methyl-2,3-diphenylpyrrolidin-1-yl)ethan-1-
one (48m) (dr = 74:26) as a colorless oil after flash silica gel column 
chromatography (diethyl ether / n-pentane, 1:1). Rf (diethyl ether / n-pentane, 1:1) = 0.13, 
Staining: Ninhydrin (UV active). 1H NMR (Major Diastereomer, 400 MHz, CDCl3): δ 7.40 – 7.08 
(m, 10H), 5.12 (s, 1H), 3.99 (dd, J = 12.1, 7.9 Hz, 1H), 3.41 (dd, J = 12.1, 10.2 Hz, 1H),  3.25 
– 3.18 (m, 1H), 2.82 – 2.62 (m, 1H), 1.91 (s, 3H), 0.68 (d, J = 6.8 Hz, 3H). 1H NMR (Minor 
Diastereomer, 400 MHz, CDCl3): δ 7.40 – 7.08 (m, 10H), 5.50 (s, 1H), 3.89 (dd, J = 9.9, 7.6 
Hz, 1H), 3.32 (t, J = 10.0 Hz, 1H), 3.25 – 3.18 (m, 1H), 2.82 – 2.62 (m, 1H), 2.24 (s, 3H), 0.70 
(d, J = 6.8 Hz, 3H). 13C NMR (Major Diastereomer, 101 MHz, CDCl3): δ 170.6, 142.8, 140.4, 
129.1, 128.9, 128.1, 127.7, 127.2, 125.6, 69.1, 58.7, 52.4, 33.2, 22.5, 13.9. 13C NMR (Minor 
Diastereomer, 101 MHz, CDCl3): δ 169.5, 142.6, 139.9, 128.7, 128.6, 128.2, 127.1, 127.0, 
125.5, 66.5, 56.5, 53.9, 35.0, 23.0, 13.9. IR (neat): 3064, 3030, 2963, 2930, 2874, 1722, 1648, 
1495, 1454, 1409, 1357, 1279, 1245, 1178, 1137, 1081, 1029, 973, 913, 865, 801, 749, 701 
cm-1. HRMS (APCI) m/z calculated for C19H22NO ([M+H]+) 280.1696, found 280.1702.  
2.2.3. Synthesis of Starting Materials for enantiopure Pyrrolidines 
Isopropyl (2S,3R)-3-acetamido-2-hydroxy-3-phenylpropanoate (64) 
A 100 mL round bottom flask equipped with a magnetic stir bar was 
charged with K2OsO4∙2H2O (176 mg, 0.5 mmol, 4.0 mol%) and dissolved 
in 36 mL of an aqueous solution of LiOH∙H2O (514 mg, 12.2 mmol, 
1.0 equiv.). After addition of tBuOH (72 mL), (DHQD)2PHAL (468 mg, 
0.6 mmol, 5.0 mol%) was added and the mixture was stirred for 10 min to give a clear pink 
solution. Subsequently, water (72 mL) was added and the mixture was immersed in an ice 
bath. Isopropyl cinnamate (63) (2.3 g, 12.0 mmol, 1.0 equiv.) was added in one portion followed 
by N-bromoacetamide (1.8 g, 13.2 mmol, 1.1 equiv.) which resulted in an immediate color 
change to green. The mixture was stirred while still cooling by an ice bath for 20 h. After full 
conversion as judged by TLC analysis and pH control at pH 7, Na2SO3 (6.0 g) was added in 
one portion and the resulting mixture was stirred at room temperature for 30 min. EtOAc 
(60 mL) was added, the organic layer was separated, and the aqueous phase was extracted 
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with EtOAc (3x 120 mL). The combined organic layers were washed with brine (60 mL), dried 
over anhydrous MgSO4, filtered and the solvent evaporated under reduced pressure. The 
crude product was purified by silica gel column chromatography (hexanes / EtOAc, 1:1) to give 
2.9 g (10.9 mmol, 90%, 99% ee) of isopropyl (2S,3R)-3-acetamido-2-hydroxy-3-
phenylpropanoate (64) as a white solid. Spectral data are in agreement with those reported in 
literature. Rf (hexanes / EtOAc, 2:3) = 0.40, Staining: Ninhydrin (UV active). 1H NMR (300 
MHz, CDCl3): δ 7.46 – 7.21 (m, 5H), 6.51 (d, J = 9.4 Hz, 1H), 5.54 (dd, J = 9.4, 2.3 Hz, 1H), 
5.09 (hept, J = 6.3 Hz, 1H), 4.46 (d, J = 2.3 Hz, 1H), 3.41 (bs, 1H), 1.96 (s, 3H), 1.27 (dd, J = 
9.0, 6.3 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 172.5, 169.6, 139.0, 128.7, 127.8, 127.0, 73.4, 
70.8, 54.5, 23.2, 21.8, 21.6. 
Ethyl (2S,3R)-3-amino-2-hydroxy-3-phenylpropanoate (65) 
A 100 mL round bottom flask equipped with a magnetic stir bar and reflux 
condenser was charged with isopropyl (2S,3R)-3-acetamido-2-hydroxy-3-
phenylpropanoate (64) (1.6 g, 5.9 mmol, 1.0 equiv) and HCl (aq., 10%, 
60 mL) and the reaction mixture was refluxed for 16h. After evaporating the 
solvent in vacuo, the obtained white solid was transferred into a Dean-Stark-apparatus and 
dissolved in EtOH (60 mL). After Addition of H2SO4 (98%, 0.5 mL) the reaction mixture was 
refluxed for 16 h. After evaporating the solvent, the residue was dissolved in EtOAc (20 mL) 
and washed with Na2CO3 solution (10%, 20 mL). The aqueous phase was extracted wih EtOAc 
(3x 20 mL) and the combined organic layers were dried over anhydrous Na2SO4. After the 
evaporation of the solvent the obtained residue was purified by silica gel column 
chromatography (EtOAc/Et3N, 99:1) to give 640 mg (3.1 mmol, 52%) of ethyl (2S,3R)-3-amino-
2-hydroxy-3-phenylpropanoate (65) was obtained as white solid. Rf (EtOAc / NEt3, 99:1) = 
0.28, Staining: Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 7.48 – 7.21 (m, 5H), 4.41 – 
4.05 (m, 4H), 2.42 (s, 3H), 1.24 (t, J = 6.0 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 173.5, 142.3, 
128.6, 127.7, 126.9, 75.2, 61.9, 58.1, 14.2. 
Ethyl (2S,3R)-3-(allylamino)-2-hydroxy-3-phenylpropanoate (66) 
A 100 mL round bottom flask equipped with a magnetic stir bar was 
charged with ethyl (2S,3R)-3-amino-2-hydroxy-3-phenylpropanoate (65) 
(548 mg, 2.62 mmol, 1.0 equiv) and triethylamine (399 µL, 292 mg, 
2.9 mmol, 1.1 equiv) in THF (1 mL). Allyl bromide (38e) (245 µL, 333 mg, 
2.8 mmol, 1.1 equiv) was added dropwise and the reaction mixture was stirred at room 
temperature for 24 h. Additional triethylamine (399 µL, 292 mg, 2.9 mmol, 1.1 equiv) and allyl 
bromide (38e) (245 µL, 333 mg, 2.8 mmol, 1.1 equiv) were added and the mixture was stirred 
for 24 h. The white precipitate was filtered off and the solvent was evaporated under reduced 
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pressure. The crude product was purified by silica gel column chromatography (hexanes / 
EtOAc, 2:1 to 0:1) to give 285 mg (1.1 mmol, 44%) of ethyl (2S,3R)-3-(allylamino)-2-hydroxy-
3-phenylpropanoate (66) as a colorless oil. Rf (hexanes / EtOAc, 1:1) = 0.31, Staining: KMnO4 
(UV active). 1H NMR (400 MHz, CDCl3): δ 7.48 – 7.26 (m, 5H), 5.90 – 5.69 (m, 1H), 5.18 – 
5.00 (m, 2H), 4.30 – 4.09 (m, 3H), 3.98 (d, J = 3.2 Hz, 1H), 3.28 – 3.14 (m, 1H), 2.99 (dd, J = 
12.0, 8.0 Hz, 1H), 2.79 (bs, 2H), 1.20 (t, J = 8.0 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 173.5, 
139.7, 136.6, 128.6, 127.9, 127.8, 116.3, 74.9, 63.9, 61.8, 49.5, 14.2. IR (neat):  3403, 3202, 
3064, 2982, 2851, 1737, 1580, 1502, 1402, 1100,1021, 924, 760, 701 cm-1. HRMS (ESI) m/z 
calculated for C14H20NO3 ([M+H]+) 250.1438, found 250.1440. 
rac. (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-3-carboxylic acid (69) 
 A 10 mL round bottom flask equipped with a magnetic stir bar  was charged 
with rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48a´) (89 mg, 267 µmol, 1.0 equiv) and hydrochloric acid 
(6M, aq., 10 mL). The resulting mixture was stirred for 24 h at room 
temperature.  The solvent was removed in vacuo and the residue was  dissolved in 
hydrochloric acid (0.1M, aq., 5 ml). The solution was loaded on to a Dowex 50X8  (H+) ion 
exchange column, washed with water (250 mL) and the column was eluted with ammonium 
hydroxide solution (16%, aq.,) until the product was detected by TLC analysis (Staining: 
Ninhydrin). The solvent was removed in vacuo and lyophilised to afford 53 mg (258 µmol, 97%) 
of rac. (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-3-carboxylic acid (69) as white solid. 1H NMR 
(400 MHz, D2O) δ 7.54 – 7.42 (m, 5H), 4.74 (d, J = 11.4 Hz, 1H), 3.68 (dd, J = 11.7, 8.4 Hz, 
1H), 3.10 (dd, J = 11.7, 10.1 Hz, 1H), 2.89 (t, J = 11.1 Hz, 1H), 2.66 (tdd, J = 10.3, 8.4, 6.6 Hz, 
1H), 1.24 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, D2O) δ 177.6, 133.4, 129.8, 129.3, 127.6, 
66.5, 59.5, 50.9, 38.1, 15.4. IR (neat):  2960, 2874, 2363, 2110, 1644, 1558, 1498, 1461, 1379, 
1267, 1197, 1144, 1100, 1006, 962, 865, 760, 731 cm-1. HRMS (ESI) m/z calculated 
for C12H16NO2 ([M+H]+) 206.1176, found 206.1177. 
2-(allylamino)-1,1-diphenylethan-1-ol (73) 
A 250 mL round bottom flask equipped with a magnetic stir bar and reflux 
condenser was charged with 2-amino-1,1-diphenylethan-1-ol (72) (639 mg, 
3.0 mmol, 1.0 equiv), DBU (670 µL, 684 mg, 4.5 mmol, 1.5 equiv) and 
toluene (150 mL). 3-bromoprop-1-ene (38e) (388 µL, 544 mg, 4.5 mmol, 1.5 equiv) was added 
dropwise at room temperature and the reaction mixture was stirred for 72 h at 60 °C. After 
addition of water (100 mL) the mixture was extracted with EtOAc (2x 100 mL). The combined 
organic layers were washed with water (3x 100 mL), dried over anhydrous Na2SO4, the solvent 
was evaporated in vacuo and the residue purified by silica gel column chromatography 
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(hexanes / EtOAc,  2:1 to 1:1) to give 440 mg (1.7 mmol, 58%) of 2-(allylamino)-1,1-
diphenylethan-1-ol (73) as a colorless oil. Rf (hexanes / EtOAc, 1:1) = 0.45, Staining: Ninhydrin 
(UV active). 1H NMR (300 MHz, CDCl3) δ 7.53 – 7.43 (m, 4H), 7.39 – 7.29 (m, 4H), 7.28 – 7.17 
(m, 2H), 5.84 (ddt, J = 17.2, 10.2, 6.0 Hz, 1H), 5.24 – 5.00 (m, 2H), 3.33 (s, 2H), 3.28 (dt, J = 
6.0, 1.4 Hz, 2H), 2.83 (bs, 2H). 13C NMR (75 MHz, CDCl3) δ 145.7, 136.5, 128.4, 127.1, 126.2, 
116.6, 76.3, 58.1, 52.4. IR (neat):  3302, 3068, 2937, 2878, 2822, 1644, 1603, 1495, 1450, 
1327, 1275, 1230, 1200, 1144, 1103, 1066, 1025, 910, 869, 820, 772 cm-1. HRMS (ESI) m/z 
calculated for C17H20NO ([M+H]+) 254.1539, found 254.1541. 
tert-butyl allyl(2-hydroxy-2,2-diphenylethyl)carbamate (74) 
A 25 mL round bottom flask equipped with a magnetic stir bar was charged 
with 2-(allylamino)-1,1-diphenylethan-1-ol (73) (342 mg, 1.4 mmol, 
1.0 equiv), triethylamine (225 µL, 164 mg, 1.6 mmol, 1.2 equiv) and CH2Cl2 
(20 mL). After addition of di-tertbutyl dicarbonate (354 mg, 1.6 mmol, 1.2 equiv) the solution 
was stirred for 20 h at room temperature. After the addition of CH2Cl2 (20 mL) and 1M HCl 
(15 mL), the mixture was partitioned. The organic layer was washed with 1M HCl (2x 15 mL) 
solution, dried over anhydrous Na2SO4, and the solvent evaporated under reduced pressure. 
The obtained residue was purified by silica gel column chromatography (hexanes / EtOAc, 9:1 
to 6:1) to give 429 mg (1.2 mmol, 90%) of tert-butyl allyl(2-hydroxy-2,2-
diphenylethyl)carbamate (74) as a colorless oil. Rf (hexanes / EtOAc, 6:1) = 0.54, Staining: 
Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 7.54 – 7.40 (m, 4H), 7.36 – 7.15 (m, 6H), 
5.76 (bs, 1H), 5.61 – 5.41 (m, 1H), 5.04 (d, J = 10.0 Hz, 1H), 4.90 (dq, J = 17.1, 1.6 Hz, 1H), 
4.06 (s, 2H), 3.17 (s, 2H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 159.2, 145.8, 133.5, 128.1, 
127.1, 126.6, 116.5, 81.2, 78.7, 57.3, 51.9, 28.4. IR (neat):  3355, 3064, 2978, 2933, 1659, 
1599, 1454, 1409, 1364, 1308, 1252, 1163, 1062, 995, 857, 753 cm-1. HRMS (ESI) m/z 
calculated for C22H27NNaO3 ([M+Na]+) 376.1883, found 376.1890. 
2.2.4. Synthesis of Bicyclic Products 
Methyl 2-(allylamino)benzoate (86) 
A 100 mL round bottom flask equipped with a magnetic stir bar was  charged  
with methyl 2-aminobenzoate (85) (21.2 g, 140 mmol,  2.0 equiv) in dry DMF 
(15 mL) and cooled to 0 °C. Allyl bromide (38e) (6.2 mL, 8.5 g, 70.0 mmol, 
1.0 equiv) was added dropwise and the reaction mixture was stirred 16 h at 
40 °C.  After the addition of H2O (50 mL) the mixture was extracted with EtOAc (3x 50 mL). 
The organic layer was washed with H2O (2x 25 mL), dried over anhydrous MgSO4 and the 
solvent evaporated under reduced pressure. The obtained residue was purified by silica gel 
column chromatography (hexanes / EtOAc, 19:1 to 10:1) to give 13.2 g (69.0 mmol, 99%) of 
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methyl 2-(allylamino)benzoate (86) as a colorless oil. Rf (hexanes / EtOAc, 9:1) = 0.60, 
Staining: Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 7.92 (dd, J = 8.0, 1.8 Hz, 2H), 
7.35 (ddd, J = 8.7, 7.1, 1.7 Hz, 1H), 6.74 – 6.54 (m, 2H), 5.97 (ddt, J = 17.1, 10.2, 5.0 Hz, 1H), 
5.31 (dq, J = 17.2, 1.7 Hz, 1H), 5.19 (dq, J = 10.3, 1.6 Hz, 1H), 3.94 – 3.80 (m, 5H). 13C NMR 
(75 MHz, CDCl3) δ 169.2, 151.0, 134.6, 134.6, 131.7, 116.1, 114.8, 111.6, 110.1, 51.6, 45.3. 
(2-(allylamino)phenyl)methanol (87) 
A 100 mL round bottom flask equipped with a magnetic stir bar was charged 
with methyl 2-(allylamino)benzoate (86) (4.2 g, 22.0 mmol, 1.0 equiv) in dry 
THF (100 mL). A solution of LiAlH4 (3.3 g, 87.9 mmol, 4.0 equiv) in THF 
(100 mL) was added dropwise while the temperature was maintained at 
0 °C. The resulting mixture was allowed to warm to room temperature and was stirred for 2 h. 
The mixture was then hydrolyzed by addition of H2O (100 mL), the resulting suspension was 
filtered, and the precipitate was washed with EtOAc (3x 100 mL). The combined organic layer 
was dried over anhydrous Na2SO4 and solvent evaporated under reduced pressure to give 
3.5 g (21.7 mmol, 99%) of (2-(allylamino)phenyl)methanol (87) as yellow oil. Rf (hexanes / 
EtOAc, 3:1) = 0.40, Staining: KMnO4 (UV active).  1H NMR (300 MHz, CDCl3) δ 7.22 (td, J = 
8.0, 1.6 Hz, 1H), 7.07 (dd, J = 7.5, 1.6 Hz, 1H), 6.78 – 6.59 (m, 2H), 5.99 (ddt, J = 17.2, 10.4, 
5.3 Hz, 1H), 5.30 (dq, J = 17.2, 1.7 Hz, 1H), 5.18 (dq, J = 10.3, 1.5 Hz, 1H), 4.68 (s, 2H), 3.83 
(dt, J = 5.2, 1.7 Hz, 2H), 3.29 (bs, 2H). 13C NMR (75 MHz, CDCl3) δ 147.4, 135.4, 129.7, 129.2, 
124.5, 116.7, 116.2, 111.1, 64.8, 46.1. IR (neat): 3384, 3079, 3012, 2922, 2870, 1644, 1606, 
1513, 1461, 1312, 1260, 1193, 1074, 992, 921, 850, 798 cm-1. HRMS (APCI) m/z calculated 
for C10H14NO ([M+H]+) 164.1070, found 164.1073. 
tert-butyl allyl(2-(hydroxymethyl)phenyl)carbamate (88) 
A 100 mL round bottom flask equipped with a magnetic stir bar and a reflux 
condenser was charged with (2-(allylamino)phenyl)methanol (87) (979 mg,  
6.0 mmol, 1.0 equiv) and di-tertbutyl  dicarbonate (2.0 g, 9.0 mmol,  
1.5 equiv) in ethanol (70 mL) and the  solution was stirred for 16 h at 50 °C. 
After evaporation of solvent under reduced pressure the obtained residue 
was purified by silica gel column chromatography (hexanes / EtOAc, 9:1 to 4:1) to give 1.5 g 
(5.7 mmol, 95%) of tert-butyl allyl(2-(hydroxymethyl)phenyl)carbamate (88) as a white solid. Rf 
(hexanes / EtOAc, 6:1) = 0.25, Staining: Ninhydrin, KMnO4 (UV active). 1H NMR (400 MHz, 
CDCl3) δ 7.53 – 7.47 (m, 1H), 7.32 – 7.27 (m, 2H), 7.16 (bs, 1H), 5.90 (ddt, J = 16.7, 10.2, 6.4 
Hz, 1H), 5.24 – 5.01 (m, 2H), 4.60 (d, J = 12.0 Hz, 1H), 4.44 – 4.32 (m, 1H), 4.26 – 3.92 (m, 
2H), 3.44 (s, 1H), 1.71 – 1.20 (m, 9H). 13C NMR (101 MHz, CDCl3) δ 138.6, 133.7, 131.0, 
129.1, 128.0, 127.5, 118.0, 81.3, 61.9, 54.2, 28.4, 27.5. IR (neat):  3433, 3075, 2978, 2930, 
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1674, 1491, 1454, 1390, 1305, 1275, 1148, 1044, 1006, 924, 857, 760, 731 cm-1. HRMS 
(APCI) m/z calculated for C15H22NO3 ([M+H]+) 264.1594, found 264.1599. mp: 56 °C. 
2-(allyl(tert-butoxycarbonyl)amino)benzyl ethyl oxalate (89) 
A 50 mL round bottom flask equipped with a magnetic stir bar was 
charged with tert-butyl allyl(2-(hydroxymethyl)phenyl)carbamate (88) 
(206 mg, 782 µmol, 1.0 equiv), dry pyridine (126 µL, 124 mg, 1.6 mmol, 
2.0 equiv) and dry CH2Cl2 (10 mL). The solution was cooled to 0 °C and 
ethyl 2-chloro-2-oxoacetate (15) (174 µL, 214 mg, 1.6 mmol, 2.0 equiv) 
was added over 1 h. Afterwards, the mixture was stirred in an ice bath for 4 h, allowed to come 
to room temperature and stirred overnight. CH2Cl2 (50 mL) was added and the reaction mixture 
was washed with water (3x 20 mL), dried over anhydrous MgSO4 and the solvent was 
evaporated under reduced pressure to yield 268 mg (269 mg, 740 µmol, 95%) of 2-(allyl(tert-
butoxycarbonyl)amino)benzyl ethyl oxalate (89) as a colorless oil. Rf (hexanes / EtOAc, 6:1) = 
0.42, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.48 – 7.42 (m, 1H), 7.38 – 
7.27 (m, 2H), 7.23 – 7.09 (m, 1H), 5.95 (ddt, J = 16.8, 12.1, 6.4 Hz, 1H), 5.26 (q, J = 12.8 Hz, 
2H), 5.16 – 5.03 (m, 2H), 4.40 – 4.26 (m, 3H), 4.00 (bs, 1H), 1.54 – 1.25 (m, 12H). 13C NMR 
(101 MHz, CDCl3) δ 157.8, 157.7, 154.5, 141.2, 133.6, 132.6, 129.6, 129.3, 128.5, 127.7, 
118.3, 80.8, 64.9, 63.3, 53.1, 28.4, 14.1. IR (neat):  3079, 2982, 2937, 1767, 1740, 1696, 1498, 
1457, 1368, 1305, 1148, 1010, 928, 861, 760 cm-1. HRMS (ESI) m/z calculated 
for C19H29N2O6 ([M+NH4]+) 381.2020, found 381.2028. 
2-(allyl(tert-butoxycarbonyl)amino)benzyl 3,5-bis(trifluoromethyl)benzoate (90) 
A 100 mL Schlenk flask equipped with a magnetic stir bar was charged 
with tert-butyl allyl(2-(hydroxymethyl)phenyl)carbamate (88) (308 mg, 
1.2 mmol, 1.0 equiv) and dissolved in dry CH2Cl2 (12 mL). N,N-
diisoproylethylamine (398 µL, 302 mg, 2.3 mmol, 2.0 equiv) was added 
followed by 3,5-bis(trifluoromethyl)benzoic anhydride (46) (699 mg, 
1.4 mmol, 1.2 equiv). After stirring for 4 h at room temperature, CH2Cl2 
(60 mL) was added and the organic layer was washed with Na2CO3 (aq. 
10%, 60 mL) and water (60 mL). The organic phase was dried over Na2SO4 and the solvent 
evaporated under reduced pressure. The residue was purified by flash chromatography 
(hexanes / EtOAc, 5:1 to 3:1) to give 575 mg (1.1 mmol, 98%) of 2-(allyl(tert-
butoxycarbonyl)amino)benzyl 3,5-bis(trifluoromethyl)-benzoate (90) as colorless oil. Rf 
(hexanes / EtOAc, 6:1) = 0.75, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 8.52 
(s, 2H), 8.07 (s, 1H), 7.50 (d, J = 7.3 Hz, 1H), 7.40 – 7.30 (m, 2H), 7.20 (bs, 1H), 6.05 – 5.89 
(m, 1H), 5.42 (s, 2H), 5.12 (d, J = 11.6 Hz, 2H), 4.33 (dd, J = 15.2, 6.1 Hz, 1H), 4.07 (bs, J = 
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15.3 Hz, 1H), 1.57 – 1.27 (m, 9H). 19F NMR (376 MHz, CDCl3) δ -63.55 (s, 6F). 13C NMR 
(101 MHz, CDCl3) δ 163.8, 154.5, 141.0, 133.7, 133.3, 132.4 (q, J = 34.1 Hz), 132.4, 130.0 – 
129.8 (m), 129.4, 129.1, 128.5, 127.8, 126.7 – 126.5 (m), 123.0 (q, J = 272.9 Hz), 118.1, 117.6, 
80.7, 64.2, 53.2, 28.3. IR (neat):  3083, 2982, 2933, 1733, 1700, 1625, 1498, 1457, 1368, 
1279, 1241, 1174, 1133, 992, 943, 913, 846, 764, 701 cm-1. HRMS (ESI) m/z calculated 
for C24H23F6NNaO4 ([M+Na]+) 526.1423, found 526.1424. 
tert-butyl 3-methyl-3,4-dihydroquinoline-1(2H)-carboxylate (91) 
From oxalate ester: A flame dried Schlenk tube was charged with 2-
(allyl(tert-butoxycarbonyl)amino)benzyl ethyl oxalate (89) (206 mg, 
567 µmol, 1.0 equiv) in DMF (5.7 mL). After addition of fac-Ir(ppy)3 (3.8 mg, 
0.57 µmol, 1 mol%) the reaction mixture was degassed by freeze-pump-thaw cycles (3x) and 
pumped through a micro reactor (which was sparged with N2 too) equipped with 8 LED's at a 
flow rate of 0.30 mL/h via a syringe pump while heated at 80 °C. Afterwards, the reaction 
mixture was diluted with diethyl ether (80 mL) and extracted with water (3x 50 mL). The 
combined organic layers were dried over anhydrous Na2SO4, the solvent was evaporated 
under reduced pressure and the residue was purified by flash column chromatography (diethyl 
ether / n-pentane, 1:10 to 1:1) to give tert-butyl 3-methyl-3,4-dihydroquinoline-1(2H)-
carboxylate (91) (53 mg, 214 µmol, 38%) as colorless oil.  
From 3,5-bis(trifluoromethyl) benzoate ester: Following the procedure described for oxalate 
ester 84 using 2-(allyl(tert-butoxycarbonyl)amino)benzyl 3,5-bis(trifluoromethyl)benzoate (90) 
(311 mg, 618 µmol, 1.0 equiv), fac-Ir(ppy)3 (4.1 mg, 6.2 µmol, 1.0 mol%) and DMF (6.2 mL, 
0.1 M) at a flow rate of 0.30 mL/h gave 57 mg (230 µmol, 37%) of tert-butyl 3-methyl-3,4-
dihydroquinoline-1(2H)-carboxylat (91) as a colorless oil after flash column purification (diethyl 
ether / n-pentane, 1:10 to 1:1). Rf (diethyl ether / n-pentane, 1:9) = 0.50, Staining:  KMnO4 (UV 
active). 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 8.2 Hz, 1H), 7.13 (t, J = 7.7 Hz, 1H), 7.06 (d, 
J = 7.0 Hz, 1H), 6.97 (td, J = 7.4, 1.2 Hz, 1H), 3.97 (ddd, J = 12.6, 4.2, 1.4 Hz, 1H), 3.10 (dd, 
J = 12.6, 9.8 Hz, 1H), 2.87 (dd, J = 16.2, 5.4 Hz, 1H), 2.42 (dd, J = 16.2, 9.6 Hz, 1H), 2.12 – 
1.97 (m, 1H), 1.53 (s, 9H), 1.06 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 154.1, 138.4, 
129.3, 128.9, 125.7, 124.0, 123.3, 80.9, 51.1, 36.1, 29.2, 28.5, 19.1. IR (neat):  2960, 2930, 
2874, 1700, 1491, 1457, 1368, 1297, 1252, 1211, 1156, 1036, 1006, 982, 861, 753 cm-1. 
HRMS (ESI) m/z calculated for C15H21NNaO2 ([M+Na]+) 270.1465, found 270.1460. 
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N-allyl-N-(2-(hydroxymethyl)phenyl)acetamide (95) 
A 50 mL  Schlenk  flask  equipped  with  a  magnetic  stir  bar was  charged 
while cooling at 0 °C  with (2-(allylamino)phenyl)methanol (87) (330 mg,  
2.0 mmol,  1.0 equiv), acetyl chloride (144 µL, 159 mg, 2.0 mmol,  1.0 equiv) 
and NaHCO3 (200 mg, 2.4 mmol, 1.2 equiv) in dry CH2Cl2 (20 mL) and  the  
solution  was  stirred  for  4 h  at 0 °C and then 16 h at room temperature.  The organic phase 
was washed with water (3x 20 mL), the aqueous phase was extracted with CH2Cl2 (2x 20 mL) 
and the organic phase was dried with anhydrous Na2SO4. After evaporation of solvent under 
reduced pressure the  obtained residue was  purified  by  silica  gel  column  chromatography  
(hexanes  / EtOAc,  5:1 to 1:1) to  give 276 mg  (1.3 mmol,  67%)  of  N-allyl-N-(2-
(hydroxymethyl)phenyl)acetamide (95) as a colorless oil. Rf (hexanes / EtOAc, 1:1) = 0.14, 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.63 – 7.57 (m, 1H), 7.44 – 7.29 
(m, 2H), 7.08 (dt, J = 7.8, 1.2 Hz, 1H), 5.89 (ddddd, J = 17.1, 10.1, 7.0, 6.0, 1.0 Hz, 1H), 5.16 
– 4.99 (m, 2H), 4.66 – 4.49 (m, 3H), 3.87 (ddd, J = 14.4, 7.3, 1.5 Hz, 1H), 2.62 (bs, 1H), 1.77 
(s, 3H). 13C NMR (75 MHz, CDCl3) δ 170.9, 140.4, 138.4, 132.9, 129.5, 129.3, 129.0, 128.9, 
118.8, 60.8, 52.0, 22.6. IR (neat):  3377, 3079, 2922, 2874, 1629, 1491, 1431, 1394, 1282, 
1230, 1144, 1115, 1040, 984, 924, 820, 775, 742, 664 cm-1. HRMS (ESI) m/z calculated 
for C12H16NO2 ([M+H]+) 206.1176, found 206.1178. 
 
2-(N-allylacetamido)benzyl acetate (96) 
A 50 mL  round  bottom  flask  equipped  with  a  magnetic  stir  bar was  
charged while cooling at 0 °C  with (2-(allylamino)phenyl)methanol (87) 
(179 mg,  1.1 mmol,  1.0 equiv) and acetic anhydride (156 µL, 168 mg, 
1.7 mmol,  1.5 equiv) in diethyl ether (20 mL) and  the  solution  was  stirred  
for  2 h  at 0 °C and then 18 h at room temperature.  After evaporation of solvent under reduced 
pressure the  obtained residue was  purified  by  silica  gel  column  chromatography  (hexanes  
/ EtOAc,  5:1 to 1:1) to  give 180 mg  (728 µmol,  66%)  of  2-(N-allylacetamido)benzyl acetate 
(96) as a colorless oil. Rf (hexanes / EtOAc, 3:1) = 0.13, Staining: KMnO4 (UV active). 1H NMR 
(300 MHz, CDCl3) δ 7.51 – 7.45 (m, 1H), 7.43 – 7.35 (m, 2H), 7.16 – 7.08 (m, 1H), 5.89 (dddd, 
J = 17.2, 10.1, 7.4, 5.9 Hz, 1H), 5.16 – 4.98 (m, 4H), 4.67 (ddt, J = 14.4, 5.9, 1.4 Hz, 1H), 3.77 
(ddt, J = 14.3, 7.3, 1.1 Hz, 1H), 2.09 (s, 3H), 1.79 (s, 3H).13C NMR (75 MHz, CDCl3) δ 170.7, 
170.6, 141.5, 133.8, 132.7, 130.7, 129.9, 129.8, 129.0, 118.9, 62.5, 52.0, 22.6, 21.0. IR 
(neat):  3079, 2982, 1737, 1659,1495, 1454, 1379, 1279, 1223, 1081, 1029, 977, 924, 887, 
839, 779, 753, 664 cm-1. HRMS (ESI) m/z calculated for C14H17KNO3 ([M+K]+) 286.0840, 
found 286.0840. 
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2-(N-allylacetamido)benzyl ethyl oxalate (97) 
A 50 mL round bottom flask equipped with a magnetic stir bar was 
charged with N-allyl-N-(2-(hydroxymethyl)phenyl)acetamide (95) 
(170 mg, 828 µmol, 1.0 equiv), dry pyridine (134 µL, 131 mg, 1.7 mmol, 
2.0 equiv) and dry CH2Cl2 (10 mL). The solution was cooled to 0 °C and 
ethyl 2-chloro-2-oxoacetate (184 µL, 226 mg, 1.7 mmol, 2.0 equiv) was 
added over 1 h. Afterwards, the mixture was stirred in an ice bath for 4 h, allowed to come to 
room temperature and stirred overnight. CH2Cl2 (50 mL) was added and the reaction mixture 
was washed with water (3x 20 mL), dried over anhydrous MgSO4 and the solvent was 
evaporated under reduced pressure to yield 252 mg (825 µmol, 100%) of 2-(N-
allylacetamido)benzyl ethyl oxalate (97) as a colorless oil. Rf (hexanes / EtOAc, 1:1) = 0.43, 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.57 – 7.51 (m, 1H), 7.45 – 7.39 
(m, 2H), 7.19 – 7.12 (m, 1H), 5.89 (dddd, J = 17.3, 10.0, 7.4, 5.9 Hz, 1H), 5.24 (s, 2H), 5.12 
(dd, J = 10.1, 1.4 Hz, 1H), 5.05 (dd, J = 17.1, 1.4 Hz, 1H), 4.66 (ddt, J = 14.3, 6.0, 1.3 Hz, 1H), 
4.34 (q, J = 7.2 Hz, 2H), 3.83 (ddt, J = 14.4, 7.4, 1.1 Hz, 1H), 1.81 (s, 3H), 1.36 (t, J = 7.1 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 170.6, 157.5, 157.3, 141.9, 132.6, 132.2, 131.1, 130.6, 130.1, 
129.1, 119.1, 64.6, 63.5, 52.1, 22.6, 14.0. IR (neat):  3079, 2986, 2937, 1767, 1744, 1662, 
1454, 1405, 1383, 1297, 1156, 1115, 1014, 980, 932, 861, 757, 664 cm-1. HRMS (ESI) m/z 
calculated for C16H20NO5 ([M+H]+) 306.1336, found 306.1340. 
1-(3-methyl-3,4-dihydroquinolin-1(2H)-yl)ethan-1-one (98) 
 A flame dried Schlenk tube was charged with 2-(N-allylacetamido)benzyl 
ethyl oxalate (97) (231 mg, 757 µmol, 1.0 equiv) in DMF (7.6 mL). After 
addition of fac-Ir(ppy)3 (5.0 mg, 0.76 µmol, 1 mol%) the reaction mixture was 
degassed by freeze-pump-thaw cycles (3x) and pumped through a micro reactor (which was 
sparged with N2 too) equipped with 8 LED's at a flow rate of 0.30 mL/h via a syringe pump 
while heated at 80 °C. Afterwards, the reaction mixture was diluted with diethyl ether (100 mL) 
and extracted with water (3x 60 mL). The combined organic layers were dried over anhydrous 
Na2SO4, the solvent was evaporated under reduced pressure and the residue purified by flash 
column chromatography (diethyl ether / n-pentane, 1:10 to 1:1) to give 1-(3-methyl-3,4-
dihydroquinolin-1(2H)-yl)ethan-1-one (98) (38 mg, 201 µmol, 27%)  as colorless oil. Rf 
(hexanes / EtOAc, 4:1) = 0.19, Staining: Ninhydrin (UV active). 1H NMR (400 MHz, CDCl3) δ 
7.22 – 7.06 (m, 4H), 4.03 (s, 1H), 3.21 (dd, J = 12.6, 9.7 Hz, 1H), 2.85 (dd, J = 15.8, 5.5 Hz, 
1H), 2.38 (dd, J = 15.8, 9.7 Hz, 1H), 2.24 (s, 3H), 2.06 (dq, J = 9.9, 4.3 Hz, 1H), 1.08 (d, J = 
6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 170.2, 139.1, 128.8, 126.1, 125.1, 124.4, 49.9, 35.7, 
30.5, 23.3, 19.6. IR (neat): 3027, 2956, 2930, 2874, 1655, 1491, 1457, 1372, 1327, 1279, 
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1204, 1122, 1085, 1040, 984, 951, 857, 798, 760 cm-1. HRMS (ESI) m/z calculated 
for C12H16NO ([M+H]+) 190.1226, found 190.1226. 
(2-(allyl(methyl)amino)phenyl)methanol (99) 
 A 50 mL round bottom flask equipped with a magnetic stir bar was charged 
with (2-(allylamino)phenyl)methanol (87) (326 mg, 2.0 mmol, 1.0 equiv) and 
K2CO3 (415 mg, 3.0 mmol, 1.5 equiv) and dry DMF (10 mL). The solution 
was cooled to 0 °C and iodomethane (137 µL, 312 mg, 2.2 mmol, 1.1 equiv) was added over 
1 h. Afterwards, the mixture was stirred in an ice bath for 4 h, allowed to come to room 
temperature and stirred overnight. CH2Cl2 (50 mL) was added and the reaction mixture was 
washed with water (3x 50 mL), dried over anhydrous MgSO4 and the solvent was evaporated 
under reduced pressure to yield 267 mg (1.5 mmol, 75%) of (2-
(allyl(methyl)amino)phenyl)methanol (99) as a colorless oil. Rf (hexanes / EtOAc, 3:1) = 0.45, 
Staining: Vanillin (UV active). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.23 (m, 1H), 7.21 – 7.15 
(m, 2H), 7.09 (td, J = 7.3, 1.3 Hz, 1H), 5.87 (ddt, J = 16.7, 10.1, 6.4 Hz, 1H), 5.39 (bs, 1H), 
5.24 (dt, J = 17.2, 1.5 Hz, 1H), 5.19 (dt, J = 10.1, 1.4 Hz, 1H), 4.81 (s, 2H), 3.53 (dt, J = 6.6, 
1.3 Hz, 2H), 2.69 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 151.2, 135.9, 134.5, 128.7, 128.2, 
124.8, 121.5, 118.6, 64.9, 60.2, 41.7. IR (neat):  3340, 3071, 2982, 2948, 2848, 2796, 1644, 
1599, 1491, 1454, 1420, 1347, 1223, 1170, 1085, 1025, 999, 917, 828, 764, 723 cm-1. HRMS 
(ESI) m/z calculated for C11H16NO ([M+H]+) 178.1226, found 178.1230. 
2-(allyl(methyl)amino)benzyl ethyl oxalate (100) 
 A 50 mL round bottom flask equipped with a magnetic stir bar was 
charged with (2-(allyl(methyl)amino)phenyl)methanol (99) (150 mg, 
846 µmol, 1.0 equiv), dry pyridine (137 µL, 134 mg, 1.7 mmol, 2.0 equiv) 
and dry CH2Cl2 (10 mL). The solution was cooled to 0 °C and ethyl 2-
chloro-2-oxoacetate (188 µL, 231 mg, 1.7 mmol, 2.0 equiv) was added 
over 1 h. Afterwards, the mixture was stirred in an ice bath for 4 h, allowed to come to room 
temperature and stirred overnight. CH2Cl2 (50 mL) was added and the reaction mixture was 
washed with water (3x 20 mL), dried over anhydrous MgSO4 and the solvent was evaporated 
under reduced pressure to yield 234 mg (844 µmol, 100%) of 2-(allyl(methyl)amino)benzyl 
ethyl oxalate (100) as a colorless oil. Rf (hexanes / EtOAc, 6:1) = 0.53, Staining: KMnO4 (UV 
active). 1H NMR (400 MHz, CDCl3) δ 7.42 (dd, J = 7.6, 1.6 Hz, 1H), 7.36 – 7.30 (m, 1H), 7.17 
(dd, J = 8.1, 1.2 Hz, 1H), 7.11 (td, J = 7.5, 1.2 Hz, 1H), 5.85 (ddt, J = 17.2, 10.2, 6.1 Hz, 1H), 
5.45 (s, 2H), 5.24 (dt, J = 17.2, 1.6 Hz, 1H), 5.15 (dq, J = 10.2, 1.4 Hz, 1H), 4.34 (q, J = 7.1 
Hz, 2H), 3.52 (d, J = 6.1 Hz, 2H), 2.69 (s, 3H), 1.36 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 158.0, 157.9, 152.7, 135.1, 130.5, 129.7, 129.7, 124.1, 121.4, 117.5, 65.4, 63.2, 60.9, 
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42.1, 14.1. IR (neat):  3075, 2982, 2851, 2796, 1767, 1741, 1677, 1644, 1603, 1495, 1454, 
1379, 1305, 1230, 1178, 1018, 980, 928, 865, 760, 731, 678 cm-1. LRMS (ESI) showed no 
product signal, but hydrolysis product: m/z calculated for C11H16NO ([M+H]+) 178.1226, 
found 178.1223 and methanolysis product: m/z calculated for C12H18NO ([M+H]+) 192.1383, 
found 192.1388. These results indicate the lability of the product during the HPLC purification. 
(2-(allylamino)phenyl)diphenylmethanol (104) 
A 250 mL round bottom flask equipped with a magnetic stir bar was charged 
with methyl 2-(allylamino)benzoate (86) (1.2 g, 6.0 mmol, 1.0 equiv) in dry 
THF (100 mL). A solution of phenylmagnesium bromide (3.5 g, 19.2 mmol, 
3.2 equiv) in THF (100 mL) was added dropwise while the temperature was 
maintained at 0 °C. The resulting mixture was allowed to warm to room temperature and was 
stirred for 2 h. The mixture was then hydrolyzed by addition of H2O (100 mL), the resulting 
suspension was filtered, and the precipitate was washed with EtOAc (3x 100 mL). The 
combined organic layer was dried over anhydrous Na2SO4 and solvent evaporated under 
reduced pressure to give 1.6 g (5.1 mmol, 85%) of (2-(allylamino)phenyl)diphenylmethanol 
(104) as yellow oil after purification with column chromatography (hexanes / EtOAc, 9:1). Rf 
(hexanes / EtOAc, 9:1) = 0.38, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.39 
– 7.30 (m, 10H), 7.27 – 7.20 (m, 1H), 6.81 (dd, J = 8.1, 1.2 Hz, 1H), 6.67 (td, J = 7.6, 1.2 Hz, 
1H), 6.53 (dd, J = 7.8, 1.6 Hz, 1H), 5.75 (ddt, J = 17.3, 10.3, 5.0 Hz, 1H), 5.02 (dq, J = 10.5, 
1.5 Hz, 1H), 4.96 (dq, J = 17.2, 1.7 Hz, 1H), 4.72 (bs, 2H), 3.61 (dt, J = 5.0, 1.8 Hz, 2H). 13C 
NMR (101 MHz, CDCl3) δ 145.8, 145.6, 134.8, 132.7, 130.1, 129.0, 128.2, 127.9, 127.5, 118.0, 
115.9, 114.3, 82.8, 46.5. IR (neat):  3340, 3291, 3056, 3030, 2874 1580, 1521, 1487, 1446, 
1323, 1115, 1003, 924, 846, 794 cm-1. HRMS (ESI) m/z calculated for C22H22NO ([M+H]+) 
316.1696, found 316.1698. 
(2-(allyloxy)phenyl)methanol (109) 
A 250 mL round bottom flask equipped with a magnetic stir bar was charged 
with methyl 2-(allylamino)benzoate (108) (1.0 g, 5.2 mmol, 1.0 equiv) in dry 
THF (50 mL). A solution of LiAlH4 (790 mg, 20.8 mmol, 4.0 equiv) in THF 
(50 mL) was added dropwise while the temperature was maintained at 0 °C. The resulting 
mixture was allowed to warm to room temperature and was stirred for 2 h. The mixture was 
then hydrolyzed by addition of H2O (100 mL), the resulting suspension was filtered, and the 
precipitate was washed with EtOAc (3x 100 mL). The combined organic layer was dried over 
anhydrous Na2SO4 and solvent evaporated under reduced pressure to give 650 mg (4.0 mmol, 
76%) of (2-(allyloxy)phenyl)methanol (109) as pale yellow oil after purification with column 
chromatography (hexanes / EtOAc, 6:1). Rf (hexanes / EtOAc, 6:1) = 0.24, Staining: KMnO4 
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(UV active). 1H NMR (300 MHz, CDCl3) δ 7.35 – 7.19 (m, 2H), 6.96 (td, J = 7.4, 1.1 Hz, 1H), 
6.88 (dd, J = 8.2, 1.0 Hz, 1H), 6.07 (ddt, J = 17.3, 10.4, 5.2 Hz, 1H), 5.43 (dq, J = 17.3, 1.6 Hz, 
1H), 5.31 (dq, J = 10.5, 1.5 Hz, 1H), 4.72 (s, 2H), 4.59 (dt, J = 5.2, 1.6 Hz, 2H), 2.50 (s, 1H). 
13C NMR (75 MHz, CDCl3) δ 156.5, 133.1, 129.5, 128.9, 128.8, 120.9, 117.7, 111.5, 68.8, 62.2.  
2-(allyloxy)benzyl ethyl oxalate (110) 
A 50 mL round bottom flask equipped with a magnetic stir bar was 
charged with (2-(allyloxy)phenyl)methanol (109) (207 mg, 1.3 mmol, 
1.0 equiv), dry pyridine (204 µL, 199 mg, 2.5 mmol, 2.0 equiv) and dry 
CH2Cl2 (10 mL). The solution was cooled to 0 °C and ethyl 2-chloro-2-
oxoacetate (15) (280 µL, 344 mg, 2.5 mmol, 2.0 equiv) was added over 1 h. Afterwards, the 
mixture was stirred in an ice bath for 4 h, allowed to come to room temperature and stirred 
overnight. CH2Cl2 (50 mL) was added and the reaction mixture was washed with water (3x 
20 mL), dried over anhydrous MgSO4 and the solvent was evaporated under reduced pressure 
to yield 280 mg (1.1 mmol, 84%) of 2-(allyloxy)benzyl ethyl oxalate (110) as a colorless oil. Rf 
(hexanes / EtOAc, 9:1) = 0.38, Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.47 
– 7.22 (m, 2H), 6.96 (td, J = 7.5, 1.1 Hz, 1H), 6.88 (dd, J = 8.3, 1.0 Hz, 1H), 6.04 (ddt, J = 17.3, 
10.3, 5.1 Hz, 1H), 5.45 – 5.36 (m, 3H), 5.27 (dq, J = 10.6, 1.5 Hz, 1H), 4.58 (dt, J = 5.1, 1.6 
Hz, 2H), 4.34 (q, J = 7.1 Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 158.0, 
158.0, 156.8, 133.1, 130.4, 130.3, 123.0, 120.8, 117.5, 112.0, 69.0, 64.3, 63.2, 14.1. IR 
(neat):  2986, 1778, 1741, 1607, 1495, 1454, 1379, 1308, 1249, 1152, 1018, 924, 809, 801, 
753 cm-1. HRMS (ESI) m/z calculated for C14H16NaO5 ([M+Na]+) 287.0890, found 287.0891.   
  
rac. ethyl (2S,3S)-2-hydroxy-3-((4-methoxybenzyl)amino)-3-phenylpropanoate (117) 
A 100 mL round bottom flask equipped with a magnetic stir bar and reflux 
condenser was charged with ethyl 3-phenyloxirane-2-carboxylate (36a) 
(980 mg, 5.1 mmol, 1.0 equiv), (4-methoxyphenyl)methanamine (666 µL, 
699 mg, 5.1 mmol, 1.0 equiv) and EtOH (50 mL). The resulting mixture 
was refluxed for 24 h at 80 °C. Afterwards the solvent was evaporated in 
vacuo, and the residue was purified by silica gel column chromatography 
(hexanes / EtOAc, 9:1 to 1:1) to give 1.2 g (3.6 mmol, 70%) of rac. ethyl 
(2S,3S)-2-hydroxy-3-((4-methoxybenzyl)amino)-3-phenylpropanoate (117) as white solid. Rf 
(hexanes / EtOAc, 1:1) = 0.34, Staining: Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 
7.43 – 7.12 (m, 7H), 6.96 – 6.75 (m, 2H), 4.52 (d, J = 4.1 Hz, 1H), 4.12 – 3.99 (m, 3H), 3.80 
(s, 3H), 3.71 (d, J = 12.8 Hz, 1H), 3.56 (d, J = 12.8 Hz, 1H), 1.13 (t, J = 7.2 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ 172.7, 158.8, 137.8, 131.8, 129.6, 129.6, 128.5, 128.0, 128.0, 113.9, 73.5, 
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63.7, 61.5, 55.4, 50.4, 14.2. IR (neat): 3474, 3329, 3064, 3030, 2982, 2836, 1730, 1610, 1584, 
1513, 1454, 1367, 1301, 1245, 1204, 1111, 1029, 932, 813, 753, 701 cm-1. HRMS (ESI) m/z 
calculated for C19H24NO4 ([M+H]+) 330.1700, found 330.1706. mp: 54 °C. 
rac. ethyl (2S,3S)-3-((tert-butoxycarbonyl)(4-methoxybenzyl)amino)-2-hydroxy-3-
phenylpropanoate (118) 
A 250 mL round bottom flask equipped with a magnetic stir bar and a 
reflux condenser was charged with rac. ethyl (2S,3S)-2-hydroxy-3-((4-
methoxybenzyl)amino)-3-phenylpropanoate (117) (2.7 g,  8.3 mmol,  
1.0 equiv) and di-tertbutyl  dicarbonate (2.0 g, 9.1 mmol,  1.1 equiv) in 
ethanol (150 mL) and the  solution  was  stirred  for  48 h  at 60 °C.  After 
evaporation of solvent under reduced pressure the obtained residue 
was purified by silica gel column chromatography (hexanes / EtOAc, 9:1 
to 3:1) to give 2.7 g (6.2 mmol, 75%) of rac. ethyl (2S,3S)-3-((tert-
butoxycarbonyl)(4-methoxybenzyl)amino)-2-hydroxy-3-phenylpropanoate (118) as a colorless 
oil. Rf (hexanes / EtOAc, 3:1) = 0.32, Staining: Ninhydrin (UV active). 1H NMR (400 MHz, 
CDCl3) δ 7.37 – 7.19 (m, 5H), 7.03 – 6.93 (m, 2H), 6.77 – 6.71 (m, 2H), 5.36 (bs, 1H), 4.82 (t, 
J = 5.0 Hz, 1H), 4.58 – 4.29 (m, 2H), 4.16 (qd, J = 7.1, 2.5 Hz, 2H), 3.75 (s, 3H), 1.38 (s, 9H), 
1.19 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 173.1, 158.5, 156.2, 136.9, 131.3, 128.9, 
128.4, 127.8, 113.6, 80.8, 72.3, 62.6, 62.1, 55.3, 49.6, 28.4, 14.1. IR (neat): 3444, 3064, 2978, 
2937, 2840, 1737, 1685, 1614, 1513, 1454, 1394, 1364, 1301, 1245, 1159, 1118, 1033, 943, 
891, 850, 816, 753, 701 cm-1. HRMS (ESI) m/z calculated for C24H31NNaO6 ([M+Na]+) 
452.2044, found 452.2051. 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(4-methoxybenzyl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl ethyl oxalate (119) 
A 25 mL round bottom flask equipped with a magnetic stir bar was 
charged with rac. ethyl (2S,3S)-3-((tert-butoxycarbonyl)(4-
methoxybenzyl)amino)-2-hydroxy-3-phenylpropanoate (118) (859 mg, 
2.0 mmol, 1.0 equiv), dry pyridine (242 µL, 237 mg, 1.5 mmol, 
1.5 equiv) and dry CH2Cl2 (30 mL). The solution was cooled to 0 °C 
and ethyl 2-chloro-2-oxoacetate (15) (341 µL, 410 mg, 1.5 mmol, 
1.5 equiv) was added over 1 h. Afterwards, the mixture was stirred in 
an ice bath for 4 h, allowed to come to room temperature and stirred 
overnight. CH2Cl2 (100 mL) was added and the reaction mixture was 
washed with water (3x 20 mL), dried over anhydrous MgSO4 and the solvent was evaporated 
under reduced pressure to yield 1.1 g (2.0 mmol, 99%) of rac. (1S,2S)-1-((tert-
butoxycarbonyl)(4-methoxybenzyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl ethyl oxalate 
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(119) as a colorless oil. Rf (hexanes / EtOAc, 3:1) = 0.45, Staining: KMnO4 (UV active). 1H NMR 
(300 MHz, CDCl3) δ 7.66 – 7.20 (m, 5H), 7.05 – 6.49 (m, 4H), 6.26 – 5.54 (m, 2H), 4.58 – 4.18 
(m, 4H), 4.09 (qd, J = 7.2, 1.1 Hz, 2H), 3.74 (s, 3H), 1.61 – 1.21 (m, 12H), 1.09 (t, J = 7.1 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 166.7, 158.4, 156.5, 156.4, 135.3, 129.6, 128.6, 128.4, 113.5, 
81.2, 75.3, 63.4, 62.2, 55.3, 28.4, 14.0, 13.9. IR (neat): 2982, 2840, 1748, 1689, 1614, 1513, 
1454, 1394, 1368, 1305, 1245, 1156, 1021, 962, 924, 887, 857, 820, 753, 701  
cm-1. HRMS (ESI) m/z calculated for C28H35NNaO9 ([M+Na]+) 552.2204, found 552.2200. 
rac. ethyl (2S,3S)-2-hydroxy-3-((4-methoxyphenyl)amino)-3-phenylpropanoate (120) 
A 500 mL round bottom flask equipped with a magnetic stir bar and 
reflux condenser was charged with ethyl 3-phenyloxirane-2-
carboxylate (36a) (5.0 g, 26.0 mmol, 1.0 equiv), 4-methoxyaniline 
(3.2 mg, 26.0 mmol, 1.0 equiv) and EtOH (250 mL). The resulting 
mixture was refluxed for 24 h at 80 °C.  Afterwards the solvent was 
evaporated in vacuo, and the residue was purified by silica gel 
column chromatography (hexanes / EtOAc, 9:1 to 1:1) to give 8.1 g (25.7 mmol, 99%) of rac. 
ethyl (2S,3S)-2-hydroxy-3-((4-methoxyphenyl)amino)-3-phenylpropanoate phenylpropanoate 
(120) as a brown solid. Rf (hexanes / EtOAc, 1:1) = 0.63, Staining: Ninhydrin (UV active). 
1H NMR (300 MHz, CDCl3) δ 7.32 – 7.21 (m, 5H), 6.74 – 6.67 (m, 2H), 6.64 – 6.56 (m, 2H), 
4.79 (d, J = 3.5 Hz, 1H), 4.67 (d, J = 3.5 Hz, 1H), 4.15 (qd, J = 7.2, 2.6 Hz, 2H), 3.69 (s, 3H), 
1.24 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 172.3, 152.7, 140.1, 137.2, 128.5, 128.1, 
127.7, 115.7, 114.9, 73.5, 62.0, 60.8, 55.8, 14.2. IR (neat): 3384, 3280, 3064, 3034, 2989, 
2945, 2907, 2833, 1707, 1513, 1454, 1409, 1342, 1297, 1215, 1096, 1029, 906, 864, 813, 753, 
697 cm-1. HRMS (ESI) m/z calculated for C18H22NO4 ([M+H]+) 316.1543, found 316.1544. 
rac. ethyl (2S,3S)-2-((tert-butoxycarbonyl)oxy)-3-((4-methoxyphenyl)amino)-3-
phenylpropanoate (121) 
A 50 mL round bottom flask equipped with a magnetic stir bar was 
charged  with ethyl 2-hydroxy-3-((4-methoxyphenyl)amino)-3-
phenylpropanoate (120) (358 mg, 1.1 mmol, 1.0 equiv),  
triethylamine (189 µL, 138 mg, 1.4 mmol, 1.2 equiv), di-tertbutyl  
dicarbonate (297 mg, 1.4 mmol,  1.2 equiv) and DMAP (3 mg, 
23 µmol, 0.02 equiv) in  CH2Cl2 (30 mL). and the solution was stirred for 72 h at room 
temperature. The solvent was evaporated under reduced pressure and the obtained residue 
was purified by silica gel column chromatography (hexanes / EtOAc,  9:1 to 3:1) to  give 460 mg  
(1.1 mmol, 98%) of rac. ethyl (2S,3S)-2-((tert-butoxycarbonyl)oxy)-3-((4-
methoxyphenyl)amino)-3-phenylpropanoate (121) as a brown solid. Rf (hexanes / EtOAc, 1:1) 
= 0.58, Staining: Ninhydrin (UV active). 1H NMR (300 MHz, CDCl3) δ 7.44 – 7.21 (m, 5H), 6.71 
Experimental Part 
177 
(d, J = 8.9 Hz, 2H), 6.56 (d, J = 9.0 Hz, 2H), 5.22 (d, J = 4.8 Hz, 1H), 4.86 (d, J = 4.8 Hz, 1H), 
4.42 (bs, 1H), 4.09 (qd, J = 7.2, 5.4 Hz, 2H), 3.70 (s, 3H), 1.48 (s, 9H), 1.10 (t, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3) δ 168.2, 152.7, 140.2, 137.8, 128.6, 128.1, 127.7, 115.6, 114.8, 
83.6, 77.0, 61.6, 59.5, 55.8, 27.8, 14.0. IR (neat): 3355, 2982, 2837, 1744, 1710, 1513, 1457, 
1394, 1290, 1234, 1200, 1159, 1115, 1021, 872, 824, 798, 753, 701, 664 cm-1. HRMS (ESI) 
m/z calculated for C23H30NO6 ([M+H]+) 416.2068, found 416.2069. mp: 86 °C. 
rac. ethyl (2S,3S)-2-acetoxy-3-((4-methoxyphenyl)amino)-3-phenylpropanoate (122) 
A 50 mL  Schlenk  flask  equipped  with  a  magnetic  stir  bar was  
charged while cooling at 0 °C  with rac. ethyl (2S,3S)-2-hydroxy-3-
((4-methoxyphenyl)amino)-3-phenylpropanoate phenylpropanoate 
(120) (136 mg,  431 µmol,  1.0 equiv), acetyl chloride (31 µL, 34 mg, 
431 µmol,  1.0 equiv) and triethylamine (60 µL, 44 mg, 431 µmol, 
1.0 equiv) in dry CH2Cl2 (20 mL) and  the  solution  was  stirred  for  4 h  at 0 °C and then 44 h 
at room temperature. After evaporation of solvent under reduced pressure the  obtained 
residue was  purified  by  silica  gel  column  chromatography  (hexanes  / EtOAc,  12:1 to 3:1) 
to  give 51 mg  (143 µmol,  33%)  of  rac. ethyl (2S,3S)-2-acetoxy-3-((4-methoxyphenyl)amino)-
3-phenylpropanoate (122) as a yellow oil. Rf (hexanes / EtOAc, 3:1) = 0.39, Staining: Ninhydrin 
(UV active). 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.22 (m, 5H), 6.77 – 6.67 (m, 2H), 6.62 – 6.51 
(m, 2H), 5.32 (d, J = 5.0 Hz, 1H), 4.84 (d, J = 5.1 Hz, 1H), 4.08 (q, J = 7.2 Hz, 2H), 3.70 (s, 
3H), 2.13 (s, 3H), 1.11 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 170.3, 168.2, 152.8, 
140.4, 138.0, 128.7, 128.2, 127.6, 115.5, 114.9, 75.0, 61.7, 59.6, 55.8, 20.8, 14.0. IR 
(neat): 3377, 2986, 2937, 2832, 1737, 1618, 1513, 1454, 1372, 1223, 1129, 1092, 1029, 939, 
857, 820, 753, 701 cm-1. HRMS (ESI) m/z calculated for C20H24NO5 ([M+H]+) 358.1649, 
found 358.1650. 
rac. (2S,3S)-1-ethoxy-3-(2-ethoxy-N-(4-methoxyphenyl)-2-oxoacetamido)-1-oxo-3-
phenylpropan-2-yl ethyl oxalate (123) 
A 50 mL round bottom flask equipped with a magnetic stir 
bar was charged with rac. ethyl (2S,3S)-2-hydroxy-3-((4-
methoxyphenyl) amino)-3-phenylpropanoate phenyl-
propanoate (120) (315 mg, 1.0 mmol, 1.0 equiv), dry 
pyridine (194 µL, 190 mg, 2.4 mmol, 2.4 equiv) and dry 
CH2Cl2 (20 mL). The solution was cooled to 0 °C and ethyl 
2-chloro-2-oxoacetate (15) (269 µL, 328 mg, 2.4 mmol, 
2.4 equiv) was added over 1 h. Afterwards, the mixture was stirred in an ice bath for 4 h, 
allowed to come to room temperature and stirred overnight. CH2Cl2 (50 mL) was added and 
the reaction mixture was washed with water (3x 20 mL), dried over anhydrous MgSO4 and the 
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solvent was evaporated under reduced pressure to yield 493 mg (956 µmol, 96%) of rac. 
(2S,3S)-1-ethoxy-3-(2-ethoxy-N-(4-methoxyphenyl)-2-oxoacetamido)-1-oxo-3-phenylpropan-
2-yl ethyl oxalate (123) as a brownish oil. Rf (hexanes / EtOAc, 1:1) = 0.34, Staining: Ninhydrin 
(UV active). 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.10 (m, 6H), 7.09 – 6.41 (m, 3H), 6.26 (d, J 
= 7.9 Hz, 1H), 5.86 (d, J = 7.9 Hz, 1H), 4.30 – 4.14 (m, 4H), 3.93 (q, J = 7.1 Hz, 2H), 3.74 (s, 
3H), 1.29 (t, J = 7.1 Hz, 3H), 1.23 (t, J = 7.1 Hz, 3H), 0.94 (t, J = 7.1 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ 166.5, 162.7, 162.1, 160.1, 156.5, 133.3, 132.4, 130.1, 129.0, 128.8, 
128.5, 113.8, 73.2, 63.5, 62.8, 61.7, 59.2, 55.5, 14.0, 13.9, 13.8. IR (neat): 3064, 2986, 2941, 
2844, 1760, 1744, 1670, 1607, 1510, 1457, 1405, 1372, 1301, 1252, 1178, 1018, 921, 842, 
801, 734, 701 cm-1. HRMS (ESI) m/z calculated for C26H30NO10 ([M+H]+) 516.1864, 
found 516.1870. 
2.2.5. Preparation of Straing Materials for the Synthesis of Lactames 
rac. Ethyl (2S,3S)-3-acrylamido-2-hydroxy-3-phenylpropanoate (126) 
A 100 mL round bottom flask equipped with a magnetic stir bar and reflux 
condenser was charged with ethyl 3-amino-2-hydroxy-3-phenylpropanoate 
(37a) (244 mg, 1.2 mmol, 1.0 equiv), acryloyl chloride (100 µL, 111 mg, 
1.2 mmol, 1.1 equiv) and CH2Cl2 (50 mL). The reaction mixture was stirred 
for 72 h at rt, after addition of water (100 mL) the mixture was extracted 
with CH2Cl2 (2x 100 mL). The combined organic layers were washed with water (3x 100 mL), 
dried over anhydrous Na2SO4, the solvent was evaporated in vacuo and the residue purified 
by silica gel column chromatography (hexanes / EtOAc,  2:1 to 1:1) to give 154 mg (585 µmol, 
50%) of rac. ethyl (2S,3S)-3-acrylamido-2-hydroxy-3-phenylpropanoate (126) as a colorless 
oil. Rf (hexanes / EtOAc, 1:1) = 0.30, Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) 
δ 7.38 – 7.17 (m, 5H), 6.78 (d, J = 8.7 Hz, 1H), 6.31 (dd, J = 17.0, 1.7 Hz, 1H), 6.16 (dd, J = 
16.9, 10.0 Hz, 1H), 5.65 (dd, J = 10.0, 1.7 Hz, 1H), 5.51 (dd, J = 8.8, 3.5 Hz, 1H), 4.59 (d, J = 
3.5 Hz, 1H), 4.13 (qd, J = 7.1, 3.1 Hz, 2H), 3.16 (bs, 1H), 1.23 (t, J = 7.1 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 171.8, 164.8, 136.5, 130.6, 128.6, 128.4, 127.8, 127.3, 72.9, 62.3, 55.2, 14.2. 
IR (neat): 3310, 3064, 3034, 2982, 1730, 1655, 1521, 1409, 1372, 1267, 1211, 1107, 1021, 
984, 861, 805, 753, 701 cm-1. HRMS (ESI) m/z calculated for C14H18NO4 ([M+H]+) 264.1230, 
found 264.1232.  
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rac. (1S,2S)-1-acrylamido-3-ethoxy-3-oxo-1-phenylpropan-2-yl ethyl oxalate (127) 
A 50 mL round bottom flask equipped with a magnetic stir bar was 
charged with rac. ethyl (2S,3S)-3-acrylamido-2-hydroxy-3-
phenylpropanoate (126) (139 mg, 528 µmol, 1.0 equiv), dry pyridine 
(47 µL, 46 mg, 581 µmol, 1.1 equiv) and dry CH2Cl2 (10 mL). The solution 
was cooled to 0 °C and ethyl 2-chloro-2-oxoacetate (15) (64 µL, 79 mg, 
581 µmol, 1.1 equiv) was added over 1 h. Afterwards, the mixture was 
stirred in an ice bath for 4 h, allowed to come to room temperature and 
stirred overnight. CH2Cl2 (50 mL) was added and the reaction mixture was washed with water 
(3x 20 mL), dried over anhydrous MgSO4 and the solvent was evaporated under reduced 
pressure to yield 183 mg (504 µmol, 95%) of rac. (1S,2S)-1-acrylamido-3-ethoxy-3-oxo-1-
phenylpropan-2-yl ethyl oxalate (127) as a colorless oil. Rf (hexanes / EtOAc, 1:1) = 0.45, 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.48 – 7.40 (m, 2H), 7.38 – 7.30 
(m, 3H), 6.36 – 6.29 (m, 2H), 6.13 (dd, J = 17.0, 10.2 Hz, 1H), 5.75 (dd, J = 8.2, 4.5 Hz, 1H), 
5.69 (dd, J = 10.2, 1.5 Hz, 1H), 5.60 (d, J = 4.4 Hz, 1H), 4.38 (q, J = 7.1 Hz, 2H), 4.07 (qd, J = 
7.1, 1.7 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H), 1.10 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
166.0, 164.8, 156.9, 156.7, 135.7, 130.2, 129.0, 128.9, 128.0, 128.0, 75.6, 63.7, 62.3, 53.5, 
14.0, 14.0. IR (neat): 3370, 3280, 3034, 2986, 2941, 1744, 1659, 1629, 1525, 1405, 1372, 
1308, 1178, 1088, 1018, 913, 857, 805, 753, 701, 667 cm-1. HRMS (ESI) m/z calculated for 
C18H22NO7 ([M+H]+) 364.1391, found 364.1395.  
N-allyl-2-hydroxypropanamide (130) 
A 100 mL  round bottom  flask  equipped  with  a  magnetic  stir  bar and reflux 
condenser was  charged with ethyl 2-hydroxypropanoate (129) (11.8 g,  
100.0 mmol,  1.0 equiv) and allylamine (40a) (10.2 mL, 7.7 g, 135.2 mmol,  
1.3 equiv) and  the  mixture  was  refluxed  for 72 h. After evaporation of all 
volatile compounds under reduced pressure the  obtained residue was  destilled (134 °C, 
3 mbar) to  give 10.4 g  (80.3 mmol,  80%)  of N-allyl-2-hydroxypropanamide (130) as a yellow 
oil. Rf (hexanes / EtOAc, 1:1) = 0.14, Staining: KMnO4, Ninhydrin (UV inactive). 1H NMR 
(300 MHz, CDCl3) δ 6.97 (s, 1H), 5.81 (ddt, J = 17.3, 10.4, 5.5 Hz, 1H), 5.26 – 5.04 (m, 2H), 
4.20 (q, J = 6.8 Hz, 2H), 3.85 (ddt, J = 5.7, 3.3, 1.7 Hz, 2H), 1.40 (d, J = 6.8 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ 175.1, 133.8, 116.5, 68.4, 41.5, 21.3.  
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1-(allylamino)-1-oxopropan-2-yl 3,5-bis(trifluoromethyl)benzoate (131) 
A 50 mL Schlenk flask equipped with a magnetic stir bar was charged 
with N-allyl-2-hydroxypropanamide (130) (129 mg, 1.0 mmol, 1.0 equiv) 
and dissolved in dry CH2Cl2 (20 mL). N,N-diisoproylethylamine (349 µL, 
258 mg, 2.0 mmol, 2.0 equiv) was added followed by 3,5-
bis(trifluoromethyl)benzoic anhydride (46) (598 mg, 1.2 mmol, 
1.2 equiv). After stirring for 20 h at room temperature, CH2Cl2 (30 mL) 
was added and the organic layer was washed with Na2CO3 (aq. 10%, 
20 mL) and water (20 mL). The organic phase was dried over Na2SO4 and the solvent 
evaporated under reduced pressure. The residue was purified by flash chromatography 
(hexanes / EtOAc, 5:1 to 3:1) to give 357 mg (967 µmol, 97%) of 1-(allylamino)-1-oxopropan-
2-yl 3,5-bis(trifluoromethyl)benzoate (131) as white solid. Rf (hexanes / EtOAc, 1:1) = 0.70, 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 8.50 (s, 2H), 8.11 (s, 1H), 6.11 (bs, 
1H), 5.84 (ddt, J = 17.2, 10.2, 5.6 Hz, 1H), 5.46 (q, J = 6.9 Hz, 1H), 5.27 – 5.12 (m, 2H), 3.94 
(tt, J = 5.7, 1.6 Hz, 2H), 1.66 (d, J = 6.9 Hz, 3H). 19F NMR (282 MHz, CDCl3) δ -63.47 (s, 6F). 
13C NMR (75 MHz, CDCl3) δ 169.5, 163.2, 133.6, 132.6 (q, J = 34.2 Hz), 131.7, 130.0 (d, J = 
3.1 Hz), 127.3 – 126.9 (m), 122.9 (q, J = 273.1 Hz), 117.0, 72.4, 41.9, 17.9. IR (neat): 3291, 
3097, 2993, 1733, 1662, 1566, 1454, 1387, 1282, 1245, 1174, 1129, 1044, 995, 917, 816, 772, 
701 cm-1. HRMS (ESI) m/z calculated for C15H14F6NO3 ([M+H]+) 370.0872, found 370.0870.  
1-(allylamino)-1-oxopropan-2-yl ethyl oxalate (131´) 
A 50 mL round bottom flask equipped with a magnetic stir bar was charged 
with N-allyl-2-hydroxypropanamide (130) (646 mg, 5.0 mmol, 1.0 equiv), dry 
pyridine (484 µL, 475 mg, 6.0 mmol, 1.2 equiv) and dry CH2Cl2 (30 mL). The 
solution was cooled to 0 °C and ethyl 2-chloro-2-oxoacetate (15) (671 µL, 
819 mg, 6.0 mmol, 1.2 equiv) was added over 1 h. Afterwards, the mixture 
was stirred in an ice bath for 4 h, allowed to come to room temperature and 
stirred overnight. CH2Cl2 (50 mL) was added and the reaction mixture was washed with water 
(3x 20 mL), dried over anhydrous MgSO4 and the solvent was evaporated under reduced 
pressure to yield 1.1 g (5.0 mmol, 99%) of 1-(allylamino)-1-oxopropan-2-yl ethyl oxalate (131´) 
as a brownish oil. Rf (hexanes / EtOAc, 1:1) = 0.48, Staining: Ninhydrin (UV active). 1H NMR 
(300 MHz, CDCl3) δ 6.40 (s, 1H), 5.83 (ddt, J = 17.2, 10.3, 5.6 Hz, 1H), 5.34 (q, J = 6.8 Hz, 
1H), 5.25 – 5.12 (m, 2H), 4.37 (q, J = 7.2 Hz, 2H), 3.91 (tt, J = 5.7, 1.6 Hz, 2H), 1.58 (d, J = 
6.9 Hz, 3H), 1.39 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 168.9, 157.2, 156.2, 133.5, 
116.9, 73.2, 63.8, 41.7, 17.9, 14.0. IR (neat): 3276, 3094, 2989, 2941, 1744, 1655, 1569, 1454, 
1420, 1383, 1338, 1252, 1197, 1096, 1014, 924, 850, 768, 701 cm-1. HRMS (ESI) m/z 
calculated for C10H16NO5 ([M+H]+) 230.1023, found 230.1020. 
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1-chloro-1-oxopropan-2-yl acetate (135) 
A 100 mL round bottom flask equipped with a magnetic stir bar was charged 
with 2-acetoxypropanoic acid (134) (5.3 g, 40.0 mmol, 1.0 equiv), sulfurous 
dichloride (3.5 mL, 5.7 g, 48.0 mmol, 1.2 equiv) and N,N-dimethylformamide 
(154 µL, 146 mg, 2.0 mmol, 0.05 equiv) in CH2Cl2 (50 mL) while cooling in an 
ice bath. The mixture was allowed to come to room temperature and stirred overnight. All 
volatiles were evaporated under reduced pressure and the product was destilled under 
reduced pressure to yield 4.1 g (27.4 mmol, 69%) of 1-chloro-1-oxopropan-2-yl acetate (135) 
as a colorless oil. 1H NMR (300 MHz, CDCl3) δ 5.20 (q, J = 7.1 Hz, 1H), 2.16 (s, 3H), 1.61 (d, 
J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 173.0, 170.1, 75.1, 20.5, 16.4. 
1-(allyl(tert-butyl)amino)-1-oxopropan-2-yl acetate (138) 
A 50 mL round bottom flask equipped with a magnetic stir bar was charged 
with 1-chloro-1-oxopropan-2-yl acetate (135) (151 mg, 1.0 mmol, 1.0 equiv) 
and N-(tert-butyl)prop-2-en-1-amine (137) (113 mg, 1.0 mmol, 1.0 equiv) while 
cooling in an ice bath. The mixture was allowed to come to room temperature 
and stirred overnight. CH2Cl2 (100 mL) was added and the reaction mixture was washed with 
water (3x 50 mL), dried over anhydrous MgSO4 and the solvent was evaporated under reduced 
pressure and the residue was purified by column chromatography (hexanes/ EtOAc, 9:1 to 3:1) 
to yield 175 mg (770 µmol, 77%) of 1-(allyl(tert-butyl)amino)-1-oxopropan-2-yl acetate (138) 
as a colorless oil. Rf (hexanes / EtOAc, 4:1) = 0.30 Staining: KMnO4 (UV active). 1H NMR 
(400 MHz, CDCl3) δ 5.98 – 5.82 (m, 1H), 5.31 – 5.17 (m, 2H), 5.11 (qd, J = 6.6, 1.0 Hz, 1H), 
4.20 – 4.07 (m, 1H), 3.95 – 3.84 (m, 1H), 2.07 (s, 3H), 1.43 – 1.32 (m, 12H). 13C NMR 
(101 MHz, CDCl3) δ 171.9, 170.9, 136.3, 116.5, 68.9, 58.0, 46.9, 28.5, 21.0, 17.8. IR 
(neat): 2982, 1737, 1659, 1454, 1409, 1364, 1297, 1241, 1197, 1133, 1085, 1036, 977, 947, 
801, 738, 697 cm-1. HRMS (ESI) m/z calculated for C12H22NO3 ([M+H]+) 228.1594, 
found 228.1595. 
N-allyl-N-(tert-butyl)-2-hydroxypropanamide (139) 
A 100 mL round bottom flask equipped with a magnetic stir bar was charged 
with 1-(allyl(tert-butyl)amino)-1-oxopropan-2-yl acetate (138) (2.5 g, 
10.9 mmol, 1.0 equiv) and K2CO3 (6.0 g, 43.6 mmol, 4.0 equiv) in MeOH/H2O 
(2:1, 50 mL) and the reaction mixture was stirred for 40 h. H2O (120 mL) was 
added, the reaction mixture was extracted with EtOAc (3x 100 mL), dried over anhydrous 
Na2SO4 and the solvent was evaporated under reduced pressure to give the crude product. 
After purification by column chromatography (hexanes / EtOAc, 4:1) 1.9 g (10.3 mmol, 94%) 
of N-allyl-N-(tert-butyl)-2-hydroxypropanamide (139) were obtained as a colorless oil. 
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Rf (hexanes / EtOAc, 4:1) = 0.33, Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 
5.79 (dddd, J = 17.2, 10.7, 5.0, 4.2 Hz, 1H), 5.23 – 5.13 (m, 2H), 4.25 (q, J = 6.4 Hz, 1H), 3.95 
(ddt, J = 18.7, 5.1, 1.8 Hz, 1H), 3.82 (ddt, J = 18.7, 4.2, 2.1 Hz, 1H), 3.73 (bs, 1H), 1.41 (s, 
9H), 1.25 (d, J = 6.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 176.3, 135.6, 116.6, 65.5, 58.2, 
46.3, 28.6, 22.1. IR (neat): 3422, 2974, 2930, 1778, 1741, 1640, 1454, 1364, 1260, 1200, 
1118, 1077, 1029, 977, 921, 794, 746 cm-1. HRMS (ESI) m/z calculated for C10H20NO2 ([M+H]+) 
186.1489, found 186.1489. 
1-(allyl(tert-butyl)amino)-1-oxopropan-2-yl ethyl oxalate (140) 
A 50 mL round bottom flask equipped with a magnetic stir bar was 
charged with N-allyl-N-(tert-butyl)-2-hydroxypropanamide (139) 
(185 mg, 1.0 mmol, 1.0 equiv), dry pyridine (121 µL, 119 mg, 1.5 mmol, 
1.5 equiv) and dry CH2Cl2 (20 mL). The solution was cooled to 0 °C and 
ethyl 2-chloro-2-oxoacetate (15) (170 µL, 205 mg, 1.5 mmol, 1.5 equiv) 
was added over 1 h. Afterwards, the mixture was stirred in an ice bath for 4 h, allowed to come 
to room temperature and stirred overnight. CH2Cl2 (50 mL) was added and the reaction mixture 
was washed with water (3x 20 mL), dried over anhydrous MgSO4 and the solvent was 
evaporated under reduced pressure to yield 274 mg (960 µmol, 96%) of 1-(allyl(tert-
butyl)amino)-1-oxopropan-2-yl ethyl oxalate (140) as a colorless oil. Rf (hexanes / EtOAc, 1:1) 
= 0.33, Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 5.91 (dddd, J = 17.3, 10.5, 
5.4, 3.7 Hz, 1H), 5.36 – 5.14 (m, 3H), 4.33 (q, J = 7.2 Hz, 2H), 4.13 (ddt, J = 19.1, 5.4, 1.8 Hz, 
1H), 3.89 (ddt, J = 19.1, 3.7, 2.2 Hz, 1H), 1.51 (d, J = 6.6 Hz, 3H), 1.41 (s, 9H), 1.35 (t, J = 7.1 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 170.1, 157.5, 157.4, 135.7, 116.9, 71.5, 63.4, 58.3, 46.8, 
28.4, 17.6, 14.0. IR (neat): 3083, 2982, 2941, 1741, 1662, 1450, 1409, 1361, 1327, 1256, 
1182, 1118, 1081, 1014, 939, 909, 857, 801, 727, 690 cm-1. LRMS (ESI) showed no product 
signal, but hydrolysis product: m/z calculated for C10H20NO2 ([M+H]+) 186.1489, 
found 186.1493 This result indicates the lability of the product towards methanol during the 
HPLC purification. 
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2.3. NMR Spectra 
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13C NMR  second image 
  
19F NMR  third image 
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rac. Ethyl (2S,3S)-3-(((E)-but-2-en-1-yl)amino)-2-hydroxy-3-phenylpropanoate (39aa) 
 
 
NMR-Solvent: CDCl3  
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rac. Ethyl (2S,3S)-2-hydroxy-3-((3-methylbut-2-en-1-yl)amino)-3-phenylpropanoate 
(39ab)  
 
 
NMR-Solvent: CDCl3  
Experimental Part 
186 
rac. Ethyl (2S,3S)-2-hydroxy-3-((2-methylallyl)amino)-3-phenylpropanoate (39ac) 
 
 
NMR-Solvent: CDCl3  
Experimental Part 
187 
rac. Ethyl (2S,3S)-3-(cyclohex-2-en-1-ylamino)-2-hydroxy-3-phenylpropanoate (39ad) 
 
 
NMR-Solvent: CDCl3   
Experimental Part 
188 
 (1S,2S)-2-(allylamino)-1-(4-nitrophenyl)propane-1,3-diol (43) 
 
 
NMR-Solvent: CDCl3  
Experimental Part 
189 
rac. Ethyl allyl-D-allothreoninate (39ba´) 
 
 
NMR-Solvent: CDCl3   
Experimental Part 
190 
rac. Ethyl (2S,3S)-3-(allylamino)-2-hydroxybutanoate (39ba) 
 
 
NMR-Solvent: CDCl3  
Experimental Part 
191 
rac. Isopropyl (2S,3S)-3-(allylamino)-2-hydroxy-3-phenylpropanoate (39bc) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
192 
rac. Ethyl (2S,3S)-2-hydroxy-3-phenyl-3-(prop-2-yn-1-ylamino)propanoate (39bd) 
 
 
NMR-Solvent: CDCl3  
Experimental Part 
193 
1-Phenyl-2-(prop-2-yn-1-ylamino)ethan-1-ol (39bf) 
 
 
NMR-Solvent: CDCl3  
Experimental Part 
194 
rac. (1R,2S)-2-(allylamino)-1,2-diphenylethan-1-ol (39bg) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
195 
rac. Ethyl (2S,3S)-3-(but-3-yn-1-ylamino)-2-hydroxy-3-phenylpropanoate (39bh) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
196 
rac. Ethyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate 
(44a)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
197 
rac. Ethyl (2S,3S)-3-(((E)-but-2-en-1-yl)(tert-butoxycarbonyl)amino)-2-hydroxy-3-
phenylpropanoate (44b)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
198 
rac. Ethyl (2S,3S)-3-((tert-butoxycarbonyl)(3-methylbut-2-en-1-yl)amino)-2-hydroxy-3-
phenylpropanoate (44c)  
 
 
NMR-Solvent: CDCl3  
Experimental Part 
199 
rac. Ethyl (2S,3S)-3-((tert-butoxycarbonyl)(2-methylallyl)amino)-2-hydroxy-3-phenyl-
propanoate) (44d)  
 
 
NMR-Solvent: CDCl3  
Experimental Part 
200 
rac. Ethyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxybutanoate (44e) 
 
 
NMR-Solvent: CDCl3  
Experimental Part 
201 
tert-Butyl allyl((1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)carbamate (44f)  
 
 
NMR-Solvent: CDCl3  
Experimental Part 
202 
rac. Ethyl (2S,3S)-3-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-2-hydroxy-3-
phenylpropanoate (44g) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
203 
tert-Butyl-(2-hydroxy-2-phenylethyl)(prop-2-yn-1-yl)carbamate (44h)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
204 
tert-Butyl allyl(2-hydroxy-2-phenylethyl)carbamate (44i)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
205 
rac. Isopropyl (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-2-hydroxy-3-phenyl-
propanoate (44j)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
206 
rac. N-allyl-N-((1S,2R)-2-hydroxy-1,2-diphenylethyl)acetamide (44m)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
207 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 
ethyl oxalate (45a)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
208 
rac. (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-1-ethoxy-1-oxobutan-2-yl ethyl oxalate 
(45e) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
209 
Rotamer measurement 
 
NMR-Solvent: DMSO-d6 
 
 
 
 
  
 
 
 
 
  
Experimental Part 
210 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-3-oxo-1-phenyl-
propan-2-yl ethyl oxalate (45g) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
211 
2-((tert-Butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl ethyl oxalate (45h) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
212 
2-(Allyl(tert-butoxycarbonyl)amino)-1-phenylethyl ethyl oxalate (45i) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
213 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-isopropoxy-3-oxo-1-phenylpropan-2-
yl ethyl oxalate (45j) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
214 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-phenylpropan-2-yl 
3,5-bis(trifluoromethyl)benzoate (47a) 
 
 
Experimental Part 
215 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
216 
rac. (1S,2S)-1-(((E)-but-2-en-1-yl)(tert-butoxycarbonyl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47b) 
 
 
Experimental Part 
217 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
218 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(3-methylbut-2-en-1-yl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47c) 
 
 
 
Experimental Part 
219 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
220 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(2-methylallyl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl 3,5-bis(trifluoromethyl)benzoate (47d) 
 
 
 
Experimental Part 
221 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
222 
rac. (2S,3S)-3-(allyl(tert-butoxycarbonyl)amino)-1-ethoxy-1-oxobutan-2-yl 3,5-
bis(trifluoromethyl)benzoate (47e) 
 
 
Experimental Part 
223 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
224 
(1S,2S)-2-(allyl(tert-butoxycarbonyl)amino)-1-(4-nitrophenyl)propane-1,3-diyl bis(3,5-
bis(trifluoro-methyl)benzoate) (47f) 
 
 
Experimental Part 
225 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
226 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-ethoxy-3-oxo-1-phenyl-
propan-2-yl 3,5-bis(trifluoromethyl)benzoate (47g) 
 
 
Experimental Part 
227 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
228 
2-((tert-Butoxycarbonyl)(prop-2-yn-1-yl)amino)-1-phenylethyl 3,5-bis(trifluoro-
methyl)benzoate (47h) 
 
 
Experimental Part 
229 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
230 
2-(Allyl(tert-butoxycarbonyl)amino)-1-phenylethyl 3,5-bis(trifluoromethyl)benzoate (47i) 
 
 
Experimental Part 
231 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
232 
rac. (1S,2S)-1-(allyl(tert-butoxycarbonyl)amino)-3-isopropoxy-3-oxo-1-phenylpropan-2-
yl 3,5-bis(trifluoromethyl)benzoate (47j) 
 
 
Experimental Part 
233 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
234 
rac. (1R,2S)-2-(N-allylacetamido)-1,2-diphenylethyl 3,5-bis(trifluoro-methyl)benzoate 
(47m) 
 
 
Experimental Part 
235 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
236 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4S)-4-methyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48a) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
237 
 
 
 
 
 
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
Experimental Part 
238 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48a´) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
239 
 
  
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
Experimental Part 
240 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4S)-4-ethyl-2-phenylpyrrolidine-1,3-dicarboxylate (48b) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
241 
 
 
 
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
Experimental Part 
242 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4R)-4-ethyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48b´)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
243 
 
 
  
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
 
Experimental Part 
244 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4R)-4-isopropyl-2-phenylpyrrolidine-1,3-dicarboxy-late 
(48c) / rac. 1-(tert-butyl) 3-ethyl (2R,3R,4S)-2-phenyl-4-(prop-1-en-2-yl)pyrrolidine-1,3-
dicarboxylate (48cS1) 
 
NMR-Solvent: CDCl3 
Experimental Part 
245 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4S)-4-isopropyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48c´) / rac. 1-(tert-butyl) 3-ethyl (2R,3R,4R)-2-phenyl-4-(prop-1-en-2-yl)pyrrolidine-1,3-
dicarboxylate (48c´S1)  
 
NMR-Solvent: CDCl3 
Experimental Part 
246 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4R)-4 isopropyl-2-phenylpyrrolidine-1,3-dicarboxy-late 
(48c) 
 
NMR-Solvent: CDCl3 
Experimental Part 
247 
 
 
  
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
Experimental Part 
248 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R,4S)-4-isopropyl-2-phenylpyrrolidine-1,3-dicarboxylate 
(48c´) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
249 
 
 
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
Experimental Part 
250 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R)-4,4-dimethyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48d) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
251 
 
 
  
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
 
Experimental Part 
252 
rac. 1-(tert-Butyl) 3-ethyl (2S,3R,4S)-2,4-dimethylpyrrolidine-1,3-dicarboxylate (48e)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
253 
 
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
 
Experimental Part 
254 
rac. 1-(tert-Butyl) 3-ethyl (2S,3R,4R)-2,4-dimethylpyrrolidine-1,3-dicarboxylate (48e´) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
255 
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
256 
tert-Butyl (2R,3S,4R)-2-(((3,5-bis(trifluoromethyl)benzoyl)oxy)methyl)-4-methyl-3-(4-
nitrophenyl)pyrrolidine-1-carboxylate (48f)  
 
 
 
Experimental Part 
257 
 
NMR-Solvent: CDCl3 
 
  
 
 
Experimental Part 
258 
rac. 1-(tert-Butyl) 3-ethyl (2R,3R)-4-methylene-2-phenylpyrrolidine-1,3-dicarboxylate 
(48g) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
259 
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
 
 
Experimental Part 
260 
tert-Butyl-3-methylene-4-phenylpyrrolidine-1-carboxylate (48h) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
261 
tert-butyl 3-methyl-4-phenylpyrrolidine-1-carboxylate (48i) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
262 
rac. 1-(tert-Butyl) 3-isopropyl (2R,3R,4S)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48j)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
263 
rac. 1-(tert-Butyl) 3-isopropyl (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-1,3-
dicarboxylate (48j´) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
264 
rac. 1-((2R,3S,4S)-4-methyl-2,3-diphenylpyrrolidin-1-yl)ethan-1-one (48m) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
265 
 
 
 
 
 
 
 
NOESY Analysis 
 
 
 
 
 
 
 
Experimental Part 
266 
Isopropyl (2S,3R)-3-acetamido-2-hydroxy-3-phenylpropanoate (64) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
267 
Ethyl (2S,3R)-3-amino-2-hydroxy-3-phenylpropanoate (65)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
268 
Ethyl (2S,3R)-3-(allylamino)-2-hydroxy-3-phenylpropanoate (66) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
269 
 rac. (2R,3R,4R)-4-methyl-2-phenylpyrrolidine-3-carboxylic acid (69) 
 
 
NMR-Solvent: D2O  
Experimental Part 
270 
2-(Allylamino)-1,1-diphenylethan-1-ol (73) 
 
 
NMR-Solvent: CDCl3  
Experimental Part 
271 
 tert-Butyl allyl(2-hydroxy-2,2-diphenylethyl)carbamate (74) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
272 
Methyl 2-(allylamino)benzoate (86) 
 
NMR-Solvent: CDCl3 
 
Experimental Part 
273 
 (2-(Allylamino)phenyl)methanol (87) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
274 
tert-Butyl allyl(2-(hydroxymethyl)phenyl)carbamate (88)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
275 
2-(Allyl(tert-butoxycarbonyl)amino)benzyl ethyl oxalate (89) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
276 
2-(Allyl(tert-butoxycarbonyl)amino)benzyl 3,5-bis(trifluoromethyl)benzoate (90) 
 
 
Experimental Part 
277 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
278 
tert-Butyl 3-methyl-3,4-dihydroquinoline-1(2H)-carboxylate (91) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
279 
N-allyl-N-(2-(hydroxymethyl)phenyl)acetamide (95) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
280 
2-(N-allylacetamido)benzyl acetate (96) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
281 
2-(N-allylacetamido)benzyl ethyl oxalate (97) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
282 
1-(3-Methyl-3,4-dihydroquinolin-1(2H)-yl)ethan-1-one (98) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
283 
 (2-(Allyl(methyl)amino)phenyl)methanol (99) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
284 
2-(Allyl(methyl)amino)benzyl ethyl oxalate (100) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
285 
(2-(Allylamino)phenyl)diphenylmethanol (104) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
286 
 (2-(Allyloxy)phenyl)methanol (109) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
287 
2-(Allyloxy)benzyl ethyl oxalate (110) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
288 
rac. Ethyl (2S,3S)-2-hydroxy-3-((4-methoxybenzyl)amino)-3-phenylpropanoate (117) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
289 
rac. Ethyl (2S,3S)-3-((tert-butoxycarbonyl)(4-methoxybenzyl)amino)-2-hydroxy-3-
phenylpropanoate (118) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
290 
rac. (1S,2S)-1-((tert-butoxycarbonyl)(4-methoxybenzyl)amino)-3-ethoxy-3-oxo-1-
phenylpropan-2-yl ethyl oxalate (119) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
291 
rac. Ethyl (2S,3S)-2-hydroxy-3-((4-methoxyphenyl)amino)-3-phenylpropanoate (120) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
292 
rac. Ethyl (2S,3S)-2-((tert-butoxycarbonyl)oxy)-3-((4-methoxyphenyl)amino)-3-
phenylpropanoate (121)  
 
 
NMR-Solvent: CDCl3 
Experimental Part 
293 
rac. Ethyl (2S,3S)-2-acetoxy-3-((4-methoxyphenyl)amino)-3-phenylpropanoate (122) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
294 
rac. (2S,3S)-1-ethoxy-3-(2-ethoxy-N-(4-methoxyphenyl)-2-oxoacetamido)-1-oxo-3-
phenylpropan-2-yl ethyl oxalate (123) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
295 
rac. Ethyl (2S,3S)-3-acrylamido-2-hydroxy-3-phenylpropanoate (126) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
296 
rac. (1S,2S)-1-acrylamido-3-ethoxy-3-oxo-1-phenylpropan-2-yl ethyl oxalate (127) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
297 
N-allyl-2-hydroxypropanamide (130) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
298 
1-(Allylamino)-1-oxopropan-2-yl 3,5-bis(trifluoromethyl)benzoate (131) 
 
 
Experimental Part 
299 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
300 
1-(Allylamino)-1-oxopropan-2-yl ethyl oxalate (131´) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
301 
1-Chloro-1-oxopropan-2-yl acetate (135) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
302 
1-(Allyl(tert-butyl)amino)-1-oxopropan-2-yl acetate (138) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
303 
N-allyl-N-(tert-butyl)-2-hydroxypropanamide (139) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
304 
1-(Allyl(tert-butyl)amino)-1-oxopropan-2-yl ethyl oxalate (140) 
 
 
NMR-Solvent: CDCl3 
Experimental Part 
305 
2.4. HPLC Analysis 
Determination of enantiomeric excess by chiral HPLC analysis 
 
 
Experimental Part 
306 
 
 
 
 
Experimental Part 
307 
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3. Chapter C: Copper Mediated Photochemical 
Iodoperfluoroalkylation  
3.1. Synthesis of Literature Known Compounds and Reagents 
The following compounds were synthesized according to the reported literature procedures. 
The spectral data were in agreement with the data reported: tert-butyl allylcarbamate17, 
(allyloxy)benzene18, tert-butyl phenyl(prop-2-yn-1-yl)carbamate19, 2-(allyloxy)phenol (21)20, 
methyl 2-allylbenzoate (23)21, methyl 2-(allyloxy)benzoate (26)14, diethyl 2,2-diallylmalonate 
(33)22, (1-cyclopropylvinyl)benzene (36)23. 
For the synthesis of (2-(allyloxy)phenyl)methanol (27) see Chapter B: Synthesis of 
Heterocycles via Visible Light Mediated Deoxygenation Reaction. 
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3.2. Quantum Yield Determination 
The quantum yield  of the visible light driven perfluorination of styrene (12a) with C8F17I (6) 
was determined using a method developed by E. Riedle et al.24 For irradiation, a green LED 
(500 mA operating current, max = 528 nm, OSRAM LTCP7P-KXKZ) was used. The radiant 
power was measured with a commercial power meter (PowerMax USB - PS19Q Power Sensor 
from Coherent) using computer-aided read out with PowerMax software. 
A flame dried pressure tube was charged with C8F17I (6) (2120 µL, 8.0 mmol, 2.0 equiv) and 
[Cu(dap)2]Cl (45) (35.2 mg, 40.0 µmol, 1.0 mol%) or [Cu(dap)Cl2] (47) (21.0 mg, 40.0 µmol, 
1.0 mol%) under nitrogen atmosphere. Anhydrous MeCN (4.0 mL) was added and the reaction 
mixture was degassed by three freeze-pump-thaw cycles. Styrene (12a) (416 mg, 4.0 mmol, 
1.0 equiv) was added under a slight nitrogen overpressure. A flame dried fluorescence cuvette 
equipped with a stirring bar and a septum was flushed with nitrogen. Immediately prior to the 
quantum yield measurement, 2.0 mL of the reaction solution (corresponding to 2.0 mmol of 
styrene (12a)) was transferred to the measuring cuvette under a nitrogen atmosphere. In order 
to minimize ambient light, the measurement was accomplished in a dark room. The radiant 
power of light transmitted by the cuvette with a blank solution (Pref) was measured. The cuvette 
with the blank solution was exchanged by the cuvette containing the reaction mixture and the 
transmitted radiant power (Psample) was determined. The transmitted radiant power was 
monitored during the whole irradiation and remained constant. The sample was irradiated for 
the indicated time (cf. Table 1) and the yield was determined by 1H NMR analysis using 
diphenoxymethane as internal standard. 
The quantum yield  was calculated as follows: 
 
𝛷 =
𝑁𝑝𝑟𝑜𝑑
𝑁𝑝ℎ,𝑎𝑏𝑠
=
𝑛𝑝𝑟𝑜𝑑 ∗ 𝑁𝐴 ∗ ℎ ∗ 𝑐
𝑃𝑎𝑏𝑠 ∗ ∆𝑡 ∗ 𝜆
=
𝑛𝑝𝑟𝑜𝑑 ∗ 𝑁𝐴 ∗ ℎ ∗ 𝑐
(𝑃𝑟𝑒𝑓 − 𝑃𝑠𝑎𝑚𝑝𝑙𝑒) ∗ 𝑓 ∗ ∆𝑡 ∗ 𝜆
 
 
Here,  is quantum yield, Nprod is the number of molecules created, Nph, abs is the number of 
photons absorbed, NA is Avogadro´s constant in mol-1, nprod is the molar amount of product 
molecules created in mol, Pabs is the radiant power absorbed in Watt, t is the irradiation time 
in seconds, h is Planck´s constant in Js, c is the speed of light in ms-1,  is the wavelength of 
the irradiation source in meters, Pref is the radiant power transmitted by a blank cuvette in Watt, 
Psample is the radiant power transmitted by the cuvette with the reaction mixture in Watt and f 
Experimental Part 
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is a correction factor. The correction factor f depends on the reflection coefficient R of the air-
glass-interface. Neglecting second order effects, f can be calculated from: 
 
𝑓 =
1 + 𝑅 ∗
𝑃𝑠𝑎𝑚𝑝𝑙𝑒
𝑃𝑟𝑒𝑓
1 − 𝑅
 
 
For a fused silica cuvette and  = 528 nm, R = 0.0357. 
 
𝑃𝑎𝑏𝑠 = (𝑃𝑟𝑒𝑓 − 𝑃𝑠𝑎𝑚𝑝𝑙𝑒) ∗ 𝑓 
 
Calculation using the data of entry 1 (Table 1): 
 
𝑓 =
1 + 𝑅 ∗
𝑃𝑠𝑎𝑚𝑝𝑙𝑒
𝑃𝑟𝑒𝑓
1 − 𝑅
=
1 + 0.0357 ∗
13.2𝑚𝑊
25.5𝑚𝑊
1 − 0.0357
= 1.056 
 
𝛷 =
𝑛𝑝𝑟𝑜𝑑 ∗ 𝑁𝐴 ∗ ℎ ∗ 𝑐
(𝑃𝑟𝑒𝑓 − 𝑃𝑠𝑎𝑚𝑝𝑙𝑒) ∗ 𝑓 ∗ ∆𝑡 ∗ 𝜆
= 
=
0.80 ∗ 10−3𝑚𝑜𝑙 ∗ 6.022 ∗ 1023𝑚𝑜𝑙−1 ∗ 6.626 ∗ 10−34 ∗ 2.998 ∗ 108𝑚𝑠−1
(25.5 − 13.2) ∗ 10−3𝐽𝑠−1 ∗ 1.056 ∗ 28800𝑠 ∗ 528 ∗ 10−9𝑚
= 0.484 
≅ 48% 
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Table 1. Results of quantum yield measurement. 
 
Entry 
 
Catalyst t / h 
Pref 
/ mW 
Psample 
/ mW 
Pabs 
/ mW 
NMR 
Yield  
1 [Cu(dap)2]Cl (45) 8 25.5 13.2 13.0 40% 48% 
2 [Cu(dap)Cl2] (47) 8 25.8 16.1 10.3 34% 52% 
        
        
Reaction conditions: styrene (12a) (2.0 mmol, 1.0 equiv), C8F17I (6) (4.0 mmol, 2.0 equiv), [Cu(dap)2]Cl 
or [Cu(dap)Cl2] (1.0 mol%), degassed anh. MeCN (2.0 mL), irradiation with green LED (530 nm), stirred 
reaction mixture. The NMR yields were determined by 1H NMR using diphenoxymethane as internal 
standard.  
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3.3. LED Power Measurement 
The light transmitted power of the LEDs used for ATRA reaction was determined using the 
COHERENT FieldMate Laser Power Meter. The combined apparatus of the LED with the glas 
stick was measured. 
Blue LED wavelength emission: ca. 445 nm. Blue LED with glas stick: 207 mW. 
 
Green LED wavelength emission: ca. 520 nm. Green LED with glas stick: 97 mW. 
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3.4. UV-Spectra of [Cu(dap)2]Cl (45) and [Cu(dap)Cl2] (47) 
The UV-spectra of the Cu-catalysts [Cu(dap)2]Cl (45) (Cu(I)) and [Cu(dap)Cl2] (47) (Cu(II)) 
(each 0.02 mM in anh. MeCN) were measured with Agilent Technologies Cary Series 100 UV-
Vis-Spectrometer.  
 
 
3.5. Fluorescence Measurement of [Cu(dap)2]Cl (45) and 
[Ru(bpy)3]Cl2  
For the following measurements a Horiba Scientific FluoroMax®-4 & FluoroMax®-4P with USB 
was used.  
In a cuvette with septum for fluorescent measurements 2 mL of dry, degassed MeCN was used 
with respective photocatalyst [Cu(dap)2]Cl (45) (1 µmol, 0.5 mM) or [Ru(bpy)3]Cl2 (1 µmol, 
0.5 mM) and respective amount of styrene (see spectra). The solutions with [Cu(dap)2]Cl were 
excitated at a wavelength of 530 nm, the solutions with [Ru(bpy)3]Cl2 were excitated at a 
wavelength of 455 nm. 
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3.6. Compound Characterization 
Synthesis of Cu-catalysts [Cu(dap)2]Cl (45) and [Cu(dap)Cl2] (47) 
6,7-Dihydro-5H-[1,4]diazepino[1,2,3,4-lmn][1,10]phenanthroline-4,8-diium bromide 
(45S1) 
A three-neck flask equipped with a magnetic stirring bar, dropping funnel and 
a reflux condenser was charged with 1,10-phenanthroline (10.6 g, 
58.8 mmol, 1.0 equiv) and dissolved in nitrobenzene (80 mL). Afterwards, 
1,3-dibromopropane (31 mL, 306 mmol, 5.2 equiv) was dropwise added and 
the mixture was stirred at 130 °C for 5 h. During the reaction, the product precipitated from the 
reaction mixture. Then, the mixture was allowed to cool to room temperature and the 
precipitate was collected by filtration, washed with hexanes and dried over CaCl2 in a 
desiccator overnight to yield the product 45S1 as a yellowish solid (22.5 g, 57.6 mmol, 98%). 
1H NMR (400 MHz, D2O) δ 9.71 (dd, J = 5.8, 1.3 Hz, 2H), 9.49 (dd, J = 8.5, 1.3 Hz, 2H), 8.63 
(s, 2H), 8.59 (dd, J = 8.4, 5.8 Hz, 2H), 5.19 (t, J = 7.0 Hz, 4H), 3.47 (p, J = 7.0 Hz, 2H). 13C NMR 
(101 MHz, D2O) δ 150.9, 147.4, 134.2, 133.5, 130.3, 127.4, 60.5, 31.0. 
6,7-Dihydro-5H-[1,4]diazepino[1,2,3,4-lmn][1,10]phenanthroline-3,9-dione (45S2) 
A mixture of compound 45S1 (30.0 g, 78.5 mmol, 1.0 equiv) and KOtBu 
(37.0 g, 329.7 mmol, 4.2 equiv) in tert-butyl alcohol (400 mL) was stirred at 
40 °C overnight in an open flask. Afterwards, oxygen was bubbled once to 
the suspension via a balloon. Then, water (100 mL) and CHCl3 (100 mL) 
was added and extracted with CHCl3 (5x 50 mL). The combined organic layers were washed 
with brine (2x 100 mL), dried over anhydrous Na2SO4 and the solvent was removed under 
reduced pressure to yield the pure product 45S2 as a brown solid (18.8 g, 74.6 mmol, 95%). 
1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 9.5 Hz, 2H), 7.36 (s, 2H), 6.81 (d, J = 9.5 Hz, 2H), 
4.31 (s, 4H), 2.45 (p, J = 6.5 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 162.8, 139.0, 132.2, 123.2, 
123.0, 122.9, 45.9, 25.9. 
2,9-Dichloro-1,10-phenanthroline (45S3) 
A flame dried three-neck flask equipped with a magnetic stirring bar and a 
reflux condenser was charged with compound 45S2 (18.8 g, 74.5 mmol, 
1.0 equiv.) and PCl5 (31.0 g, 149 mmol, 2.0 equiv) under nitrogen 
atmosphere. After addition of POCl3 (300 mL) the mixture was stirred 
overnight at 145 °C. The excess of POCl3 was removed by distillation. The resulting brown 
residue was cooled to 0 °C and quenched carefully by the addition of ice followed by aqueous 
NH3 (1 M) until neutral pH. Then, the dark solution was extracted with CH2Cl2 (4x 75 mL). The 
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combined organic layers were washed with brine (1x 100 mL), dried over anhydrous MgSO4 
and the solvent was removed under reduced pressure. The residue was purified by column 
chromatography on silica gel (CH2Cl2) to afford 45S3 as a yellowish solid (13.4 g, 53.6 mmol, 
72%). Rf (CH2Cl2) = 0.53. Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 8.20 (d, 
J = 8.4 Hz, 2H), 7.81 (s, 2H), 7.63 (d, J = 8.4 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 152.0, 
145.0, 138.9, 127.8, 126.4, 125.0. 
2,9-Bis(4-methoxyphenyl)-1,10-phenanthroline (45S4) 
A flame dried three-neck round bottom flask equipped with 
a reflux condenser was charged with 2,9-dichloro-1,10-
phenanthroline (45S3) (2.5 g, 10.0 mmol, 1.0 equiv), (4-
methoxyphenyl)boronic acid (3.3 g, 22.0 mmol, 2.2 equiv), 
PPh3 (131 mg, 500 µmol, 5.0 mol%) and Pd2dba3 (100 mg, 
109 µmol, 1.2 mol%) in freshly distilled glyme (80 mL) under 
nitrogen atmosphere. The reaction mixture was degassed by three freeze-pump-thaw cycles. 
Afterwards, a solution of K2CO3 (3.0 g, 22.0 mmol, 2.2 equiv) in H2O (8 mL) was added and 
the mixture was degassed by one freeze-pump-thaw cycle. The resulting solution was stirred 
for 48 h at 100 °C. Then, the mixture was allowed to cool to room temperature and extracted 
with CH2Cl2 (4x 50 mL). The combined organic layers were washed with brine (4x 50 mL), 
dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. The 
residue was purified by flash column chromatography on silica gel (CH2Cl2 followed by CH2Cl2-
MeOH, 95:5) followed by recrystallization from hot toluene to afford the product 45S4 as a 
yellowish solid (3.3 g, 8.4 mmol, 84%). Rf (CH2Cl2 / MeOH, 9:1) = 0.82. Staining: KMnO4 (UV 
active). 1H NMR (400 MHz, CDCl3) δ 8.44 (d, J = 8.9 Hz, 4H), 8.26 (d, J = 8.5 Hz, 2H), 8.09 (d, 
J = 8.4 Hz, 2H), 7.74 (s, 2H), 7.12 (d, J = 8.9 Hz, 4H), 3.93 (s, 6H). 13C NMR (101 MHz, CDCl3) 
δ 161.1, 156.3, 145.5, 137.2, 131.9, 129.1, 127.6, 125.7, 119.6, 114.3, 55.5. 
[Cu(dap)2]Cl (45) 
In a 100 mL round bottom flask 2,9-Bis-(4-methoxy-
phenyl)-[1,10]phenanthroline (45S4) (1.0 g, 2.6 mmol, 
2.0 equiv.) was dissolved in chloroform (30 mL) and stirred 
at room temperature for 20 min. CuCl (126 mg, 1.3 mmol, 
1.0 equiv.) was added slowly and the mixture was stirred 
for 20 min. The violet solution was stirred at 60 °C for 
20 min, the solvent was removed under reduced pressure 
and the product 45 was isolated as violet-black solid (1.1 g, 
1.3 mmol, > 99 %). 1H NMR (400 MHz, CDCl3) δ 8.52 (d, J = 8.0 Hz, 4H), 8.03 (s, 4H), 7.86 (d, 
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J = 7.8 Hz, 4H), 7.40 (d, J = 8.1 Hz, 8H), 6.05 (d, J = 8.1 Hz, 8H), 3.48 (s, 12H). 13C NMR 
(101 MHz, CDCl3) δ 160.2, 156.3, 143.5, 137.2, 131.1, 129.2, 127.9, 126.2, 124.5, 112.6, 55.4.  
[Cu(dap)Cl2] (47) 
In a round bottom flask, CuCl2 (8.8 mg, 65 µmol, 1.0 equiv) was 
suspended in chloroform (0.7 mL) and sonicated at room temperature 
for 3 min. To the stirred solution, 2,9-bis(para-anisyl)-1,10-
phenanthroline (dap) (45S4) (25.3 mg, 65 µmol, 1.0 equiv) and 
0.3 mL chloroform were added. The mixture was sonicated at room 
temperature for 3 min, and stirred for 60 min. After evaporation of the 
solvent the resulting solid was recrystallized from chloroform and 
diethyl ether. The crystallization was completed in a freezer. This procedure afforded 
compound 47 as brownish green crystals (23.0 mg, 44 µmol, 68%).  
General Procedure for Iodoperfluoroalkylation of Alkenes/Alkynes with [Cu(dap)2]Cl 
(45) or  [Cu(dap)Cl2] (47) (GP-1) 
 
A flame dried Schlenk tube equipped with a magnetic stir bar was charged with alkene/alkyne 
4/5 (0.5 mmol, 1.0 equiv), perfluorooctyl iodide 6 (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and 
[Cu(dap)2]Cl (45) / [Cu(dap)Cl2] (47)  (5.0 µmol, 1.0 mol%) in anh. MeCN (1.0 mL). The 
reaction mixture was degassed by three freeze-pump-thaw cycles, placed under 
N2-atmosphere and irradiated with a green LED (λmax = 530 nm) at room temperature. After 
completion of the reaction (judged by TLC), the solvent was evaporated under reduced 
pressure and the residue was purified by flash column chromatography on silica gel to yield 
pure product 7. 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododecyl)benzene (7e) 
Cu(II)-catalysis: Following general procedure GP-1, using styrene (12a) 
(57 µL, 52 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 
2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 288 mg (443 µmol, 89%) 
of 7e as a white solid after flash column purification (hexanes). Rf (hexanes) = 0.51. Staining: 
KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.39 (m, 2H), 7.39 – 7.21 (m, 3H), 
5.45 (dd, J = 9.6, 5.1 Hz, 1H), 3.40 – 3.06 (m, 2H). 19F NMR (376 MHz, CDCl3) δ -81.36 (t, J = 
10.1 Hz, 3F), -112.45 – -115.70 (m, 2F), -121.97 – -122.76 (m, 6F), -123.27 (s, 2F), -124.05 
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(s, 2F), -126.66 (s, 2F). 13C NMR (101 MHz, CDCl3) δ 142.9, 129.1, 128.7, 126.9, 122.9 – 
107.0 (m), 42.7 (t, J = 20.6 Hz), 16.7.   
1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododecyl)-4-methylbenzene 
(13a) 
Cu(I)-catalysis: Following general procedure GP-1, using 1-methyl-
4-vinylbenzene (66 µL, 59 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) 
(265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) 
(4.4 mg, 5.0 μmol, 1.0 mol%) gave 291 mg (438 µmol, 88%, DCM as 
solvent) of 13a as a white solid after flash column purification (hexanes). 
Cu(II)-catalysis: Following general procedure GP-1, using 1-methyl-4-vinylbenzene (66 µL, 
59 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] 
(47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 281 mg (423 µmol, 85%, DCM as solvent/ 145 mg, 
218 µmol, 44%, MeCN as solvent) of 13a as a white solid after flash column purification 
(hexanes). Rf (hexanes) = 0.59. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 
7.35 (d, J = 8.2 Hz, 2H), 7.15 (d, J = 7.9 Hz, 2H), 5.49 (dd, J = 9.7, 5.2 Hz, 1H), 3.46 – 3.06 
(m, 2H), 2.34 (s, 3H). 19F NMR (282 MHz, CDCl3) δ -81.55 (t, J = 10.0 Hz, 3F), -112.92 (dt, J 
= 271.1, 14.6 Hz, 1F), -114.68 – -116.02 (m, 1F), -122.00 – -122.91 (m, 6F), -123.42 (s, 2F), -
124.17 (s, 2F), -126.68 – -127.04 (m, 2F). 13C NMR (75 MHz, CDCl3) δ 140.1, 138.8, 129.7, 
129.6 – 127.3 (m), 126.7, 126.0 – 104.0 (m), 42.7 (t, J = 20.5 Hz), 21.3, 17.2.  
1-Chloro-4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododecyl)benzene 
(13b) 
Cu(II)-catalysis: Following general procedure GP-1, using 1-chloro-
4-vinylbenzene (60 µL, 69 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) 
(265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 
5.0 μmol, 1.0 mol%) gave 298 mg (435 µmol, 87%) of 13b as a white 
solid after flash column purification (hexanes). Rf (hexanes) = 0.54. Staining: KMnO4 (UV 
active). 1H NMR (300 MHz, CDCl3) δ 7.40 – 7.33 (m, 2H), 7.33 – 7.27 (m, 2H), 5.41 (dd, J = 
10.0, 5.1 Hz, 1H), 3.39 – 3.02 (m, 2H). 19F NMR (282 MHz, CDCl3) δ -81.30 (t, J = 9.9 Hz, 3F), 
-111.84 – -113.11 (m, 1F), -114.56 – -115.84 (m, 1F), -121.92 – -122.67 (m, 6F), -123.26 (s, 
2F), -123.84 – -124.15 (m, 2F), -126.51 – -126.80 (m, 2F). 13C NMR (101 MHz, CDCl3) δ 141.4, 
134.4, 129.3, 130.3 – 127.1 (m), 128.2, 121.0 – 107.4 (m), 42.7 (t, J = 20.6 Hz), 15.3.  
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1-Chloro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododecyl)benzene 
(13c) 
Cu(II)-catalysis: Following general procedure GP-1, using 1-chloro-3-
vinylbenzene (65 µL, 69 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 
546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 
1.0 mol%) gave 295 mg (431 µmol, 86%) of 13c as a white solid after 
flash column purification (hexanes). Rf (hexanes) = 0.52. Staining: KMnO4 (UV active). 
1H NMR (300 MHz, CDCl3) δ 7.42 (q, J = 1.5 Hz, 1H), 7.35 – 7.22 (m, 3H), 5.36 (dd, J = 9.6, 
5.3 Hz, 1H), 3.41 – 3.00 (m, 2H). 19F NMR (282 MHz, CDCl3) δ -81.36 (t, J = 9.9 Hz, 3F), -
112.08 – -113.36 (m, 1F), -115.21 (dt, J = 271.2, 13.7 Hz, 1F), -121.85 – -122.77 (m, 6F), -
123.30 (s, 2F), -123.83 – -124.20 (m, 2F), -126.54 – -126.92 (m, 2F). 13C NMR (75 MHz, CDCl3) 
δ 144.7, 134.7, 130.3, 128.9, 127.1, 125.1, 42.5 (t, J = 20.6 Hz), 14.7.  
1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododecyl)-3-methoxybenzene 
(13d) 
Cu(I)-catalysis: Following general procedure GP-1, using 1-methoxy-3-
vinylbenzene (138 µL, 134 mg, 1.0 mmol, 1.0 equiv), C8F17I (6) (530 μL, 
1.09 g, 2.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) (8.8 mg, 10.0 μmol, 
1.0 mol%) gave 290 mg (426 µmol, 43%, MeCN as solvent/ 283 mg, 
416 µmol, 42%, DCM as solvent) of 13d as a colorless oil after 72 h and flash column 
purification (hexanes). 
Cu(II)-catalysis: Following general procedure GP-1, using 1-methoxy-3-vinylbenzene (69 µL, 
67 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] 
(47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 139 mg (204 µmol, 41% (66% brsm), MeCN as 
solvent/ 150 mg, 221 µmol, 42% (66% brsm), DCM as solvent) of 13d as a colorless oil after 
72 h and flash column purification (hexanes). Rf (hexanes / EtOAc, 4:1) = 0.78. Staining: 
KMnO4, Vanillin (UV active). 1H NMR (400 MHz, CDCl3) δ 7.26 (t, J = 8.0 Hz, 1H), 7.03 (ddd, 
J = 7.7, 1.8, 0.9 Hz, 1H), 6.97 (t, J = 2.1 Hz, 1H), 6.83 (ddd, J = 8.3, 2.5, 0.9 Hz, 1H), 5.42 (dd, 
J = 9.5, 5.3 Hz, 1H), 3.84 (s, 3H), 3.40 – 3.07 (m, 2H). 19F NMR (377 MHz, CDCl3) δ -81.37 (t, 
J = 10.0 Hz, 3F), -113.16 (dt, J = 271.0, 14.5 Hz, 1F), -114.57 – -115.69 (m, 1F), -121.99 – -
122.23 (m, 2F), -122.30 – -122.68 (m, 4F), -123.29 (s, 2F), -124.06 (s, 2F), -126.48 – -126.89 
(m, 2F). 13C NMR (101 MHz, CDCl3) δ 159.8, 144.3, 130.1, 119.2, 122.4 – 107.4 (m), 114.0, 
112.9, 55.4, 42.6 (t, J = 20.6 Hz), 16.6 – 16.2 (m). IR (neat): 3015, 2952, 2848, 1599, 1491, 
1465, 1435, 1372, 1331, 1200, 1144, 1044, 954, 876, 779, 746, 716 cm-1. LRMS (EI) m/z (%): 
553.0 ([M-I]+•, 100), 134.1 (30), 554.1 (26), 183.1 (13), 534.1 (11), 135.1 (7), 139.1 (7). HRMS 
(EI) m/z calculated for C17H10OF17I ([M]+•) 679.9499, found 679.9497. 
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1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododecyl)-2-(trifluoromethyl) 
benzene (13e) 
Cu(II)-catalysis: Following general procedure GP-1, using 1-
(trifluoromethyl)-2-vinylbenzene (73 µL, 86 mg, 0.5 mmol, 1.0 equiv), 
C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) 
(2.6 mg, 5.0 μmol, 1.0 mol%) gave 307 mg (428 µmol, 86%) of 13e as a 
colourless oil after flash column purification (hexanes). Rf (hexanes) = 0.53. Staining: KMnO4 
(UV active). 1H NMR (300 MHz, CDCl3) δ 7.81 (d, J = 8.2 Hz, 1H), 7.61 – 7.53 (m, 2H), 7.37 
(ddt, J = 8.4, 7.6, 1.0 Hz, 1H), 5.83 (dd, J = 9.5, 5.2 Hz, 1H), 3.55 – 3.05 (m, 2H). 19F NMR 
(282 MHz, CDCl3) δ -60.50 (s, 3F), -81.51 (t, J = 10.0 Hz, 3F), -114.5 – -114.9 (m, 2F), -122.1 
– -122.4 (m, 2F), -122.4 – -122.8 (m, 4F), -123.40 (s, 2F), -124.0 – -124.4 (m, 2F), -126.6 – -
127.0 (m, 2F). 13C NMR (101 MHz, CDCl3) δ 141.9 – 141.6 (m), 132.8, 130.2, 128.5, 127.7, 
126.2 (q, J = 5.8 Hz), 126.0 – 125.2 (m), 121.2 – 105.5 (m), 42.7 (t, J = 20.6 Hz), 9.2 – 9.0 (m).  
1,2,3,4,5-pentafluoro-6-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-
iododecyl)benzene (13f) 
Cu(I)-catalysis: Following general procedure GP-1, using 1,2,3,4,5-
pentafluoro-6-vinylbenzene (138 µL, 194 mg, 1.0 mmol, 1.0 equiv), 
C8F17I (6) (530 μL, 1.09 g, 2.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) 
(8.8 mg, 10.0 μmol, 1.0 mol%) gave 600 mg (811 µmol, 81%) of 13f 
as a colorless oil after flash column purification (hexanes). 
Cu(II)-catalysis: Following general procedure GP-1, using 1,2,3,4,5-pentafluoro-6-
vinylbenzene (69 µL, 97 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 
2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 308 mg (416 µmol, 83%) 
of 13f as a colorless oil after flash column purification (hexanes). Rf (hexanes) = 0.90. Staining: 
KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 5.68 (dd, J = 11.4, 4.6 Hz, 1H), 3.57 – 3.37 
(m, 1H), 3.18 – 2.99 (m, 1H). 19F NMR (282 MHz, CDCl3) δ -81.54 (t, J = 10.0 Hz, 3F), -113.48 
– -114.99 (m, 1F), -116.46 (dt, J = 271.4, 14.0 Hz, 1F), -122.07 – -122.90 (m, 6F), -123.42 (s, 
2F), -124.15 (s, 2F), -126.64 – -127.04 (m, 2F), -139.81 (bs, 1F), -143.83 (bs, 1F), -153.50 (tt, 
J = 20.9, 2.7 Hz, 1F), -161.44 (td, J = 21.4, 7.9 Hz, 2F). 13C NMR (101 MHz, CDCl3) δ 144.1 – 
136.1 (m), 122.1 – 119.8 (m), 118.8 (t, J = 33.0 Hz), 117.7 (t, J = 32.3 Hz), 116.5 (td, J = 14.4, 
4.3 Hz), 115.9 (t, J = 33.1 Hz), 115.3 – 106.9 (m), 40.6 (t, J = 20.6 Hz), -3.9. IR (neat): 1733, 
1651, 1505, 1427, 1357, 1312, 1238, 1200, 1148, 1047, 992, 951, 883, 827, 723 cm-1. 
LRMS (EI) m/z (%): 613.0 ([M-I]+•, 100), 199.0 (95), 243.0 (54), 181.0 (54), 197.0 (50), 194.0 
(49), 195.0 (27), 69.0 (24), 614.0 (24), 200.0 (9), 28.0 (9), 119.0 (9), 131.0 (8), 244.0 (7), 205.0 
(7). HRMS (EI) m/z calculated for C16H3F22 ([M-I]+) 612.9878, found 612.9874 .  
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tert-Butyl (4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl) 
carbamate (7b) 
Cu(II)-catalysis: Following general procedure GP-1, using tert-butyl 
allylcarbamate17 (79 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 
546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 310 mg 
(441 µmol, 88%) of 7b as a brown solid after flash column purification (hexanes). Rf (hexanes 
/ EtOAc, 5:1) = 0.72. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 5.11 – 4.68 
(rotamer present, m, 1H), 4.38 (p, J = 6.6 Hz, 1H), 3.69 – 3.36 (m, 2H), 2.98 – 2.66 (m, 2H), 
1.45 (s, 9H). 19F NMR (282 MHz, CDCl3) δ -81.28 (t, J = 9.9 Hz, 3F), -112.42 – -115.05 (m, 
2F), -121.82 – -122.65 (m, 6F), -123.25 (s, 2F), -124.14 (s, 2F), -126.53 – -126.83 (m, 2F). 
13C NMR (101 MHz, CDCl3) δ 155.7, 124.2 – 102.6 (m), 80.4, 49.1, 38.8 (t, J = 21.1 Hz), 28.4, 
18.8.  
((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)benzene 
(15a) 
Cu(I)-catalysis: Following general procedure GP-1, using 
(allyloxy)benzene18 (67 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 
546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 248 mg (365 µmol, 73%) of 15a as a colorless oil after flash column 
purification (hexanes/EtOAc 100:0 to 15:1). 
Cu(II)-catalysis: Following general procedure GP-1, using (allyloxy)benzene18 (67 mg, 
0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) 
(2.6 mg, 5.0 μmol, 1.0 mol%) gave 243 mg (357 µmol, 71%) of 15a as a colorless oil after flash 
column purification (hexanes/EtOAc 100:0 to 15:1). Rf (hexanes) = 0.35. Staining: KMnO4 (UV 
active). 1H NMR (300 MHz, CDCl3) δ 7.38 – 7.29 (m, 2H), 7.09 – 7.00 (m, 1H), 6.98 – 6.90 (m, 
2H), 4.54 (qd, J = 6.7, 5.1 Hz, 1H), 4.31 (dd, J = 10.4, 4.9 Hz, 1H), 4.20 (dd, J = 10.4, 6.8 Hz, 
1H), 3.36 – 3.07 (m, 1H), 2.98 – 2.66 (m, 1H). 19F NMR (282 MHz, CDCl3) δ -81.53 (t, J = 
10.0 Hz, 3F), -114.16 (dt, J = 41.6, 13.8 Hz, 2F), -122.04 – -122.33 (m, 2F), -122.34 – -122.75 
(m, 4F), -123.08 – -123.65 (m, 2F), -123.88 – -124.35 (m, 2F), -126.61 – -127.10 (m, 2F). 13C 
NMR (75 MHz, CDCl3) δ 157.8, 129.8, 122.0, 115.1, 122.0 – 106.3 (m), 72.9, 37.9 (t, J = 21.1 
Hz), 13.1 – 12.8 (m). IR (neat): 1599, 1498, 1465, 1368, 1331, 1200, 1148, 1077, 1047, 883, 
820, 753, 705 cm-1. LRMS (EI) m/z (%): 219.9 (100), 93.0 (68), 94.0 (67), 679.9 (65), 586.9 
(57), 65.0 (34), 77.0 (24), 69.0 (18), 172.9 (16). HRMS (EI) m/z calculated 
for C17H10OF17I ([M]+•) 679.9499, found 679.9484.  
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4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecan-1-ol (7j) 
Cu(I)-catalysis: Following general procedure GP-1, using allyl alcohol 
(43) (68 µL, 58 mg, 1.0 mmol, 1.0 equiv), C8F17I (6) (530 µL, 1.1 g, 
2.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) (8.8 mg, 10.0 μmol, 1.0 mol%) gave 54 mg 
(902 µmol, 90%) of 7j as a white solid after flash column purification (hexanes/EtOAc = 7:1). 
Cu(II)-catalysis: Following general procedure GP-1, using allyl alcohol (43) (34 µL, 29 mg, 
0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) 
(2.6 mg, 5.0 μmol, 1.0 mol%) gave 263 mg (435 µmol, 87%) of 7j as a white solid after flash 
column purification (hexanes/EtOAc = 7:1). 
AIBN reaction: A Schlenk tube equipped with a magnetic stir bar was charged with allyl 
alcohol (43) (137 µL, 116 mg, 2.0 mmol, 1.15 equiv), C8F17I (6) (477 µL, 981 mg, 1.8 mmol, 
1.0 equiv) and AIBN (28.6 mg, 173 µmol, 10 mol%) under N2-atmosphere and stirred for 14 h 
at 80 °C. After completion of the reaction (judged by TLC), the volatile components were 
evaporated under reduced pressure and the residue was purified by flash column 
chromatography on silica gel (hexanes/EtOAc = 7:1) to yield pure product 7j as a white solid 
(813 mg, 1.35 mmol, 77%). NMR-Spectra were in accordance with those reported in literature. 
Rf (hexanes) = 0.45. Staining: KMnO4 (UV inactive). 1H NMR (300 MHz, CDCl3) δ 4.44 (ddt, J 
= 7.3, 6.1, 4.9 Hz, 1H), 3.91 – 3.74 (m, 2H), 3.15 – 2.89 (m, 1H), 2.89 – 2.64 (m, 1H), 2.05 (s, 
1H). 19F NMR (282 MHz, CDCl3) δ -81.35 (t, J = 10.0 Hz, 3F), -112.33 – -113.82 (m, 1F), -
114.08 – -115.56 (m, 1F), -121.82 – -122.73 (m, 6F), -122.99 – -123.58 (m, 2F), -123.75 – -
124.26 (m, 2F), -126.47 – -126.95 (m, 2F). 13C NMR (75 MHz, CDCl3) δ 68.1 (d, J = 2.4 Hz), 
37.6 (t, J = 21.0 Hz), 22.0. 
2-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)phenol (15b) 
Cu(I)-catalysis: Following general procedure GP-1, using 2-allylphenol 
(17) (65 µL, 67 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 
1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) (4.4 mg, 5.0 μmol, 1.0 mol%) 
gave 334 mg (491 µmol, 98%) of 15b as a white solid after flash column purification (hexanes). 
Cu(II)-catalysis: Following general procedure GP-1, using 2-allylphenol (17) (65 µL, 67 mg, 
0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) 
(2.6 mg, 5.0 μmol, 1.0 mol%) gave 330 mg (485 µmol, 97%) of 15b as a white solid after flash 
column purification (hexanes). Rf (hexanes / EtOAc) = 0.45. Staining: Vanillin (UV active). 
1H NMR (300 MHz, CDCl3) δ 7.24 – 7.10 (m, 2H), 6.93 (td, J = 7.4, 1.1 Hz, 1H), 6.75 (dd, J = 
8.0, 1.1 Hz, 1H), 4.84 (s, 1H), 4.71 (dq, J = 8.9, 6.4 Hz, 1H), 3.37 (dd, J = 14.3, 6.1 Hz, 1H), 
3.22 (dd, J = 14.3, 8.9 Hz, 1H), 2.92 (dddd, J = 25.0, 12.0, 6.3, 3.2 Hz, 2H). 19F NMR (282 
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MHz, CDCl3) δ -81.46 (t, J = 10.0 Hz, 3F), -112.39 – -115.29 (m, 2F), -121.93 – -122.77 (m, 
6F), -123.36 (s, 2F), -124.22 (s, 2F), -126.62 – -127.00 (m, 2F). 13C NMR (75 MHz, CDCl3) δ 
153.6, 131.7, 128.9, 125.8, 121.2, 115.7, 115.0 – 102.3 (m), 42.7 (d, J = 2.1 Hz), 41.1 (t, J = 
21.6 Hz), 18.7 – 18.3 (m). IR (neat): 3530, 2937, 1595, 1506, 1457, 1372, 1327, 1200, 1144, 
1044, 954, 876, 828, 749 cm-1. LRMS (EI) m/z (%): 553.0 ([M-I]+•, 100), 133.1 (55), 552.0 (47), 
119.0 (39), 107.0 (37), 533.0 (25), 554.0 (22), 91.1 (20), 69.0 (13), 105.1 (12), 534.0 (12), 
164.1 (10), 134.1 (9), 77.0 (9), 120.1 (9), 127.9 (8), 680.0 (7). HRMS (EI) m/z calculated 
for C17H10OF17I ([M]+) 679.9499, found 679.9502.  
1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-Heptadecafluoro-10-iodohexadecane (15c) 
Cu(II)-catalysis: Following general procedure GP-1, using oct-1-ene 
(79 µL, 56 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 
2.0 equiv) and [Cu(dap)Cl2] (47) (2.7 mg, 5.0 μmol, 1.0 mol%) gave 
305 mg (463 µmol, 93%) of 15c as a colourless oil after flash column purification (hexanes). 
Rf (hexanes) = 0.80. Staining: KMnO4 (UV inactive). 1H NMR (300 MHz, CDCl3) δ 4.40 – 4.27 
(m, 1H), 3.06 – 2.65 (m, 2H), 1.92 – 1.69 (m, 2H), 1.63 – 1.49 (m, 1H), 1.45 – 1.22 (m, 7H), 
0.95 – 0.84 (m, 3H). 19F NMR (282 MHz, CDCl3) δ -81.43 (t, J = 10.0 Hz, 3F), -112.32 (dt, J = 
269.9, 14.7 Hz, 1F), -114.65 – -115.88 (m, 1F), -121.90 – -122.32 (m, 2F), -122.32 – -122.74 
(m, 4F), -123.34 (s, 2F), -124.20 (s, 2F), -126.50 – -127.00 (m, 2F). 13C NMR (101 MHz, CDCl3) 
δ 123.5 – 106.5 (m), 41.9 (t, J = 20.8 Hz), 40.5 (d, J = 2.1 Hz), 31.7, 29.7, 28.4, 22.7, 21.0, 
14.1.  
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododec-1-en-1-yl)benzene (7k) 
Cu(II)-catalysis: Following general procedure GP-1, using ethynylbenzene 
(55 µL, 51 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 
2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 312 mg 
(481 µmol, 96%) of 7k in a diastereomeric ratio of E/Z = 94:06 as a white solid after flash 
column purification (hexanes). Rf (hexanes) = 0.73. Staining: Vanilin (UV active). 1H NMR 
(300 MHz, CDCl3) δ 7.41 – 7.27 (m, 5H), 6.60 (t, J = 13.5 Hz, 1H). 19F NMR (282 MHz, CDCl3) 
δ -81.34 (t, J = 9.9 Hz, 3F), -105.75 (t, J = 13.1 Hz, 2F), -121.85 – -122.20 (m, 2F), -122.27 – 
-122.66 (m, 4F), -123.05 – -123.58 (m, 4F), -126.48 – -126.91 (m, 2F). 13C NMR (101 MHz, 
CDCl3) δ 141.5, 129.4, 128.2, 127.4, 127.2, 127.0 (t, J = 2.6 Hz), 119.7 – 107.4 (m).  
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1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododec-1-en-1-yl)-4-methoxy 
benzene (7l) 
Cu(I)-catalysis: Following general procedure GP-1, using 1-ethynyl-
4-methoxybenzene (65 µL, 66 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) 
(265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 313 mg (462 µmol, 92%) of 7l in a 
diastereomeric ratio of E/Z = 97:03 as a white solid after 42 h and flash column purification 
(hexanes). 
Cu(II)-catalysis: Following general procedure GP-1, using 1-ethynyl-4-methoxybenzene 
(65 µL, 66 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and 
[Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 322 mg (475 µmol, 95%) of 7l in a 
diastereomeric ratio of E/Z = 95:05 as a white solid after 42 h and flash column purification 
(hexanes). Rf (hexanes) = 0.26. Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 
7.28 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 6.57 (t, J = 13.5 Hz, 1H), 3.82 (s, 3H). 
19F NMR (376 MHz, CDCl3) δ -81.58 (t, J = 10.0 Hz, 3F), -105.45 (t, J = 13.3 Hz, 2F), -122.11 
(s, 2F), -122.34 – -122.79 (m, 4F), -123.31 – -123.60 (m, 4F), -126.64 – -127.02 (m, 2F). 
13C NMR (101 MHz, CDCl3) δ 160.5, 133.8, 130.1, 129.0 (t, J = 2.6 Hz), 126.6 (t, J = 21.8 Hz), 
113.5, 123.1 – 105.6 (m), 55.4.  
1-(tert-Butyl)-4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododec-1-en-
1-yl)benzene (16a) 
Cu(I)-catalysis: Following general procedure GP-1, using 1-(tert-
butyl)-4-ethynylbenzene (90 µL, 79 mg, 0.5 mmol, 1.0 equiv), C8F17I 
(6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) 
(4.4 mg, 5.0 μmol, 1.0 mol%) gave 328 mg (466 µmol, 93%) of 16a in 
a diastereomeric ratio of E/Z = 93:07 as a white solid after flash column purification (hexanes). 
Cu(II)-catalysis: Following general procedure GP-1, using 1-(tert-butyl)-4-ethynylbenzene 
(90 µL, 79 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and 
[Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 339 mg (481 µmol, 96%) of 16a in a 
diastereomeric ratio of E/Z = 93:07 as a white solid after flash column purification (hexanes). 
Rf (hexanes) = 0.67. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.39 – 7.32 
(m, 2H), 7.29 – 7.21 (m, 2H), 6.59 (t, J = 13.5 Hz, 1H), 1.33 (s, 9H). 19F NMR (282 MHz, CDCl3) 
δ -81.5 (t, J = 10.0 Hz, 3F), -105.6 (t, J = 13.1 Hz, 2F), -121.8 – -122.2 (m, 2F), -122.3 – -122.8 
(m, 4F), -123.1 – -123.7 (m, 4F), -126.5 – -127.1 (m, 2F). 13C NMR (101 MHz, CDCl3) δ 152.8, 
138.5, 127.0 (t, J = 2.1 Hz), 126.7, 126.5, 125.1, 119.7 – 107.1 (m), 34.9, 31.3.  
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4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoro-2-iodoundec-2-en-1-ol (16b) 
Cu(II)-catalysis: Following general procedure GP-1, using prop-2-yn-1-ol 
(30 µL, 28 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 
2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 147 mg 
(244 µmol, 49%, DCM as solvent/ 144 mg, 239 µmol, 48%, MeCN as 
solvent) of 16b in a diastereomeric ratio of E/Z = 52:48 as a yellow solid after flash column 
purification (hexanes/EtOAc 100:0 to 7:1). Rf (hexanes / EtOAc, 7:1) = 0.27. Staining: KMnO4 
(UV active). 1H NMR (300 MHz, CDCl3) δ 6.80 (tt, J = 13.4, 1.8 Hz, 1H), 6.47 (t, J = 14.6 Hz, 
1H), 4.35 (s, 4H), 2.33 (s, 2H). 19F NMR (282 MHz, CDCl3) δ -81.48 (t, J = 10.0 Hz, 6F), -
105.49 – -105.76 (m, 2F), -108.78 (t, J = 13.2 Hz, 2F), -121.87 – -122.26 (m, 4F), -122.26 – -
122.80 (m, 8F), -123.17 – -123.59 (m, 6F), -123.61 – -123.88 (m, 2F), -126.58 – -127.04 (m, 
4F). 13C NMR (101 MHz, CDCl3) δ 127.5 (t, J = 24.9 Hz), 122.9 (t, J = 5.9 Hz), 120.2 (t, J = 
24.0 Hz), 118.7 (t, J = 33.2 Hz), 115.9 (t, J = 32.8 Hz), 115.2 – 107.4 (m), 72.7, 65.0 (t, J = 4.8 
Hz).  
tert-Butyl-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundec-2-en-
1-yl)(phenyl)carbamate (16c) 
Cu(II)-catalysis: Following general procedure GP-1, using tert-butyl 
phenyl(prop-2-yn-1-yl)carbamate19 (116 mg, 0.5 mmol, 1.0 equiv), C8F17I 
(6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 
5.0 μmol, 1.0 mol%) gave 280 mg (360 µmol, 72%) of 16c in a diastereomeric ratio of 
E/Z = 73:27 as a colourless oil after flash column purification (hexanes). Rf (hexanes / EtOAc, 
5:1) = 0.72. Staining: Vanilin (UV active). 1H NMR (300 MHz, CDCl3, rotamers present) δ 7.42 
– 7.14 (m, 5H), 6.49 (t, J = 12.7 Hz, 1H), 4.74 – 4.56 (m, 2H), 1.46 (s, 9H). 19F NMR (282 MHz, 
CDCl3) δ -81.42 (t, J = 9.9 Hz, 3F), [-106.23 (minor diastereomer, s, 2F), -108.90 (major 
diastereomer, s, 2F)], -121.78 – -122.22 (m, 2F), -122.22 – -122.77 (m, 4F), -123.10 – -123.89 
(m, 4F), -126.53 – -126.98 (m, 2F). 13C NMR (101 MHz, CDCl3) δ 154.0, 141.8, 129.1, 128.9, 
127.4, 126.9, 126.6, 125.9, 121.6 (t, J = 23.8 Hz), 118.7 (t, J = 33.0 Hz), 115.9 (t, J = 33.1 Hz), 
114.2 – 113.2 (m), 113.1 – 107.4 (m), 81.9, 64.1, 28.4 (minor diastereomer), 28.2 (major 
diastereomer).  
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iodo-2-methyldec-1-en-1-yl) 
benzene (16e) 
Cu(II)-catalysis: Following general procedure GP-1, using prop-1-yn-1-
ylbenzene (63 µL, 58 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 
1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 
134 mg (202 µmol, 40%, DCM as solvent/ 133 mg, 201 µmol, 40%, MeCN as solvent) of 16e 
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in a diastereomeric ratio of E/Z > 99:01 as a white solid after flash column purification 
(hexanes). Rf (hexanes) = 0.68. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 
7.35 – 7.22 (m, 3H), 7.21 – 7.15 (m, 2H), 2.29 (s, 3H). 19F NMR (282 MHz, CDCl3) δ -81.33 (t, 
J = 10.0 Hz, 3F), -103.73 (s, 2F), -119.78 – -120.27 (m, 2F), -122.5 (s, 6F), -123.3 (s, 2F), -
126.7 (s, 2F). 13C NMR (101 MHz, CDCl3) δ 144.3, 130.2 (t, J = 20.5 Hz), 128.8, 128.3, 127.8, 
126.9, 119.3 – 105.1 (m), 26.8 (p, J = 3.5 Hz).  
 (2-allylphenyl)methanol (24) 
A 100 mL round bottom flask equipped with a magnetic stir bar was charged 
with methyl 2-allylbenzoate (23)21 (881 mg, 5.0 mmol, 1.0 equiv) in dry THF 
(30 mL). A solution of LiAlH4 (380 mg, 10.0 mmol, 2.0 equiv) in THF (20 mL) was added 
dropwise while the temperature was maintained at 0 °C. The resulting mixture was allowed to 
warm to room temperature and was stirred for 2 h. The mixture was then hydrolyzed by addition 
of H2O (70 mL), the resulting suspension was filtered, and the precipitate was washed with 
EtOAc (3x 70 mL). The combined organic layer was dried over anh. Na2SO4 and solvent 
evaporated under reduced pressure to give 679 mg (4.6 mmol, 92%) of (2-
allylphenyl)methanol (24)25 as pale yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.42 – 7.35 (m, 
1H), 7.30 – 7.19 (m, 3H), 6.01 (ddt, J = 17.2, 10.1, 6.2 Hz, 1H), 5.09 (dq, J = 10.1, 1.6 Hz, 1H), 
5.01 (dq, J = 17.0, 1.8 Hz, 1H), 4.69 (s, 2H), 3.48 (dt, J = 6.3, 1.7 Hz, 2H), 1.99 (bs, 1H).  
2-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)phenol 
(29a) 
Cu(I)-catalysis: Following general procedure GP-1, using 2-
(allyloxy)phenol (21)20 (75 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) 
(265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) 
(4.4 mg, 5.0 μmol, 1.0 mol%) gave 254 mg (365 µmol, 73%) of 29a 
as a colorless oil after flash column purification (hexanes/EtOAc 100:0 to 15:1). 
Cu(II)-catalysis: Following general procedure GP-1, using 2-(allyloxy)phenol (21)20 (75 mg, 
0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) 
(2.6 mg, 5.0 μmol, 1.0 mol%) gave 244 mg (351 µmol, 70%) of 29a as a colorless oil after flash 
column purification (hexanes/EtOAc 100:0 to 15:1). Rf (hexanes / EtOAc 15:1) = 0.50. 
Staining: Vanillin (UV active). 1H NMR (300 MHz, CDCl3) δ 7.07 – 6.91 (m, 2H), 6.86 (dd, J = 
3.5, 1.2 Hz, 2H), 5.65 (s, 1H), 4.60 (dq, J = 7.6, 5.6 Hz, 1H), 4.33 – 4.18 (m, 2H), 3.20 – 2.78 
(m, 2H). 19F NMR (282 MHz, CDCl3) δ -80.70 (t, J = 10.0 Hz, 3F), -111.24 – -112.60 (m, 1F), -
114.26 (dt, J = 269.3, 14.1 Hz, 1F), -121.05 – -122.16 (m, 6F), -122.67 (s, 2F), -123.31 (s, 2F), 
-125.79 – -126.43 (m, 2F). 13C NMR (75 MHz, CDCl3) δ 146.3, 144.8, 123.3, 120.5, 115.7, 
113.4, 73.7 (d, J = 2.5 Hz), 38.5 (t, J = 21.5 Hz), 13.9. IR (neat): 3370, 1599, 1513, 1461, 1431, 
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1372, 1331, 1238, 1193, 1141, 1111, 1070, 1010, 917, 895, 842, 790, 742, 705 cm-1. 
LRMS (EI) m/z (%): 109.0 (100), 586.9 (43), 84.0 (32), 49.0 (31), 110.0 (29), 85.9 (21), 121.0 
(19), 91.0 (16), 51.0 (16), 81.0 (15), 69.0 (13), 172.9 (11), 695.9 (10), 568.0 (7), 235.9 (7). 
HRMS (EI) m/z calculated for C17H10O2F17I ([M]+•) 695.9449, found 695.9450.  
(2-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)phenyl)-
methanol (29b) 
Cu(I)-catalysis: Following general procedure GP-1, using (2-
allylphenyl)methanol (24) (74 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) 
(265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 240 mg (346 µmol, 69%) of 29b as a colorless oil after flash column 
purification (hexanes/EtOAc 100:0 to 10:1). 
Cu(II)-catalysis: Following general procedure GP-1, using (2-allylphenyl)methanol (24) (74 
mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] 
(47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 224 mg (323 µmol, 65%) of 29b as a colorless oil after 
flash column purification (hexanes/EtOAc 100:0 to 15:1). Rf (hexanes / EtOAc 15:1) = 0.29. 
Staining: Vanillin (UV active). 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 7.4, 1.7 Hz, 1H), 7.33 
– 7.27 (m, 1H), 7.04 (td, J = 7.5, 1.0 Hz, 1H), 6.84 (dd, J = 8.2, 1.0 Hz, 1H), 4.78 (q, J = 12.9 
Hz, 2H), 4.64 (dq, J = 7.2, 5.5 Hz, 1H), 4.29 (h, J = 5.3 Hz, 2H), 3.27 – 3.06 (m, 1H), 3.03 – 
2.81 (m, 1H), 2.35 (s, 1H). 19F NMR (377 MHz, CDCl3) δ -80.96 (t, J = 10.0 Hz, 3F), -112.43 
(dt, J = 269.6, 14.5 Hz, 1F), -114.35 (dt, J = 269.6, 14.1 Hz, 1F), -121.29 – -122.35 (m, 6F), -
122.83 (s, 2F), -123.17 – -123.82 (m, 2F), -126.02 – -126.53 (m, 2F). 13C NMR (101 MHz, 
CDCl3) δ 155.5, 129.7, 129.3, 129.2, 122.0, 111.4, 72.3 (d, J = 2.4 Hz), 61.7, 38.4 (t, J = 21.3 
Hz), 13.7 – 13.6 (m). IR (neat): 3317, 1491, 1431, 1368, 1331, 1200, 1148, 1044, 999, 880, 
824, 749, 705 cm-1. LRMS (EI) m/z (%): 549.0 (([M-I-H2O]+•,100), 567.1 (35), 129.1 (24), 84.0 
(22), 550.1 (21), 49.0 (20), 86.0 (15), 130.1 (14), 115.1 (13), 105.1 (13), 116.1 (12), 160.1 (11), 
128.1 (9), 69.0 (9), 119.0 (7), 568.1 (7), 77.0 (7), 51.0 (7), 135.1 (7), 120.1 (7), 133.1 (7). HRMS 
(EI) m/z calculated for C18H12OF17I ([M]+•) 693.9656, found 693.9654.  
(2-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)phenyl)-
methanol (29c) 
Cu(I)-catalysis: Following general procedure GP-1, using (2-
(allyloxy)phenyl)methanol (27) (82 mg, 0.5 mmol, 1.0 equiv), C8F17I 
(6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)2]Cl (45) 
(4.4 mg, 5.0 μmol, 1.0 mol%) gave 200 mg (282 µmol, 56%) of 29c as a colorless oil after flash 
column purification (hexanes/EtOAc 100:0 to 14:1). 
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Cu(II)-catalysis: Following general procedure GP-1, using (2-(allyloxy)phenyl)methanol (27) 
(82 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and 
[Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 217 mg (306 µmol, 61%) of 29c as a 
colorless oil after flash column purification (hexanes/EtOAc 100:0 to 14:1). Rf (hexanes / 
EtOAc 14:1) = 0.30. Staining: Vanillin (UV active). 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.35 
(m, 1H), 7.34 – 7.29 (m, 2H), 7.25 – 7.20 (m, 1H), 4.77 – 4.66 (m, 2H), 4.61 (dq, J = 9.3, 6.4 Hz, 
1H), 3.44 – 3.26 (m, 2H), 3.14 – 2.77 (m, 2H), 1.96 (s, 1H). 19F NMR (377 MHz, CDCl3) δ  
-81.00 (t, J = 10.0 Hz, 3F), -111.84 (dt, J = 269.3, 14.5 Hz, 1F), -113.49 – -114.59 (m, 1F),  
-121.50 – -121.79 (m, 2F), -121.79 – -122.27 (m, 4F), -122.68 – -123.08 (m, 2F), -123.50 –  
-123.86 (m, 2F), -126.13 – -126.51 (m, 2F). 13C NMR (101 MHz, CDCl3) δ 138.7, 137.8, 130.2, 
129.5, 128.4, 127.9, 122.1 – 107.1 (m), 43.6 (d, J = 2.1 Hz), 41.5 (t, J = 20.7 Hz), 20.0 – 19.8 
(m). IR (neat): 3355, 2878, 1603, 1491, 1454, 1368, 1331, 1200, 1148, 1044, 861, 828, 753, 
705 cm-1. LRMS (EI) m/z (%): 95.1 (100), 106.0 (99), 249.9 (98), 107.0 (60), 77.0 (59), 710.0 
(([M]+•,45), 123.0 (31), 121.0 (30), 586.9 (29). HRMS (EI) m/z calculated 
for C18H12O2F17I ([M]+•) 709.9605, found 709.9598. 
2,2,6,6-tetramethyl-1-((perfluorooctyl)oxy)piperidine (32) 
Cu(II)-catalysis: Following general procedure GP-1, using styrene (12a) 
(57 µL, 52 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 546 mg, 1.0 mmol, 
2.0 equiv), 2,2,6,6-Tetramethylpiperidinyloxyl (78 mg, 0.5 mmol, 1.0 equiv) and 
[Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 144 mg (222 µmol, 
44%) of 32 as a colorless oil after flash column purification (hexanes). Rf (hexanes) = 0.55. 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 1.62 – 1.54 (m, 5H), 1.42 – 1.33 
(m, 1H), 1.18 (s, 12H). 19F NMR (282 MHz, CDCl3) δ -78.89 – -79.09 (m, 2F), -81.26 (t, J = 
9.9 Hz, 3F), -121.96 – -122.59 (m, 6F), -123.04 – -123.41 (m, 2F), -123.92 – -124.24 (m, 2F), 
-126.42 – -126.77 (m, 2F). 13C NMR (75 MHz, CDCl3) δ 62.1, 40.6, 33.6 (t, J = 5.4 Hz), 20.8, 
17.0. IR (neat): 3012, 2945, 1539, 1469, 1372, 1334, 1238, 1200, 1133, 999. 880, 816, 783, 
727, 664 cm-1. HRMS (ESI) m/z calculated for C17H19F17NO ([M+H]+) 576.1190, 
found 576.1203. 
rac. Diethyl (3R,4R)-3-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononyl)-4-(iodo-
methyl)cyclopentane-1,1-dicarboxylate (34) 
Cu(II)-catalysis: Following general procedure GP-1, using diethyl 2,2-
diallylmalonate (33)22 (120 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) (265 µL, 
546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 5.0 μmol, 
1.0 mol%) gave 275 mg (350 µmol, 70%) of 34 in a diastereomeric ratio of cis/trans = 92:08 
as a yellow solid after flash column purification (hexanes/EtOAc 100:0 to 7:1). Rf (hexanes / 
EtOAc, 5:1) = 0.58. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 4.25 – 4.14 (m, 
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4H), 3.16 (dd, J = 9.8, 5.3 Hz, 1H), 3.04 (t, J = 9.6 Hz, 1H), 2.69 – 2.44 (m, 4H), 2.37 – 1.99 
(m, 4H), 1.25 (td, J = 7.1, 3.4 Hz, 6H). 19F NMR (282 MHz, CDCl3) δ -81.32 (t, J = 9.9 Hz, 3F), 
-112.12 – -113.49 (m, 1F), -114.97 (dt, J = 270.1, 13.8 Hz, 1F), -121.85 – -122.74 (m, 6F), -
123.27 (s, 2F), -123.73 – -124.20 (m, 2F), -126.49 – -126.97 (m, 2F). 13C NMR (101 MHz, 
CDCl3) δ 172.4, 172.1, 122.4 – 107.2 (m), 62.1, 62.0, 58.4, 45.6, 39.9, 38.5 (d, J = 2.5 Hz), 
35.5, 30.2 – 29.5 (m), 14.1, 14.1, 5.7. 
(6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,13-Heptadecafluoro-1-iodotridec-3-en-4-yl) 
benzene (37) 
Cu(II)-catalysis: Following general procedure GP-1, using (1-
cyclopropylvinyl)benzene (36)23 (72 mg, 0.5 mmol, 1.0 equiv), C8F17I (6) 
(265 µL, 546 mg, 1.0 mmol, 2.0 equiv) and [Cu(dap)Cl2] (47) (2.6 mg, 
5.0 μmol, 1.0 mol%) gave 290 mg (420 µmol, 84%) of 37 in a diastereomeric ratio of 
E/Z = 96:04 as a colourless oil after flash column purification (hexanes). Rf (hexanes) = 0.35. 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.42 – 7.30 (m, 5H), 6.01 (t, J = 7.3 
Hz, 1H), 3.44 – 3.21 (m, 4H), 2.85 (q, J = 7.0 Hz, 2H). 19F NMR (282 MHz, CDCl3) δ -81.53 (t, 
J = 10.0 Hz, 3F), -111.89 (t, J = 14.2 Hz, 2F), -121.93 – -122.34 (m, 2F), -122.34 – -122.79 (m, 
4F), -123.21 – -123.56 (m, 2F), -123.57 – -123.91 (m, 2F), -126.64 – -126.99 (m, 2F). 13C NMR 
(75 MHz, CDCl3) δ 142.2, 135.0, 130.9, 128.7, 127.8, 126.5, 122.3 – 106.1 (m), 33.1, 31.7 (t, 
J = 22.1 Hz), 4.2.  
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3.7. NMR Spectra 
1H NMR  first image 
  
13C NMR  second image 
  
19F NMR  third image 
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6,7-Dihydro-5H-[1,4]diazepino[1,2,3,4-lmn][1,10]phenanthroline-4,8-diium bromide 
(45S1) 
 
 
NMR-Solvent: D2O 
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6,7-Dihydro-5H-[1,4]diazepino[1,2,3,4-lmn][1,10]phenanthroline-3,9-dione (45S2) 
 
 
NMR-Solvent: CDCl3 
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2,9-Dichloro-1,10-phenanthroline (45S3) 
 
 
NMR-Solvent: CDCl3 
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2,9-Bis(4-methoxyphenyl)-1,10-phenanthroline (45S4) 
 
 
NMR-Solvent: CDCl3 
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 [Cu(dap)2]Cl (45) 
 
 
NMR-Solvent: CDCl3 
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 (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododecyl)benzene (7e) 
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NMR-Solvent: CDCl3 
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1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododecyl)-4-methylbenzene 
(13a) 
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NMR-Solvent: CDCl3 
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1-Chloro-4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododecyl)benzene 
(13b) 
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NMR-Solvent: CDCl3 
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1-Chloro-3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododecyl)benzene 
(13c) 
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NMR-Solvent: CDCl3 
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1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododecyl)-3-methoxybenzene 
(13d)  
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NMR-Solvent: CDCl3 
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1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododecyl)-2-(trifluoromethyl) 
benzene (13e) 
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NMR-Solvent: CDCl3 
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1,2,3,4,5-pentafluoro-6-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-
iododecyl)benzene (13f) 
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NMR-Solvent: CDCl3 
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tert-Butyl (4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl) 
carbamate (7b)  
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NMR-Solvent: CDCl3 
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((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)benzene 
(15a) 
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NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
355 
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecan-1-ol (7j) 
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NMR-Solvent: CDCl3 
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2-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)phenol (15b) 
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NMR-Solvent: CDCl3 
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1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-Heptadecafluoro-10-iodohexadecane (15c) 
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NMR-Solvent: CDCl3 
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(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododec-1-en-1-yl)benzene (7k) 
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NMR-Solvent: CDCl3 
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1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iododec-1-en-1-yl)-4-methoxy 
benzene (7l) 
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NMR-Solvent: CDCl3 
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1-(tert-Butyl)-4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-iododec-1-en-
1-yl)benzene (16a) 
 
 
Experimental Part 
366 
 
NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
367 
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoro-2-iodoundec-2-en-1-ol (16b)  
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NMR-Solvent: CDCl3 
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tert-Butyl-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundec-2-en-
1-yl)(phenyl)carbamate (16c) 
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NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
371 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro-1-iodo-2-methyldec-1-en-1-yl) 
benzene (16e)  
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NMR-Solvent: CDCl3 
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(2-allylphenyl)methanol (24) 
 
NMR-Solvent: CDCl3 
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2-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)phenol 
(29a) 
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NMR-Solvent: CDCl3 
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(2-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)phenyl)-
methanol (29b) 
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NMR-Solvent: CDCl3 
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(2-((4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-2-iodoundecyl)oxy)phenyl)-
methanol (29c) 
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379 
 
NMR-Solvent: CDCl3 
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2,2,6,6-tetramethyl-1-((perfluorooctyl)oxy)piperidine (32) 
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NMR-Solvent: CDCl3 
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rac. Diethyl (3R,4R)-3-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononyl)-4-(iodo-
methyl)cyclopentane-1,1-dicarboxylate (34) 
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383 
 
NMR-Solvent: CDCl3 
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(6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,13-Heptadecafluoro-1-iodotridec-3-en-4-yl) 
benzene (37)  
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385 
 
NMR-Solvent: CDCl3 
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4. Chapter D: Copper Mediated Chlorosulfonylation of Alkenes 
4.1. Synthesis of Literature Known Compounds and Reagents 
The following compounds were synthesized according to the reported literature procedures. 
The spectral data were in agreement with the data reported: tert-butyl allylcarbamate (1e)17, 
(allyloxy)benzene (1c)18, 1-allyl-2-methoxybenzene (1j)26, 2-allylphenyl tert-butyl carbonate 
(1k)27, methyl 2-allylbenzoate (1l)21, methyl 2-(allyloxy)benzoate (1m)14, diethyl 2,2-
diallylmalonate (21)22. 
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4.2. Compound Characterization 
1-((2-chloro-2-phenylethyl)sulfonyl)-4-methylbenzene (3a) 
Cu(I)-catalysis: A Schlenk tube equipped with a magnetic stir bar was charged 
with 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv) and 
[Cu(dap)2]Cl (25) (4.4 mg, 5.0 µmol, 1.0 mol%) in anh. MeCN (2.0 mL). The reaction mixture 
was degassed by three freeze-pump-thaw cycles and placed under N2-atmosphere. Styrene 
(1a) (57 µL, 52 mg, 0.5 mmol, 1.0 equiv) was added and the reaction mixture was irradiated 
with a green LED (λmax = 530 nm) at room temperature for 20 h. The solvent was evaporated 
under reduced pressure and the residue was purified by flash column chromatography on silica 
gel (hexanes / EtOAc 9:1 to 4:1) to yield 140 mg (475 µmol, 95%) of rac. 1-((2-chloro-2-
phenylethyl)sulfonyl)-4-methylbenzene (3a) as a white solid. 
Cu(II)-catalysis: A Schlenk tube equipped with a magnetic stir bar was charged with 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) 
(2.6 mg, 5.0 µmol, 1.0 mol%) in anh. MeCN (2.0 mL). The reaction mixture was degassed by 
three freeze-pump-thaw cycles and placed under N2-atmosphere. Styrene (1a) (57 µL, 52 mg, 
0.5 mmol, 1.0 equiv) was added and the reaction mixture was irradiated with a green LED (λmax 
= 530 nm at room temperature for 20 h. The solvent was evaporated under reduced pressure 
and the residue was purified by flash column chromatography on silica gel (hexanes / EtOAc 
9:1 to 4:1) to yield 138 mg (468 µmol, 94%) of rac. 1-((2-chloro-2-phenylethyl)sulfonyl)-4-
methylbenzene (3a) as a white solid. Rf (hexanes / EtOAc) = 0.29. Staining: Vanillin (UV 
active). 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.3 Hz, 2H), 7.29 – 7.19 (m, 7H), 5.33 (t, J = 
6.9 Hz, 1H), 3.94 (dd, J = 14.8, 6.9 Hz, 1H), 3.84 (dd, J = 14.8, 6.9 Hz, 1H), 2.40 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 145.0, 138.7, 136.3, 129.8, 129.1, 129.0, 128.2, 127.2, 64.2, 
55.2, 21.7.  
General Procedure for Chlorosulfonylation of Unactivated Olefins (GP-1): 
 
A Schlenk tube equipped with a magnetic stir bar was charged with sulfonyl chloride derivative 
2 (0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) / 
[Cu(dap)Cl2] (27)  (5.0 µmol, 1.0 mol%) in anh. MeCN (2.0 mL). The reaction mixture was 
degassed by three freeze-pump-thaw cycles and placed under N2-atmosphere. Alkene 31 
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(1.0 mmol, 2.0 equiv) was added and the reaction mixture was irradiated with a green LED 
(λmax = 530 nm) at room temperature. After completion of the reaction (judged by TLC, usually 
48 h), the reaction mixture was washed with brine solution (20 mL) and the aqueous phase 
was extracted with EtOAc (3 x 20 mL). The combined organic fractions were dried over 
anhydrous Na2SO4, the solvent was evaporated under reduced pressure and the residue was 
purified by flash column chromatography on silica gel to yield pure product 3 / 15. 
rac. (1S,2R,3R,4R)-2-chloro-3-tosylbicyclo[2.2.1]heptane (3b) 
Cu(I)-catalysis: Following general procedure GP-1, using rac. (1R,4S)-
bicyclo[2.2.1]hept-2-ene (1b) (94.2 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95.3 mg, 0.5 mmol, 1.0 equiv), Na2CO3 
(53.0 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 
1.0 mol%) gave 130 mg (456 µmol, 91%) of 3b as a white solid after flash 
column purification (hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using rac. (1R,4S)-bicyclo[2.2.1]hept-2-
ene (1b) (94.2 mg, 1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95.3 mg, 
0.5 mmol, 1.0 equiv), Na2CO3 (53.0 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 
5.0 μmol, 1.0 mol%) gave 118 mg (414 µmol, 83%) of 3b as a white solid after flash column 
purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.49. Staining: KMnO4 
(UV active). 1H NMR (300 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 
4.41 (ddd, J = 5.6, 4.1, 1.8 Hz, 1H), 2.88 (dd, J = 5.2, 2.2 Hz, 1H), 2.82 (d, J = 4.1 Hz, 1H), 
2.54 – 2.48 (m, 1H), 2.44 (s, 3H), 2.04 – 1.96 (m, 1H), 1.89 (dddd, J = 12.8, 9.3, 4.9, 2.3 Hz, 
1H), 1.69 (tt, J = 12.3, 4.6 Hz, 1H), 1.51 (dtd, J = 12.6, 4.1, 1.8 Hz, 1H), 1.41 (dq, J = 10.8, 
1.8 Hz, 1H), 1.36 – 1.25 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 145.0, 135.3, 130.0, 128.6, 75.3, 
59.8, 44.0, 39.3, 36.1, 29.7, 21.8, 21.5. HRMS (EI) m/z calculated for C14H17O2SCl ([M]+•) 
284.0632, found 284.0628.  
1-((2-chloro-3-phenoxypropyl)sulfonyl)-4-methylbenzene (3c) 
Cu(I)-catalysis: Following general procedure GP-1, using 
(allyloxy)benzene (1c) (134 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv), and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 118 mg (363 µmol, 73%) of 3c as a 
colorless oil after flash column purification (hexanes /  
EtOAc 9:1 to 4:1). 
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Cu(II)-catalysis: Following general procedure GP-1, using (allyloxy)benzene (1c) (134 mg, 
1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv), and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 1.0 mol%) 
gave 115 mg (354 µmol, 71%) of 3c as a colorless oil after flash column purification (hexanes 
/ EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.41. Staining: Vanillin (UV active). 1H NMR 
(400 MHz, CDCl3) δ 7.81 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.31 – 7.24 (m, 2H), 
7.04 – 6.95 (m, 1H), 6.89 – 6.81 (m, 2H), 4.60 (p, J = 5.4 Hz, 1H), 4.25 (dd, J = 10.3, 4.8 Hz, 
1H), 4.18 (dd, J = 10.3, 5.4 Hz, 1H), 3.88 (dd, J = 14.8, 5.9 Hz, 1H), 3.58 (dd, J = 14.8, 6.8 Hz, 
1H), 2.43 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 157.7, 145.4, 136.3, 130.1, 129.7, 128.2, 
121.9, 114.8, 70.1, 60.0, 51.3, 21.8. IR (neat): 3042, 2930, 1599, 1495, 1461, 1398, 1290, 
1238, 1141, 1085, 1044, 928, 842, 816, 753, 690 cm-1. LRMS (EI) m/z (%): 133.1 (100), 91.1 
(87), 155.0 (46), 139.0 (45), 77.0 (32), 231.0 ([M]+•-C6H5O•,17), 195.0 ([M]+•-C6H5O•-HCl,15), 
324.1 (([M]+•,3), 288.1 ([M]+•-HCl, 2). HRMS (EI) m/z calculated for C16H17O3SCl ([M]+•) 
324.0581, found 324.0588.  
1-((2-chloro-3-phenylpropyl)sulfonyl)-4-methylbenzene (3d) 
Cu(I)-catalysis: Following general procedure GP-1, using allyl benzene 
(1d) (132 µL, 118 mg, 1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl 
chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 
1.0 equiv), and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 1.0 mol%) gave 
117 mg (379 µmol, 76%) of 3d as a white solid after flash column 
purification (hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using allyl benzene (1d) (132 µL, 118 mg, 
1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv), and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 1.0 mol%) 
gave 111 mg (359 µmol, 72%) of 3d as a white solid after 72 h and flash column purification 
(hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc) = 0.48. Staining: KMnO4 (UV active). 
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.3 Hz, 2H), 7.35 – 7.21 (m, 5H), 7.20 – 7.15 (m, 2H), 
4.46 (dq, J = 7.7, 6.1 Hz, 1H), 3.48 (d, J = 6.3 Hz, 2H), 3.25 (dd, J = 14.3, 5.5 Hz, 1H), 3.06 
(dd, J = 14.3, 7.7 Hz, 1H), 2.41 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 145.3, 136.4, 136.0, 
130.1, 129.7, 128.7, 128.3, 127.4, 62.4, 54.6, 43.9, 21.8. IR (neat): 3042, 2989, 2911, 1595, 
1495, 1454, 1390, 1342, 1297, 1185, 1137, 1088, 895, 820, 768, 701 cm-1. HRMS (ESI) m/z 
calculated for C16H21ClNO2S ([M+NH4]+) 326.0976, found 326.0980. 
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tert-butyl (2-chloro-3-tosylpropyl)carbamate (3e) 
Cu(I)-catalysis: Following general procedure GP-1, using tert-butyl 
allylcarbamate (1e) (157 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 140 mg (402 µmol, 80%) of 3e as a colorless 
oil after flash column purification (hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using tert-butyl allylcarbamate (1e) 
(157 mg, 1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 
1.0 mol%) gave 131 mg (377 µmol, 75%) of 3e as a colorless oil after flash column purification 
(hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.25. Staining: Ninhydrin (UV active). 
1H NMR (300 MHz, CDCl3): δ 7.82 (d, J = 8.3 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 5.15 – 4.70 
(m, 1H, rotamer present), 4.34 (p, J = 5.7 Hz, 1H), 3.76 – 3.38 (m, 4H), 2.45 (s, 3H), 1.43 (s, 
9H); 13C NMR (75 MHz, CDCl3): δ 155.8, 145.4, 136.3, 130.2, 128.4, 80.3, 60.9, 53.7, 46.5, 
28.4, 21.8. IR (neat): 3377, 3001, 2915, 1700, 1599, 1521, 1457, 1431, 1394, 1334, 1290, 
1167, 1006, 943, 883, 805, 705 cm-1. HRMS (ESI) m/z calculated 
for C15H26ClN2O4S ([M+NH4]+) 365.1296, found 365.1297. 
2-chloro-3-tosylpropan-1-ol (3f)  
 Cu(I)-catalysis: Following general procedure GP-1, using prop-2-en-1-ol 
(1f) (68 µL, 58 mg, 1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride 
(2a) (95 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) 
and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 1.0 mol%) gave 96 mg 
(386 µmol, 77%) of 3f as a colorless oil after flash column purification 
(hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using prop-2-en-1-ol (1f) (68 µL, 58 mg, 
1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 
90 mg (362 µmol, 72%) of 3f as a colorless oil after flash column purification (hexanes / EtOAc 
9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.11. Staining: KMnO4 (UV active). 1H NMR (300 MHz, 
CDCl3): δ 7.79 (d, J = 8.4 Hz, 2H), 7.36 (d, J = 8.2 Hz, 2H), 4.38 (tt, J = 6.4, 4.6 Hz, 1H), 3.92 
(dd, J = 12.3, 4.7 Hz, 1H), 3.84 (dd, J = 12.3, 4.5 Hz, 1H), 3.71 (dd, J = 14.6, 6.5 Hz, 1H), 3.49 
(dd, J = 14.7, 6.3 Hz, 1H), 2.71 (bs, 1H), 2.44 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 145.5, 
136.1, 130.2, 128.2, 65.6, 59.7, 54.8, 21.8; IR (neat): 3493, 3064, 2926, 2881, 1595, 1495, 
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1454, 1402, 1290, 1137, 1085, 972, 898, 854, 813, 760, 708, 667 cm-1. HRMS (APCI) m/z 
calculated for C10H17ClNO3S ([M+NH4]+) 266.0612, found 266.0611. 
1-((2-chlorooctyl)sulfonyl)-4-methylbenzene (3g) 
 Cu(I)-catalysis: Following general procedure GP-1, using oct-1-ene 
(1g) (157 µL, 112 mg, 1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl 
chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 
1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 1.0 mol%) gave 
127 mg (419 µmol, 84%) of 3g as a colorless oil after flash column 
purification (hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis Following general procedure GP-1, using oct-1-ene (1g) (157 µL, 112 mg, 
1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 1.0 mol%) gave 
130 mg (429 µmol, 86%) of 3g as a colorless oil after flash column purification (hexanes / 
EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.68. Staining: KMnO4 (UV active). 1H NMR 
(300 MHz, CDCl3): δ 7.82 – 7.76 (m, 2H), 7.40 – 7.33 (m, 2H), 4.29 (dtd, J = 8.8, 6.3, 3.9 Hz, 
1H), 3.55 (dd, J = 14.6, 6.2 Hz, 1H), 3.45 (dd, J = 14.6, 6.5 Hz, 1H), 2.45 (s, 3H), 1.96 (dddd, 
J = 14.0, 9.9, 5.8, 3.9 Hz, 1H), 1.84 – 1.66 (m, 1H), 1.56 – 1.16 (m, 8H), 0.94 – 0.81 (m, 3H); 
13C NMR (75 MHz, CDCl3): δ 145.3, 136.6, 130.1, 128.3, 63.6, 54.7, 38.0, 31.6, 28.5, 25.8, 
22.6, 21.8, 14.1. IR (neat): 2930,2859, 1595, 1495, 1461, 1402, 1305, 1141, 1088, 1040, 924, 
891, 842, 816, 757, 693 cm-1. HRMS (APCI) m/z calculated for C15H27ClNO2S ([M+NH4]+) 
320.1446, found 320.1450. 
1-((4-bromo-2-chlorobutyl)sulfonyl)-4-methylbenzene (3h) 
Cu(I)-catalysis: Following general procedure GP-1, using 4-bromobut-1-
ene (1h) (203 µL, 270 mg, 2.0 mmol, 4.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 156 mg (479 µmol, 96%) of 3h as a colorless 
oil after flash column purification (hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using 4-bromobut-1-ene (1h) (203 µL, 
270 mg, 2.0 mmol, 4.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 
1.0 mol%) gave 140 mg (430 µmol, 86%) of 3h as a colorless oil after flash column purification 
(hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.50. Staining: KMnO4 (UV active). 
1H NMR (300 MHz, CDCl3): δ 7.82 (d, J = 8.3 Hz, 2H), 7.43 – 7.36 (m, 2H), 4.46 (dddd, J = 
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10.4, 8.0, 5.3, 2.8 Hz, 1H), 3.68 – 3.44 (m, 4H), 2.65 (dddd, J = 15.1, 8.9, 7.0, 2.9 Hz, 1H), 
2.47 (s, 3H), 2.31 – 2.14 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 145.6, 136.0, 130.3, 128.4, 
63.1, 52.7, 40.1, 29.0, 21.9; IR (neat): 3049, 2974, 2926, 1595, 1495, 1439, 1402, 1301, 1256, 
1215, 1141, 1085, 1036, 988, 939, 876, 813, 757, 705, 671 cm-1. HRMS (ESI) m/z calculated 
for C11H18BrClNO2S ([M+NH4]+) 341.9925, found 341.9929. 
1-(2-chloro-3-tosylpropyl)-2-methoxybenzene (3j) 
Cu(I)-catalysis: Following general procedure GP-1, using 1-allyl-2-
methoxybenzene (1j) (148 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 140 mg (413 µmol, 83%) of 3j as a colorless 
oil after flash column purification (hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using 1-allyl-2-methoxybenzene (1j) 
(148 mg, 1.00 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 
1.0 mol%) gave 117 mg (345 µmol, 69%) of 3j as a colorless oil after flash column purification 
(hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.22. Staining: KMnO4 (UV active). 
1H NMR (300 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 2H), 7.37 – 7.30 (m, 2H), 7.29 – 7.22 (m, 
1H), 7.09 (dd, J = 7.4, 1.8 Hz, 1H), 6.92 – 6.80 (m, 2H), 4.65 – 4.51 (m, 1H), 3.79 (s, 3H), 3.53 
(dd, J = 6.2, 1.5 Hz, 2H), 3.22 (dd, J = 13.8, 6.8 Hz, 1H), 3.04 (dd, J = 13.8, 7.5 Hz, 1H), 2.45 
(s, 3H); 13C NMR (75 MHz, CDCl3): δ 157.5, 145.0, 136.5, 131.6, 129.9, 128.9, 128.4, 124.4, 
120.6, 110.6, 62.9, 55.3, 53.4, 39.8, 21.8. IR (neat): 3004, 2922, 2840, 1737, 1599, 1495, 
1402, 1401, 1320, 1290, 1245, 1137, 1088, 1029, 943, 861, 816, 753, 667 cm-1. HRMS (ESI) 
m/z calculated for C17H23ClNO3S ([M+NH4]+) 356.1082, found 356.1086.  
tert-butyl (2-(2-chloro-3-tosylpropyl)phenyl) carbonate (3k) 
Cu(I)-catalysis: Following general procedure GP-1, using 2-allylphenyl 
tert-butyl carbonate (1k) (234 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 112 mg (264 µmol, 53% (brsm 77%)) of 3k as 
a colorless oil after flash column purification (hexanes /  
EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using 2-allylphenyl tert-butyl carbonate 
(1k) (234 mg, 1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 
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1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 µmol, 
1.0 mol%) gave 75 mg (177 µmol, 35%, (brsm 57%)) of 3k as a colorless oil after flash column 
purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.43. Staining: KMnO4 
(UV active). 1H NMR (300 MHz, CDCl3): δ 7.84 (d, J = 8.3 Hz, 2H), 7.38 – 7.11 (m, 6H), 4.48 
(dtd, J = 8.4, 6.2, 5.4 Hz, 1H), 3.54 (dd, J = 6.3, 1.3 Hz, 2H), 3.41 (dd, J = 14.3, 5.5 Hz, 1H), 
2.98 (dd, J = 14.4, 8.4 Hz, 1H), 2.44 (s, 3H), 1.56 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 151.8, 
149.6, 145.2, 136.4, 131.7, 130.1, 128.7, 128.4, 128.4, 126.1, 122.6, 84.1, 62.9, 53.7, 38.8, 
27.7, 21.8. IR (neat): 2982, 2933, 1756, 1595, 1491, 1454, 1398, 1327, 1275, 1226, 1141, 
1047, 1014, 947, 891, 865, 816, 749, 664 cm-1. HRMS (ESI) m/z calculated 
for C21H29ClNO5S ([M+NH4]+) 442.1449, found 442.1458. 
Methyl 2-(2-chloro-3-tosylpropyl)benzoate (3l) 
Cu(I)-catalysis: Following general procedure GP-1, using methyl 2-
allylbenzoate (1l) (176 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 104 mg (283 µmol, 57% (brsm 74%)) of 3l as 
a colorless oil after flash column purification (hexanes / EtOAc 9:1 to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using methyl 2-allylbenzoate (1l) 
(176 mg, 1.0 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 µmol, 
1.0 mol%) gave 126 mg (343 µmol, 69%, (brsm 78%)) of 3l as a colorless oil after flash column 
purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.30. Staining: KMnO4 
(UV active). 1H NMR (300 MHz, CDCl3): δ 7.95 (dd, J = 7.8, 1.5 Hz, 1H), 7.78 (d, J = 8.4 Hz, 
2H), 7.45 (td, J = 7.5, 1.5 Hz, 1H), 7.38 – 7.23 (m, 4H), 4.57 (dddd, J = 8.5, 7.5, 5.5, 4.8 Hz, 
1H), 3.87 (s, 3H), 3.75 – 3.51 (m, 3H), 3.32 (dd, J = 13.6, 8.4 Hz, 1H), 2.43 (s, 3H); 13C NMR 
(75 MHz, CDCl3): δ 167.4, 145.0, 138.0, 136.5, 132.7, 132.3, 131.3, 129.9, 129.6, 128.4, 127.6, 
63.0, 54.7, 52.3, 42.8, 21.8. IR (neat): 3027, 2952, 1715, 1599, 1491, 1435, 1402, 1260, 1189, 
1137, 1081, 1018, 962, 906, 857, 813, 749, 708, 664 cm-1. HRMS (ESI) m/z calculated 
for C18H23ClNO4S ([M+NH4]+) 384.1031, found 384.1038. 
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Methyl 2-(2-chloro-3-tosylpropoxy)benzoate (3m) 
Cu(I)-catalysis: Following general procedure GP-1, using methyl 2-
(allyloxy)benzoate (1m) (192 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 100 mg (261 µmol, 52% (brsm 73%)) of 3m 
as a colorless oil after flash column purification (hexanes / EtOAc 9:1 
to 4:1). 
Cu(II)-catalysis: Following general procedure GP-1, using methyl 2-(allyloxy)benzoate (1m) 
(192 mg, 1.00 mmol, 2.0 equiv), 4-methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)Cl2] (27) (2.6 mg, 5.0 μmol, 
1.0 mol%) gave 145 mg (379 µmol, 76%, (brsm 83%)) of 3m as a colorless oil after flash 
column purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.26. Staining: 
KMnO4 (UV active). 1H NMR (300 MHz, CDCl3): δ 7.85 – 7.76 (m, 3H), 7.42 (ddd, J = 8.3, 7.4, 
1.8 Hz, 1H), 7.31 – 7.23 (m, 2H), 7.01 (td, J = 7.6, 1.0 Hz, 1H), 6.82 (dd, J = 8.3, 1.0 Hz, 1H), 
4.64 (tdd, J = 6.4, 5.3, 4.1 Hz, 1H), 4.40 – 4.15 (m, 3H), 3.87 (s, 3H), 3.58 (dd, J = 14.7, 6.6 Hz, 
1H), 2.38 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 166.2, 157.3, 145.2, 136.4, 133.7, 132.1, 130.0, 
128.2, 121.5, 120.5, 113.8, 70.7, 59.4, 52.1, 51.1, 21.7. IR (neat): 2952, 1722, 1599, 1491, 
1454, 1402, 1305, 1245, 1137, 1085, 1051, 962, 936, 906, 880, 842, 816, 753, 705 cm-1. 
HRMS (ESI) m/z calculated for C18H20ClO5S ([M+H]+) 383.0714, found 383.0718.  
1-((2-chloro-3-phenoxypropyl)sulfonyl)-4-methoxybenzene (15b) 
Cu(I)-catalysis: Following general procedure GP-1, using 
(allyloxy)benzene (1c) (134 mg, 1.0 mmol, 2.0 equiv), 4-
methoxybenzenesulfonyl chloride (2b) (103 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.50 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 130 mg (381 µmol, 76%) of 1-((2-chloro-3-
phenoxypropyl)sulfonyl)-4-methoxybenzene (15b) as colorless oil after flash column 
purification (hexanes / EtOAc 9:1 to 3:1). Rf (hexanes / EtOAc, 4:1) = 0.25. Staining: KMnO4 
(UV active). 1H NMR (300 MHz, CDCl3) δ 7.85 (d, J = 8.9 Hz, 2H), 7.32 – 7.23 (m, 2H), 7.03 – 
6.94 (m, 3H), 6.89 – 6.81 (m, 2H), 4.59 (dq, J = 6.7, 5.5 Hz, 1H), 4.21 (qd, J = 10.3, 5.1 Hz, 
2H), 3.92 – 3.80 (m, 4H), 3.58 (dd, J = 14.8, 6.8 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 164.2, 
157.8, 130.7, 130.5, 129.7, 121.9, 114.9, 114.7, 70.2, 60.3, 55.8, 51.4. IR (neat): 3064, 2933, 
2840, 1595, 1495, 1461, 1413, 1297, 1238, 1137, 1088, 1021, 928, 835, 753, 693 cm-1. HRMS 
(ESI) m/z calculated for C16H21ClNO4S ([M+NH4]+) 358.0874, found 358.0882.   
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2-chloro-3-((4-methoxyphenyl)sulfonyl)propan-1-ol (15b´) and (E)-3-((4-methoxy-
phenyl)-sulfonyl)prop-2-en-1-ol (16b´) 
 Cu(I)-catalysis: Following general procedure GP-1, 
using prop-2-en-1-ol (1f) (68 µL, 58 mg, 1.0 mmol, 
2.0 equiv), 4-methoxybenzenesulfonyl chloride (2b) 
(103 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 
0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 66 mg (249 µmol, 50%) of 2-chloro-3-((4-
methoxyphenyl)sulfonyl)propan-1-ol (15b´) and 33 mg (145 µmol, 29%) of (E)-3-((4-
methoxyphenyl)sulfonyl)prop-2-en-1-ol (16b´) as colorless oils after flash column purification 
(hexanes / EtOAc 9:1 to 1:2). Rf (15b´, hexanes / EtOAc, 2:1) = 0.13. Staining: KMnO4 (UV 
active). Rf (16b´, hexanes / EtOAc, 2:1) = 0.08. Staining: KMnO4 (UV active). 1H NMR (15b´, 
300 MHz, CDCl3) δ 7.88 – 7.79 (m, 2H), 7.06 – 6.97 (m, 2H), 4.38 (tt, J = 6.4, 4.5 Hz, 1H), 3.98 
– 3.80 (m, 5H), 3.70 (dd, J = 14.6, 6.6 Hz, 1H), 3.48 (dd, J = 14.6, 6.2 Hz, 1H), 2.57 (bs, 1H). 
1H NMR (16b´, 300 MHz, CDCl3) δ 7.81 – 7.75 (m, 2H), 7.02 – 6.92 (m, 3H), 6.62 (dtd, J = 
15.0, 2.2, 0.5 Hz, 1H), 4.35 (dd, J = 3.2, 2.3 Hz, 2H), 3.86 (s, 3H), 2.36 (s, 1H). 13C NMR (15b´, 
75 MHz, CDCl3) δ 164.3, 130.5, 114.8, 65.7, 60.0, 55.9, 55.0. 13C NMR (16b´, 75 MHz, CDCl3) 
δ 163.7, 144.5, 131.7, 130.1, 130.0, 114.7, 61.0, 55.8. IR (15b´, neat): 3499, 3101, 2937, 2844, 
1595, 1498, 1461, 1416, 1297, 1260, 1133, 1088, 1021, 973, 902, 835, 805, 768, 693 cm-1. IR 
(16b´, neat): 3496, 3064, 2974, 2848, 1633, 1595, 1498, 1461, 1435, 1357, 1312, 1264, 1193, 
1133, 1085, 1018, 943, 828, 805, 764, 671 cm-1. HRMS (15b´, ESI) m/z calculated 
for C10H17ClNO4S ([M+NH4]+) 282.0561, found 282.0565. HRMS (16b´, ESI) m/z calculated 
for C10H16NO4S ([M+NH4]+) 246.0795, found 246.0797.  
(2-chloro-3-(phenylsulfonyl)propoxy)benzene (15c) 
 Cu(I)-catalysis: Following general procedure GP-1, using 
(allyloxy)benzene (1c) (134 mg, 1.0 mmol, 2.0 equiv), benzenesulfonyl 
chloride (2c) (88 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 
1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 1.0 mol%) gave 91 mg 
(293 µmol, 59%) of (2-chloro-3-(phenylsulfonyl)propoxy)benzene (15c) as colorless oil after 
flash column purification (hexanes / EtOAc 9:1 to 3:1). Rf (hexanes / EtOAc, 4:1) = 0.35. 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 8.00 – 7.91 (m, 2H), 7.71 – 7.62 
(m, 1H), 7.61 – 7.52 (m, 2H), 7.34 – 7.24 (m, 2H), 7.04 – 6.96 (m, 1H), 6.90 – 6.83 (m, 2H), 
4.69 – 4.57 (m, 1H), 4.27 (dd, J = 10.3, 4.8 Hz, 1H), 4.19 (dd, J = 10.3, 5.5 Hz, 1H), 3.90 (dd, 
J = 14.8, 5.7 Hz, 1H), 3.61 (dd, J = 14.8, 7.0 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 157.8, 
139.3, 134.3, 129.7, 129.6, 128.3, 122.0, 114.9, 70.2, 60.1, 51.2. IR (neat): 3064, 2930, 1599, 
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1495, 1446, 1390, 1305, 1238, 1141, 1085, 1044, 928, 883, 842, 820, 787, 749, 686 cm-1. 
HRMS (ESI) m/z calculated for C15H19ClNO3S ([M+NH4]+) 328.0769, found 328.0774.  
2-chloro-3-(phenylsulfonyl)propan-1-ol (15c´) and (E)-3-(phenylsulfonyl)prop-2-en-1-ol 
(16c´) 
 Cu(I)-catalysis: Following general procedure GP-
1, using prop-2-en-1-ol (1f) (68 µL, 58 mg, 
1.0 mmol, 2.0 equiv), benzenesulfonyl chloride (2c) 
(88 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 
0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 1.0 mol%) gave 35 mg 
(149 µmol, 30%) of 2-chloro-3-(phenylsulfonyl)propan-1-ol (15c´) and 48 mg (242 µmol, 48%) 
of (E)-3-(phenylsulfonyl)prop-2-en-1-ol (16c´) as colorless oils after flash column purification 
(hexanes / EtOAc 9:1 to 1:1). Rf (15c´, hexanes / EtOAc, 2:1) = 0.18. Staining: KMnO4 (UV 
active). Rf (16c´, hexanes / EtOAc, 2:1) = 0.13. Staining: KMnO4 (UV active). 1H NMR (15c´, 
300 MHz, CDCl3) δ 7.97 – 7.91 (m, 2H), 7.74 – 7.66 (m, 1H), 7.64 – 7.55 (m, 2H), 4.43 (ddt, J 
= 6.7, 6.1, 4.4 Hz, 1H), 4.02 – 3.84 (m, 2H), 3.73 (dd, J = 14.6, 6.8 Hz, 1H), 3.53 (dd, J = 14.6, 
6.1 Hz, 1H), 2.31 (bs, 1H). 1H NMR (16c´, 300 MHz, CD3CN) δ 7.91 – 7.84 (m, 2H), 7.74 – 
7.53 (m, 3H), 7.03 (dt, J = 15.1, 3.2 Hz, 1H), 6.64 (dt, J = 15.0, 2.2 Hz, 1H), 4.25 (dt, J = 5.0, 
2.8 Hz, 2H), 3.25 (s, 1H). 13C NMR (15c´, 75 MHz, CDCl3) δ 139.1, 134.4, 129.6, 128.2, 65.7, 
59.7, 54.9. 13C NMR (16c´, 75 MHz, CD3CN) δ 148.3, 141.7, 134.4, 130.4, 129.5, 128.2, 61.0. 
IR (15c´, neat): 3489, 3064, 2930, 1588, 1446, 1394, 1305, 1141, 1085, 977, 902, 854, 787, 
749, 686 cm-1. IR (16c´, neat): 3489, 3056, 2922, 2851, 1629, 1390, 1275, 1226, 1197, 1137, 
1081, 1018, 943, 842, 760, 716 cm-1.  HRMS (15c´, ESI) m/z calculated 
for C9H15ClNO3S ([M+NH4]+) 252.0456, found 252.0459. HRMS (16c´, ESI) m/z calculated 
for C9H14NO3S ([M+NH4]+) 216.0689, found 216.0692.    
1-((2-chloro-3-phenoxypropyl)sulfonyl)-4-(trifluoromethyl)benzene (15d) and (E)-1-((3-
phenoxyprop-1-en-1-yl)sulfonyl)-4-(trifluoromethyl)benzene (16d) 
Cu(I)-catalysis: Following general procedure GP-1, 
using (allyloxy)benzene (1c) (134 mg, 1.0 mmol, 
2.0 equiv), 4-(trifluoromethyl)benzenesulfonyl chloride 
(2d) (122 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 
0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 82 mg (216 µmol, 43%) of 1-((2-chloro-3-phenoxypropyl)sulfonyl)-
4-(trifluoromethyl)benzene (15d) and 29 mg (85 µmol, 17%) of (E)-1-((3-phenoxyprop-1-en-1-
yl)sulfonyl)-4-(trifluoromethyl)benzene (16d) as colorless oils after flash column purification 
(hexanes / EtOAc 9:1 to 3:1). Rf (15d, hexanes / EtOAc, 4:1) = 0.47. Staining: KMnO4 (UV 
active). Rf (16d, hexanes / EtOAc, 4:1) = 0.43. Staining: KMnO4 (UV active). 1H NMR (15d, 
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400 MHz, CDCl3) δ 8.09 (d, J = 8.2 Hz, 2H), 7.82 (d, J = 8.3 Hz, 2H), 7.28 (dd, J = 8.5, 7.4 Hz, 
2H), 7.00 (t, J = 7.4 Hz, 1H), 6.87 – 6.80 (m, 2H), 4.64 (ddt, J = 7.5, 5.9, 4.8 Hz, 1H), 4.27 (dd, 
J = 10.3, 4.5 Hz, 1H), 4.15 (dd, J = 10.3, 5.9 Hz, 1H), 3.95 (dd, J = 15.0, 5.0 Hz, 1H), 3.66 (dd, 
J = 15.0, 7.5 Hz, 1H). 1H NMR (16d, 400 MHz, CDCl3) δ 8.02 (d, J = 8.2 Hz, 2H), 7.80 (d, J = 
8.3 Hz, 2H), 7.30 – 7.23 (m, 2H), 7.18 (dt, J = 15.0, 3.3 Hz, 1H), 6.97 (t, J = 7.4 Hz, 1H), 6.87 
– 6.82 (m, 2H), 6.77 (dt, J = 15.0, 2.2 Hz, 1H), 4.73 (dd, J = 3.3, 2.2 Hz, 2H). 19F NMR (15d, 
377 MHz, CDCl3) δ -63.72 (s, 3F). 19F NMR (16d, 377 MHz, CDCl3) δ -63.72 (s, 3F). 13C NMR 
(15d, 101 MHz, CDCl3) δ 157.6, 143.0 – 142.9 (m), 135.9 (q, J = 33.3 Hz), 129.8, 129.0, 126.7 
(q, J = 3.6 Hz), 123.1 (q, J = 273.2 Hz), 122.1, 114.8, 70.0, 60.1, 50.9. 13C NMR (16d, 101 MHz, 
CDCl3) δ 157.6, 143.9 – 143.8 (m), 142.5, 135.4 (q, J = 33.2 Hz), 130.6, 129.8, 128.5, 126.6 
(q, J = 3.6 Hz), 123.3 (q, J = 273.1 Hz), 122.0, 114.7, 65.6. IR (15d, neat): 3101, 3068, 2997, 
2945, 2889, 1599, 1498, 1402, 1320, 1290, 1245, 1167, 1122, 1085, 1059, 924, 887, 850, 799, 
753, 693 cm-1. IR (16d, neat): 3105, 3056, 2915, 2885, 1640, 1588, 1495, 1439, 1402, 1320, 
1234, 1163, 1118, 1014, 951, 869, 829, 805 cm-1. HRMS (15d, ESI) m/z calculated 
for C16H18ClF3NO3S ([M+NH4]+) 396.0643, found 396.0640. HRMS (16d, ESI) m/z calculated 
for C16H17F3NO3S ([M+NH4]+) 360.0876, found 360.0870. 
(E)-3-((4-(trifluoromethyl)phenyl)sulfonyl)prop-2-en-1-ol (16d´) 
Cu(I)-catalysis: Following general procedure GP-1, using prop-2-en-1-ol 
(1f) (68 µL, 58 mg, 1.0 mmol, 2.0 equiv), 4-(trifluoromethyl)benzenesulfonyl 
chloride (2d) (122 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 
1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 1.0 mol%) gave 100 mg 
(376 µmol, 75%) of (E)-3-((4-(trifluoromethyl)phenyl)sulfonyl)prop-2-en-1-
ol (16d´) as colorless oil after flash column purification (hexanes / EtOAc 9:1 to 1:1). Rf 
(hexanes / EtOAc, 4:1) = 0.09. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 8.00 
(d, J = 8.2 Hz, 2H), 7.80 (d, J = 8.2 Hz, 2H), 7.11 (dt, J = 15.0, 3.0 Hz, 1H), 6.66 (dt, J = 14.9, 
2.2 Hz, 1H), 4.40 (dd, J = 3.1, 2.3 Hz, 2H), 2.49 (bs, 1H). 19F NMR (282 MHz, CDCl3) δ -63.16 
(s, 3F). 13C NMR (75 MHz, CDCl3) δ 147.6, 143.8 (q, J = 1.6 Hz), 135.3 (q, J = 33.3 Hz), 128.7, 
128.4, 126.6 (q, J = 3.9 Hz), 125.0, 121.4, 61.0. IR (neat): 3496, 3064, 1633, 1439, 1405, 1320, 
1290, 1223, 1163, 1126, 1085, 1014, 948, 857, 790, 738 cm-1. HRMS (ESI) m/z calculated 
for C10H10F3O3S ([M+H]+) 267.0297, found 267.0303.  
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1-((2-chloro-3-phenoxypropyl)sulfonyl)-4-nitrobenzene (15e) and (E)-1-nitro-4-((3-
phenoxyprop-1-en-1-yl)sulfonyl)benzene (16e) 
Cu(I)-catalysis: Following general procedure GP-1, 
using (allyloxy)benzene (1c) (134 mg, 1.0 mmol, 
2.0 equiv), 4-nitrobenzenesulfonyl chloride (2e) 
(111 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 
0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) (4.4 mg, 
5.0 μmol, 1.0 mol%) gave 69 mg (194 µmol, 39%) of 1-((2-chloro-3-phenoxypropyl)sulfonyl)-
4-nitrobenzene (15e) and 32 mg (100 µmol, 20%) of (E)-1-nitro-4-((3-phenoxyprop-1-en-1-
yl)sulfonyl)benzene (16e) as colorless oils after flash column purification (hexanes / EtOAc 9:1 
to 2:1). Rf (15e, hexanes / EtOAc, 4:1) = 0.33. Staining: KMnO4 (UV active). Rf (16e, hexanes 
/ EtOAc, 4:1) = 0.28. Staining: KMnO4 (UV active). 1H NMR (15e, 400 MHz, CDCl3) δ 8.40 – 
8.33 (m, 2H), 8.18 – 8.11 (m, 2H), 7.31 – 7.23 (m, 2H), 6.99 (td, J = 7.3, 1.0 Hz, 1H), 6.84 – 
6.78 (m, 2H), 4.64 (ddt, J = 7.7, 6.1, 4.5 Hz, 1H), 4.26 (dd, J = 10.3, 4.4 Hz, 1H), 4.12 (dd, J = 
10.3, 6.2 Hz, 1H), 3.99 (dd, J = 15.2, 4.7 Hz, 1H), 3.69 (dd, J = 15.2, 7.8 Hz, 1H).1H NMR (16e, 
400 MHz, CDCl3) δ 8.39 (d, J = 8.8 Hz, 2H), 8.10 (d, J = 8.8 Hz, 2H), 7.33 – 7.21 (m, 3H), 7.00 
(tt, J = 7.2, 1.0 Hz, 1H), 6.87 (dt, J = 7.9, 1.0 Hz, 2H), 6.80 (dt, J = 14.9, 2.2 Hz, 1H), 4.78 (dd, 
J = 3.2, 2.2 Hz, 2H). 13C NMR (15e, 101 MHz, CDCl3) δ 157.4, 151.1, 145.0, 129.9, 129.8, 
124.7, 122.2, 114.7, 69.8, 60.2, 50.9. 13C NMR (16e, 101 MHz, CDCl3) δ 157.5, 150.8, 146.0, 
143.5, 130.1, 129.9, 129.3, 124.7, 122.1, 114.7, 65.6. IR (15e, neat): 3109, 3071, 3038, 2930, 
2870, 1603, 1528, 1491, 1387, 1349, 1305, 1230, 1156, 1081, 1044, 902, 854, 760, 738, 690 
cm-1. IR (16e, neat): 3109, 3079, 2904, 2859, 1640, 1599, 1543, 1491, 1443, 1349, 1305, 
1238, 1182, 1141, 1085, 1021, 872, 757, 682 cm-1. HRMS (15e, ESI) m/z calculated 
for C15H18ClN2O5S ([M+NH4]+) 373.0619, found 373.0619. HRMS (16e, ESI) m/z calculated 
for C15H17N2O5S ([M+NH4]+) 337.0853, found 337.0853. 
(E)-3-((4-nitrophenyl)sulfonyl)prop-2-en-1-ol (16e´) 
Cu(I)-catalysis: Following general procedure GP-1, using prop-2-en-1-ol 
(1f) (68 µL, 58 mg, 1.0 mmol, 2.0 equiv), 4-nitrobenzenesulfonyl chloride 
(2e) (111 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) 
and [Cu(dap)2]Cl (25) (4.4 mg, 5.0 μmol, 1.0 mol%) gave 85 mg (349 µmol, 
70%) of (E)-3-((4-nitrophenyl)sulfonyl)prop-2-en-1-ol (16e´) as colorless oil 
after flash column purification (hexanes / EtOAc 9:1 to 1:2). Rf (hexanes / EtOAc, 2:1) = 0.15. 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CD3CN) δ 8.36 (d, J = 8.9 Hz, 2H), 8.08 (d, 
J = 8.9 Hz, 2H), 7.16 (dtd, J = 14.8, 3.0, 1.1 Hz, 1H), 6.70 (dt, J = 15.0, 2.3 Hz, 1H), 4.28 (s, 
2H), 3.30 (s, 1H). 13C NMR (75 MHz, CD3CN) δ 151.0, 147.2, 129.8, 128.2, 125.5, 61.1. IR 
(neat): 3481, 3101, 3068, 3038, 2930, 2855, 1633, 1603, 1528, 1431, 1398, 1349, 1275, 1141, 
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1081, 1006, 939, 835, 764, 686 cm-1. HRMS (ESI) m/z calculated for C9H10NO5S ([M+H]+) 
244.0274, found 244.0279.  
rac. Diethyl (3R,4S)-3-(chloromethyl)-4-(tosylmethyl)cyclopentane-1,1-dicarboxylate 
(21) 
Cu(I)-catalysis: Following general procedure GP-1, using diethyl 
2,2-diallylmalonate (20) (240 mg, 1.0 mmol, 2.0 equiv), 4-
methylbenzenesulfonyl chloride (2a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (53 mg, 0.5 mmol, 1.0 equiv) and [Cu(dap)2]Cl (25) 
(4.4 mg, 5.0 μmol, 1.0 mol%) gave 178 mg (413 µmol, 83%) of 21 
in a diastereomeric ratio of 96:04 colorless oil after flash column purification (hexanes / EtOAc 
9:1 to 4:1). Rf (hexanes / EtOAc, 4:1) = 0.31. Staining: KMnO4 (UV active). 1H NMR (300 MHz, 
CDCl3): δ 7.76 (d, J = 8.3 Hz, 2H), 7.38 – 7.31 (m, 2H), 4.16 (qd, J = 7.1, 1.9 Hz, 4H), 3.45 (d, 
J = 6.5 Hz, 2H), 3.23 (dd, J = 14.0, 5.0 Hz, 1H), 3.09 (dd, J = 14.0, 8.4 Hz, 1H), 2.65 – 2.17 
(m, 9H), 1.22 (td, J = 7.1, 2.1 Hz, 6H); 13C NMR (101 MHz, CDCl3): δ 172.1, 171.9, 145.1, 
136.5, 130.2, 128.2, 62.0, 61.9, 58.7, 56.0, 44.5, 43.9, 38.5, 37.1, 36.0, 21.8, 14.2; IR (neat): 
2982, 1722, 1599, 1446, 1398, 1368, 1301, 1256, 1182, 1141, 1088, 1059, 861, 816, 760, 667 
cm-1. HRMS (ESI) m/z calculated for C20H28ClO6S ([M+H]+) 431.1290, found 431.1300. 
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4.3. NMR Spectra 
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13C NMR  second image 
  
19F NMR  third image 
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1-((2-Chloro-2-phenylethyl)sulfonyl)-4-methylbenzene (3a) 
 
 
NMR-Solvent: CDCl3 
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rac. (1S,2R,3R,4R)-2-Chloro-3-tosylbicyclo[2.2.1]heptane (3b)  
 
  
NMR-Solvent: CDCl3   
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1-((2-Chloro-3-phenoxypropyl)sulfonyl)-4-methylbenzene (3c) 
 
 
NMR-Solvent: CDCl3 
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1-((2-Chloro-3-phenylpropyl)sulfonyl)-4-methylbenzene (3d) 
 
 
NMR-Solvent: CDCl3 
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tert-Butyl (2-chloro-3-tosylpropyl)carbamate (3e)  
 
 
NMR-Solvent: CDCl3 
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 2-Chloro-3-tosylpropan-1-ol (3f)  
 
 
NMR-Solvent: CDCl3 
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 1-((2-Chlorooctyl)sulfonyl)-4-methylbenzene (3g)  
 
 
NMR-Solvent: CDCl3 
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1-((4-Bromo-2-chlorobutyl)sulfonyl)-4-methylbenzene (3h) 
 
 
NMR-Solvent: CDCl3 
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1-(2-Chloro-3-tosylpropyl)-2-methoxybenzene (3j)  
 
 
NMR-Solvent: CDCl3 
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tert-Butyl (2-(2-chloro-3-tosylpropyl)phenyl) carbonate (3k)  
 
 
NMR-Solvent: CDCl3 
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Methyl 2-(2-chloro-3-tosylpropyl)benzoate (3l)  
 
    
NMR-Solvent: CDCl3 
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Methyl 2-(2-chloro-3-tosylpropoxy)benzoate (3m)  
 
 
NMR-Solvent: CDCl3 
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1-((2-Chloro-3-phenoxypropyl)sulfonyl)-4-methoxybenzene (15b)  
 
 
NMR-Solvent: CDCl3 
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2-Chloro-3-((4-methoxyphenyl)sulfonyl)propan-1-ol (15b´) 
 
 
NMR-Solvent: CDCl3 
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 (E)-3-((4-Methoxyphenyl)-sulfonyl)prop-2-en-1-ol (16b´) 
 
 
NMR-Solvent: CDCl3  
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 (2-Chloro-3-(phenylsulfonyl)propoxy)benzene (15c)  
 
 
NMR-Solvent: CDCl3 
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2-Chloro-3-(phenylsulfonyl)propan-1-ol (15c´)  
 
 
NMR-Solvent: CDCl3 
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 (E)-3-(Phenylsulfonyl)prop-2-en-1-ol (16c´) 
 
 
NMR-Solvent: CD3CN 
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1-((2-Chloro-3-phenoxypropyl)sulfonyl)-4-(trifluoromethyl)benzene (15d) 
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NMR-Solvent: CDCl3 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
421 
(E)-1-((3-Phenoxyprop-1-en-1-yl)sulfonyl)-4-(trifluoromethyl)benzene (16d)  
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NMR-Solvent: CDCl3 
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(E)-3-((4-(Trifluoromethyl)phenyl)sulfonyl)prop-2-en-1-ol (16d´)  
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NMR-Solvent: CDCl3 
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1-((2-Chloro-3-phenoxypropyl)sulfonyl)-4-nitrobenzene (15e)  
 
 
NMR-Solvent: CDCl3 
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(E)-1-Nitro-4-((3-phenoxyprop-1-en-1-yl)sulfonyl)benzene (16e)  
 
 
NMR-Solvent: CDCl3 
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(E)-3-((4-Nitrophenyl)sulfonyl)prop-2-en-1-ol (16e´)  
 
 
NMR-Solvent: CD3CN 
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rac. Diethyl 3-(chloromethyl)-4-(tosylmethyl)cyclopentane-1,1-dicarboxylate (21)  
 
 
NMR-Solvent: CDCl3 
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5. Chapter E: Copper Mediated Light Promoted Synthesis of 
Allylsulfones  
5.1. Synthesis of Literature Known Compounds and Reagents 
The following compounds were synthesized according to the reported literature procedures. 
The spectral data were in agreement with the data reported: fac-Ir(ppy)33, 3-bromocyclohex-1-
ene (18f)28. 
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5.2. Compound Characterization 
General Procedure for the Formation of Allylsulfones (GP-1): 
 
A Schlenk tube equipped with a magnetic stir bar was charged with sulfonyl chloride derivative 
19 (0.5 mmol, 1.0 equiv), Na2CO3 (5.3 mg, 50 µmol, 0.1 equiv) and [Cu(dap)2]Cl (5.0 µmol, 
1.0 mol%) in anh. MeCN (2.0 mL). The reaction mixture was degassed by three freeze-pump-
thaw cycles and placed under N2-atmosphere. Allyl bromide 18 (3.0 mmol, 6.0 equiv) was 
added and the reaction mixture was irradiated with a green LED (λmax = 530 nm) at room 
temperature. After completion of the reaction (judged by TLC, usually 48 h), the reaction 
mixture was filtered through a short plug of silica, the solvent was evaporated under reduced 
pressure and the residue was purified by flash column chromatography on silica gel to yield 
pure product 46. The results for reactions with fac-Ir(ppy)3 and with no catalyst were obtained 
by crude NMR-analysis after filtration through a short plug of silica. For Ir-catalysis no Na2CO3 
was used. 
1-(Allylsulfonyl)-4-methylbenzene (20a) 
Cu(I)-catalysis: Following general procedure GP-1, using 4-
methylbenzenesulfonyl chloride (19a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) 
(259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 91 mg (464 µmol, 93%) of 1-(allylsulfonyl)-4-methylbenzene (20a) 
as a colorless oil after flash column purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / 
EtOAc) = 0.38. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.71 (d, J = 8.3 Hz, 
2H), 7.35 – 7.28 (m, 2H), 5.75 (ddt, J = 17.5, 10.2, 7.4 Hz, 1H), 5.29 (dq, J = 10.1, 0.9 Hz, 1H), 
5.12 (dq, J = 17.1, 1.2 Hz, 1H), 3.76 (dt, J = 7.4, 1.0 Hz, 2H), 2.41 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 144.8, 135.3, 129.7, 128.5, 124.8, 124.6, 60.9, 21.7. IR (neat): 3030, 2974, 2922, 
1640, 1595, 1495, 1454, 1316, 1241, 1197, 1141, 1085, 1044, 992, 936, 872, 816, 775, 708 
cm-1. HRMS (ESI) m/z calculated for C10H13O2S ([M+H]+) 197.0631, found 197.0630. 
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1-(Allylsulfonyl)-4-methoxybenzene (20b) 
Cu(I)-catalysis: Following general procedure GP-1, using 4-
methoxybenzenesulfonyl chloride (19b) (103 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-
ene (18a) (259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 
1.0 mol%) gave 88 mg (415 µmol, 83%) of 1-(allylsulfonyl)-4-methoxybenzene (20b) as a 
colorless oil after flash column purification (hexanes / EtOAc 9:1 to 3:1). Rf (hexanes / EtOAc 
4:1) = 0.21. Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 8.9 Hz, 
2H), 6.99 (d, J = 8.9 Hz, 2H), 5.78 (ddt, J = 17.5, 10.2, 7.4 Hz, 1H), 5.31 (dq, J = 10.2, 0.9 Hz, 
1H), 5.13 (dq, J = 17.1, 1.2 Hz, 1H), 3.87 (s, 3H), 3.77 (dt, J = 7.4, 1.0 Hz, 2H). 13C NMR 
(101 MHz, CDCl3) δ 163.9, 130.8, 130.0, 125.1, 124.6, 114.3, 61.3, 55.8. IR (neat): 3079, 2974, 
2844, 1640, 1595, 1498, 1461, 1416, 1293, 1260, 1182, 1133, 1088, 1021, 936, 872, 835, 716, 
682 cm-1. HRMS (ESI) m/z calculated for C10H13O3S ([M+H]+) 213.0580, found 213.0583. 
(Allylsulfonyl)benzene (20c) 
Cu(I)-catalysis: Following general procedure GP-1, using benzenesulfonyl 
chloride (19c) (88 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (5.3 mg, 0.1 mmol, 
1.0 equiv), 3-bromoprop-1-ene (18a) (259 µL, 363 mg, 3.0 mmol, 6.0 equiv) 
and [Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) gave 57 mg (313 µmol, 63%) of 
(allylsulfonyl)benzene (20c) as a colorless oil after flash column purification (hexanes / EtOAc 
9:1 to 3:1). Rf (hexanes / EtOAc 4:1) = 0.33. Staining: KMnO4 (UV active). 1H NMR (300 MHz, 
CDCl3) δ 7.90 – 7.83 (m, 2H), 7.68 – 7.60 (m, 1H), 7.59 – 7.49 (m, 2H), 5.78 (ddt, J = 17.5, 
10.2, 7.4 Hz, 1H), 5.32 (dq, J = 10.2, 0.9 Hz, 1H), 5.14 (dq, J = 17.0, 1.2 Hz, 1H), 3.80 (dt, J = 
7.4, 1.1 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 138.4, 133.9, 129.2, 128.6, 124.8, 124.7, 61.0. 
IR (neat): 3064, 2974, 2919, 1640, 1588, 1480, 1446, 1398, 1308, 1241, 1197, 1144, 1085, 
1025, 992, 936, 872, 790, 753, 727, 690 cm-1. HRMS (ESI) m/z calculated 
for C9H11O2S ([M+H]+) 183.0474, found 183.0473. 
1-(Allylsulfonyl)-4-(trifluoromethyl)benzene (20d) 
Cu(I)-catalysis: Following general procedure GP-1, using 4-
(trifluoromethyl)benzenesulfonyl chloride (19d) (122 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene 
(18a) (259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 87 mg (348 µmol, 70%) of 1-(allylsulfonyl)-4-
(trifluoromethyl)benzene (20d) as a colorless oil after flash column purification (hexanes / 
EtOAc 9:1 to 3:1). Rf (hexanes / EtOAc 4:1) = 0.39. Staining: KMnO4 (UV active). 1H NMR 
(400 MHz, CDCl3) δ 8.01 (d, J = 8.2 Hz, 2H), 7.82 (d, J = 8.3 Hz, 2H), 5.79 (ddt, J = 17.4, 10.1, 
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7.4 Hz, 1H), 5.38 – 5.33 (m, 1H), 5.16 (dq, J = 17.0, 1.2 Hz, 1H), 3.84 (dt, J = 7.4, 1.0 Hz, 2H). 
19F NMR (377 MHz, CDCl3) δ -63.75 (s, 3F). 13C NMR (101 MHz, CDCl3) δ 141.8, 135.6 (q, J 
= 33.2 Hz), 129.3, 126.3 (q, J = 3.6 Hz), 125.5, 124.3, 123.2 (q, J = 273.1 Hz), 60.9. IR (neat): 
3109, 2974, 2930, 1402, 1316, 1185, 1129, 1059, 947, 839, 794, 716 cm-1. HRMS (ESI) m/z 
calculated for C10H10F3O2S ([M+H]+) 251.0348, found 251.0355. 
1-(Allylsulfonyl)-4-nitrobenzene (20e) 
Cu(I)-catalysis: Following general procedure GP-1, using 4-
nitrobenzenesulfonyl chloride (19e) (110 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) 
(259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) gave 
78 mg (343 µmol, 69%) of 1-(allylsulfonyl)-4-nitrobenzene (20e) as a colorless oil after flash 
column purification (hexanes / EtOAc 9:1 to 2:1). Rf (hexanes / EtOAc 4:1) = 0.23. Staining: 
KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 8.39 (d, J = 8.8 Hz, 2H), 8.07 (d, J = 8.8 Hz, 
2H), 5.80 (ddt, J = 17.4, 10.2, 7.4 Hz, 1H), 5.37 (dq, J = 10.1, 0.8 Hz, 1H), 5.15 (dq, J = 17.1, 
1.2 Hz, 1H), 3.87 (dt, J = 7.4, 1.0 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 151.0, 143.8, 130.2, 
125.8, 124.4, 124.1, 60.9. IR (neat): 3101, 3038, 2967, 2919, 2870, 1607, 1528, 1424, 1402, 
1349, 1297, 1241, 1200, 1144, 1085, 1006, 951, 876, 828, 790, 727, 682 cm-1. HRMS (ESI) 
m/z calculated for C9H10NO4S ([M+H]+) 228.0325, found 228.0331. 
1-(Allylsulfonyl)-2-methylbenzene (20h) 
Cu(I)-catalysis: Following general procedure GP-1, using 2-
methylbenzenesulfonyl chloride (19h) (72 µL, 95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) (259 µL, 
363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) gave 41 mg 
(209 µmol, 42% (brsm 79%)) of 1-(allylsulfonyl)-2-methylbenzene (20h) as a colorless oil after 
flash column purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc 4:1) = 0.38. 
Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.93 (dd, J = 7.9, 1.5 Hz, 1H), 7.51 
(td, J = 7.5, 1.5 Hz, 1H), 7.39 – 7.30 (m, 2H), 5.85 – 5.67 (m, 1H), 5.30 (dq, J = 10.1, 0.9 Hz, 
1H), 5.17 (dq, J = 17.0, 1.2 Hz, 1H), 3.85 (dt, J = 7.4, 1.1 Hz, 2H), 2.70 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 138.2, 136.6, 133.9, 132.7, 130.9, 126.6, 124.7, 124.6, 60.2, 20.7. IR (neat): 
3064, 3023, 2982, 2926, 1640, 1595, 1569, 1454, 1398, 1312, 1238, 1197, 1148, 1082, 992, 
936, 872, 805, 760, 708, 678 cm-1. HRMS (APCI) m/z calculated for C10H16NO2S ([M+NH4]+) 
214.0896, found 214.0899. 
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1-(Allylsulfonyl)-2,3,4,5,6-pentafluorobenzene (20i) 
Cu(I)-catalysis: Following general procedure GP-1, using 2,3,4,5,6-
pentafluorobenzenesulfonyl chloride (19i) (74 µL, 133 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene 
(18a) (259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 95 mg (349 µmol, 70%) of 1-(allylsulfonyl)-2,3,4,5,6-
pentafluorobenzene (20i) as a colorless oil after flash column purification (hexanes / EtOAc 
9:1 to 4:1). Rf (hexanes / EtOAc 4:1) = 0.50. Staining: KMnO4 (UV active). 1H NMR (300 MHz, 
CDCl3) δ 6.01 – 5.81 (m, 1H), 5.45 (dq, J = 10.1, 0.8 Hz, 1H), 5.32 (dq, J = 17.1, 1.2 Hz, 1H), 
4.04 (ddd, J = 7.4, 1.3, 0.7 Hz, 2H). 19F NMR (282 MHz, CDCl3) δ -135.40 – -135.78 (m, 2F), -
143.14 (tt, J = 20.9, 7.4 Hz, 1F), -158.08 – -158.47 (m, 2F). 13C NMR (75 MHz, CDCl3) δ 148.1 
– 135.5 (m), 126.5, 123.5, 62.3. IR (neat): 2978, 2922, 1640, 1543, 1495, 1398, 1353, 1293, 
1244, 1204, 1148, 1092, 992, 951, 883, 842, 779, 727 cm-1. HRMS (APCI) m/z calculated 
for C9H9F5NO2S ([M+NH4]+) 290.0269, found 290.0271. 
2-(Allylsulfonyl)thiophene (20j) 
Cu(I)-catalysis: Following general procedure GP-1, using thiophene-2-
sulfonyl chloride (19j) (91 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (5.3 mg, 
0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) (259 µL, 363 mg, 3.0 mmol, 
6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) gave 86 mg (457 µmol, 91%) of 2-
(allylsulfonyl)thiophene (20j) as a colorless oil after flash column purification (hexanes / EtOAc 
9:1 to 2:1). Rf (hexanes / EtOAc 4:1) = 0.23. Staining: KMnO4 (UV active). 1H NMR (300 MHz, 
CDCl3) δ 7.71 (dd, J = 5.0, 1.4 Hz, 1H), 7.63 (dd, J = 3.8, 1.4 Hz, 1H), 7.13 (dd, J = 5.0, 3.8 Hz, 
1H), 5.82 (ddt, J = 17.0, 10.1, 7.4 Hz, 1H), 5.36 (dq, J = 10.1, 0.9 Hz, 1H), 5.20 (dq, J = 17.0, 
1.2 Hz, 1H), 3.88 (ddd, J = 7.3, 1.3, 0.8 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 139.1, 134.7, 
134.3, 127.9, 125.1, 124.6, 62.1. IR (neat): 3094, 2974, 2919, 1640, 1506, 1402, 1316, 1226, 
1197, 1137, 1088, 1014, 936, 853, 779, 723, 678 cm-1. HRMS (APCI) m/z calculated 
for C7H12NO2S2 ([M+NH4]+) 206.0304, found 206.0306.  
5-(Allylsulfonyl)-2,3-dichlorothiophene (20k)  
Cu(I)-catalysis: Following general procedure GP-1, using 4,5-
dichlorothiophene-2-sulfonyl chloride (19k) (126 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene 
(18a) (259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 107 mg (416 µmol, 83%) of 5-(allylsulfonyl)-2,3-dichlorothiophene 
(20k) as a colorless oil after flash column purification (hexanes / EtOAc 9:1 to 3:1). Rf (hexanes 
/ EtOAc 4:1) = 0.50. Staining: KMnO4 (UV active). 1H NMR (300 MHz, CDCl3) δ 7.44 (s, 1H), 
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5.84 (ddt, J = 17.0, 10.1, 7.4 Hz, 1H), 5.46 (dq, J = 10.1, 0.9 Hz, 1H), 5.30 (dq, J = 17.0, 1.2 Hz, 
1H), 3.89 (dt, J = 7.4, 1.0 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 135.4, 134.1, 133.6, 126.0, 
125.6, 124.2, 62.0. IR (neat): 3094, 3023, 2974, 2915, 1640, 1513, 1402, 1323, 1241, 1193, 
1133, 1081, 1021, 939, 865, 779, 705 cm-1. HRMS (APCI) m/z calculated 
for C7H10Cl2NO2S2 ([M+NH4]+) 273.9525, found 273.9528. 
3-(Ethylsulfonyl)prop-1-ene (20l)  
Cu(I)-catalysis: Following general procedure GP-1, using ethanesulfonyl 
chloride (19l) (47 µL, 64 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (5.3 mg, 
0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) (259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and 
[Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) gave 47 mg (350 µmol, 70%) of 3-
(ethylsulfonyl)prop-1-ene (20l) as a colorless oil after flash column purification (hexanes / 
EtOAc 9:1 to 1:1). Rf (hexanes / EtOAc 4:1) = 0.10. Staining: KMnO4 (UV inactive). 1H NMR 
(300 MHz, CDCl3) δ 5.95 (ddt, J = 17.0, 10.2, 7.4 Hz, 1H), 5.56 – 5.40 (m, 2H), 3.70 (dq, J = 
7.5, 1.0 Hz, 2H), 2.99 (q, J = 7.5 Hz, 2H), 1.39 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) 
δ 125.3, 124.6, 57.0, 45.7, 6.6. IR (neat): 3090, 2982, 2945, 1640, 1457, 1423, 1308, 1241, 
1126, 1085, 1044, 992, 939, 880, 801, 723, 675 cm-1. HRMS (APCI) m/z calculated 
for C5H14NO2S ([M+NH4]+) 152.0740, found 152.0739. 
1-Methyl-4-((2-methylallyl)sulfonyl)benzene (23c)  
Cu(I)-catalysis: Following general procedure GP-1, using 4-
methylbenzenesulfonyl chloride (19a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromo-2-methylprop-1-ene 
(18c) (302 µL, 405 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 97 mg (461 µmol, 92%) of 1-methyl-4-((2-
methylallyl)sulfonyl)benzene (23c) as a colorless oil after flash column purification (hexanes / 
EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc) = 0.43. Staining: KMnO4 (UV active). 1H NMR 
(400 MHz, CDCl3) δ 7.74 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 5.01 (p, J = 1.5 Hz, 1H), 
4.68 (p, J = 1.0 Hz, 1H), 3.73 (s, 2H), 2.43 (s, 3H), 1.87 – 1.82 (m, 3H). 13C NMR (101 MHz, 
CDCl3) δ 144.7, 135.6, 133.6, 129.7, 128.6, 120.7, 64.6, 22.8, 21.7. IR (neat): 3068, 3031, 
2974, 2915, 1774, 1644, 1595, 1491, 1454, 1308, 1241, 1159, 1126, 1088, 1018, 910, 835, 
809, 783, 708, 686 cm-1. HRMS (ESI) m/z calculated for C11H18NO2S ([M+NH4]+) 228.1053, 
found 228.1056. 
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1-(But-3-en-2-ylsulfonyl)-4-methylbenzene (23d´), (E)-1-(but-2-en-1-ylsulfonyl)-4-
methylbenzene (E-23d) and (Z)-1-(but-2-en-1-ylsulfonyl)-4-methylbenzene (Z-23d)  
Cu(I)-catalysis: 
Following general 
procedure GP-1, 
using 4-methylbenzenesulfonyl chloride (19a) (95 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (5.3 mg, 
0.1 mmol, 1.0 equiv), (E)-1-bromobut-2-ene (18d) (364 µL, 405 mg, 3.0 mmol, 6.0 equiv) and 
[Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) gave 53 mg (250 µmol, 50%) of 1-(but-3-en-2-
ylsulfonyl)-4-methylbenzene (23d´) and a E/Z mixture with 24 mg (114 µmol, 23%) of (E)-1-
(but-2-en-1-ylsulfonyl)-4-methylbenzene (E-23d) and 8 mg (39 µmol, 8%) of (Z)-1-(but-2-en-
1-ylsulfonyl)-4-methylbenzene (Z-23d) as colorless oils after flash column purification 
(hexanes / EtOAc 9:1 to 4:1). Rf (23d´, hexanes / EtOAc 4:1) = 0.42. Staining: KMnO4 (UV 
active). Rf (E-23d, hexanes / EtOAc 4:1) = 0.38. Staining: KMnO4 (UV active). Rf (Z-23d, 
hexanes / EtOAc 4:1) = 0.38. Staining: KMnO4 (UV active). 1H NMR (23d´, 400 MHz, CDCl3) 
δ 7.71 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 5.82 (ddd, J = 17.2, 10.3, 7.8 Hz, 1H), 5.26 
(dt, J = 10.3, 0.9 Hz, 1H), 5.09 (dt, J = 17.2, 1.0 Hz, 1H), 3.74 – 3.64 (m, 1H), 2.44 (s, 3H), 
1.42 (d, J = 7.0 Hz, 3H). 1H NMR (E/Z mixture 23d, 400 MHz, CDCl3) δ 7.75 (Z-isomer, d, J = 
8.3 Hz, 2H), 7.73 (E-isomer d, J = 8.3 Hz, 2H), 7.33 (E/Z-isomer d, J = 8.0 Hz, 2H), 5.87 – 5.76 
(Z-isomer, m, 1H), 5.56 (E-isomer, dqt, J = 14.9, 6.3, 1.0 Hz, 1H), 5.41 (E/Z-isomer, dtq, J = 
12.9, 7.3, 1.6 Hz, 1H), 3.83 (Z-isomer, dt, J = 7.9, 0.9 Hz, 2H), 3.70 (E-isomer, dt, J = 7.3, 
1.1 Hz, 2H), 2.44 (E/Z-isomer, s, 3H), 1.67 (E-isomer, dd, J = 6.2, 1.2 Hz, 3H), 1.36 (Z-isomer, 
dd, J = 7.0, 1.8 Hz, 3H). 13C NMR (23d´, 101 MHz, CDCl3) δ 144.7, 134.0, 131.5, 129.6, 129.5, 
121.8, 64.3, 21.8, 13.2. 13C NMR (E/Z mixture 23d, 101 MHz, CDCl3) δ 144.7 (E-isomer), 144.7 
(Z-isomer), 136.5 (E/Z-isomer), 135.8 (E-isomer), 135.8 (Z-isomer), 133.9 (Z-isomer), 129.8 
(Z-isomer), 129.7 (E-isomer), 128.6 (Z-isomer), 128.6 (E-isomer), 117.3 (E-isomer), 116.5 (Z-
isomer), 60.3 (E-isomer), 55.0 (Z-isomer), 21.8 (E/Z-isomer), 18.3 (E-isomer), 12.9 (Z-isomer). 
IR (23d´, neat): 3064, 3030, 2986, 2937, 2878, 1640, 1595, 1495, 1454, 1312, 1230, 1144, 
1021, 932, 865, 816, 749, 667 cm-1. IR (E/Z-mixture 23d, neat): 3034, 2971, 2922, 1670, 1595, 
1495, 1446, 1402, 1290, 1238, 1170, 1141, 1088, 1044, 965, 932, 869, 816, 727, 686 cm-1. 
HRMS (23d´, ESI) m/z calculated for C11H18NO2S ([M+NH4]+) 228.1053, found 228.1054. 
HRMS (E-23d, ESI) m/z calculated for C11H18NO2S ([M+NH4]+) 228.1053, found 228.1052. 
HRMS (Z-23d, ESI) m/z calculated for C11H18NO2S ([M+NH4]+) 228.1053, found 228.1053. 
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(E/Z)-1-((4-chloro-3-methylbut-2-en-1-yl)sulfonyl)-4-methylbenzene (23e) and (E/Z)-1-((4-
bromo-3-methylbut-2-en-1-yl)sulfonyl)-4-methylbenzene (23e´) 
Cu(I)-catalysis: Following general 
procedure GP-1, using 4-
methylbenzenesulfonyl chloride 
(19a) (95 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 1-bromo-3-
methylbut-2-ene (18e) (365 µL, 447 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 59 mg (195-228 µmol, 39-46%) of an inseparable mixture of (E/Z)-
1-((4-chloro-3-methylbut-2-en-1-yl)sulfonyl)-4-methylbenzene (23e) and (E/Z)-1-((4-bromo-3-
methylbut-2-en-1-yl)sulfonyl)-4-methylbenzene (23e´) as a colorless oil after flash column 
purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc 4:1) = 0.30. Staining: KMnO4 
(UV active). 1H NMR (300 MHz, CDCl3) δ 7.76 – 7.69 (E/Z-isomers, m, 2H), 7.36 – 7.31 (E/Z-
isomers, m, 2H), 5.65 – 5.55 (Z-isomers, m, 1H), 5.44 – 5.35 (E-isomers, m, 1H), 3.88 (Z-
isomers, s, 2H), 3.87 (E-isomers, s, 1H), 3.84 (E-isomers, s, 1H), 3.79 (Z-isomers, d, J = 
8.0 Hz, 2H), 3.74 (E-isomers, s, 2H), 2.44 (E/Z-isomers, s, 3H), 1.84 (E-isomers, d, J = 1.5 Hz, 
3H), 1.47 – 1.43 (Z-isomers, m, 3H). 13C NMR (75 MHz, CDCl3) δ 145.0, 141.6, 135.3, 130.5, 
130.4, 130.0, 129.9, 128.6, 128.6, 116.6, 65.8, 56.2, 39.0, 27.0, 21.8, 16.9, 15.0. IR (neat): 
3060, 3023, 2986, 2937, 1651, 1595, 1491, 1446, 1409, 1286, 1204, 1148, 1085, 1036, 902, 
820, 731, 671 cm-1. HRMS (Cl-Product, APCI) m/z calculated for C12H19ClNO2S ([M+NH4]+) 
276.0820, found 276.0824. HRMS (E-isomer Br-Product, APCI) m/z calculated 
for C12H19BrNO2S ([M+NH4]+) 320.0314, found 320.0320. HRMS (Z-isomer Br-Product, APCI) 
m/z calculated for C12H19BrNO2S ([M+NH4]+) 320.0314, found 320.0317.  
1-((2,3-Dichloropropyl)sulfonyl)-4-methylbenzene (24)  
Cu(I)-catalysis: Following general procedure GP-1, using 4-
methylbenzenesulfonyl chloride (19a) (95 mg, 0.5 mmol, 1.0 equiv), 
Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-chloroprop-1-ene (18a) 
(246 µL, 230 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 
5.0 µmol, 1.0 mol%) gave 17 mg (86 µmol, 17%) of 1-(allylsulfonyl)-4-methylbenzene (20a) 
and 75 mg (282 µmol, 56%) of 1-((2,3-dichloropropyl)sulfonyl)-4-methylbenzene (24) as 
colorless oils after flash column purification (hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc 
9:1) = 0.40. Staining: KMnO4 (UV active). 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.3 Hz, 
2H), 7.38 (d, J = 8.0 Hz, 2H), 4.53 (qd, J = 6.2, 4.6 Hz, 1H), 3.95 (dd, J = 11.9, 4.6 Hz, 1H), 
3.86 – 3.74 (m, 2H), 3.49 (dd, J = 14.7, 6.4 Hz, 1H), 2.46 (s, 3H). 13C NMR (101 MHz, CDCl3) 
δ 145.7, 136.2, 130.3, 128.3, 60.3, 52.8, 47.9, 21.8. IR (neat): 3015, 2978, 2922, 1595, 1495, 
1431, 1394, 1349, 1282, 1238, 1189, 1137, 1036, 977, 924, 861, 813, 708 cm-1. HRMS (APCI) 
m/z calculated for C10H16Cl2NO2S ([M+NH4]+) 284.0273, found 284.0278. 
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Diethyl 2-allylmalonate (40)  
Cu(I)-catalysis: Following general procedure GP-1, using diethyl 2-
bromomalonate (38) (120 mg, 0.5 mmol, 1.0 equiv), Na2CO3 (5.3 mg, 
0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) (259 µL, 363 mg, 3.0 mmol, 
6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) gave 105 mg 
(376 µmol, 75%) of diethyl 2-allyl-2-bromomalonate (39)29  and 11 mg (55 µmol, 11%) of 
diethyl 2-allylmalonate (40) as colorless oils after flash column purification (hexanes / EtOAc 
9:1 to 4:1). 
Ir(III)-catalysis: Following general procedure GP-1, using diethyl 2-bromomalonate (38) 
(120 mg, 0.5 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) (259 µL, 363 mg, 3.0 mmol, 
6.0 equiv) and fac-Ir(ppy)3 (3.3 mg, 5.0 µmol, 1.0 mol%) gave 84 mg (420 µmol, 84%) of 
diethyl 2-allylmalonate (40) as a colorless oil after flash column purification (hexanes / EtOAc 
9:1 to 4:1). The 1H NMR spectra was in accordance with the reported literature30. 1H NMR 
(300 MHz, CDCl3) δ 5.77 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H), 5.18 – 5.01 (m, 2H), 4.19 (qd, J = 
7.2, 1.0 Hz, 4H), 3.41 (t, J = 7.6 Hz, 1H), 2.63 (ddt, J = 7.6, 6.8, 1.3 Hz, 2H), 1.26 (t, J = 7.1 Hz, 
6H). 13C NMR (75 MHz, CDCl3) δ 169.0, 134.2, 117.6, 61.5, 51.8, 33.0, 14.2. 
1-Allyl-4-nitrobenzene (44)  
Cu(I)-catalysis: Following general procedure GP-1, using 4-
nitrobenzenediazonium tetrafluoroborate (43) (119 mg, 0.5 mmol, 
1.0 equiv), Na2CO3 (5.3 mg, 0.1 mmol, 1.0 equiv), 3-bromoprop-1-ene 
(18a) (259 µL, 363 mg, 3.0 mmol, 6.0 equiv) and [Cu(dap)2]Cl (4.4 mg, 5.0 µmol, 1.0 mol%) 
gave 23 mg (141 µmol, 28%) of 1-allyl-4-nitrobenzene (44) as a white solid after flash column 
purification (hexanes / EtOAc 9:1 to 4:1). 
Ir(III)-catalysis: Following general procedure GP-1, using 4-nitrobenzenediazonium 
tetrafluoroborate (43) (119 mg, 0.5 mmol, 1.0 equiv), 3-bromoprop-1-ene (18a) (259 µL, 
363 mg, 3.0 mmol, 6.0 equiv) and fac-Ir(ppy)3 (3.3 mg, 5.0 µmol, 1.0 mol%) gave 36 mg 
(221 µmol, 44%) of 1-allyl-4-nitrobenzene (44) as a white solid after flash column purification 
(hexanes / EtOAc 9:1 to 4:1). Rf (hexanes / EtOAc 4:1) = 0.69. Staining: KMnO4 (UV active). 
The 1H NMR spectra was in accordance with the reported literature31.  1H NMR (300 MHz, 
CDCl3) δ 8.16 (d, J = 8.7 Hz, 2H), 7.35 (dt, J = 8.9, 0.7 Hz, 2H), 5.94 (ddt, J = 16.9, 10.1, 
6.7 Hz, 1H), 5.22 – 5.06 (m, 2H), 3.49 (d, J = 6.7 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 147.9, 
135.6, 129.5, 123.8, 117.6, 40.1. 
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5.3. NMR Spectra 
 1H NMR  first image 
  
13C NMR  second image 
  
19F NMR  third image 
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1-(Allylsulfonyl)-4-methylbenzene (20a)  
 
 
NMR-Solvent: CDCl3 
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1-(Allylsulfonyl)-4-methoxybenzene (20b)  
 
  
NMR-Solvent: CDCl3 
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 (Allylsulfonyl)benzene (20c)  
 
 
NMR-Solvent: CDCl3 
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1-(Allylsulfonyl)-4-(trifluoromethyl)benzene (20d)  
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NMR-Solvent: CDCl3 
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1-(Allylsulfonyl)-4-nitrobenzene (20e)  
 
 
NMR-Solvent: CDCl3 
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1-(Allylsulfonyl)-2-methylbenzene (20h)  
 
 
NMR-Solvent: CDCl3 
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1-(Allylsulfonyl)-2,3,4,5,6-pentafluorobenzene (20i)  
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NMR-Solvent: CDCl3 
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2-(Allylsulfonyl)thiophene (20j)  
 
 
NMR-Solvent: CDCl3 
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5-(Allylsulfonyl)-2,3-dichlorothiophene (20k)  
 
 
NMR-Solvent: CDCl3 
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3-(Ethylsulfonyl)prop-1-ene (20l)  
 
 
NMR-Solvent: CDCl3 
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1-Methyl-4-((2-methylallyl)sulfonyl)benzene (23c)  
 
 
NMR-Solvent: CDCl3 
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1-(But-3-en-2-ylsulfonyl)-4-methylbenzene (23d´)  
  
 
NMR-Solvent: CDCl3 
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(E)-1-(But-2-en-1-ylsulfonyl)-4-methylbenzene (E-23d) and (Z)-1-(But-2-en-1-ylsulfonyl)-
4-methylbenzene (Z-23d)  
 
NMR-Solvent: CDCl3 
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(E/Z)-1-((4-Chloro-3-methylbut-2-en-1-yl)sulfonyl)-4-methylbenzene (23e) and (E/Z)-1-
((4-Bromo-3-methylbut-2-en-1-yl)sulfonyl)-4-methylbenzene (23e´)  
 
 
NMR-Solvent: CDCl3 
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1-((2,3-Dichloropropyl)sulfonyl)-4-methylbenzene (24)  
 
 
NMR-Solvent: CDCl3  
Experimental Part 
456 
Diethyl 2-allylmalonate (40)  
 
 
NMR-Solvent: CDCl3 
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1-Allyl-4-nitrobenzene (44)  
 
 
NMR-Solvent: CDCl3 
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